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 Abstract 
 The introduction of conformational restrictions into biologically active molecules is a 
commonly used strategy in drug design because locking the compound into its favourable binding 
conformation might enhance the potency and the selectivity, improve the pharmacokinetic profile and 
reduce the side effects.  
Polyhydroxylated piperidines, also known as iminosugars, are potent inhibitors of many carbohydrate-
processing enzymes what makes them potential antiviral, anticancer and antidiabetic agents in 
different therapeutic areas as well as in agrochemical science. Among many naturally occurring 
iminosugars, deoxynojirimycin, swainsonine and castanospermine have been used as the starting 
point in the drug development for many years but due to the lack of selectivity or potency only few 
compounds have been progressed beyond the discovery phase.  
The main challenge in the development of the iminosugars as therapeutic agents is to overcome 
promiscuous inhibition by modulating the selectivity and the potency toward given biological target. It 
has already been demonstrated that the use of cyclopropane and cyclopentane as conformational 
restrictions can help and therefore, the development of new synthetic methods for the construction of 
conformationally restricted N-heterocycles is essential for achieving additional diversity. In this thesis, 
the methodologies for merging a piperidine core and other N-heterocycles with cyclopropane and 
cyclopentane rings were explored. 
 In general, the synthesis of cyclopropane-fused piperidine core 4 presented within this thesis 
is based on the OH-directed Simmons-Smith cyclopropanation of corresponding enecarbamate ester 2 
(Scheme 1). The different hydroxylated enecarbamate esters could be prepared through a Pd-
catalyzed methoxycarbonylation of valerolactam-derived enol phosphates. To this end, enantiopure 5-
hydroxy-piperidin-2-one and 4,5-dihydroxy-piperidin-2-one were prepared according to a previously 
developed methodology from commercially available (S)-(+)-γ-hydroxymethyl-γ-butyrolactone and 2-
deoxy-D-ribose, while racemic 5-hydroxy-6-hydroxymethyl-piperidin-2-one was prepared from δ-
valerolactam.   
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Scheme 1. Synthesis of polyhydroxylated cyclopropane-fused piperidine core. 
 The fact that gold(I) catalysis has become a very powerful methodology for the construction of 
5-membered rings, prompted us to explore the tandem gold(I)-catalyzed rearrangement/cyclization 
reactions of piperidine-derived enynyl acetates 6, 9 and 14.  
Among the explored methods, the tandem gold(I)-catalyzed [3,3]-rearrangement/Nazarov reaction of 
piperidine-derived enynyl acetates bearing a C-2 propargylic ester side-chain (6) was the most robust 
and reliable (Scheme 2). To understand the influence of the reaction conditions and substrate 
structural features the whole process was studied in details both experimentally and computationally. 
The scope and the limitations of the reaction were assessed by varying the substituents on the 
propargylic side-chain and on the piperidine ring as well as the N-heterocycle. Since the protected 
hydroxyl groups at C-5 and C-6 in substrate 6 were well tolerated in the gold(I)-catalyzed step, this 
method is then suitable for the synthesis of conformationally restricted iminosugars. 
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Scheme 2. Cyclopenta-fused piperidines 8 via gold(I)-catalyzed [3,3]- 
 rearrangement/Nazarov cyclization. 
 The shift of the propargylic ester side-chain from position C-2 to C-3 of the piperidine ring 
(Scheme 3) influenced the reactivity of intermediate 10 thus giving the corresponding cyclopenta-fused 
product with alternate position of C=O group on the five-membered ring, although in moderate yield.  
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Scheme 3. Gold(I)-catalyzed [3,3]-rearrangement/Nazarov cyclization of enynyl acetate 9.  
Instead, indole-derived enynyl acetates bearing a C-3 propargylic ester side-chain (12) provided 3,4-
dihydro-cyclopenta[b]indol-1-ones (13) in excellent yields (15 examples, up to 84% yield). These 
cyclopenta[b]indoles possess a substitution pattern on the five-membered ring which allows an easy 
entry to the bruceollines and other naural products possessing the cyclopenta[b]indol-1-one nucleus.  
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Scheme 4. Gold(I)-catalyzed [3,3]-rearrangement/Nazarov cyclization of indole-derived enynyl 
acetate 12. 
 Finally, modification of the propargylic moiety (14) allowed us the preparation of cyclopenta-
fused compound with C=O group at the central position of the five membered ring (Scheme 5).  
 N
Ts OAc
Au(I)
14
N
Ts
15
RR
O
 
Scheme 5.  Gold(I)-catalyzed Rautenstrauch rearrangement of enynyl acetate 14. 
 All these pentannulated piperidines will be in future converted into novel polyhydroxylated 
conformationally restricted iminosugars and tested toward the suitable targets.  
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Introduction 
Chapter 1: Conformational Restriction 
 The conformational restriction could be defined as any structural feature of the molecule that 
causes decreased freedom of molecular motion, particularly the rotation around the chemical bonds. 
The introduction of conformational restrictions is a well known and commonly used strategy in modern 
drug design to improve the selectivity and the potency of biologically active molecules, or to improve 
their pharmacokinetic and pharmacodynamic profile. In general, flexible molecules could be rigidified 
by introducing extended network of intramolecular hydrogen bonds or other weak interactions, bulky 
substituents, small rings such as cyclopropane, or by incorporating the flexible part of the molecule 
into a new ring.  
However, this approach should not be oversimplified. When it comes to the thermodynamics of the 
binding, a flexible molecule has to adopt the active conformation in order to bind to the active site of 
the target enzyme or receptor. Adopting the binding conformation results in a decrease in entropy 
which consequently affects the free energy of the binding and thus lower the binding affinity. Assuming 
that the binding interactions are exactly the same, a molecule locked in its active conformation will bind 
to the active site without loss of the entropy.1 
DG = DH – TDS 
DG = - RT ln Ki 
(DG – the free energy of the binding; DH – the energy of the binding interactions; 
DS – the entropy; Ki – the binding affinity) 
  
 The conformation-constrained strategy has been used in drug discovery for many years and 
there are many examples in different research areas.2  
Since the main focus of my research was to develop methodologies for merging cyclopropane and 
cyclopentane with piperidine rings with the potential of being converted into new conformationally 
restricted polyhydroxylated N-heterocycles, next chapter will focus on iminosugars and their 
conformationally restricted analogues.  
 
References 
[1] Gram L. Patrick in An Introduction to Medicinal Chemistry, 4th edition, OXFORD University Press 
2009, Chapter 13, 234 – 237.		 
[2] Z. Fang, Y. Song, P. Zhan, Q. Zhang, X. Liu, Future Med. Chem. 2014, 8, 885 – 901. 
 
 2	
Chapter 2: Polyhydroxylated N-Heterocycles (Iminosugars) 
 Iminosugars, whether of natural or synthetic origin, are small organic molecules that resemble 
monosaccharides; the oxygen atom within the pyranose ring has been replaced by the more basic 
nitrogen atom. Structurally, iminosugars are derivatives of pyrrolidine, piperidine, azepane, 
pyrrolizidine, indolizidine and nortropane (Figure 1). These mono- and bicyclic templates are typically 
substituted by hydroxyls, which makes them polyhydroxylated N-heterocycles, but many other 
functional groups such as carboxylic acids and amides could be present in both natural and synthetic 
analogues.  
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Figure 1. General structures of iminosugars. 
 Historically, iminosugars are known as very potent inhibitors of glycosidases, enzymes 
involved in many biologically important processes, such as intestinal digestion, post-translational 
processing of the sugar chain of glycoproteins and lysosomal catabolism of glycoconjugates.1 Hence, 
they have been used as lead compounds for the development of new therapeutic agents in a wide 
range of diseases such as diabetes, viral infections or lysosomal storage disorders.2  
Among over two hundred of naturally-occurring iminosugars, deoxynojirimycin, swainsonine and 
castanospermine have commonly been used as the lead compounds in the drug development 
process. Although the synthesis of iminosugar derivatives is very challenging because of the polar 
nature, the lack of UV chromophores and stereochemical complexity,3 many compounds have been 
synthesized and tested against many different biological targets but only few of them have been 
progressed to the clinical trials. The main limitation associated with the use of iminosugars is the lack 
of adequate selectivity which results to detrimental side effects for the therapeutic application.   
 Taking into account the amazing diversity of enzymes that could be inhibited by iminosugars 
and scientific tendency and effort to develop the perfect inhibitor for a specific enzyme, huge number 
of compounds have been synthesized and tested during the last 50 years.4 The purpose of the next 
section is just to emphasize the importance of conformational restrictions in the design of novel 
iminosugar analogues.  
 
NOTE: According to the standard rules of carbohydrate nomenclature,5 the term “iminosugar” refers to 
the imino-analogue of glycoside. The anomeric hydroxyl could be replaced either by hydrogen to give 
“iminoalditol” or any other substituent to give “imino-C-glycoside”. Azasugars are the synthetic 
analogues of monosaccharides where the anomeric carbon has been replaced by a nitrogen atom and 
the oxygen by a methylene group. 
Iminosugar Iminoalditol Imino-C-glycoside 1-Azasugar
H
N OH
HO
()n
H
N
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N
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R NHHO
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2.1. Iminosugars as Glycosidase Inhibitors 
 Glycosidases, sometimes also called glycoside hydrolases, are enzymes responsible for the 
hydrolysis of the glycosidic bonds in complex carbohydrates and glycoconjugates. They can be 
classified into families on the basis of substrate specificity (glucosidase, mannosidase, maltase, etc.) 
and the mechanism of bond cleavage (inversion or retention of anomeric configuration).  
In general, the putative mechanism of enzymatic hydrolysis of disaccharide involves the formation of 
an oxycarbocation, cleavage of the glycosidic bond and the charge neutralization.  
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Figure 2. Transition state of enzymatic glycoside hydrolysis and proposed transition state 
mimicry of different iminosugars. 
Iminosugars, as a carbohydrate mimics, simulate the shape and the functionalities of the natural 
substrates in the ground or transition state. Factors that contribute to the transition state character of 
an iminosugar are half-chair conformation, proper relative configuration of hydroxyl groups, geometry 
at anomeric carbon, charge distribution, and the ability to be directionally protonated.6 
In general, the spatial arrangement of the hydroxyl groups is important for the recognition by specific 
glycosidase, whereas the nitrogen atom has an impact on the conformation and electrostatic 
properties of the molecule and hence the strength of the binding. 
 
 
2.2. Conformational Restrictions in Iminosugars 
 The very first iminosugar isolated from natural source was nojirimycin.7 It was a good inhibitor 
of both α- and β-glucosidases, which was not very suprising giving its structural resemblance to the D-
glucose. However, due to the instability of hemiaminal function at neutral pH the use of nojirimycin and 
similar iminosugars is quite limited. 
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Figure 3. D-Glucose in pyranose form and naturally occurring analogues. 
 The removal of the hydroxyl group from the anomeric position via catalytic hydrogenation 
over PtO2 or reduction of nojirimycin with NaBH4 led to the formation of much more stable 1-
 4	
deoxyderivative (iminoalditol) known as 1-deoxynojirimycin.7b The finding of 1-deoxynojirimycin’s 
biological activity as inhibitor of α-glucosidases by Bayer chemists in 19768 triggered an enormous 
interest in imino-analogues of glycosides. Since then, many of the analogues have been synthesized 
but also, due to the improvement of purification techniques and procedures more than 200 analogues 
have been isolated from different plants, bacteria, fungi and marine organisms. 
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Figure 4. 1-Deoxynojirimycin and its N-substituted analogues used in the treatment of type II 
diabetes (Glyset) and type I Gaucher disease (Zavesca). 
 Bicyclic iminosugars have attracted huge attention because of their high and specific 
glycosidase inhibitory activity which has been attributed to their rigid structure. Natural products of this 
class always possess a fused bicyclic system with nitrogen atom in the ring junction (Figure 5). It is 
worth to mention that many synthetic analogues have the bridgehead nitrogen whereas the examples 
where the nitrogen is not in the ring junction are very rare. A development of the methods for the 
pentannulation of piperidines and pyrrolidines would therefore enlarge the diversity of analogues.    
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Figure 5. Naturally occurring bicyclic iminosugars. 
One of the most studied bicyclic iminosugars is castanospermine. It appears almost as a result of 
rational drug design; it is a more potent inhibitor of almond β-glucosidase than 1-deoxynojirimycin and 
it is inactive against yeast α-glucosidase.9 Structurally, castanospermine is a polyhydroxylated 
indolizidine analogue but also it could be seen as an analogue of 1-deoxynojirimycin where a 
conformationally restricted ethylene bridge is inserted between the hydroxymethyl group and the 
nitrogen. Structure – activity studies have shown that the incorporation of second ring forced the 6-
hydroxyl group of deoxynojirimycin to be locked in axial position, this conformation being responsible 
for the observed higher enzyme specificity in comparison with monocyclic 1-deoxynojirimycin (Figure 
6).6a,10 
NHO
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NHHO
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OH
1-Deoxynojirimycin
HO
Castanospermine  
Figure 6. Castanospermine as conformationally restricted 1-deoxynojirimycin. 
 To further improve the potency and the selectivity of castanospermine, all four stereogenic 
centers have been systematically modified by inversion of the configuration, removed or transformed 
into other functional groups but all modifications were found to abolish the biological activity.11 
The fact that the rigidification of flexible 1-deoxynojirimycin influenced the potency and the selectivity 
toward β-glucosidase stimulated the synthesis of conformationally restricted analogues with novel 
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bicyclic cores (Figure 7) such as 5-azacastanospermine (1),12 2-oxacastanospermine (2),13 
perhydrazaazulene (3),14 1-aza-bicyclo[5.3.0]octane (4)15 and tetrahydropyridino-imidazole (5).16  
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Figure 7. Polyhydroxylated N-heterocycles as iminosugar analogues. 
2.2.1. Cyclopropane as Conformational Restriction 
 Jérôme Désiré and Michael Shipman incorporated a cyclopropane as a conformational 
restriction into deoxymannojirimycin.17 The cyclopropane moiety was introduced in highly selective 
Simmons-Smith cyclopropanation of imino glucal 7, prepared from tetra-O-benzyl-D-glucopyranose 6 
in 7 steps (Scheme 6).18  
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Scheme 6. Synthesis of cyclopropane-fused deoxymannojirimycin 9. Reagents and conditions: 
i) 1. Et2Zn, CH2I2, toluene, 2. morpholine; ii) H2, Pd/C, HCl in EtOH. 
To rationalize the stereoselectivity, the authors suggested that imino glucal 7 adopts a half-chair 
conformation in which the substituents at C-4 and C-5 adopt pseudo equatorial orientations. Carbenoid 
addition anti to the OBn substituent at C-3 accounts for the formation of the observed diastereomer. 
The deprotection of nitrogen and hydroxyls afforded conformationally constrained 
deoxymannojirimycin analogue 9 in quantitative yield as its hydrochloride salt. Based on the coupling 
constants of cyclopropane-fused piperidine 8, authors excluded the chair conformation. The biological 
tests revealed that, in comparison with 1-deoxynojirimycin, the introduction of cyclopropane did not 
improve the target inhibitory activity against α-mannosidase.  
 Laroche et al. used cyclopropane ring to conformationally restrain pyrrolidine-derived 
iminosugars 10 and 11, potent α-fucosidase inhibitors (Figure 8).19 They prepared a small library of 
spirocyclopropyl azasugars 12 and evaluated their inhibitory activities.20 Among tested compounds, 
compound 13 showed the best profile. Although weaker, compound 13 was more selective α-L-
fucosidase inhibitor than analogues 10 or 11.   
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Figure 8. Pyrrolidine-derived iminosugars and their spiro-analogues. 
2.2.2. Cyclopentane as Conformational Restriction  
 In 2013, Marta Magdycz and Sławomir Jarosz merged the cyclopentane ring with a piperidine 
which resulted in new unnatural iminosugar derivatives 24 and 25 (Scheme 8). These compounds 
could be considered as castanospermine analogues with the nitrogen atom shifted from the ring 
junction to the 6-membered ring.21  
The key intermediate, highly functionalyzed polyhdroxylated unsaturated aldehyde 19, was obtained in 
a Lewis acid-induced fragmentation of D-gluco-configured allyltin 18.22 A typical procedure for the 
preparation of sugar derived allyltin compounds starts with the conversion of partially protected hexose 
(D-gluco, D-galacto, D-manno) or pentose (D-ribo, D-xylo) into homologated allylic alcohol (Scheme 7). 
The allylic alcohol is then converted into xanthates which undergo the thermal rearrangement into 
thiocarbonates. The thiocarbonate in the last step reacts with tributyltin hydride affording the allyltin 
sugar as a mixture of geometrical isomers, with the (E)-form strongly predominating.23  
Imine formed in acid-catalysed condensation between unsaturated aldehyde 19 and tosylamine 
underwent spontaneously hetero Diels-Alder cyclization giving the cyclopenta-fused piperidine 
derivative 21 in yield of 66 % as a single stereoisomer. 
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19
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BnO
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Ts
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2120  
Scheme 7. Synthesis of cyclopenta-fused piperidine derivative 21. Reagents and conditions: i) 
1. Swern oxidation, 2. Ph3P=CHCO2Me, 3. DIBAL-H; ii) NaH, CS2, MeI; iii) toluene, 110°C, 
2 h; iv) Bu3SnH, toluene, 110°C, 2 h; v) ZnCl2; vi) TsNH2, TsOH. 
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The cis-dihydroxylation of olefin 21 afforded diol 22 as a single stereoisomer in 85 % yield while the 
trans-dihydroxylation of 21 (formic acid/H2O2 then NaOH) afforded the mixture of two stereoisomeric 
diols in a 6 : 1 ratio in favour of 23 (Scheme 8). The deprotection afforded unnatural iminosugars 24 
and 25 respectively.  
i N
TsH
BnO
OBn
H
BnO
OHHO
N
TsH
BnO
OBn
H
BnO
21
N
TsH
BnO
OBn
H
BnO
OHHO
22
23
ii
iii
iii
NH
H
HO
OH
H
HO
OHHO
NH
H
HO
OH
H
HO
OHHO
24
25  
Scheme 8. Dihydroxylation of 21. Reagents and conditions: i) OsO4, NMO, THF/t-BuOH/H2O   
(85 %); ii) 1. HCO2H, H2O2, 2. NaOH in MeOH (55 %); iii) Na/NH3, -78°C, THF.  
In the same paper, the synthesis of azepane analogue 31 was described (Scheme 9). The reaction of 
unsaturated aldehyde 19 with hydroxylamine gave derivative 27 whose formation was rationalized 
through the 1,3-dipolar cycloaddition24 also known as olefin/oxime cyclization. The latter was then 
converted into tricyclic derivative 29 via allylation followed by ring closing metathesis. Osmylation of 29 
under standard catalytic conditions gave diol 30. The cleavage of the O–N bond carried out with an 
excess of metallic zinc and the removal of the benzyl groups with sodium in liquid ammonia provided 
free polyhydroxylated aza-bicyclo[5.3.0]decane 31.  
Conformationally restricted iminosugars 24, 25 and 31 were tested against  α-glucosidase, β-
glucosidase, α-mannosidase and α-fucosidase but they did not show significant inhibitory activity. 
19
i N
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O
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H
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Scheme 9. Synthesis of polyhydroxylated cyclopenta-fused azepane analogue 31. Reagents 
and conditions: i) NH2OH; ii) allylation; iii) RCM; iv) OsO4, NMO, THF/t-BuOH/H2O; v) 1. Zn; 
2. Na/NH3, -78°C, THF.  
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There are some points related to this first synthesis of cyclopenta-fused piperidine and azepane cores 
which should be emphasized. Although not very long, the reaction sequence comprised the use and 
the synthesis of nasty sulphur and tin derivatives. The hydroxyl groups on the 5-membered ring are 
coming from the starting material and therefore their number and the stereochemistry are defined in 
starting sugar. The type of the ring fusion depends on the cyclization reaction; Diels-Alder reaction of 
20 afforded trans cyclopenta-fused piperidine, while 1,3-dipolar cycloaddition of 26 led to the formation 
of cis cyclopenta-fused azepane. Furthermore, the synthesis of derivatives bearing alkyl chain at C-2 
position is not straightforward, whereas reductive amination and alkylation of nitrogen are an easy 
entry to the new derivatives.   
 
 
2.3. Conformational Restrictions in Azasugars 
 Azasugars are the synthetic analogues of monosaccharides where the anomeric carbon has 
been replaced by a nitrogen atom and the oxygen by a methylene group.  
In 1994 Bols et al. designed and prepared isofagomine (32), an isomer of natural product fagomine, as 
a potential transition state-like analogue inhibitor of glycosidase enzymes.25 Isofagomine turned out to 
be very potent inhibitor of β-glycosidase and glycogen phosphorylase (Table 1). 
 
Table 1. Ki values in μM of deoxynojirimycin (DNJ) and isofagomine (32) toward various glycosidases. 
 
Enzyme inhibition IC50 (µM) 
α-glucosidase 
(yeast) 
β-glucosidase 
(almond) 
Isomaltase 
(yeast) 
Glucoamylase 
(a. Awamori) 
α-mannosidase 
(jack bean) 
Glycogen 
phosphorylase 
(pig liver) 
NHHO
HO
OH
OH
DNJ  
25 47 11 9.8 270 55000 
NH
HO
HO
OH
32  
86 0.11 7.2 3.7 770 0.7 
 
Since then, Bols’s group prepared deoxyisofagomine analogues, analogues with other substituents at 
positions 3, 4, 5 and 6,26 analogues bearing nitrogen27 and oxygen28 at position 2, but the inhibitory 
activity was not significantly improved. 
HO
HO
H
N
OH
HO
HO
H
N
OH
NH
OH
OHHO
33 34Isofagomine (32)(boat)  
Figure 9. Isofagomine in proposed binding conformation and its synthetic analogues. 
With the aim of investigating the binding conformation of isofagomine to α-and β-glucosidase, Bols’s 
group opted to conformationally restrict isofagomine into its boat conformations (33 and 34) using 6-
azabicyclo[3.1.0]hexane ring system (Figure 9).29 The compounds 33 and 34 were tested against α- 
and β-glucosidase and since they did not show significant inhibitory activity the conclusion is that 
isofagomine does not bind the investigated glycosidases in the boat conformation. 
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 In addition, Schoenfeld et al.30 prepared conformationally restricted 1-azasugars 35 and 36 as 
mimetics of D-galactose and D-mannose (Figure 10). Both 35 and 36 were tested against yeast  α-
glucosidase, almond β-glucosidase, green coffee bean α-galactosidase, bovine liver β-galactosidase, 
and jack bean α-mannosidase. Despite its resemblance to the galactose, racemic 35 had no effect on 
any of the enzymes while racemic 36 inhibited α-mannosidase only. 
NCH3
OH
HO
HO NCH3
HO
HO
OH
35 36
O
OH
HO
HO
OH
OH
Galactose  
Figure 10. Galactose and its conformationally restricted analogues.  
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Chapter 3: Homogeneous Gold Catalysis: Gold(I)-Catalyzed 
Pentannulation 
 
“While the ancient alchemists investigated the question of how to make gold, 
now the question is what to make with gold”1 
Stephen K. Hashmi 
 
 Gold is a precious metal unaffected by air, moisture and most corrosive reagents. Through 
the centuries the primary use of the gold was making the jewellery and ornamental objects to unveil 
the wealth and power. Due to its chemical resistance and conductivity, from 20th century it has been 
widely used in electronic industry as a thin layer coating for electrical connectors, switches and relay 
contacts, connecting wires and connection strips.  
 In the field of the catalysis, gold was traditionally considered to be catalytically inactive 
because of its inertness in elemental state. Since the beginning of the 1970’s the area of 
heterogeneous gold catalysis has been developing,2 but until 20 years ago only a few chemists dared 
to use gold for the catalysis of organic reactions under homogeneous conditions.3 All changed in 1998 
when Teles et al. of BASF described cationic gold(I) complexes as highly efficient catalysts for the 
addition of alcohols to alkynes.4 Since then the chemists around the world changed their view of gold 
and the number of methodological and mechanistic studies on gold-catalyzed organic reactions has 
been rapidly increasing.  
For example, gold(I) complexes have been proven to efficiently catalyse the cycloisomerization 
reactions of 1,n-enynes, enynes bearing propargylic carboxylates or ethers, addition of N, O, S and C 
nucleophiles to the C-C multiple bonds, hydroarylation reactions, hydrogenation of C-C multiple bonds 
and activation of sp, sp2 and sp3 C-H bonds.1,5 Owing to the mild reaction conditions, high atom 
economy, high functional group tolerance and often increase in molecular complexity, some of these 
recently developed methods have found application in the synthesis of natural products.6  
 Although there are examples of the transformations catalyzed by gold(III) complexes under 
homogenous conditions, this chapter is intended to give only the general aspects of gold(I) catalysis 
without focusing on a particular transformation and a personal selection of gold(I)-catalyzed 
pentannulations.  
 
 
3.1. Gold(I) Catalyst Systems 
 Commonly used gold precatalysts are commercially available as a bench stable LAu(I) 
halides where L is spectator ligand such as phosphine, phosphite, phosphoramidite or NHC-carbene. 
These linear covalent complexes are catalytically inactive and have to be activated (Figure 1). 
P Au
R
R
R Cl P Au
RO
RO
RO Cl P Au
R'2N
RO
RO Cl
Au Cl
N
N
R
R
P Au
R
R
R CH3
Au OH
N
N
R
R
P Au
R
R
R N
O
O  
Figure 1. Gold(I) precatalysts (R = alkyl or aryl; R' = alkyl). 
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The dominant method for the generation of catalytically active cationic gold species [LAu]+ is in situ 
anion metathesis between LAuCl complexes and silver salts whose anion does not coordinate strongly 
to the gold center such as AgSbF6, AgBF4, AgNTf2, AgPF6 or AgOTf. Formed gold species enters 
catalytic cycle by ligand exchange with unsaturated substrate (Scheme 1). 
LAuCl + AgX [LAu]+X- + AgCl
R1 R2
R1 R2
LAu
X-
 
Scheme 1. Formation of catalytically active gold(I) species by an anion exchange between 
gold(I) chloride and silver salt (X = SbF6, BF4, NTf2, PF6 or OTf). 
Although this two component catalytic system is quite easy to handle and many gold and silver salts 
are readily available, it suffers from several limitations. For example, silver salts are poorly soluble in 
organic solvents, light sensitive and highly hydroscopic causing the difficulties during the weighing. 
Due to the high affinity of the silver toward the gold and the chloride, less reactive gold intermediates 
could be formed during the anion metathesis.1 In addition, there is the evidence that silver chloride 
formed as the by-product in anion exchange has an impact on the rate and the selectivity of some 
gold(I)-catalyzed reactions8 and therefore the alternative, silver-free methods for catalyst activation are 
developed.  
For example, the use of AgNTf2 as a source of very weakly coordinating anion enabled the isolation of 
cationic LAuNTf complexes free of silver.9 Copper salts,10 TfOH11 as well as alkali metal salts of 
borates12 have all successfully been used as activating reagents for LAuCl precatalyst.  
A very attractive alternative to anion metathesis is the protonolysis of alkyl gold (LAu-CH3),14 
phthalimide gold (LAu-Pht)15 and gold hydroxide (NHC-Au-OH)16 precatalysts with Brønsted acids 
such as TfOH, MsOH, Tf2NH, HBF4 or H3PW12O40.  
Au
NN
X
P
Au
X
P
Au
O O
O
X
tBu
But
But
tBu
But
tBu
CF3
CF3F3C
P
Au
X
MeO
MeO
PAr2
PAr2
P Au X
P Au X
PAr2
PAr2
O
O
O
O
PAr2
PAr2
 
Figure 2. Commonly used achiral and chiral gold(I) species (for example X = SbF6, OTf, NTf2). 
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 The reactivity and the selectivity of gold could be easily tuned by the choice of the ligand. For 
example, while gold(I) complexes containing phosphine ligands are more electrophilic than those with 
electron-donating N-heterocyclic carbene ligands, complexes bearing phosphite ligands are the most 
electrophilic species. The use of dinuclear gold(I) complexes LAu2Cl2 bearing the chiral diphosphine 
ligands led to the development of efficient asymmetric gold-catalyzed transformations. The effect of an 
aurophilic interaction between gold centres in LAu2X2 on the enantioselectivity remains to be 
elucidated. 
 Although there is no guideline to the optimum choice of the counterion and a certain degree 
of screening is still necessary, the influence of the counterion on the chemoselectivity, regioselectivity 
and stereoselectivity is well documented in literature and has been recently reviewed.17  
O
O
P
O
O Au L
iPr
iPr
Pri
iPr
iPr
Pri  
Figure 3. Chiral counterion used in asymmetric gold-catalysis. 
 Gold-catalyzed reactions could be carried out in a wide range of organic solvents among 
which halogenated solvents (DCM, DCE, CHCl3) and arenes (toluene, benzene) are the most 
abundant.  
 
 
3.2. Gold as a “Soft” Lewis Acid (π-acidity) 
 According to the general definition of Lewis acid, every metal cation and metal cationic 
complex belongs to this category. The species capable to accept the electron density from C-C 
multiple bonds and therefore making them electrophilic are “soft” Lewis acids or π-acids.  
Among the late transition metals, gold(I) is the most effective in electrophilic activation of unsaturated 
systems. This strong π-acidity18 and consequently the observed reactivity are related to strong 
relativistic effect; the contraction of the 6s and 6p orbitals and the expansion of the 5d orbitals.19 While 
the contraction of 6s orbitals results in strong L-AuX bond, expanded d orbitals have diffused character 
that ensures high affinity for the π-systems. 
Calculations on Au(I) – ethylene and Au(I) – ethyne complexes20 indicate that the largest bonding 
contribution has the overlap between the π-system with a gold d orbital of suitable symmetry. Some 
back-donation occurs due to the overlap between filled Au 5d orbitals and lower-energy non-bonding 
p-orbitals of π-system. Thus, the strong electron donation of π-system to the Au(I) and weak back-
bonding from Au(I) into π-system render these complexes electron deficient and prone to the 
nucleophilic addition. 
 
 
3.3. Gold(I) Catalytic Cycle 
In general, all homogeneous gold(I)-catalyzed reactions are initiated by the coordination of C-C 
multiple bonds to the cationic gold centre. As a soft π-acid, gold(I) is not very selective in the 
coordination of the multiple bonds and therefore coordinates to alkynes, allenes, alkenes and arenes 
but the formed π-complexes show significant difference in the reactivity.21,22 In other words, the 
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pronounced alkynophilicity of the gold is not related to the coordination preference for the triple bond 
but to the high reactivity of the formed alkyne-gold complex. Since the alkyne-gold complex is the most 
reactive it is used to describe the general gold(I) catalytic cycle (Figure 4).   
LAu
R1 R2
R1 R2
LAuAu
R2HNu
R1
L
H
R2Nu
R1
NuH
Electrophilic 
activation
Addition of nucleophile
(alkene, amine, alcohol, thiol...)
Protodeauration
 
Figure 4. General mechanism of gold(I)-catalyzed transformations. 
As a very electrophilic species, formed alkyne-gold complex immediately undergoes nucleophilic 
attack in either intra- or intermolecular fashion. In most cases an anti attack takes place resulting in the 
formation of the trans alkenyl-gold intermediate. The experimental evidences and computational 
studies suggest that depending on the type of the gold ligand and the substrate, formed organogold 
intermediate can exist as gold coordinated carbocation or gold stabilized carbene. Depending on the 
exact nature of that gold intermediate, various rearrangements, fragmentations, eliminations or 
additions are possible.  
The final step of the gold(I) catalytic cycle is the protodeauration where gold is replaced by hydrogen 
and thus regenerated. There are many examples in literature where instead of the replacement with 
hydrogen gold is replaced by other electrophiles such as iodine or electrophilic C-atoms.  
 In gold catalyzed reactions either the electrophilic activation or the protodeauration could be 
the rate determining step, and both could be controlled by the choice of the ligand.23 While electron-
poor ligands will accelerate the electrophilic activation, protodeauration will be accelerated by electron-
rich ligands. Furthermore, the additives which are hydrogen bond acceptors such as DMPU, pyridine 
N-oxide and benzotriazole can efficiently promote the protodeauration.24 
 
 
3.4. Gold(I) Deactivation 
 The drawback of many gold-catalyzed reactions is the relatively high catalyst loading or low 
turnover number due to the disproportionation of active gold(I) species. Although cationic complex 
[LAu]+X- is relatively stable in itself, when unsaturated systems are present it decays at fast rates into 
non-reactive Au(0) and [L2Au]+ species.  
The detailed experimental study on the deactivation of cationic gold25 has shown that the choice of the 
ligand and the counterion has an enormous effect on the stability of cationic gold in reaction media. In 
general, the use of electron-rich ligands could enhance the stability of cationic gold. While electron- 
donating ligands could have a detrimental effect on reactivity, ligands containing a o-biphenyl steric 
handle can reduce the decay without influencing the reactivity.  
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Figure 5. Gold(I) catalysts with enhanced stability. 
The turnover number of gold catalyzed reactions could be significantly reduced due to the poisoning of 
the active catalyst by the halides, bases and other high gold affinity impurities present in solvents, 
drying agents and substrates. Kumar et al. demonstrated that the portion of catalyst deactivated in this 
way could be regenerated by suitable acid activator such as TfOH and In(OTf)3.26 
 
 
3.5. Pentannulations Using Alkynes 
3.5.1. Rearrangements of Propargylic Carboxylates and Acetates 
 In general, propargylic esters and acetals are versatile substrates for gold(I) catalysis (Figure 
6). After the electrophilic activation of the alkyne, the carbonyl unit acts as the nucleophile and based 
on the substitution pattern undergoes 1,2- or 1,3-migration through 5-exo-dig or 6-endo-dig cyclization. 
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R2 = H, CO2Me
AuL
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LAu
R2
R1
R2
AuL
R1
OCOCH3
R2 = alkyl, aryl
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O O
R1 R2
AuL
•
R2
OCOCH3H
R1 AuL
O O
R1 R2
AuL
1,2-migration 1,3-migration
 
Figure 6. General pathways in the isomerisation of propargylic acetates. 
When terminal alkynes are used 1,2- migration of the acetate affords vinyl metal species which can 
result in the formation of the “carbenoid” species. In contrast, internal alkynes undergo 1,3-acyloxy 
migration to form allenyl acetate, which can be additionally activated in the presence of the metal 
catalyst. Once formed, the gold vinyl carbenoid species or allene-gold complex can react in inter- or 
intramolecular fashion giving complex skeletons in a step economic way. 
 
Pentannulations triggered by Au(I)-catalyzed 1,2-migration 
 Toste’s group explored the gold(I)-catalyzed isomerisation of indole-derived propargyl acetate 
1 and acetal 4. Propargyl acetate 1 underwent gold(I)-catalyzed Rautenstrauch rearrangement giving 
the cyclopenta[b]indole 3 in good yield but in poor enantioselectivity even when chiral phosphine 
ligands were used because the reaction was under the control of chiral transition state 3 (Scheme 2).  
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Scheme 2. Rautenstrauch rearrangement of indole-derived propargylic acetate 1. Used 
catalysts and ee values: Ph3PAuCl/AgSbF6 (72% yield), [(S)-DTMB-
Segphos](AuCl)2/AgSbF6 (9% ee),  [(S)-DTMB-MeO-biphep(AuCl)2/AgSbF6 38% ee). 
Replacing the acetate by acetal functionality (Scheme 3), the cleavage of the C-O bond in oxonium 
species 5 became rapid and gave planar gold-intermediate 7 whose cyclization was under control of 
the chiral phosphine ligand and allowed the synthesis of cyclopenta[b]indoles in excellent 
enantioselectivities.27  
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Scheme 3. Mechanistic rationale for enantioselective Rautenstrauch rearrangement of indole-
derived propargylic acetal 4.  
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Pentannulations triggered by Au(I)-catalyzed 1,3-migration 
 In 2004, Zhang and Wang demonstrated that electrophilic activation of 1,3-enynes bearing 
propargylic carboxylate (9) triggers 1,3-acyloxy migration and gives pentadienylic cation 10 that 
undergoes Nazarov cyclization (Scheme 4).28 Selective protodeauration of Au-containing 
cyclopentenylic cation led to the formation of acetate 13 which can hydrolyse spontaneously under the 
reaction conditions giving the cyclopentenone 14. Mild reaction conditions, good functional group 
tolerance and excellent control of the double bond position in the cyclopentenone ring render this 
method an attractive approach for the synthesis of pentannulated carbocycles such as 15 and 16.  
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R2 AuL
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1-5% (Ph3P)3AuCl/AgSbF6
wet DCM, rt
in situ
O
Bu
O
BuH
H
54% 84%
R1
R2
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AuL
R3H
H
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10 15 1611 12  
Scheme 4. Tandem Au(I)-catalyzed [3,3]-rearrangement/Nazarov reaction.  
 Malacria’s group showed that in case when the side-chain (R3) bears alkene functionality, the 
cyclopentadienyl gold species 11 (in resonance with gold carbene 12) could undergo an electrophilic 
cyclopropanation giving rise to valuable polycyclic compounds.29 Thus, starting from enynyl acetates 
17, tetracyclic 19 was prepared in one single step, in excellent yield and as a single diastereomer 
(Scheme 5). Furthermore, cycloisomerization of enantioenriched substrates led to the formation of 
enantioenriched products. 
OAc
2% (Ph3P)3AuCl/AgSbF6
DCM, rt
OAc
H H
98%
AuL
OAc
H H
17 18 19  
Scheme 5. Tandem gold(I)-catalyzed [3,3]-rearrangement, Nazarov reaction and electrophilic 
cyclopropanation. 
 In addition, gold(I) was efficient in the synthesis of indenes (Scheme 6).30 Electrophilic 
activation of aryl derived propargylic acetates 20 triggers 1,3-acyloxy migration followed by 
hydroarylation. While the reaction of para-substituted arenes was chemoselective, ortho-substituted 
arenes and tertinary acetates led to the formation of indenes 23 as minor products.   
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Scheme 6. Indene synthesis via tandem [3,3]-rearrangement/hydroarylation. 
3.5.2. Oxidative Reactions of Alkynes  
 In general, alkynes could be oxidized via gold(I)-catalyzed addition of nucleophilic oxygen 
from oxidants such as sulfoxides, pyridine N-oxides, nitrones, as well as nitroso- and nitrobenzenes 
(Scheme 7, Z = S and N).31 The cleavage of Z-O bond gives very electrophilic α-oxo-gold carbene that 
could be trapped in intra- or intermolecular fashion by different nucleophiles. From a general point of 
view the formation of α-oxo-gold carbene is favoured by strongly σ-donating and weakly π-acidic 
ligand in combination with a highly electron-deficient leaving group. 
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Scheme 7. General mechanism of Au(I)-catalyzed alkyne oxidation. DMSO, pyridine N-oxide, 
piperidine-derived nitrone and nitrozobenzene as examples of oxidant species Z+-O-. 
 In 2011, Liu’s group demonstrated that the alkyne substitution influences the oxidation step 
(Scheme 8).32 In case of terminal alkynes the oxidation was favoured at the C-2 alkynyl carbon atom 
(25) while aminoalkynes prefered the oxidation of C-1 carbon atom (26).  
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Scheme 8. Oxidative cyclizations of 1,5-enynes.  
Two years later, the same group showed that α-oxo-carbene intermediate 30 reacts reversibly with 8-
methylquinoline (Z, by-product of alkyne oxidation) to generate adduct 31 (Scheme 9).33 The ylide 
intermediate 32, formed from 31 after dissociation of the gold, undergoes intarmolecular [3+2] 
cycloaddition with electron-deficient alkene affording polycyclic derivative 33. To suppress the 
formation of cyclopropyl indanone as the side-product external 8-methylquinoline was added. 
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Scheme 9. Gold-catalyzed oxidative cycloaddition of 1,5-enynes to quinolone. 
3.5.3. Pentannulations via Dual-Gold Catalysis 
 A new reactivity pattern of Au(I) in which two gold centres synchronously activate a diyne 
system (Scheme 10) was independently described by Zhang34 and Hashmi.35 Initially, one gold(I) 
species coordinates the terminal alkyne forming a gold–acetylide 34 whereas the other acts as π-
Lewis acid activating the disubstituted triple bond. Nucleophilic addition of gold-acetylide to the 
previously activated triple bond in a 5-endo-dig fashion will generate highly reactive gold–vinylidene 36 
which undergoes C(sp3)−H insertion and protodeauration to form tricyclic product 38. 
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Scheme 10. General mechanism for dual-gold-catalyzed cyclization of diyne systems. 
Dual-gold catalyzed cyclization of 3,4-substituted thiophenes 39 resulted therefore in new 
pentaleno[c]thiophene scaffold 40.36 Different alkanes were tolerated in C(sp3)-H insertion leading to 
the tricyclic, tetracyclic or spirocyclic products in moderate to high yields (Scheme 11).  
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Scheme 11. Pentaleno[c]thiophenes prepared via dual-gold-catalysis. 
When sulfonamide or OH groups were present in one alkyne chain of starting dialkyne, gold vinylidene 
36 inserts readily into N-H and O−H leading to the formation of tricyclic pyrrole 42 or furan 44 (Scheme 
12). The choice of the catalyst and the base were crucial for this transformation; BrettPhos ligand in a 
combination with weak base like pyridine N-oxide was superior catalytic system. 
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Scheme 12. Pyrrole and furan derivatives prepared via dual-gold-catalysis. 
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3.5.4. Pentannulations Triggered by Addition of Heteronucleophiles to Alkynes  
Once the alkyne is activated it can undergo addition of O- or N-nucleophile in inter- or 
intramolecular fashion. Trapping the vinyl gold intermediate with an electrophile other than proton 
allows the formation of new bonds and thus increasing the molecular complexity of the product. This 
strategy has often been used for the synthesis of cyclopenta-fused heterocycles.   
For example, indenoindoles 49 were prepared by tandem gold(I)-catalyzed cycloisomerization/Friedel-
Crafts alkylation from 2-aminophenylpropargylic alcohols 45 (Scheme 13).37 The reaction started with 
the intramolecular addition of the N-nucleophile to the Au(I)-activated triple bond in a 5-exo-dig 
manner. The protodeauration of 47 followed by intramolecular Friedel-Crafts alkylation afforded 
indenyl-fused indoles.  
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Scheme 13. Tandem cycloisomerization/Friedel–Crafts alkylation. 
Cyclopenta[b]indoles 53 were prepared from 2-aminophenyl propargylic secondary alcohols 49 via 
Au(I)/Brønsted acid catalyzed sequential one-pot two-step process (Scheme 14).38 Once indoline 50 
was formed, the addition of a Brønsted acid promoted the formation of an indolylmethyl cation which 
was trapped by the 1,3-dicarbonyl compound. The reaction displayed significant tolerance towards 
various alkynols bearing electron-donating and electron-withdrawing aryl groups, heteroaryls and the 
alkyl groups (R1 and R2). Furthermore, alkyl and aryl-bearing 1,3-diketones, 1,3,5-triketones, β-
ketoesters and β-ketoamides were also well tolerated under the reaction conditions. 
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Scheme 14. Au(I)/Brønsted acid catalyzed tandem process. 
In case R2 is alkene, under the acidic conditions indolinole 55 is transformed to pentadienyl cation 
which undergoes Nazarov cyclization (Scheme 15).39 
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Scheme 15. Au(I)/Brønsted acid catalyzed hydroamination/Nazarov cyclization. 
 In 2013, Zi and Toste demonstrated that cyclopentannulated compounds could be obtained in 
carboalkoxylation of alkynes with high enantioselectivity and excellent yields (Scheme 16).40 
Mechanistic studies suggested that coordination of the chiral cationic gold(I) complex L(AuCl)2 to the 
alkyne moiety followed by alkoxylation led to the chiral intermediate 58. Rearrangement to the achiral 
oxocarbenium intermediate 59 enabled the cyclization under the control of the chiral catalyst.  
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Scheme 16. Enantioselective carboalkoxylation of alkynes. 
 
 
3.6. Pentannulations Using Allenes 
 Differently substituted cyclopenta[b]indoles 62 were prepared in good yields via selective 
electrophilic activation of 3-allenylindoles 61 (Scheme 17).41 As for the mechanism, the authors 
suggested intramolecular addition of the indole to the gold-activated allene intermediate followed by 
deprotonative rearomatization and protodeauration. 
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Scheme 17. Au(I)-catalyzed cyclization of 3-allenylindoles.  
In addition, 3-allenylindole bearing terminal allene underwent regioselective Au(I)-catalyzed imino-
Nazarov cyclization giving indole-fused cyclopentenamides 64 (Scheme 18). 
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Scheme 18. Au(I)-catalyzed imino-Nazarov reaction.  
Under the gold(I) catalysis, indole bearing allene side-chain (65) underwent [3+2] cycloaddition 
reaction affording indole-fused tricyclic system 69 with several contiguous stereocenters in an atom-
economical way.43 A plausible mechanism involves the allene activation, nucleophilic atack of indole 
(C3) onto the Au-allene complex and formation of the product through tandem cyclization, hydride 
migration and an elimination process through cationic intermediate 67 and Au-carbene intermediate 68 
(Scheme 19).  
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Scheme 19. Intramolecular Au(I)-catalyzed [3+2] cycloaddition of allene and indole. 
  
 While gold(I)-catalyzed pentannulation of indoles bearing structurally different unsaturated 
side-chains at C-2 or C-3 position is a widely explored research area, the examples of gold(I)-
catalyzed pentannulation of other N-heterocycles are very rare.  
For instance, the cyclic enamides bearing a propargylic or allene moiety at position C-2 or C-3 have 
never been exposed to the gold(I) catalysis and therefore their behaviour is unknown. The fact that 
these substrates would allow an easy entry to cyclopenta-fused N-heterocycles, prompted us to 
explore if and how the presence of the nitrogen atom influence the rate and the regiochemical 
outcome of tandem gold(I)-catalyzed rearrangement/cyclization reactions.  
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Scope of the Work 
 Taking into account the benefits of conformational restrictions in drug development, especially 
when incorporated into promiscuous molecules to improve selectivity, the methodologies for merging 
piperidines and other N-heterocycles with cyclopropane and cyclopentane rings have been explored.  
The synthesis of the cyclopropane-fused piperidine core is based on OH-directed Simmons-Smith 
cyclopropanation of corresponding enecarbamate esters, an approach which has already been used in 
our group to prepare conformationally restricted pipecolic acids. Within this thesis, relying on this 
approach, dihydroxylated piperidine was successfully merged with a cyclopropane ring.  
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Figure 1. Polyhydroxylated cyclopropane-fused piperidine derivatives synthesized within this 
thesis. 
 Another approach toward conformationally restricted piperidines and other N-heterocycles is 
based on merging the heterocyclic core with a cyclopentane and for this purpose we exploited tandem 
gold(I)-catalyzed rearrangement/electrocyclization processes. Suitably assembled piperidine-derived 
enynyl acetates 4-6 undergo gold(I)-catalyzed tandem processes giving rise to pentannulated 
piperidines 7-9.  
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Scheme 1. Synthesis of cyclopenta-fused piperidines via gold(I)-catalyzed tandem 
rearrangement/cyclization processes explored within this thesis.   
In a view of possible application to the synthesis of conformationally restricted polyhydroxylated N-
heterocycles, the gold(I)-catalyzed tandem [3,3]-rearrangemet/Nazarov cyclization of 4 is the most 
general and robust method. In addition, simple and preliminary chemical modifications of 7 (Figure 2), 
such as hydrogenation of double bond, reduction of carbonyl group and α-hydroxylation, were carried 
out in high diastereoselectivity.   
 28	
N
H
H OH
HO
Ts
N
H
H OHTs
N
OTs
OH
10 11 12  
Figure 2. Functionalization of cyclopenta-fused piperidines 7. 
Furthermore, gold(I)-catalyzed pentannulation of N-heterocycles would represent a new synthetic 
approach to cyclopenta-fused piperidines, azepanes and indoles, core structures of many natural 
products. The synthetic potential of this methodology was demonstrated in this thesis by the first total 
synthesis of bruceolline H.  
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Figure 3. Natural compounds containing a cyclopenta-fused N-heterocyclic core.  
 Finally, with the aim to transfer the solution phase synthesis of piperine derivatives to the solid 
support, diazenyl protected δ-valerolactam 14 was synthesized in solution via RuO4 catalyzed 
oxidation of triazene 13. This oxidation, successfully extended to other diazenyl-protected N-
heterocycles (pyrrolidine, azepane), presents a new entry to functionalized lactams.  
N
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N
N 30% RuCl3 H2O
5 eq NaIO4
CCl4/ACN/phosphate buffer
pH = 8, [0.3 M] = 2/2/3
N
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N
N
O
13 14  
Scheme 2. Synthesis of δ-valerolactam via oxidation of diazenyl protected piperidine. 
 29	
Results and Discussion 
Chapter 4: Synthesis of Polyhydroxylated Cyclopropane-Fused 
Piperidines 
The general approach for the synthesis of polyhydroxylated cyclopropane-fused piperidine analogus is 
shown in Scheme 1 and entails the conversion of suitably functionalized enantiopure or racemic 
lactams 4 into the corresponding enecarbamate esters 3 by means of Pd-catalyzed 
methoxycarbonylation of the lactam-derived enol phosphates, followed by the stereoselective, OH-
directed cyclopropanation. To demonstrate the suitability of this approach in the synthesis of 
polyhydroxylated derivatives, enantiopure lactam 7 was transformed into a series of cis-4,5-dihydroxy 
cyclopropane-fused piperidines.  
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Scheme 1. Retrosynthetic analysis for the synthesis of polyhydroxylated cyclopropane-fused 
piperidines.  
Just as a mention, on the basis of this approach 4-hydroxy-substituted cyclopropane pipecolic acid 
methyl ester 51 and all four stereoisomers of 5-hydroxy pipecolic acid derivative 62 have already been 
prepared and used as conformationally restricted templates for linear and cyclic peptidomimetics.3  
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Scheme 2. 4-OH and 5-OH-cyclopropane-fused piperidines as templates for peptidomimetics. 
As we have seen in previous chapters, to affect the selectivity and activity, the conformational 
restriction has to lock an active molecule into its favourable binding conformation. In case of 
iminosugars and their analogus that means the right position and the right orientation of hydroxyls on 
the N-heterocyclic core. Therefore, for the success of the aforementioned approach, the availability of 
polyhydroxylated enantiopure or racemic lactams is of the crucial importance.  
N
H
OH
HO
O
N
H
HO
O
HO
N
H
HO
O
HO
OH
7 8 9  
Scheme 3. Examples of different di- and trihydroxylated δ-valerolactams.4-6  
Taking into account the importance of 6-substituted trans-5-hydroxypiperidin-2-ones 8 as the key 
intermediate in the synthesis of piperidine alkaloids,7 we decided to investigate if the methodology 
applied to the synthesis of both enantiomers of trans-3-hydroxy-pipecolic acid8 combined with the 
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oxidation of N-tosyl protected piperidines 10 and 11 into corresponding lactams 129 and 1310 could 
furnish protected lactam 14.  
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Scheme 4. The oxidation of sulfonamines into sulfonamides as the final step in the synthesis of 
lactam 14. 
 
 
4.1. Syntheses of Hydroxylated Lactams 
Enantiopure cis-4,5-dihydroxy δ-valerolactam 7 was prepared from commercially available 2-deoxy-L-
ribose in 4 steps in overall yield of 36 % according to previously established procedure (Scheme 5).4 
Oxidation of 2-deoxy-L-ribose with Br2 in water for 5 days led to the formation of 2-deoxy-D-
ribonolactone 18 in good yield (75 %) after chromatography. In the next step, the treatment of lactone 
18 with 4-toluenesulfonyl chloride in pyridine at –15 °C and then leaving the reaction mixture at 0 °C 
for 7 h, led to the isolation of corresponding primary O-tosyl derivative 19 in 57 % yield after 
chromatography. Nucleophilic substitution of tosylate with azide was acomplished using NaN3 in 
acetonitrile at reflux for 18 h in 90 % yield. Hydrogenation of obtained azido-L-ribonolactone 20 at 
atmospheric pressure over 10 % Pd/C gave pure dihydroxylated lactam (4R,5S)-7 in 95 % yield.  
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Scheme 5. Synthesis of enantiopure cis-4,5-dihydroxylated lactam 7. Reagents and conditions: 
(a) Br2, H2O, 5 days (75 %); (b) TsCl, pyridine, -15 - 0°C, ~ 7h (57 %); (c) NaN3, 15-crown-5, 
ACN, reflux, ~ 18h (90 %); (d) H2, Pd/C, MeOH, rt, 16h (95 %). 
Starting from commercially available D-pipecolic acid, protected 6-(hydroxymethyl)piperidin-2-one 13 
was prepared in 5 steps in 40 % overall yield (Scheme 6). Thus, conditions for the synthesis of more 
complex analogue 14 were tested and optimized. The final and the key step of the sequence, the 
RuO4-catalyzed oxidation of sulfonamine 11, was achieved in moderate but acceptable yield of 55 %. 
In the past, both enantiomers of 6-(hydroxymethyl)piperidin-2-one bearing different protecting groups 
 31	
have been prepared many times using starting material from the chiral pool,11 but also relying on 
asymmetric transformations of achiral synthons.12       
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Scheme 6. Synthesis of enantiopure protected lactam 13. Reagents and conditions: (a) SOCl2, 
MeOH, 0 °C, 3 h (98 %); (b) TsCl, Et3N, DMAP, DCM, r.t., on (84 %); (c) LiBH4, THF, r.t., on 
 (95 %); (d) TBSCl, imidazole, THF, r.t., on, (97 %); (e) RuO2·nH2O, NaIO4, 
EtOAc/H2O, r.t., on (55 %). 
The protection of δ-valerolactam followed by the transformation into corresponding phosphate and the 
Suzuki coupling with 2-furanyl boronic acid afforded the enesulfonamide 24 (Scheme 7). Surprisingly, 
the product was unstable and it was isolated in only 60 % yield over two consecutive purifications. The 
next step, hydroboration/oxidation carried out with BH3·DMS/NaOH-H2O2 at room temperature, 
provided racemic alcohol 25 in moderate yield (44 %) which was protected as silyl ether. The expected 
trans stereochemistry in 25 was assigned on the basis of coupling constant values for protons at C-2 
and C-3, which appear as broad singlets at δ = 5.17 and 4.24 ppm, respectively, in the 1H NMR 
spectrum because of their equatorial orientation. Consequently, both the furyl and OH groups are 
axially oriented. 
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Scheme 7. Synthesis of lactam 30.  Reagents and conditions: (a) 1. n-BuLi, THF, -78 °C, TsCl 
  (86 %), 2. KHMDS, -78 °C, 1.5 h; then (PhO)2POCl, -78 °C, 1 h (80 %), 3. 
(Ph3P)2PdCl2, 2-furanyl boronic acid, Na2CO3(aq)/THF, 40 °C, 2 h (70 %); (b) 1. (CH3)2S·BH3, 
THF, 25 °C, on, 2. EtOH, H2O2, NaOH, 1 h, reflux (43 %); (c) TBSOTf, DIPEA, DCM, r.t., on 
(93 %); (d) 1. RuO2·nH2O, NaIO4, EtOAc/H2O/ACN, r.t., 25 min, 2. Cs2CO3, MeI, DMF,  
 25 °C, 16 h (68 %); (e) DIBAL-H, THF, 0 °C, 1 h (57 %); (f) TBSCl, imidazole, DCM, 
25 °C, 16 h (83 %); (g) RuO2·nH2O, NaIO4, EtOAc/H2O, 25 °C, 24 h (74 %). 
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In next step, the furyl ring in 26 was oxidized under standard oxidative conditions. The reaction was 
carried out with catalytic amount of RuO2·nH2O using 5 eq of NaIO4 as co-oxidant in EtOAc/H2O 
mixture. The 1H NMR analysis of crude reaction mixture showed desired carboxylic acid in a mixture 
with unidentified impurities. Since all attempts to purify resulting carboxylic acid on silica gel and direct 
reduction to the alcohol 28 failed, the crude carboxylic acid was immediately subjected to esterification 
in DMF using Cs2CO3 and MeI. Methyl ester 27 was reduced to corresponding alcohol 28 which was 
protected as silyl ether (29) in next step. Oxidation of sulfonamine 29, the final step of the synthesis, 
was carried out under previously optimised conditions giving valerolactam 30 in yield of 74%.  
 
 
4.2. Cyclopropanation 
The synthesis of cyclopropane-fused piperidine derivatives described in this section was published as 
a part in “Cyclopropane Pipecolic Acids as Templates for Linear and Cyclic Peptidomimetics. 
Application to the Synthesis of RGD-Containing Peptide as a new Integrin Ligand” in Chem. Eur. J. 
2014, 20, 11187 – 11203. 
 
Enantiopure (4R,5S)-7 was chosen as the model substrate to set up the methodology for the synthesis 
of polyhydroxylated cyclopropane-fused piperidine derivatives.  
First, hydroxy groups were protected as acetonide in 75 % yield (Scheme 8) and then the nitrogen 
atom was protected as benzyl carbamate (83 %). Protected valerolactam 32 was transformed into enol 
phosphate 33 by treatment with potassium bis(trimethylsilyl)amide (KHMDS) at –78 °C in THF followed 
by the addition of diphenylchlorophosphate. Palladium-catalyzed methoxycarbonylation reaction of 
phosphate 33, carried out in anhydrous DMF at 1 atm of CO at 75 °C in the presence of an excess of 
MeOH, led to the formation of enecarbamate ester 34 in 72 % yield over two steps.  
The deprotection of 34 to obtain intermediate 35 had to be performed very carefully, with a strict 
control of both reaction times and acidity to avoid epimerization at C-4 giving epi-35 through the 
formation of the allylic carbocation. The reaction was thus carried out with trifluoroacetic acid (TFA) in 
a mixture with a chloroform and water in 1 : 5 : 0.1 ratio, respectively, and stopped after 10 min, to 
provide a 1 : 1 mixture of 34 and 35. These were separated by chromatography and the 34 subjected 
again to the same reaction conditions. Repeating this sequence three times, compound 35 was 
isolated in the overall yield of 60 %. 
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Scheme 8. Synthesis of 4,5-dihydroxy enecarbamate ester 35. Reagents and conditions: (a) 
pTsOH, MeOH, 55 °C, 3 h (75 %); (b) CbzCl, n-BuLi, -78 °C, THF (83 %); (c) (PhO)2POCl, 
KHMDS, THF, -78 °C; (d) Pd(OAc)2, PPh3, CO, DMF, Et3N, MeOH, 75°C (60 %);  
 (e) CHCl3 : TFA : H2O = 5 : 1 : 0.1, r.t., 10 min (60%).  
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The deprotection of 34 set the stage for the OH-directed cyclopropanation (Scheme 9). Since the 
Simmons–Smith cyclopropanation of similar carbocyclic diols has rarely been reported in literature,13 
the reaction was carried out under the optimized reaction conditions for the cyclopropanation of 
corresponding 4-hydroxy derivative by using Charette’s zinc carbenoid.2 It was anticipated that in this 
process, immediately after the formation of Zn-carbenoid from Et2Zn and CH2I2, 4-OH and/or 5-OH 
groups will coordinate Zn and direct the delivery of the carbenoid onto the double bond in 
stereoselective manner. Reaction was initially carried out at room temperature with an excess amount 
(6 equiv) of Charette’s zinc carbenoid, but it was very slow and reached only 50 % conversion after 16 
h. However, repeating the reaction under reflux conditions conversion was complete in 1 h providing 
the target compound 36 in yield of 59 % after chromatography. Removal of Cbz group by 
hydrogenation over 10 % Pd/C at 1 atm gave conformational restricted cis-4,5-dihydroxylated pipecolic 
acid derivative (37) which could be used, for example as a template for the synthesis of 
peptidomimetics.  
N
OH
HO
CO2Me
Cbz
N
OH
HO
CO2Me
Cbz
NCbz
OH
OMeO2C
ZnI
N
H
OH
HO
CO2Me
a b
35 36 37  
Scheme 9. Simmons-Smith cyclopropanation of 35. Reagents and conditions: (a) TCP, Et2Zn, 
CH2I2, -40 °C, 15 min, then reflux, 1 h (59%); (b) H2, Pd/C, EtOAc (80%). 
The cylopropane-fused diol 36 was benzylated with BnBr/NaH in DMF affording 38 in yield of 74 % 
(Scheme 10). The reduction of the ester group was carried out with Super-H in THF at 0 °C and led to 
the formation of 39 in 92% yield after acidic work-up. After the hydrogenation over 10 % Pd/C at 1 atm 
under slightly acidic conditions, compound 40 was isolated as hydrochloride salt. Since hydroxylated 
derivatives of pipecolic acid are incorporated in biologically active substances,14 the reliable synthesis 
of compounds 36 and 39 could also be of interest for the agro- and pharmaceutical industry.  
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Scheme 10. Reagents and conditions: (a) NaH, BnBr, TBAI, DMF, r.t., 3 h (74 %); (b) Super-H, 
THF, 0 °C, 1.5 h (92 %); (c) H2, Pd/C, HCl, MeOH, r.t., 16 h (92 %). 
Some of very potent glycosidase inhibitors are in form of glycoside15 and therefore 39 was coupled to 
the glucose (Scheme 11). Benzyl protected glucopyranosyl trichloroacetamidate 41 had been chosen 
as a glucosyl donor and the reaction was carried out in diethyl ether at –20 °C in the presence of 
TMSOTf.16,17 Product 42 was obtained in high yield but as a mixture of α/β-anomers in 1:1 ratio. In the 
final step of the synthesis, the protecting groups were removed by hydrogenation over Pd/C under 
slightly acidic conditions and product 43 was purified by DOWEX 50WX8 resin. 
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Scheme 11. Synthesis of glycoside 43. Reagents and conditions: (a) TMSOTf, Et2O, -20 °C, 1 h 
(96 %); (b) H2, HCl, Pd/C, HCl, MeOH, r.t., 16 h (90 %). 
 The herein presented synthesis of polyhydroxylated cyclopropane-fused piperidine 
derivatives 37, 40 and 43 demonstrated that OH-directed cyclopropanation is feasible approach 
toward conformationally restricted iminosugars. In addition, the syntheses of protected 6-
hydroxymethyl-piperidin-2-one 13 and 5-hydroxy-6-hydroxymethyl-piperidin-2-one 30 together with 
previously developed methodology for the synthesis of both cis- and trans-4,5-dihydroxy-piperidin-2-
one (7) offer versatility in the view of the number, position and the orientation of hydroxyls for the future 
syntheses of cyclopropane-fused piperidines as conformationally restricted iminosugar analogues.  
 
 
4.3. Experimental Part 
General Information 
Solvents and reagents were used either as received from commercial suppliers or, when necessary, 
purified using standard laboratory techniques according to methods published in “Purification of 
Laboratory Chemicals” by Perrin, Armarego, and Perrin (Pergamon Press, 1966). All reactions were 
conducted in oven- or flame-dried glassware under an inert atmosphere of dry nitrogen. 
Chromatographic separations were performed under pressure on silica gel by flash-column 
techniques; Rf values refer to TLC carried out on 0.25-mm silica gel plates (Merck F254), with the same 
eluent as indicated for the column chromatography. Melting points were recorded on a Buchi-540 
melting point apparatus and are uncorrected. Optical rotation values were recorded on a Jasco DIP-
370 polarimeter at indicated temperature in the specified solvents and concentrations. 1H NMR and 
13C NMR spectra were recorded at 400 and 100.4 MHz, respectively, in the specified deuterated 
solvent at room temperature. Solvent reference lines were set at 7.26 and 77.00 (CDCl3), 2.05 and 
29.84 (acetone-d6), 3.31 and 49.00 (CD3OD) in 1H and 13C NMR spectra, respectively. Mass spectra 
were carried out by direct inlet of a 20 ppm solution either in CH3OH or CH3OH + 0.1% HCO2H on a 
LCQ FleetTM Ion Trap LC/MS system (Thermo Fisher Scientific) with an electrospray ionization (ESI) 
interface in the positive mode. Microanalyses were carried out with a CHN Thermo FlashEA 1112 
Series elemental analyzer. 
N
H
O
O  
Piperidine-2-carboxylic acid methyl ester hydrochloric salt (21). 
SOCl2 (0.74 mL, 10.16 mmol) was added dropwise to the cooled suspension of D-pipecolic acid (1 g, 
7.74 mmol) in MeOH (7.75 mL) over 10 min. Formed solution was stirred for 20 h. Methanol and the 
excess of SOCl2 were evaporated and obtained yellow solid was suspended in methyl tert-butyl ether 
(10 mL). The solid was collected by filtration and washed with chilled methyl tert-butyl ether (3 x 5 mL). 
The drying under reduced pressure afforded 21 as a white solid (1.35 g, 98 %) with the spectroscopic 
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data identical to those of the racemic compound.18 M.p. = 157.8 – 159.0 °C. [𝛼]$%& = + 7.9 (c = 1.2, 
H2O). 
N O
OTs  
1-(Toluene-4-sulfonyl)-piperidine-2-carboxylic acid methyl ester (22). 
A solution of tosyl chloride (1.7 g, 8.91 mmol) in DCM (10 mL) was added dropwise to the cooled 
solution of 21 (1.33 g, 7.42 mmol), Et3N (4.2 mL, 29.7 mmol) and DMAP (181 mg, 1.48 mmol) in DCM 
(50 mL). The ice bath was removed and reaction mixture was stirred at room temperature for 20 h. 
Saturated NaHCO3 (60 mL) was added and layers were separated. The product was extracted with 
DCM (2 x 30 mL) and organic layer was dried over anhydrous Na2SO4 for 30 min, filtered and 
concentrated. The oily residue was purified by flash chromatography (heptane/EtOAc, 2 : 1, Rf = 0.3) 
to give the product 22 (1.95 g, 84 %) as a colourless oil with the spectroscopic data identical to those 
of the enantiomeric compound.19 	[𝛼]$%(= + 39.5 (c = 0.98, DCM).  
N
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[1-(Toluene-4-sulfonyl)-piperidin-2-yl]-methanol (23). 
To the cooled solution of 22 (1.6 g, 5.38 mmol) in THF (35 mL) LiBH4 (705 mg, 32.3 mmol) was added 
portionwise. The reaction mixture was stirred at room temperature for 48 h. The excess of LiBH4 was 
quenched with MeOH (3 mL). Reaction mixture was neutralized with 2M HCl and the product was 
extracted with EtOAc (3 x 40 mL). Combined organic layer was dried over anhydrous Na2SO4 for 30 
min, filtered and concentrated. The oily residue was purified by flash chromatography (heptane/EtOAc, 
3 : 2, Rf = 0.28) to give the product 23 (1.38 g, 95 %) as a colourless oil with the spectroscopic data 
identical to those of the enantiomeric compound.20 [𝛼]$%) = + 34.3 (c = 1.16, DCM). 
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2-(tert-Butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-sulfonyl)-piperidine (11). 
To the solution of 23 (1.38, 5.12 mmol) in THF (52 mL) imidazole (522 mg, 7.68 mmol) and TBSCl 
(1.16 g, 7.68 mmol) were added at 0 °C. Reaction mixture was stirred at room temperature. After 20 h 
water (50 mL) was added and the product was extracted with EtOAc (3 x 40 mL). Combined organic 
layer was dried over anhydrous Na2SO4 for 30 min, filtered and concentrated. The oily residue was 
purified by flash chromatography (heptane/EtOAc, 5 : 1, Rf = 0.38) to give the product 11 (1.90 g, 97 
%) as a colourless oil. [𝛼]$%( = + 32.2 (c = 0.48, DCM). 1H NMR (400 MHz, CDCl3) δ = 7.72 (d, J = 8.2 
Hz, 2H, Ts), 7.49 (d, J = 8.2 Hz, 2H, Ts), 4.05 – 3.97 (m, 1H, 2-H), 3.80 – 3.69 (m, 2H, 6-H and 2-
CH2OTBS), 3.60 (dd, J = 9.9, 5.4 Hz, 1-H, 2-CH2OTBS), 3.01 (td, J = 13.7, 2.6 Hz, 1H, 6-H), 2.42 (s, 
3H, CH3-Ts), 1.84 (d, J = 13.7 Hz, 1H, 5-H), 1.53 – 1.48 (m, 2H, 4-H), 1.40 – 1.20 (m, 3H, 5-H and 3-
H), 0.86 (s, 9H, CH3-TBS), 0.03 (s, 3H, CH3-TBS), 0.02 (s, 3H, CH3-TBS) ppm. 13C NMR (100.4 MHz, 
CDCl3) δ = 142.6 (s, Ts), 138.6 (s, Ts), 129.3 (d, 2C, Ts), 126.8 (d, 2C, Ts), 61.3 (t, CH2OTBS), 53.0 (d, 
C-2), 41.6 (t, C-6), 25.8 (q, CH3-Ts), 24.4 (t, C-3), 23.9 (t, C-5), 21.3 (t, C-4), 18.4 (q, 3C, CH3-TBS) 
18.7 (s, TBS), 5.5 (q, CH3-TBS), 5.7 (q, CH3-TBS) ppm. MS (ESI) m/z (%): 384 ([M+1]+, 25).21 
Elemental analysis calcd (%) for C19H33NO3SSi: C 59.49; H 8.67; N 3.65; found C 59.61, H 8.62, N 
3.70. 
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6-(tert-Butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-sulfonyl)-piperidin-2-one (13). 
NaIO4 (5.3 g, 24.8 mmol) was dissolved in water (20 mL) and RuO2·nH2O (200 mg, 1.48 mmol) was 
added under nitrogen atmosphere, to the solution which rapidly turned yellow while being stirred. Then 
a solution of 11 (1.90 g, 4.95 mmol) in EtOAc (30 mL) was added and the reaction mixture was stirred 
at room temperature. After 24 h the catalyst was quenched by the addition of i-PrOH (1 mL). Reaction 
mixture was filtered and the two phases were separated. The aqueous layer was extracted with EtOAc 
(2 x 50 mL), and the combined organic layer was dried over sodium sulfate. After filtration and 
evaporation of the solvent the crude was purified by flash chromatography (heptane/EtOAc, 5 : 1, Rf = 
0.36) to give pure 13 (1.06 g, 55 %) as a white wax. [𝛼]$%% = + 41.8 (c = 0.44, DCM). 1H NMR (400 
MHz, CDCl3) δ = 7.90 (d, J = 8.3 Hz, 2H, Ts), 7.28 (d, J = 8.3 Hz, 2H, Ts), 4.66 – 4.55 (m, 1H, 6-H), 
3.88 (dd, J = 10.1, 3.4 Hz, 1H, 6-CH2OTBS), 3.76 (dd, J = 10.1, 7.8 Hz, 1H, 6-CH2OTBS), 2.45 (m, 1H, 
3-H), 2.41 (s, 3H, CH3-Ts), 2.39 – 2.27 (m, 1H, 4-H), 2.25 – 2.18 (m, 1H, 5-H), 2.03 – 1.92 (m, 1H, 3-
H), 1.87 – 1.77 (m, 1H, 5-H), 1.72 – 1.64 (m, 1H, 4-H), 0.84 (s, 9H, CH3-TBS), 0.10 (s, 3H, CH3-TBS), 
0.05 (s, 3H, CH3-TBS) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.1 (s, C2), 144.3 (s, Ts), 136.5 (s, 
Ts), 129.1 (d, 2C, Ts), 128.8 (d, 2C, Ts), 63.9 (t, CH2OTBS), 56.8 (d, C6), 33.6 (t, C3), 25.6 (q, CH3Ts), 
24.9 (t, C4), 21.6 (t, C5), 18.1 (q, TBS), 16.6 (q, 3C, TBS), -5.5 (q, TBS), -5.7 (q, TBS) ppm. MS (ESI) 
m/z (%): 398 ([M+1]+, 100).21 Elemental analysis calcd (%) for C19H31NO4SSi: C 57.39; H 7.86; N 3.52; 
found C 57.36, H 7.84, N 3.56. 
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6-Furan-2-yl-1-(toluene-4-sulfonyl)-1,2,3,4-tetrahydro-pyridine (24). 
An aqueous Na2CO3 (2 M, 100 mL), (Ph3P)2PdCl2 (550 mg, 0.78 mmol) and 2-furanylboronic acid 
(2.63 g, 23.5 mmol) were added to a solution of phosphate22 (7.57 g, 15.6 mmol) in THF (200 mL). The 
mixture was heated at 40 °C for 2 h, then diluted with H2O (100 mL) and the product extracted with 
EtOAc (3 x 100 mL). The combined organic layer was dried with K2CO3. After filtration and evaporation 
of the solvent, crude was purified twice by flash chromatography (heptane/EtOAc, 4 : 1, Rf = 0.26) to 
afford 24 (3.26 g, 70 %) which was not stable and decomposed when neat. 1H NMR (400 MHz, CDCl3) 
δ = 7.66 (d, J = 8.2 Hz, Ts), 7.33 (bs, 1H, 5’-H), 7.27 (d, J = 8.2 Hz, Ts), 6.42 – 6.36 (m, 2H, 3’ and 4’-
H), 5.73 (t, J = 4.0 Hz, 1H, 3-H), 3.64 – 3.61 (m, 2H, 6-H), 2.42 (s, 3H, CH3-Ts), 2.07 – 2.02 (m, 2H, 4-
H), 1.51 – 1.45 (m, 2H, 5-H) ppm. 
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2-Furan-2-yl-1-(toluene-4-sulfonyl)-piperidin-3-ol (25). 
A solution of 2 M (CH3)2S·BH3 in THF (11 mL, 21 mmol) was added to a solution of 24 (3.2 g, 10.5 
mmol) in anhydrous THF (30 mL) at 0 °C under N2 atmosphere. The cooling bath was removed and 
the mixture was stirred at room temperature for 24 h. The reaction was cooled to 0 °C and EtOH (10 
mL), 3M solution of NaOH (9 mL) and H2O2 (35 %, 4 mL) were added. The resulting mixture was 
heated to reflux for 1 h. The solution was transferred into a flask that contained ice and the product 
was extracted with EtOAc (3 x 75 mL). The combined organic extracts were dried with Na2SO4. After 
filtration and evaporation of the solvent, the residue was purified by chromatography (heptane/EtOAc, 
3 : 2, Rf = 0.3) to give 25 (1.45 g, 43 %) as a colourless yellow oil. 1H NMR (400 MHz, CDCl3) δ = 7.62 
(d, J = 8.3 Hz, 2H, Ts), 7.21 – 7.19 (m, 3H, 5’-H and Ts), 6.23 (dd, J = 3.2, 1.8 Hz, 1H, 4’-H), 6.07 (d, J 
 37	
= 3.2 Hz, 1H, 3’-H), 5.17 (bs, 1H, 2-H), 4.24 (bs, 1H, 3-H), 3.75 – 3.66 (m, 1H, 6-H), 3.07 (td, J = 12.7, 
2.8 Hz, 1H, 6-H), 2.39 (s, 3H, CH3-Ts), 2.29 (d, J = 7.5 Hz, 1H, OH), 1.98 – 1.85 (m, 1H, 4-H), 1.83 – 
1.72 (m, 2H, 5-H), 1.53 – 1.44 (m, 1H, 4-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 150.6 (s, C1’), 
143.1 (s, Ts), 142.0 (s, Ts), 136.7 (d, C4’), 129.3 (d, 2C, Ts), 127.3 (d, 2C, Ts), 110.2 (d, C3’), 108.6 (d, 
C2’), 66.6 (d, C3), 57.3 (d, C2), 41.8 (t, C6), 26.3 (t, C5), 21.5 (q, CH3-Ts), 18.7 (C4) ppm. Elemental 
analysis calcd (%) for C16H19NO4S; C 59.79; H 5.96; N 4.36; found C 59.92, H 6.00, N 4.41.  
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3-(tert-Butyl-dimethyl-silanyloxy)-2-furan-2-yl-1-(toluene-4-sulfonyl)-piperidine (26). 
To the solution of 25 (1 g, 3.11 mmol) in DCM (31 mL) DIPEA (1.1 mL, 6.23 mmol) and TBSOTf (1.07 
mL, 4.6 mmol) were added at 0 °C. Reaction mixture was stirred at room temperature. After 20 h water 
(50 mL) was added and the product was extracted with EtOAc (3 x 40 mL). Combined organic layer 
was dried over anhydrous Na2SO4 for 30 min, filtered and concentrated. The oily residue was purified 
by flash chromatography (heptane/EtOAc, 5 : 1, Rf = 0.32) to give the product 26 (1.26 g, 93 %) as a 
colourless oil. 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.2 Hz, 2H, Ts), 7.28 (bs, 1H, 5’-H), 7.26 (d, 
J = 8.2 Hz, Ts), 6.29 (dd, J = 3.2, 1.8 Hz, 1H, 4’-H), 6.22 (d, J = 3.2 Hz, 1H, 3’-H), 5.16 (bs, 1H, 2-H), 
4.32 (d, J = 2.6 Hz, 1H, 3-H), 3.48 – 3.40 (m, 1H, 6-H), 3.17 (td, J = 12.9, 2.8 Hz, 1H, 6-H), 2.40 (s, 
3H, CH3-Ts), 2.01 – 1.85 (m, 1H, 4-H), 1.67 – 1.57 (m, 2H, 5-H), 1.36 – 1.28 (m, 1H, 4-H), 0.94 (s, 9H, 
TBS), 0.15 (s, 3H, TBS), 0.11 (s, 3H, TBS) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 151.8 (s, C1’), 
142.6 (s, Ts), 141.8 (d, C4’), 137.6 (s, Ts), 129.1 (d, 2C, Ts), 127.4 (d, 2C, Ts), 110.1 (d, C3’), 108.0 (d, 
C2’), 66.9 (d, C3), 57.4 (d, C2), 41.7 (t, C6), 27.4 (t, C-5), 25.9 (q, 3C, TBS), 21.5 (q, Ts), 18.5 (t, C-4), 
17.9 (s, TBS), -4.9 (q, 2C, TBS). MS (ESI) m/z (%): 436 ([M+1]+, 100).21 Elemental analysis calcd (%) 
for C22H33NO4SSi; C 60.65; H 7.63; N 3.22; found C 60.70, H 7.65, N 3.30. 
N
Ts
O
OTBS
O  
3-(tert-Butyl-dimethyl-silanyloxy)-1-(toluene-4-sulfonyl)-piperidine-2-carboxylic acid methyl 
ester (27). 
To a solution of NaIO4 (1.55 g, 7.25 mmol) in EtOAc (5 mL)/ACN (13 mL)/H2O (7 mL) cooled to 0 °C, 
RuO2·nH2O (4 mg, 0.03 mmol) was added. The reaction was stirred at 0 °C for 10 min and then a 
solution of 26 (640 mg, 1.45 mmol) in EtOAc (8 mL) was slowly added. After 25 min at room 
temperature, i-PrOH (2 mL) was added and the reaction mixture was filtered through the celite. Water 
was added to the mother liquid and the product was extract with EtOAc (3 x 15 mL). The combined 
organic layers were dried over anhydrous Na2SO4, filtered and evaporated.  
The crude carboxylic acid was dissolved in DMF (5 mL) and Cs2CO3 (260 mg, 0.8 mmol) and MeI (98 
μL, 1.58 mmol) were added. Reaction mixture was left to stir at room temperature and after 72 h water 
(50 mL) was added. The product was extract with Et2O (4 x 10 mL). The combined organic layers were 
dried over anhydrous Na2SO4, filtered and and concentrated. The oily residue was purified by flash 
chromatography (n-hexane/EtOAc, 10 : 1, Rf = 0.26) to give the product 27 (420 g, 68 %) as a yellow 
wax. 1H NMR (400 MHz, CDCl3) δ = 7.79 (d, J = 7.8 Hz, 2H, Ts), 7.25 (d, J = 7.8 Hz, 2H, Ts), 4.60 (d, J 
= 2.9 Hz, 1H, 2-H), 4.36 (dd, J = 6.3, 2.8 Hz, 1H, 3-H), 3.68 (s, 3H, OCH3), 3.48 – 3.41 (m, 1H, 6-H), 
3.21 (td, J = 12.7, 3.1 Hz, 1H, 6-H), 2.41 (s, 3H, CH3-Ts), 1.99 – 1.84 (m, 1H, 5-H), 1.65 (dq, J = 13.6, 
2.8 Hz, 1H, 4-H), 1.51 – 1.43 (m, 1H, 4-H), 1.39 – 1.31 (m, 1H, 5-H), 0.91 (s, 9H, CH3-TBS), 0.13 (s, 
3H, CH3-TBS), 0.10 (s, 3H, CH3-TBS) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.0 (s, CO), 143.1 (s, 
Ts), 137.6 (s, Ts), 129.1 (d, 2C, Ts), 127.5 (d, 2C, Ts), 66.2 (d, C2), 61.8 (d, C3), 52.2 (q, OCH3), 42.6 
(t, C6), 28.3 (t, C5), 25.7 (q, 3C, CH3-TBS), 21.5 (q, CH3-Ts), 18.2 (t, C3), 18.1 (s, TBS), -5.1 (q, 2C, 
CH3-TBS). MS (ESI) m/z (%): 428 ([M+1]+, 43), 450 ([M+Na]+, 16), 876 ([2M+Na]+, 100). Elemental 
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analysis calcd (%) for C20H33NO5SSi; C 56.17; H 7.78; N 3.28; found C 56.21, H 7.80, N 3.28. 
N
Ts
OH
OTBS
 
[3-(tert-Butyl-dimethyl-silanyloxy)-1-(toluene-4-sulfonyl)-piperidin-2-yl]-methanol (28). 
The solution of 27 (403 mg, 0.94 mmol) in dry DCM (13 mL) was cooled by ice bath and 1 M solution 
of DIBAL-H (1.1 mL, 1.1 mmol) was added. Reaction mixture was left to stir on ice bath and after 1 h 
saturated aqueous solution of Rochelle salt (15 mL) was added. The formed two-phase system was 
left to stir for 45 min. The layers were separated and the product was extracted with DCM (3 x 10 mL). 
The combined organic layer was dried over Na2SO4. After filtration and evaporation of the solvent, the 
crude was purified by flash chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.19) affording compound 28 
(215 mg, 57 %) as a colourless oil. 1H NMR (400 MHz, CDCl3): δ = 7.82 (d, J = 8.4 Hz, 2H, Ts), 7.22 
(d, J = 8.4 Hz, 2H, Ts), 3.97 – 3.87 (m, 2H, 2-H and 3-H), 3.85 – 3.75 (m, 1H, CH2OH), 3.70 – 3.60 (m, 
1H, CH2OH), 3.38 (dt, J = 13.0, 3.2 Hz, 1H, 6-H), 3.07 (td, J = 12.8, 3.2 Hz, 1H, 6-H), 2.37 (s, 3H, CH3-
Ts), 2.19 (m, 1H, OH), 1.83 – 1.66 (m, 1H, 4-H), 1.67 – 1.52 (m, 2H, 4-H and 5-H), 1.30 (dt, J = 13.0, 
3.3 Hz, 1H, 5-H), 0.83 (s, 9H, CH3-TBS), 0.01 (s, 3H, CH3-TBS), -0.00 (s, 3H, CH3-TBS) ppm. 13C 
NMR (100.4 MHz, CDCl3) δ = 143.0 (s, Ts), 137.8 (s, Ts), 129.4 (d, 2C, Ts), 127.4 (d, 2C, Ts), 65.4 (d, 
C3), 61.8 (d, C2), 60.7 (t, CH2OH), 41.5 (t, C2), 27.8 (t, C4), 25.8 (q, 3C, CH3-TBS), 21.4 (q, CH3-Ts), 
18.6 (t, C5), 18.2 (s, TBS), -4.92 (q, 2C, CH3-TBS) ppm. MS (ESI) m/z (%): 400 ([M+1]+, 31), 422 
([M+Na]+, 30), 821 ([2M+Na]+, 100). Elemental analysis calcd (%) for C19H33NO4SSi; C 57.11; H 8.32; 
N 3.51; found C 56.99, H 8.27, N 3.49. 
N
Ts
OTBS
OTBS
 
3-(tert-Butyl-dimethyl-silanyloxy)-2-(tert-butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-
sulfonyl)-piperidine (29). 
Compound 29 was prepared from compound 28 (200 mg, 0.5 mmol) following the procedure for the 
synthesis of compound 11. After the flash chromatography (n-hexane/EtOAc, 25 : 1; Rf = 0.20) 
compound 29 (214 mg, 83 %) was obtained as a white solid. M.p. = 88.5 – 90.2 °C. 1H NMR (400 
MHz, CDCl3) δ = 7.84 (d, J = 8.0 Hz, 2H, Ts), 7.23 (d, J = 8.0 Hz, 2H, Ts), 4.22 (dd, J = 5.1, 2.4 Hz, 1H, 
3-H), 4.04 – 3.95 (m, 1H, 2-H), 3.79 – 3.68 (m, 2H, CH2OTBS), 3.46 – 3.35 (m, 1H, 6-H), 3.00 (td, J = 
12.9, 2.8 Hz, 1H, 6-H), 2.39 (s, 3H, CH3-Ts), 1.85 – 1.66 (m, 2H, 4-H and 5-H), 1.66 – 1.57 (m, 1H, 4-
H), 1.27 (m, 1H, 5-H), 0.89 (s, 9H, CH3-TBS), 0.88 (s, 9H, CH3-TBS), 0.07 (s, 3H, CH3-TBS), 0.06 (s, 
6H, CH3-TBS), 0.04 (s, 3H, CH3-TBS) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 142.8 (s, Ts), 138.3 (s, 
Ts), 129.2 (d, 2C, Ts), 127.2 (d, 2C, Ts), 64.5 (d, C3), 62.1 (t, CH2OTBS), 60.2 (d, C2), 41.6 (t, C6), 
26.5 (t, C4), 25.8 (q, 6C, CH3-TBS), 21.4 (q, CH3-Ts), 18.2 (t, C5), 18.1 (s, 2C, TBS), -4.9 (q, CH3-
TBS), -5.0 (q, CH3-TBS), -5.4 (q, CH3-TBS), -5.6 (q, CH3-TBS) ppm. MS (ESI) m/z (%): 514 ([M+1]+, 
58), 536 ([M+Na]+, 29), 1048 ([2M+Na]+, 100). Elemental analysis calcd (%) for C25H47NO4SSi2; C 
58.43; H 9.22; N 2.73; found C 58.45, H 9.20, N 2.75. 
N
Ts
OTBS
OTBS
O
 
5-(tert-Butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-
sulfonyl)-piperidin-2-one (30). 
Compound 30 was prepared from compound 29 (100 mg, 0.19 mmol) following the procedure for the 
synthesis of compound 13. After the flash chromatography (n-hexane/EtOAc, 10 : 1; Rf = 0.18) 
compound 30 (74 mg, 74 %) was obtained as a white solid. M.p. = 158.4 – 155.2 °C. 1H NMR (400 
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MHz, CDCl3) δ = 7.81 (d, J = 8.2 Hz, 2H, Ts), 7.19 (d, J = 8.2 Hz, 2H, Ts), 4.45 – 4.30 (m, 2H, 5-H and 
6-H), 3.94 (dd, J = 10.5, 3.7 Hz, 1H, CH2OTBS), 3.60 (dd, J = 10.5, 8.7 Hz, 1H, CH2OTBS), 2.47 (ddd, 
J = 18.0, 12.0, 7.6 Hz, 1H, 3-H), 2.35 (s, 3H, CH3-Ts), 2.28 (ddd, J = 18.0, 7.3, 1.4 Hz, 1H, 3-H), 2.07 
(dddd, J = 14.1, 12.0, 7.0, 2.2 Hz, 1H, 4-H), 1.74 – 1.62 (m, 1H, 4-H), 0.84 (s, 9H, CH3-TBS), 0.82 (s, 
9H, CH3-TBS), 0.08 (s, 3H, CH3-TBS), 0.06 (s, 3H, CH3-TBS), 0.03 (s, 6H, CH3-TBS) ppm. 13C NMR 
(100.4 MHz, CDCl3) δ = 167.0 (s, CO), 144.3 (s, Ts), 136.5 (s, Ts), 129.0 (d, 2C, Ts), 128.6 (d, 2C, Ts), 
65.0 (d, C6), 64.6 (t, CH2OTBS), 64.0 (d, C5), 28.6 (t, C3), 25.7 (q, 6C, CH3-TBS), 24.3 (t, C4), 21.5 
(q, CH3-Ts), 18.0 (q, 2C, CH3-TBS), -4.5 (q, 2C, CH3-TBS), -5.6 (q, CH3-TBS) ppm. MS (ESI) m/z (%): 
528 ([M+1]+, 33), 1077 ([2M+Na]+, 100). Elemental analysis calcd (%) for C25H45NO5SSi2; C 56.88; H 
8.59; N 2.65; found C 56.95, H 8.52, N 2.70. 
N
O
O
O
Cbz  
(3aR,7aS)-Benzyl 2,2-Dimethyl-6-oxotetrahydro[1,3]dioxolo[4,5-c]-pyridine-5(4H)-carboxylate 
(32). 
A solution of protected lactam 314 (980 mg, 5.75 mmol) in dry THF (58 mL) was cooled to -78 °C and a 
1.6 M solution of n-BuLi (3.6 mL, 5.75 mmol) was slowly added, keeping the temperature below -70 °C 
during the addition. The mixture was stirred for 15 min and then benzyl chloroformate (785 μL, 5.75 
mmol) was added dropwise. After 10 min, the cooling bath was removed and the mixture allowed to 
warm to 0 °C. Saturated NaHCO3 (25 mL) and water (25 mL) were added and the product extracted 
with DCM (4 x 30 mL). The combined organic extracts were dried with Na2SO4, filtered and 
evaporated. After purification by flash chromatography (n-hexane/EtOAc, 1 : 2; Rf = 0.30) pure 32 was 
obtained as a white solid (1.45 g, 83 %). Spectroscopic and analytical data identical to those reported 
for racemic compound.23 M.p. = 115.9 - 117.6 °C. [α]$%+	= −57.0 (c = 0.23, CHCl3). Elemental analysis 
calcd (%) for C16H19NO5; C 62.94, H 6.27, N 4.59; found C 63.10, H 6.41, N 4.49. 
 
N
O
O
CO2Me
Cbz  
5-Benzyl 6-Methyl (3aR,7aS)-2,2-dimethyl-3a,7a-dihydro[1,3]dioxolo[4,5-c]pyridine-5,6(4H)-
dicarboxylate (34). 
A 0.5 M solution of KHMDS in toluene (12.9 mL, 6.43 mmol) was diluted in anhydrous THF (48 mL) 
and cooled to -78 °C. A solution of 32 (1.57 g, 5.15 mmol) in anhydrous THF (16 mL) was added 
dropwise, keeping the temperature below -70 °C. The resulting mixture was stirred for 1.5 h below  
-70 °C and diphenylchlorophosphate (1.34 mL, 6.43 mmol) was slowly added. After 1 h, the mixture 
was allowed to warm to 0 °C. Aqueous 10 % NaOH (130 mL) was slowly added and the product 
extracted with Et2O (4 x 65 mL). The combined organic extracts were washed with 10 % NaOH (120 
mL) and dried over K2CO3 for 30 min. After filtration and evaporation of the solvent, the crude was 
purified over a short pad of silica gel (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.24) affording pure 33 
(2.75 g, 99 %) as a pale yellow oil. The product was used immediately for the next step. Spectroscopic 
and analytical data identical to those reported for racemic compound.23 
A solution of phosphate 33 (2.75 g, 5.11 mmol), Pd(OAc)2 (114.7 mg, 0.511 mmol) and Ph3P (268 mg, 
1.02 mmol) in anhydrous DMF (13 mL) was prepared under nitrogen atmosphere. The reaction mixture 
was flushed and saturated with carbon monoxide. After 10 min Et3N (1.3 mL, 10.22 mmol) and 
anhydrous MeOH (8.3 mL, 204 mmol) were added. The mixture was stirred under CO atmosphere 
(balloon) at 55 °C (external bath) for 3 h. After cooling, water (130 mL) was added and the product 
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extracted with Et2O (5 x 60 mL). The combined organic extracts were dried over Na2SO4. After filtration 
and evaporation of the solvent, crude was purified by flash chromatography (n-hexane/EtOAc, 2 : 1 +  
1 % Et3N; Rf = 0.2) affording pure 34 (1.28 g, 72 % after two steps) as a colourless oil. Spectroscopic 
and analytical data identical to those reported for racemic compound.23 [α]$%+ = +37.2 (c = 0.95, 
CHCl3). Elemental analysis calcd (%) for C18H21NO6; C 62.24, H 6.09, N 4.03; found: C 62.27, H 5.79, 
N 4.26. 
N
OH
HO
CO2Me
Cbz  
(4S,5R)-1-Benzyl 2-Methyl 4,5-Dihydroxy-5,6-dihydropyridine-1,2(4H)-dicarboxylate (35). 
A mixture of trifluoroacetic acid and water (7.15 mL, TFA/H2O, 0.1 : 1) was added to a solution of 
compound 34 (1.23 g, 3.54 mmol) in CHCl3 (32.5 mL). The reaction mixture was left to stir 10 min at 
room temperature and, after cooling to 0 °C, the reaction was quenched adding K2CO3 (7.5 g). After 3 
min a satd. solution of NaHCO3 (65 mL) was slowly added and the layers were separated. The product 
was extracted with CHCl3 (3 x 40 mL) and the combined organic extracts were dried over anhydrous 
K2CO3. After filtration and evaporation of the solvent, the crude was purified by flash chromatography 
(CHCl3/acetone, 3 : 1; Rf = 0.33) affording pure product 35 (430 mg, 40 %) as a colourless gummy oil 
and starting material 34 (462 mg) which was treated again as reported above providing pure product 
35 (148 mg, 36 %) and starting material 34 (143 mg). A further treatment of residual 34 led to total 
yield of 60 %. [α]$%+ +68.2 (c = 0.98, CHCl3). 1H NMR (400 MHz, CDCl3) δ = 7.38 - 7.30 (m, 5 H, Ph), 
5.87 (d, J = 3.6 Hz, 1H, 3-H), 5.15 (s, 2 H, CH2Ph), 4.31 (bm, 1H, 4-H), 3.95 (bm, 1H, 5-H), 3.81 (dd, J 
= 13.1, 2.8 Hz, 1 H, 6-Heq), 3.70 (dd, J = 13.1, 7.8 Hz, 1 H, 6-Hax), 3.57 (s, 3 H, OCH3), 2.57 (d, J = 5.8 
Hz, 1H, OH), 2.42 (d, J = 7.0 Hz, 1H, OH) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 164.7 (s, CO), 154.4 
(NCO2Bn), 135.3 (Carom), 133.3 (C2), 128.5 (2Carom), 128.4 (2Carom), 128.2 (Carom), 120.3 (C3), 68.5 
(CH2Ph), 66.2 (C4), 64.6 (C5), 52.3 (OCH3), 47.3 (C6) ppm. MS (ESI) m/z (%): 638 (100) [2M+Na]+, 
330 (34) [M+Na]+, 308 (15) [M+Na]+. Elemental analysis calcd (%) for C15H17NO6; C 53.63, H 5.58, N 
4.56; found: C 53.23, H 5.32, N 4.02. 
N
OH
HO
CO2Me
Cbz  
2-Benzyl 1-Methyl (1R,4R,5S,6S)-4,5-Dihydroxy-2-azabicyclo[4.1.0]heptane-1,2-dicarboxylate 
(36). 
To a solution of 2,4,6-trichlorophenol (395 mg, 2 mmol) in anhydrous CH2Cl2 (10 mL), cooled to –40 °C 
and under nitrogen atmosphere, 1 M solution of Et2Zn in hexane (2 mL, 2 mmol) was slowly added. 
The mixture was stirred for 15 min, then CH2I2 (160 μL, 6 eq) was added dropwise. After 15 min at  
–40 °C, a solution of 35 (103 mg, 0.33 mmol) in anhydrous DCM (1 mL) was added and the cooling 
bath was removed. The reaction mixture was stirred under reflux for 1 h. The suspension was cooled 
on an ice bath and a 10 % solution of citric acid (8 mL) was added dropwise under vigorous stirring. 
When the solution became clear, the layers were separated. The product was extracted with DCM (4 x 
8 mL). The combined organic layers were washed with a saturated solution of Na2CO3 (2 x 20 mL) and 
dried over Na2SO4. After filtration and evaporation of the solvent, the crude was purified by flash 
chromatography (CHCl3/acetone, 3 : 1; Rf = 0.33) affording compound 36 (55 mg, 53 %) as white 
gummy solid. [α]$%+ =	+27.4 (c = 0.98, CHCl3). 1H NMR (400 MHz, CDCl3) (3:1 mixture of rotamers) δ = 
7.36 – 7.25 (m, 5H, Ph, both rotamers), 5.23 (part A of an AB system, J = 12.8 Hz, 1 H, major rotamer), 
5.17 (AB system, J = 16.8 Hz, 2 H, minor rotamer), 5.08 (part B of an AB system, J = 12.8 Hz, 1H, 
major rotamer), 4.25 (dd, J = 14.2, 4.0 Hz, 1 H, 3-Heq, major rotamer), 4.16 (t, J = 4.2 Hz, 1H, 5-H, 
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minor rotamer), 4.17 – 4.10 (m, 2 H, 3-Heq, minor rotamer and 5-H, major rotamer) 4.01 (t, J = 4.2 Hz, 
1H, 4-H, major rotamer), 3.94 (t, J = 3.7 Hz, 1H, 4-H, minor rotamer), 3.71 (s, 3H, OCH3, minor 
rotamer), 3.55 (s, 3 H, OCH3, major rotamer), 2.96 (dd, J = 14.0, 1.2 Hz, 1H, 3-Hax, minor rotamer), 
2.89 (dd, J = 14.2, 0.8 Hz, 1H, 3-Hax, major rotamer), 1.96–1.86 (m, 2H, 6-H, both rotamers and 7-H, 
minor rotamer), 1.81 (dd, J = 10.2, 4.6 Hz, 1H, 7-H, major rotamer), 1.50 – 1.43 (m, 1H, 7-H', both 
rotamers) ppm. 13C NMR (100.4 MHz, CDCl3) (major rotamer) δ = 172.1 (CO), 157.6 (NCO2Bn), 136.4 
(Carom), 128.4 (2Carom), 127.9 (2Carom), 127.4 (Carom), 67.5 (CH2Ph), 67.3 (C4), 64.7 (C5), 52.3 (OCH3), 
46.6 (C1), 41.2 (C3) 27.9 (C6), 21.7 (C7) ppm. MS (ESI) m/z (%): 662 (100) [2M+Na]+, 344 (31) 
[M+Na]+, 321 (26) [M+Na]+. Elemental analysis calcd (%) for C16H19NO6; C 59.81, H 5.96, N 4.36; 
found C 59.48, H 6.11, N 4.67. 
N
H
OH
HO
CO2Me 
1-Methyl (1R,4R,5S,6S)-4,5-Dihydroxy-2-azabicyclo[4.1.0]heptane-1-carboxylate (37). 
To a solution of 36 (28 mg, 0.087 mmol) in ethyl acetate (2 mL), under nitrogen atmosphere, was 
added 10 % Pd/C (7 mg). The resulting suspension was stirred under an H2 atmosphere (balloon) at 
room temperature for 3 h. After filtration through a Celite pad and evaporation of the solvent, pure 
amino ester 37 (14 mg, 86 %) was obtained as a yellow oil. [α]$+- =	 +72.3 (c = 0.72, CHCl3). 1H NMR 
(400 MHz, CDCl3) δ = 4.10 (dd, J = 7.3, 5.1 Hz, 1H, 5-H), 3.81 (dd, J = 7.3, 3.8 Hz, 1H, 4-H), 3.72 (s, 
3H, OCH3), 2.97 (dd, J = 13.3, 3.8 Hz, 1H, 3-Heq), 2.61 (dd, J = 13.3, 1.2 Hz, 1H, 3-Hax), 2.48 (bs, 3H, 
NH and OH), 1.92 (dt, J = 10.2, 7.4 Hz, 1H, 6-H), 1.55 (dd, J = 10.2, 4.4 Hz, 1H, 7-H), 1.33 (dd, J = 
7.4, 4.4 Hz, 1H, 7-H') ppm. 13C NMR (100.4 MHz, CDCl3) δ = 174.7 (CO), 66.4 (C4), 65.1 (C5), 52.6 
(OCH3), 47.4 (C3), 42.3 (C1), 26.1 (C6), 24.2 (C7) ppm. MS (ESI) m/z (%): 397 (100) [2M+Na]+, 210 
(79) [M+Na]+, 188 (93) [M]+. Elemental analysis calcd (%) for C8H13NO4; C 51.33, N 7.48, H 7.00; 
found C 51.52, N 7.16, H 6.77. 
N
OBn
BnO
CO2Me
Cbz  
4,5-Bis-benzyloxy-2-aza-bicyclo[4.1.0]heptane-1,2-dicarboxylic acid 2-benzyl ester 1-methyl 
ester (38).  
The solution of 36 (170 mg, 0.53 mmol) and TBAI (39 mg, 0.1 mmol) in DMF (4 mL) was cooled to      
0 °C and NaH (63.6 mg, 1.6 mmol) was added. After 30 min, a solution of benzyl bromide (0.19 mL, 
1.6 mmol) in DMF (1 mL) was added. After 4 h, water (50 mL) was added and the product was 
extracted with Et2O (3 x 10 mL). The combined organic layer was dried over Na2SO4. After filtration 
and evaporation of the solvent, the crude was purified by flash chromatography (n-hexane/EtOAc,       
4 : 1; Rf = 0.24) affording compound 38 (195 mg, 80 %) as a colourless oil. [α]$%+	= + 3.62 (c = 0.69, 
CHCl3). 1H NMR (400 MHz, CDCl3) (mixture of rotamers 2 : 1) δ =  7.44 – 7.18 (m, 15H, Ar, both 
rotamers), 5.25 (d, J = 12.6 Hz, 1H, CH2-Cbz, both rotamers), 5.19 – 5.08 (m, 1H, CH2-Cbz, both 
rotamers), 4.73 – 4.40 (m, 4H, CH2-Bn, both rotamers), 4.36 (dd, J = 13.8, 4.8 Hz, 1H, 3-H, major 
rotamer), 4.16 – 4.02 (m, 1H, 3-H, minor rotamer), 3.96 (dd, J = 5.9, 4.1 Hz, 1H, 5-H, minor rotamer), 
3.92 (t, J = 4.6 Hz, 1H, 5-H, major rotamer), 3.78 (t, J = 3.7 Hz, 1H, 4-H, major rotamer), 3.71 (s, 4H, 
OCH3 and 4-H, minor rotamer), 3.55 (s, 3H, OCH3, major rotamer), 2.96 (dd, J = 13.5, 2.1 Hz, 1H, 3-H, 
minor rotamer), 2.79 (d, J = 12.6 Hz, 1H, 3-H, major rotamer), 2.04 – 1.83 (m, 2H, 6-H and 7-H, both 
rotamers), 1.78 – 1.66 (m, 1H, 7-H, both rotamers) ppm. 13C NMR (100.4 MHz, CDCl3) (major rotamer) 
δ = 172.5 (s, CO), 156.9 (s, CO), 137.9 (s, 2C, Ar), 136.8 (s, Ar), 128.8 - 127.3 (d, Ar), 72.2 (d, C4), 
71.4 (d, C5), 71.0 (t, Bn), 70.1 (t, Bn), 67.2 (t, Cbz), 52.3 (q, OCH3), 43.4 (t, C3), 40.4 (s, C1), 26.4 (d, 
C3), 22.3 (t, C7) ppm. MS (ESI) m/z (%): 1024 (100) [2M+Na]+, 524 (15) [M+Na]+, 501 (10) [M+1]+. 
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Elemental analysis calcd (%) for C30H31NO6; C  71.84, N 2.79, H 6.23; found C 72.01, N 2.82, H 6.18. 
N
OBn
BnO
Cbz
OH
 
4,5-Bis-benzyloxy-1-hydroxymethyl-2-aza-bicyclo[4.1.0]heptane-2-carboxylic acid benzyl ester 
(39). 
The the solution of 38 (180 mg, 0.36 mmol) in dry THF (4 mL) was cooled by ice bath and 1 M solution 
of Super-H (0.9 mL, 0.9 mmol) was added. Reaction mixture was left to stir on ice bath and after 1.5 h 
diluted AcOH (5 mL) was added. The product was extracted with DCM (3 x 5 mL). The combined 
organic layers were dried over Na2SO4. After filtration and evaporation of the solvent, the crude was 
purified by flash chromatography (n-hexane/EtOAc, 1 : 1; Rf = 0.16) affording compound 39 (157 mg, 
92 %) as a colourless oil. [α]$%)	= + 15.2 (c = 0.75, CHCl3). 1H NMR (400 MHz, CDCl3) (mixture of 
rotamers 3 : 2) δ = 7.39 – 7.20 (m, 15 H, Ar and Bn), 5.27 (d, J = 12.4 Hz, 1H, CH2-Cbz, minor 
rotamer), 5.17 (d, J = 12.4 Hz, 1H, CH2-Cbz, minor rotamer), 5.13 (d, J = 12.1 Hz, 1H, CH2-Cbz, major 
rotamer), 5.06 (d, J = 12.1 Hz, 1H, CH2-Cbz, major rotamer), 4.70 – 4.45 (m, 3H, CH2-Bn, both 
rotamers), 4.47 – 4.36 (m, 1H, 3-H, both rotamers), 4.19 – 4.06 (m, 2H, 5-H, major rotamer, CH2-Bn, 
both rotamers), 4.01 – 3.88 (m, 2H), 3.84 (d, J = 11.5 Hz, 1H, 1-CH2OH, both rotamers), 3.77 (t, J = 
4.2 Hz, 1H, 5-minor rotamer), 3.69 (t, J = 4.1 Hz, 1H, 4-H, major rotamer), 3.52 (d, J = 11.5 Hz, 1H, 1-
CH2OH, both rotamers), 3.12 (d, J = 11.0 Hz, 1H, 4-H, minor), 2.76 (d, J = 13.8 Hz, 1H, 3-H, major 
rotamer), 2.69 (d, J = 13.8 Hz, 1H, 3-H, minor rotamer), 1.58 – 1.47 (m, 1H, 7-H, both rotamers), 1.43 
– 1.28 (m, 2H, 7-H and 6-H, both rotamers) ppm. 13C NMR (100.4 MHz, CDCl3) (major rotamer) δ = 
158.9 (s, CO), 138.1 (s, Ar), 135.9 (s, Ar), 128.5 - 126.9 (d, Ar), 72.2 (d, C5), 71.9 (d, C4), 71.4 (t, Bn), 
69.7 (t, Bn), 67.8 (t, CBz), 67.3 (s, C1), 44.6 (t, C3), 21.9 (d, C6), 17.1 (t, C7) ppm. MS (ESI) m/z (%): 
968 (100) [2M+Na]+, 469 (20) [M+Na]+, 474 (8) [M+1]+. Elemental analysis calcd (%) for C29H31NO5; C  
73.55, N 2.96, H 6.60; found C 73.70, N 2.99, H 6.52. 
N
H
OH
HO
x HCl
OH
 
1-Hydroxymethyl-2-aza-bicyclo[4.1.0]heptane-4,5-diol (40). 
Prepared as reported for 37 starting from 39 (48 mg, 0.1 mmol). Reaction carried out under slightly 
acidic conditions. After drying under reduced pressure pure 40 (18 mg, 92 %) was obtained as a 
gummy white solid. [α]$%&	= -19.4 (c = 0.59, CH3OH). 1H NMR (400 MHz, CD3OD) δ =  4.19 – 4.09 (m, 
1H, 5-H), 4.07 – 3.94 (m, 1H, 4-H), 3.68 (d, J = 12.3 Hz, 1H, 1-CH2OH), 3.55 (d, J = 12.3 Hz, 1H, 1-
CH2OH), 3.16 (dd, J = 12.3, 4.8 Hz, 1H, 3-H), 2.97 (d, J = 12.3 Hz, 1H, 3-H), 1.67 (t, J = 6.5 Hz, 1H, 7-
H), 1.49 (m, 1H, 6-H), 0.96 (dd, J = 9.8, 6.5 Hz, 1H, 7-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 64.9 
(s, C1), 64.2 (d, C4), 62.8 (d, C5), 45.9 (t, C3), 43.5 (t, CH2OH), 19.9 (d, C6), 12.3 (t, C7) ppm. MS 
(ESI) m/z (%): 160 (100) [M+1]+. Elemental analysis calcd for C7H14NO3Cl; C 42.97, N 7.16, H 7.21; 
found C 43.02, N 7.05, H 7.23. 
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N
OBn
BnO
Cbz O O
OBn
OBnBnO
OBn  
4,5-Bis-benzyloxy-1-(3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxymethyl)-
2-aza-bicyclo[4.1.0]heptane-2-carboxylic acid benzyl ester (42). 
A solution of 39 (51 mg, 0.109 mmol) and benzyl protected glucopyranosyl trichloroacetamidate (126 
mg, 0.185 mmol) in dry Et2O (2.5 mL) was cooled to -20 °C and catalytic amount of TMSOTf was 
added. After 1 h reaction was warmed to room temperature, diluted with Et2O (10 mL) and washed 
with sat. Na2CO3. The organic layer was dried over Na2SO4. After filtration and evaporation of the 
solvent, the crude was purified by flash chromatography (n-hexane/Et2O, 1 : 1; Rf = 0.18) affording 
compound 42 (104 mg, 95%) as a colourless oil. Compound 42 was obtained as a mixture of α/β 
anomers in 1 : 1 ratio. MS (ESI) m/z (%): 1018 (100) [M+Na]+, 996 (9) [M+1]+. Elemental analysis 
calcd (%) for C63H65NO10Cl; C 75.96, N 1.41, H 6.58; found C 76.29, N 1.32, H 6.29. 
N
H
OH
HO
O O
OH
OHHO
OH                 
2-(4,5-Dihydroxy-2-aza-bicyclo[4.1.0]hept-1-ylmethoxy)-6-hydroxymethyl-tetrahydro-pyran-
3,4,5-triol (43). 
Prepared as reported for 37 starting from 42 (117 mg, 0.12 mmol). After the purification on DOWEX 
50WX8 resin, pure 43 (34 mg, 88 %) was obtained as a colourless oil. Compound 43 was obtained as 
a mixture of α and β anomers in 1 : 1 ratio. 1H NMR (400 MHz, CDCl3) δ = 4.79 (d, J = 6.6 Hz, 1H, 1’-
H), 4.34 (d, J = 7.9 Hz, 1H, 1’-H), 4.15 – 4.03 (m, 1H, 5-H), 3.83 – 3.50 (m, 7H, 4-H, 3-H, 1-CH2-O-
sugar and 5’-CH2OH), 3.45 – 3.13 (m, 4H, 2’-H, 3’-H, 4’-H and 5’-H), 1.15 (tt, J = 10.2, 6.5 Hz, 1H, 6-
H), 1.07 – 0.98 (m, 1H, 7-H), 0.73 (dt, J = 10.2, 5.2 Hz, 1H,7-H) ppm. 
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Chapter 5: Synthesis of Cyclopentane-Fused Piperidines 
5.1. General Approach 
A complementary approach toward conformationally restricted piperidines and other N-heterocycles is 
based on merging the heterocyclic core with a cyclopentane ring. The fact that many traditionally used 
strategies for the assemblage of cyclopenta-fused heterocyclic motifs like the Lewis acid catalyzed 
Nazarov reaction, the Pauson-Khand reaction, the ring-closing metathesis or the [3+2] cycloadditions 
often suffer from the lack of availability of the starting materials, harsh reaction conditions, multi-step 
synthetic sequence, low selectivity and/or troublesome purification,1 prompted us to explore gold(I) 
catalysis. Relying on the fact that electrophilic activation of suitably assembled enynyl esters triggers 
ester migration to form pentadienyl cations, which after electrocyclization, protodeauration and 
eventual hydrolysis provide cyclopentenones (see Chapter 3), we assumed that the same approach 
would furnish pentannulated piperidines and other N-heterocycles.  
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Scheme 1. Gold(I)-catalyzed synthesis of cyclopentenones. 
However, a few issues have to be addressed. First of all, the presence of the nitrogen atom could 
influence the stability of positively charged intermediates and therefore their reactivity. Since the gold(I) 
activates the triple bond toward nucleophilic addition, nitrogen atom has to be protected. Taking into 
account that closely related N-Boc enynes undergo gold(I)-catalyzed rearrangement to form cyclic 
urethane,2 the choice of the nitrogen protecting group could be of crucial importance. Further question 
arises about the influence of gold(I) on the torquoselectivity in ring closing step. Finally, to declare a 
tandem gold(I)-catalyzed rearrangement/electrocylization process a useful strategy for the 
pentannulation of N-heterocycles, both the reaction sequence for the synthesis of corresponding 
enynyl acetate and the tandem process have to be general, robust and scalable.   
N
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N
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9  
Figure 1. Piperidine-derived enynyl acetates. 
To this end, the piperidine-derived enynyl acetates 7aa-9 (Figure 1) were prepared as a model 
substrates and subjected to the gold(I) catalysis. The detailed experimental studies supported by DFT 
calculations demonstrated that these processes are more complex than that previously reported for 
non-heterocyclic systems, with a whole series of elements influencing the reaction outcome.  
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5.2. Gold(I)-Catalyzed Tandem [3,3]-Rearrangement/Nazarov Reaction 
of N-Heterocycles Bearing Propargyl Moiety at C-2 
The work described in this section was published as “Annulated N-Heterocycles by Tandem Gold(I)-
catalyzed [3,3]-Rearrangement/Nazarov Reaction of Propargylic Ester Derivatives: an Experimental 
and Computational Study” in Eur. J. Org. Chem. 2015, 18, 3943 – 3956.    
 
5.2.1. Preliminary Results and Optimisation of Reaction Conditions  
In order to avoid any possible interference by a N-alkoxycarbonyl group, the optimisation of the 
reaction conditions for the sequential [3,3]-rearrangement/Nazarov cyclization was carried out with 
model compound 7aa, bearing a N-Ts protecting group. The synthesis of this model compound was 
carried out by converting the N-Ts δ-valerolactam (11aa) into the corresponding enol phosphate 12aa 
which was immediately subjected to the Sonogashira coupling2a with 1-heptyn-3-ol to give alcohol 
13aa in 62 % after chromatography. In next step alcohol 13aa was treated with acetic anhydride to 
provide acetate 7aa in 79 % yield (Scheme 2). 
N
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a b
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N
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Scheme 2. Synthesis of model substrate 7aa. Reagents and conditions: (a) n-BuLi, THF, -78 °C, 
30 min; then TsCl (86 %), (b) KHMDS, -78 °C, 1.5 h; then (PhO)2POCl, -78 °C, 1 h (80 %); 
(c) heptyn-3-ol, 15 mol % CuI, 6 mol % (Ph3P)2PdCl2, CHCl3-Et3N, 1 : 2, 55 °C, 7 h (62 %); 
(d) Ac2O, Et3N, DMAP, DCM, 0 °C to r.t., on (79 %).  
The treatment of enynyl acetate 7aa with 3 mol % of Ph3PAuCl/AgSbF6 in anhydrous DCM at room 
temperature led to the formation of cyclopentenone 17aa along with the mixture of acetates 14aa and 
16aa in approximate 1 : 1 : 1 ratio (Table 1, entry 1). Since the water is necessary for the hydrolysis of 
the acetates under the reaction conditions, the reaction was carried out in DCM that was not dried 
prior use. In this case, the yield of cyclopentenone 17aa was increased to 70 %, while acetate 14aa 
was obtained in 14 % yield (entry 2). When wet DCM was used as the reaction solvent, the concurrent 
hydrolysis of acetate 16aa was faster to provide 17aa again as the major product but in a lower ratio 
with residual acetate 14aa (entry 3). Similarly, a lower ratio between 17aa and 14aa was obtained 
when the reaction was carried out with AgSbF6 in chloroform (entry 4).  
Given the role that silver can have in gold-catalyzed reaction,3 in order to exclude AgCl from the 
reaction medium the solution of Ph3PAuCl and AgSbF6 was filtered through a Celite layer (entry 5). 
Since the decomposition of the catalyst during this operation has been reported4 a larger amount of 
precatalyst (6 mol %) was used. The reaction occurred as usual, thus demonstrating that the silver 
halide does not affect neither the reaction rate nor the selectivity. On the other hand, AgSbF6 alone 
(entry 6) did catalyze the reaction, albeit to a very low extent. 
 
 
Table 1. Gold(I)-catalyzed [3,3]-rearrangement/Nazarov reaction of acetate 7aa using 
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Ph3PAuCl/AgSbF6 catalyst system.a 
N
Ts
OAc
nBu N
Ts
N
Ts
N
Ts
N
TsOAc O OAc O
nBu nBu nBu nBu
+ + +
7aa 14aa 15aa 16aa 17aa
conditions
 
Entry Catalystb Conditionsc Time (h)d, e 
Yieldf 
14aa 15aa 16aa 17aa 
1 Ph3PAuCl/AgSbF6 dry DCM 5 (0) 18g - 22g 19g 
2 Ph3PAuCl/AgSbF6 DCM 2.5 14 3 - 70 
3 Ph3PAuCl/AgSbF6 wet DCM 5 (0) 30 - - 55 
4 Ph3PAuCl/AgSbF6 CHCl3 2 (0.5) 30 - - 60 
5 Ph3PAuSbF6h DCM 3 18 - - 64 
6 AgSbF6 DCM 3 - - - <5g,i 
a Reactions carried out on 0.1-0.15 mmol, at 25 °C and left under stirring 16 h after consumption of the starting 
material. An aqueous work-up was carried out to recover the products from the reaction mixture. b Catalysts 
were prepared by adding the silver salt to a 0.004 M solution of the gold(I) chloride in the reaction solvent.  
c Solvents were not dried before use unless otherwise indicated. d Time to reach complete conversion of the 
starting material. e In brackets, time left for the hydrolysis. f Yield after chromatography unless otherwise 
indicated. g By 1H NMR analysis of the crude reaction mixture. h Reaction carried out with 6 mol % of precatalyst 
and after filtration of AgCl. i Conversion was not complete and degradation of the starting material occurred. 
 
Table 2.  Optimization of reaction conditions.a 
N
Ts
OAc
nBu N
Ts
N
Ts
N
Ts
N
TsOAc O OAc O
nBu nBu nBu nBu
+ + +
7aa 14aa 15aa 16aa 17aa
conditions
 
Entry Catalystb Conditionsc Time (h)d,e 
Yieldf 
14aa 15aa 16aa 17aa 
1 Ph3PAuCl/AgBF4 DCM 3 18 5 - 62 
2 Ph3PAuCl/AgNTf2·ACN DCM 6 18 5 - 50 
3 Ph3PAuCl/AgOTf DCM 1.5 51 - g - 35 
4 Ph3PAuCl/Cu(OTf)2 DCM 6h - 19 - 29 
5 Ph3PAuCl/Cu(OTf)2 DCM reflux 0.7 (3) - 58g - 42g 
6 Ph3PAuCl/AgOTf Toluene 1 61 - - 18 
7 Ph3PAuCl/AgOTf 
Toluene,  
0 °C 5 60 - - 15 
8 Ph3PAuCl/AgOTf THF 3 32 - - 31 
9 Ph3PAuCl/AgOTf 1,4-dioxane 24i - - - - 
10 Ph3PAuCl/AgOTf ACN 24i - - - - 
11 AgOTf DCM 3 - - - <5h 
12 Cu(OTf)2 DCM 16 (0) - - - - 
a Reactions carried out on 0.1-0.15 mmol, at 25 °C and left under stirring 16 h after consumption of the starting 
material. An aqueous work-up was carried out to recover the products from the reaction mixture. b Catalysts were 
prepared by adding the silver salt to a 0.004 M solution of the gold(I) chloride in the reaction solvent. c Solvents 
were not dried before use unless otherwise indicated. d Time to reach complete conversion of the starting material.  
e In brackets, time left for hydrolysis. f Yield after chromatography unless otherwise indicated. g By 1H NMR analysis 
of the crude reaction mixture. h Conversion was not complete and degradation of the starting material occurred. i No 
reaction, degradation of starting material.   
 
In order to investigate the influence of the counterion on the outcome of the reaction, different silver 
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salts were screened (Table 2). All reactions were carried out in DCM at room temperature with 3 % of 
precatalyst loading, monitored by TLC and after complete consumption of enynyl acetate 7aa 
reactions were left to stir at room temperature overnight. Lower ratio between cyclopentenone 17aa 
and acetate 14aa and lower overall yield were obtained using AgBF4 and AgNTf2. Interestingly, using 
AgOTf the yield of acetate 14aa was increased to 51%, while cyclopentenone 17aa was obtained in 
35% yield after chromatography. When Cu(OTf)2 was used to generate the active gold(I) catalyst,5 
cyclopentenones 17aa and 15aa were obtained in a 1.5 : 1 ratio and 48 % yield. Repeating the 
reaction in refluxing DCM (entry 5), consumption of the starting material was complete in 40 min and 
hydrolysis in 3 h, providing again a mixture of the two regiomers in a 1 : 1.4 ratio. It is interesting to 
note here that only with Cu(OTf)2 the hydrolysis of acetate 14aa was observed because copper triflate 
remains in solution and due to its Lewis acid character it accelerates the hydrolysis of both acetates. 
To increase the ratio between products 14aa and 17aa the reaction was carried out with 3 mol % of 
Ph3PAuCl/AgOTf in different solvents. In toluene at room temperature (entry 6) the ratio was increased 
to 3 : 1 in favour of acetate 14aa. Decreasing the temperature to 0 °C (entry 7) this ratio was 
additionally improved to 4 : 1 but the reaction was slower and accompanied by the degradation of the 
starting material which results in a lower overall yield. The degradation of starting enynyl acetate 7aa 
was even more significant in THF. Acetonitrile and 1,4-dioxane were not suitable solvents for this 
transformation while silver triflate and copper triflate alone did not catalyze the reaction efficiently 
(entries 11-12). 
 
Table 3.  Hydrolysis of acetate 14aa. 
N
Ts
N
Ts
N
TsOAc O O
nBu nBu nBu
+
conditions
N
Ts OAc
nBu14aa 15aa
16aa
17aa
 
Entry Conditions Time (h) 
Yield  
15aa 17aa 
1 TfOH, DCM: MeOH = 1 : 1 20 66 34 
2 pTsOH x H2O, DCM/MeOH = 1 : 1 20 93 7 
3 K2CO3, MeOH 4 degradation 
 
Furthermore, isolated acetate 14aa was subjected to the hydrolysis (Table 3). When dissolved in 
dichloromethane/MeOH and treated with a catalytic amount of monohydrate pTsOH, it slowly provided 
the corresponding cis fused cyclopentenone 15aa as the main product and cyclopentenone 17aa, 
whose formation could be accounted for an acid catalyzed [1,5]H shift. In the hydrolysis of 14aa with    
1 % TfOH in DCM/MeOH the shift was more pronounced as 15aa and 17aa were obtained in 2 : 1 
ratio. On the contrary, attempts at basic hydrolysis (K2CO3 in MeOH) of 14aa and isomerisation of 
15aa6 under basic conditions (NaOMe in MeOH and DBU in THF) led to the formation of very complex 
crude reaction mixtures.  
 
5.2.2. Nitrogen Protecting Group  
 The best reaction conditions (3 mol % Ph3PAuCl/AgSbF6 in DCM at room temperature) found 
for enyne 7aa were extended to the corresponding substrates protected as N-Boc (7b), N-Cbz (7c) 
and N-CO2Me (7d), all prepared in good overall yields as described for 7aa starting from the 
corresponding protected lactams (Scheme 3).  
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7d R = CO2Me (69%, two steps) 
Scheme 3.  Reagents and conditions: (a) KHMDS, -78 °C, 1.5 h; then (PhO)2POCl, -78 °C, 1 h; 
(b) heptyn-3-ol, 15 mol % CuI, 6 mol % (Ph3P)2PdCl2, CHCl3-Et3N, 1 : 2, 55 °C, 7 h;  
 (c) Ac2O, Et3N, DMAP, DCM, 0 °C to r.t., on.  
The reaction of N-Boc derivative 7b (Table 4, entries 1-3) only provided degradation products plus 
about 20% of the oxyauration product 18b when the reaction was carried out in toluene. The cyclic 
urethane intermediate 18b was not isolated. The crude reaction mixture was analyzed by 1H NMR. 
Diagnostic signals, the triplet at 4.71 ppm and the singlet at 5.56 ppm were assigned to protons Ha and 
Hb, respectively. Proton Hc resonates at 5.15 ppm as a triplet. The formation of this byproduct could be 
rationalized as a competing 6-endo-dig attack of the carbamate carbonyl group to the activated triple 
bond (Scheme 4).   
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7b 18b  
Scheme 4. Formation of cyclic urethane 18b. 
Table 4. Sequential gold(I)-catalyzed rearrangement/Nazarov reaction of acetates 7b-d.a,b 
N
R
OAc
nBu N
R
N
R
N
R
N
ROAc O OAc O
nBu nBu nBu nBu
+ + +
7b-d 14b-d 15b-d 16b-d 17b-d
 Ph3PAuCl
 AgSbF6
 
Entry Substrate Conditionsc Time (h)d 
Yielde 
14 15 16 17 
1 7b DCM, 25 °C 16f -g - - - 
2  Toluene, 25 °C to reflux 3f - - - - 
3  Acetone, 25 °C to reflux 3f - - - - 
4h 7c DCM, 25 °C 20j - - - 48 
5h,i  DCM, reflux 3 - - - 61 
6 7d DCM, 25 °C 2 - - - - 
7  DCM, reflux 2k 14 - - 64 
8  Toluene, reflux 1.5k 11 - - 50 
9  THF, reflux 1.5k 15 - - 45 
a Reactions carried out on 0.15-0.2 mmol, with 5 mol % of catalyst unless otherwise indicated. b Catalysts were 
prepared by adding the silver salt to the 0.004 M solution of the gold(I) chloride in the reaction solvent. c Solvents 
were not dried before use unless otherwise indicated. d Time to reach complete conversion of the starting material.  
e Yield after chromatography unless otherwise indicated. f Complete degradation of the starting material occurred.  
g Not detected by 1H NMR analysis of the crude reaction mixture. h Reaction carried out with 8 mol % of catalyst. i 
Reaction carried out on a 0.075 mmol scale. j Degradation occurred at a certain extent. k Then left 16 h at room 
temperature. 
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Better results, but only when the catalyst loading was increased to 8 mol % and temperature risen to 
reflux, were obtained with N-Cbz derivative 7c (Table 4, entries 4 and 5) which underwent reaction 
providing cyclopentenone 17c in 61 % yield after chromatography as the sole product. In this case, 
both consumption of the starting material and hydrolysis were complete after 3 h. In addition, some 
degradation of the starting material occurred, albeit in a much lower extent than with N-Boc compound 
7b.  
Also with N-CO2Me protected compound the reaction did not take place if not by heating in refluxing 
dichloromethane (Table 4, entries 6 and 7) with 5 mol % of catalyst. Interestingly, monitoring the 
reaction by TLC revealed the formation of two spots corresponding to the two acetate isomers and 
during the course of the reaction, only one disappeared to form a more polar spot corresponding to 
Nazarov product 17d. After the chromatography, Nazarov compound 17d was isolated as the major 
product in 64 %, while acetate 14d in 14 %. Carrying the raction in THF and toluene the yield and the 
ratio between 14d and 17d were not improved. 
 
5.2.3. Mechanistic Study  
 According to the literature and experimental results, the mechanism shown in Scheme 5 was 
proposed. Pentadienylic cation 20aa generated via gold-catalyzed [3,3]-rearrangement of enynyl 
acetate 7aa subsequently undergoes 4π electrocyclization giving Au-containing cyclopentadienylic 
cation 21aa with two available protons for protodeauration step. Acetate 16aa is formed via extraction 
of proton from the ring junction and hydrolyzes in situ giving thermodynamically more stable α,β-
unsaturated ketone 17aa while extraction of proton from β position with respect to the gold leads to 
acetate 14aa that is resistant to hydrolysis under the reaction conditions.  
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Scheme 5. Proposed reaction mechanism and 1H NMR spectra of reaction carried out in CDCl3 
after 0.5 h (red), 1 h (green) and 2.5 h (purple). 
To demonstrate that the formation of ketone 17aa occurs via in situ hydrolysis of acetate intermediate 
16aa, we set up one experiment in CDCl3 and monitored the progress of the reaction by 1H NMR 
spectroscopy (Scheme 5). Aliquots of the reaction mixture were filtered on a Celite layer and diluted 
after 0.5 h, 1 h and 2.5 h from the addition of the catalyst. After 30 min, 1H NMR analysis actually 
showed three new sets of signals, of which one for cyclopentenone 17aa and two for acetates 14aa 
and 16aa. The ratio between intermediates 14aa and 16aa decreased during the reaction concurrently 
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to a relative increase of 17aa. At the end of the reaction, only the signals of 17aa and acetate 14aa 
were present in the spectrum. In addition, based on the experimental results [1,5]H-shift from 14aa to 
16aa could be excluded while there is no solid evidence to exclude [1,5]H-shift from 16aa to 14aa.  
 
5.2.4. DFT Calculations 
 In order to understand this process in more detail, and help identifying the structures and 
energies of the critical steps, the DFT calculations were carried out.7 For the sake of the simplicity, the 
model substrates which contain the methyl in the propargylic position, and the N-tosyl or the N-CO2Me 
moiety were used in calculations. The overall discussion presented here is based on model Ia because 
the results with the N-tosyl derivative are very similar and reinforce the conclusions.  
The structures were located using the B3LYP8 density functional theory method as implemented in the 
Gaussian suite of programs.9 The alkynyl-gold(I) cationic complex Ia was considered as the starting 
point of the mechanism (G = 0 kcal/mol), and all reported energies in the following discussion are 
relative to it. The energy values correspond to Gibbs free energies (ΔG), computed at B3LYP/6-31G** 
level (LANL2DZ10 for gold atom).  
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Scheme 6. Computed reaction profile. Energies are in kcal/mol. 
 Initially, the coordination of the gold atom to the triple bond induces a rapid two step acetate 
rearrangement to form the pre-Nazarov cyclization complex IIIa (Scheme 6). The attack of the acetate 
carbonyl oxygen of Ia to the gold-activated alkyne leads to the formation of a cyclic intermediate IIa 
and the subsequent C-O bond breaking event renders an allylic cation (IIIa) stabilized by the presence 
of the gold atom.11 Noteworthy, the computed energies indicate that Ia and IIIa are isoenergetic (0.1 
kcal/mol difference), and that the activation energies of both steps are fairly low, cca. 10 kcal/mol, 
meaning that in the absence of further evolution, Ia and IIIa would be in an almost 1 : 1 equilibrium. 
However, complex IIIa evolves through an easy cyclization to IVa, a process that presents a very low 
barrier of 5.1 kcal/mol (TS3a). In accordance to the conrotatory nature of the Nazarov reaction under 
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thermal conditions, the reaction is predicted to be diastereoselective, with formation of the C-C bond 
that presents the two H atoms in a trans relationship.  
The results with the N-tosyl derivative (Ib) are comparable, showing activation energies of 11.4 and 
10.9 kcal/mol for the two step acetate rearrangement process, a reaction energy of +0.7 kcal/mol in 
the formation of IIIb, and an activation barrier of 4.0 kcal/mol for the Nazarov cyclization. 
At this point, we attempted to explain the diene formation through a single-step intramolecular hydride 
shift with concomitant C-Au bond breaking. In fact, the corresponding transition structure TS4a was 
located, but its accompanying activation energy (30 kcal/mol from IVa to TS4a) is too high to be 
feasible under the experimental reaction conditions.12 Therefore, an external base is needed for the 
deprotonation, and it is important to highlight that several possible candidates exist in the reaction 
media, like the gold counterion in the gold(I) salt, the anion forming the silver or copper salt or water 
molecules.  
We were particularly interested in the proton abstraction step since, based on our experimental 
findings, the regioselectivity of the reaction seems to be determined at this stage. Once the final diene-
acetates VI and VI' are formed, there are not evident signs of significant equilibration between them 
during the reaction. So, as a plausible approximation, and without knowing the exact nature of the 
molecule responsible for the abstraction, to demonstrate that this is actually the regiodetermining 
stage, the deprotonation step was computed by using the triflate anion as the base (Figure 2). The 
computational results indicate that the triflate mediated hydrogen abstraction is, in fact, not highly 
regioselective, the difference between TS5a and TS5a' being of only 0.8 kcal/mol in favour of the 
formation of V' isomer. In the case of the N-tosyl group, the difference is 0.4 kcal/mol (favouring 
TS5b'). The experimental data show a regioselectivity that ranges from 4 : 1 when using AgOTf as the 
source of the non-coordinating anion, to 1 : 5 when AgSbF6 was used which computationally accounts 
for a difference of less than 1 kcal/mol in each sense. Thus, the computed activation energies are in 
agreement with the experimental data, noting that this conclusion has to be taken with care without 
knowing the exact nature of the actual base in the system and that with different types of substrates 
the regioselectivity using AgSbF6 was complete in favour of type VII ketones derived from hydrolysis of 
VI. It is also clear that the computed thermodynamic preference for V over V', and for VI' over VI are 
not affecting the final selectivity due to the lack of equilibration.  
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Figure 2. Transition states TS5 and TS5' in the presence of triflate anion and compounds 
formed thereafter. 
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 After the formation of VI-type dienes, the most logical process would follow via hydrolysis to 
the final products (Scheme 7). There is a final interesting question at this point, regarding the very 
different experimental hydrolysis rates of both diene types, 14 and 16. Once again, as the exact nature 
of the protonating species is unknown, we chose triflic acid and H3O+ as simple models to study 
computationally this issue, and the transition states for the hydrogen transfer were located. 
Noteworthy, the protonation of VI (model of diene 16) is predicted to be three or four orders of 
magnitude faster than the corresponding protonation of VI' (model of 14), as derived from  3.5 kcal/mol 
(H3O+) or 5.7 kcal/mol (TfOH) energy difference in favour of the former. This data easily explains why 
non-hydrolyzed 14 and hydrolyzed 16 are the final adducts of the reaction. The result can be 
understood in light of the dienamine structure of compound 14 (VI'), and the donor character of the 
nitrogen atom, which can induce a stabilization of that structure making it less prone to hydrolysis. 
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Scheme 7. Hydrolysis of diene-acetates VI and VI' in the presence of a model acids 
 (TfOH and H3O+). 
 Concerning the lower reaction rates of N-alkoxycarbonyl protected substrates 7b-d, as we 
have hypothesized, DFT calculations predict the formation of a non-productive cyclized intermediate 
VIIIa, which is more stable than the starting material, thus sequestering the gold catalyst for a while 
and reducing the reaction rate (Scheme 8). The starting compound Ia can proceed through acetate 
rearrangement to form IIIa or through cyclization with the methyl ester to form VIIIa. The three 
complexes VIIIa, Ia, and IIIa are in equilibrium, which is shifted towards the non-productive, but low in 
energy (-6.1 kcal/mol) side complex VIIIa. Only the irreversible Nazarov cyclization from IIIa to IVa is 
finally able to displace this equilibrium towards the formation of the bicyclic adducts.  
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Scheme 8. DFT predicted formation of the non-productive VIIIa intermediate. 
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5.2.5. Torquoselectivity 
 A synthetically important aspect of the Nazarov reaction is the torquoselectivity of the ring 
closure. In order to evaluate the torquoselectivity, model compounds 7e and 7f were prepared from 
corresponding tosyl protected δ-valerolactams (Scheme 12).  
The reaction of enyne 7e was first carried out in DCM at room temperature (Scheme 9) in the 
presence of 5 mol % of Ph3PAuSbF6 as the catalyst and provided only cyclopentenone 17e in 78 % 
yield after chromatography. 1H NMR analysis of the crude reaction mixture revealed a mixture of 
diastereomers in 6 : 1 ration, with the cis compound being predominant. As the pre-Nazarov complex 
is a vinylgold species, a few ligands with different properties were screened to evaluate their possible 
role in the ring closure selectivity.  
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Scheme 9. Influence of different gold ligands on the torquoselectivity: (a) L = Ph3P, 78 % yield, 
cis-17e : trans - 17e = 6 : 1; (b) L = (Cy)3P, 91% yield, cis-17e : trans - 17e = 10 : 1. 
When the electron-rich (Cy)3P ligand was used, both the torquoselectivity (10 : 1) and the yield (91 %) 
were improved whereas the use of electron-poor [(pCF3C6H4)3P] ligand and NHC-carbene ligand led to 
the formation of very complex mixtures of cyclopentenones, acetates and the degradation products.  
The formation of the cis compound as predominant isomer is consistent with previous observations on 
the torquoselectivity in the Nazarov reaction.13 For stereoelectronic reasons, the ring closure occurs in 
a way to form the new bond on the opposite side of the axially oriented 6-Me group. The bases for the 
lower torquoselectivity in the gold-catalyzed process are not easy to understand, and could be kinetic 
(i.e. both clockwise and counterclockwise ring closures could take place at different rate in the putative 
intermediate IXa, Scheme 10) or steric (i.e. the geometry of the oxyallyl cation before ring closure).  
 
Figure 3. X-Ray structure of cis-17e. 
  
 
 55	
DFT Calculations carried out on model compound IX (Scheme 10) revealed that the preference for IXa 
is clear, with a difference over IXa' of 2.3 kcal/mol because of the steric reasons.14 Thus the major cis 
dimethyl diastereomer (Xa) is formed by a counterclockwise conrotatory ring closure of IXa, with a low 
activation energy of 6.4 kcal/mol (TS7), whereas its trans diastereomer XIa is formed by conrotatory 
clockwise ring closure from IXa (TS7', 9.4 kcal/mol). Because of the predominance of intermediate IXa 
it is likely that the alternative pathway from IXa' is never operative.  
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Scheme 10. DFT study on the torquoselectivity of the ring closure. 
The torquoselectivity with 4-methyl substitute enyne 7f was in line with that observed for 7e using 
Ph3PAuSbF6 as the catalyst. A separable 6 : 1 mixture of cis and trans isomers 17f was obtained in   
66 % yield after chromatography, while acetate 14f was isolated in 14% after chromatography 
(Scheme 11). In this case, the use of other ligands did not improve the torquoselectivity and led to the 
formation of very complex mixtures of all acetates and cyclopentenone isomers. 
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Scheme 11. 14% yield for 14f, 78 % yield for 17f, cis-17f : trans-17f = 6 : 1. 
 
5.2.6. Scope of the Reaction 
 To assess the scope of the reaction, a series of enynyl acetates (Scheme 12) was prepared 
by varying the substituents on the alkyne moiety and on the piperidine ring as well as the heterocycle.  
All piperidine and azepane derived acetates 7e-l were prepared in good yield over two or three steps 
from lactam-derived enol phosphates 12e-l. In addition, pyrrolidin-2-one derivatives 7m and 7n, indole-
derived enynyl acetate 7o and C-3 substituted piperidine enynyl acetate 7p were obtained from enol 
triflates 12m15 and 12n,16 12o17 and 12p respectively. Pyrrolidine derived triflates 12m and 12n as well 
as 6-methyl substituted phosphate 12e, proved to be much less stable and were used directly as crude 
reaction mixtures in the next Sonogashira step.  
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Scheme 12. Synthesis of enynyl acetates 7ab-p. Reagents and conditions: (a) KHMDS, -78 °C, 
1.5 h; then (PhO)2POCl or PhNTf2, -78 °C, 1 h, -78 °C, 1 h; (b) alkynol, 15 mol % CuI,         
6 mol % (Ph3P)2PdCl2, CHCl3-Et3N, 1 : 2, 55 °C, 7 h; (c) Ac2O, Et3N, DMAP, DCM, 0 °C to 
r.t., on. Notes: [d] Yield over two steps; [e] Prepared from 7ga; [f] Yield over three steps. 
Once isolated, enynyl acetates 7 were subjected to the gold(I)-catalyzed rearrangement/Nazarov 
reaction in DCM using Ph3PAuCl/AgSbF6 as the catalytic system. The results are summarized in 
Schemes 13 - 15.  
The number of alkyl groups at alkyl side chain affected the reactivity and the reaction outcome. 
Reaction of unsubstituted acetate 7ab was very slow and accompanied with the decomposition at 
room temperature. However, complete and clean conversion into 17ab was achieved in refluxing 
DCM. This could be due to a slower rearrangement of the propargyl acetate moiety as a positive 
charge develops on a primary C atom (C-3’) in the transition state. Interestingly, no traces of acetate 
14ab or the corresponding ketone were found in the crude reaction mixture, meaning that proton 
abstraction is much more favoured if occurs at the more substituted position to generate the most 
substituted double bond.  
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Scheme 13. Gold(I)-catalyzed tandem [3,3]-rearrangement/Nazarov reaction of 7.  
 Note: [a] reaction carried out under reflux. 
The results obtained with 3’-methyl-substituted 7ac were in line with those for our model compound 
7aa whereas, curiously, dimethyl-substituted acetate 7ad provided acetate 16ad (86 %) only, which did 
not hydrolyze spontaneously. This was later done by the treatment with pTsOH (Scheme 14) which 
furnished Nazarov compound 17ad in 86 % yield.  
With the 3’-phenyl-substituted enyne 7ae the reaction provided expected cyclopentenone 17ae in      
55 % after chromatography. Acetate 14ae, formed during the reaction in mixture with 17ae in cca. 1 : 1 
ratio, during the purification underwent [1,5]H shift giving a complex mixture of few acetate isomeric 
products. A small amount of pure 14ae was treated with pTsOH (Scheme 14), and it was converted 
into a mixture of 15ae (95 %) and 17ae. With compound 15ae it was possible to demonstrate by 1H 
NMR studies the cis fusion of the rings (in analogy to the corresponding carbocyclic systems)6a and the 
structure of most populated conformer. 7a-H is a doublet with a low coupling constant (6.8 Hz) with 4a-
H indicating its equatorial orientation, further confirmed by the lack of any NOE of 7a-H with 2-Hax and 
4-Hax. Consequently, 4a-H is axially oriented. Similarly, in compound 15aa (Table 3) 7a-H is a doublet 
with a low coupling constant (6.9 Hz) with 4a-H confirming the cis fusion also for this compound.  
Piperidine derivatives bearing hydroxyl both protected and unprotected at positions C-6 (7h) or C-5 
(7ga, 7gb) were compatibile with reaction conditions. However, while 7ga and 7h provided 
corresponding cyclopentenones 17ga and 17h as the sole products in 75 % and 73 % yield after 
chromatography, substrate 7gb furnished the acetylated derivatives 22 as the major compound (75 %), 
accompanied by a minor amount of the corresponding alcohol 17gb (16 %). Clearly, the free OH group 
acts a nucleophile by trapping the acyl cation which is released in the final step of the process. 
Furthermore, piperidine derivatives bearing protected hydroxyl or ketone at position C-4 (7i– 7k) were 
not compatibile with the reaction condition. In all cases very complex reaction mixtures were obtained. 
Incompatibility in case of 7i and 7j was attributed to the instability of protected allylic alcohol that under 
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reaction conditions could easily be protonated and expelled form the molecule resulting in the 
formation of very reactive allylic cation. To prevent the formation of allylic cation carbony group 
protected as ketal was installed at C-4 but to no avail. 
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Scheme 14. Hydrolysis of acetates 16ad and 14ae. 
Also 7-membered rings as in 7la and 7lb were compatible as these substrates provided, after 
complete hydrolysis of the corresponding acetate intermediates, Nazarov compounds 17la (81 %) and 
17lb (83 %) only and in excellent yield after chromatography (Scheme 15).  As in the case of 7aa, the 
reaction of 7lb required refluxing conditions, too. In both cases, disappearance of the starting material 
was faster than with the corresponding six-membered heterocycles and no traces of acetate isomers 
14la and 14lb were detected by 1H NMR analysis of the crude reaction mixture.  
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Scheme 15. Gold(I)-catalyzed tandem [3,3]-rearrangement/Nazarov reaction of azepane- and 
indole-derived enynyl acetates. Notes: [a] Reaction carried out under reflux.  
The ring closure of five-membered derivatives 7m and 7n did not occur at room temperature or in 
refluxing DCM. In both cases residual starting material was recovered with a certain amount of 
unidentified degradation compounds. The reaction of 7n was also carried out in refluxing toluene, but 
to no avail. As already reported,18 derivatives 7m and 7n did not undergo reaction presumably due to 
the ring strain in the intermediate azabicyclo[3.3.0]octenyl cation and the greater difficulty in the ring 
closure to give a 5/5 fused system.  
On the other hand, indole-derived propargyl acetate 7o containing a N-CO2Me protected indole 
nucleus reacted smoothly in refluxing DCM, to provide the corresponding cyclopenta-fused system 
17o in 84 % yield after 1.5 h, thus paving a new way for the synthesis of natural compounds containing 
the cyclopenta[b]indole nucleus (Scheme 15).  
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The construction of quaternary stereocenters is one of the most demanding challenges in the organic 
synthesis.19 Gold(I)-catalyzed [3,3]-rearrangemet/Nazarov cyclization of piperidine-derived enynyl 
acetates bearing a substituent on the position C-3 on a piperidine core would present a new entry to 
cyclopenta-fused systems with quaternary stereogenic center at a ring junction.  
Enynyl acetate bearing a methyl at C-3 (7p) was prepared as a model substrate and subjected to gold 
catalysis. In this case, the presence of the methyl at C-3 restrict the protodeauration step and therefore 
only the formation of acetate 14p and corresponding ketone 15p were possible (Table 5).  
 
Table 5.  Gold(I)-catalyzed rearrangement/Nazarov reaction of acetate 7p.a 
N
Ts
OAc
7p
N
OAcTs
+
N
OTs
H
14p 15p  
Entry Catalystb Conditions Time (h) 
Yieldc 
14p 15p 
1 10% Ph3PAuCl/AgOTf DCM, 50°C 4 25 17 
2 10% Ph3PAuCl/AgOTf DCE, 80°C 4 - 40 
3 5% Ph3PAuCl/AgOTf Toluene, 100°C 2 - 36 
4 5% Ph3PAuCl, 25% Cu(OTf)2 Toluene, 100°C 2 - 23 
5 5% CyJohnPhosAuCl/AgOTf DCM, 50°C 2 - 30 
a Reactions carried out on 0.1-0.15 mmol. An aqueous work-up was carried out to recover the products from 
the reaction mixture. b Catalysts were prepared by adding the silver salt to a 0.004 M solution of the gold(I) 
chloride in the reaction solvent. c Yield after chromatography. 
 
The acetate 7p was less reactive than 7aa and therefore the reactions were carried out at higher 
temperature and with higher catalyst loading. The treatment of enynyl acetate 7p with 10 mol % of 
Ph3PAuCl/AgSbF6 in refluxing DCM led to the formation of cyclopentenone 15p along with the acetate 
14p (Table 5, entry 1) in overall yield of 42 %. Since enynyl acetate 7p was recoverd from crude 
reaction mixture in 28 %, in order to improve the yield the reaction was carried out in different solvents 
and using the different catalyst systems but without significant improvement.  
Observed lower reactivity could be attributed to the methyl group at C-3 which presents sterical 
hinderence during the cyclization step.  
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5.3. Gold(I)-Catalyzed Tandem [3,3]-Rearrangement/Nazarov Reaction 
of N-Heterocycles Bearing Propargyl Moiety at C-3 
 
5.3.1. Preliminary Results and Optimisation of Reaction Conditions  
 In an effort to broaden the scope of the reaction and the diversity of products, we assumed 
that N-heterocycles bearing propargyl side-chain at C-3 when treated with gold(I) would deliver a 
cyclopenta-fused heterocyclic system with alternate position of C=O group on the five-membered ring 
(Scheme 16) and therefore piperidine derived enynyl acetate 29a was prepared as a model compound 
(Scheme 18).  
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Scheme 16. Gold(I)-catalyzed [3,3]-rearrangement/Nazarov cyclization of N-heterocyclic enynyl 
acetates 29.  
Owing to the stability and perceived compatibility with gold(I) catalysis, p-toluensulfonyl group was 
selected again to be the protecting group on the nitrogen atom. The synthesis of the model compound 
29a started with the reduction of the N-Ts δ-valerolactam (11a) into the corresponding lactamol 
(Scheme 17). Lactamol 23a was transforrmed into enesulfonamide 25a by conversion into α-sulfonyl 
derivative 24a followed by base induced elimination of methanesulfonic acid.20 In the next step, 
electrophilic addition of iodine monochloride to the double bond of enesulfonamide 25a followed by an 
nucleophilic attack of methanol onto formed iodonium ion afforded α-methoxy-β-iodo piperidine 
derivative 26a as a single stereoisomer.21 The treatment of 26a with catalytic amount of trifluoroacetic 
acid in toluene at 140 °C in 7 min led to the elimination of the methanol and provided 3-iodo 
enesulfonamide 27a in 77 % yield.22 To avoid the use of this harsh reaction conditions, we employed 
other methods but the iodination or bromination of 25a proved to be more difficult than anticipated. For 
example, attempts to obtain 3-iodo derivative 27a using I2/Cs2CO3 in dioxane,23 NIS in DMF,24 
NIS/AgNO3 in acetonitrile25 and NIS/TFA in DCM26 failed completely or provided desired product in 
complex mixture with unknown products. 
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Scheme 17. Synthesis of 3-iodoenesulfonamide 27a. Reagents and conditions: (a) DIBAL-H, 
THF, -78 °C, 1 h; (b) MsCl, Et3N, DMAP, DCM, 0 - 25 °C, 16 h (80 %); (c) ICl or NIS, MeOH,  
  25 °C, 1 h (91 %); (d) TFA (cat), toluene 140 °C, 7 min (77 %).   
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Then, iodoenesulfonamide 27a was coupled with (±)-butyn-3-ol under Sonogashira conditions27 to 
afford enynyl alcohol 28a which was treated with acetic anhydride to provide enynyl acetate 29a in 
yield of 72 % over two steps (Scheme 18). 
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Scheme 18. Synthesis of enynyl acetate 29a. Reagents and conditions: (a) (±)-butyn-3-ol,         
10 mol % CuI, 5 mol % (Ph3P)2PdCl2, Et2NH - DMF, 1 : 2, 40 °C, 10 min (85 %),                
(b) Ac2O, Et3N, DMAP, DCM, 0 - 25 °C, on (84 %). 
The treatment of enynyl acetate 29a with 5 mol % of Ph3PAuCl/AgSbF6 in DCM at room temperature 
led to the formation of cyclopentenone 30a in 66 % yield. In comparison with tandem gold(I)-catalyzed 
[3,3]-rearrangement/Nazarov reaction of enynyl acetate 7aa, the cyclization of 29a to 30a was slower 
and accompanied by many unknown compounds whose formation could be rationalized either via side 
reactions of gold intermediates or degradation of the starting enynyl acetate. Since the reaction profile 
was very dirty, all attempts to isolate and identify any of these side products failed. In order to increase 
the reaction rate and decrese the amount of side-products, different precatalysts were used, reactions 
carried out at higher temperature, but with no success (Table 6).  
  
Table 6. Gold(I)-catalyzed [3,3]-rearrangement/Nazarov reaction of 29a.a 
N
Ts
OAc
29a
conditions
N
Ts
O
30a
+
N
Ts
31a
O
 
Entry Catalystb Solventc Time (h) 
Yieldd 
30a 31a 
1 Ph3PAuCl/AgSbF6 DCM 6 66 - e 
2 (cHex)3PAuCl/AgSbF6 DCM 6 10g - 
3 (4-CF3Ph)3PAuCl/AgSbF6 DCM 6 49 -e 
4 Ph3PAuCl/AgSbF6 Dry DCM 1 < 5g - 
5 Ph3PAuCl/AgSbF6 DCMf  48 - e 
a Reactions carried out on 0.15-0.2 mmol, with 5 mol % of catalyst ar r.t. b Catalysts were 
prepared by adding the silver salt to the 0.004 M solution of the gold(I) chloride in the reaction 
solvent. c Solvents were not dried before use. d Yield after chromatography unless otherwise 
indicated. e Detected by 1H NMR analysis of the crude reaction mixture. f Reaction carried out 
in refluxing solvent. g Conversion detected by 1H NMR. 
 
In analogy with the gold(I)-catalyzed [3,3]-rearrangement/Nazarov reaction of azepane-derived enynyl 
acetates 7la and 7lb  which were faster than the reactions of corresponding piperidine analogues 7ab 
and 7ac, enynyl acetate 29l was prepared (Scheme 19). Since the reduction of caprolactam followed 
by the base catalyzed elimination of MsOH failed, the enesulfonamide 25l was prepared via palladium 
catalyzed reduction of corresponding phosphate 12l.28 Iodination and Sonogashira coupling followed 
by acetylation led to the formation of desired enynyl acetate 29l whose treatment with 5 % of 
Ph3PAuCl/AgSbF6 in DCM in 6 h afforded cyclopenta-fused product 30l in 54 % yield.  
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Scheme 19. Synthesis of 30l. Reagents and conditions: (a) 5 mol % Pd(OAc)2, 10 % Ph3P, 
HCO2H, Et3N, DME, 40 °C, 40 min (62 %); (b) 1. ICl, MeOH, 25 °C, 1 h; 2. TFA (cat), 
toluene 140 °C, 7 min (86 % two steps); (c) 1. (±)-butyn-3-ol, 10 mol % CuI, 5 mol % 
(Ph3P)2PdCl2, Et2NH - DMF, 1 : 2, 40 °C, 10 min (71 %), 2. Ac2O, Et3N, DMAP, DCM,  
 0 - 25 °C, on (84 %); (d) 5 mol % Ph3PAuCl/AgSbF6, DCM, 25 °C, 6 h (54 %). 
It is known that the π-donating ability of the nitrogen atom in enamines gives them both nucleophilic 
(C-3) and electrophilic (C-2) properties which could be controlled by adjusting the nitrogen protecting 
group.29 Therefore, in an attempt to tune the enamine reactivity, a carbamate protected analogue 29c 
was prepared from N-Cbz δ-valerolactam 11c and subjected to the gold catalysis (Scheme 20). The 
use of 5 mol % of Ph3PAu/AgSbF6 in DCM led to the formation of very complex crude and careful 
analysis of 1H NMR spectra revealed the signals of desired cyclopenta-fused product, α,β-unsaturated 
ketone and starting material in a mixture with unkown products. The change of the precatalyst and 
counterion did not improve the reaction rate or the reaction profile. The cleanest reaction profile was 
observed when the reaction was carried out with 5 % of p(CF3Ph)3PAuCl/AgSbF6 in a mixture of DCM 
and t-BuOH. After 20 h, Nazarov product 30c and α,β-unsaturated ketone 31c were formed in 1 : 1 
ratio. Chromatography afforded Nazarov compound 30c in 26% yield, while α,β-unsaturated ketone 
31c in 28% yield.  
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Scheme 20. Reagents and conditions: (a) 1. DIBAL-H, THF, -78 °C, 1 h; 2. MsCl, Et3N, DMAP, 
DCM, 0 - 25 °C, 16 h (61 % two steps); (b) 1. ICl, MeOH, 25 °C, 1 h; 2. TFA (cat), toluene 
140 °C, 7 min (75 % two steps); (c) 1. (±)-butyn-3-ol, 10 mol % CuI, 5 mol % (Ph3P)2PdCl2, 
Et2NH - DMF, 1 : 2, 40 °C, 10 min (75 %), 2. Ac2O, Et3N, DMAP, DCM, 0 - 25 °C, on (85 %); 
(d) 5 mol % p(CF3Ph)3PAuCl/AgSbF6, DCM : t-BuOH = 1 : 1, 25 °C, 20 h. 
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5.3.2. DFT Calculations 
 In order to identify the structures and the energies of the critical steps of the mechanism, the 
potential reaction coordinates of the whole tandem [3,3]-rearrangement/Nazarov cyclization were 
studied computationally.7 As the model substrate, compound 29a was used. The structures were 
located using the B3LYP8 density functional theory method as implemented in the Gaussian suite of 
programs.9 The alkynyl-gold(I) cationic complexes I was considered as the starting point of the 
mechanism (G = 0 kcal/mol), and all reported energies in the following discussion are relative to it. The 
energy values correspond to Gibbs free energies (ΔG), computed at B3LYP/6-31G** level (LANL2DZ10 
for gold atom).  
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Scheme 21. Computed reaction profile. Energies are in kcal/mol. 
In comparison with gold(I)-catalyzed [3,3]-rearrangement/Nazarov reaction of 7aa where the acetate 
rearrangement was the rate-determining step (ΔG = 10 kcal/mol) while the cyclization was a fast 
process (ΔG = 4.9 kcal/mol, Scheme 6 on page 51), the computational study carried out on substrate 
29a resulted in the cyclization of pentadienyl cation III being the rate-limiting step (ΔG = 16.9 kcal/mol). 
It is worth to notice that the acetate rearrangement proceeds with a quite high activation barrier (ΔG = 
13.6 kcal/mol) but the formation of intermediate III is exergonic process (ΔG = - 20.7 kcal/mol). The 
stability of this intermediate could be attributed to the π-donating ability of the nitrogen atom to 
stabilize the positve charge. The facts that intermediate III is very stable and the activation energy for 
the cyclization process is very high, allow intermediate III to evolve through side processes.  
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5.4. Gold(I)-Catalyzed Rautenstrauch Rearrangement of Piperidine-
Derived Propargyl Acetate  
 In 1984, the first metal-catalyzed rearrangement of propargyl acetates to give 2-
cyclopentenones was reported by Rautenstrauch.30 It was proposed that the coordination of the Pd(II) 
species to the terminal alkyne effects 1,2-acetoxy migration to give metal carbene species 33 that is in 
equilibrium with pentadienyl cation 34 (Scheme 22). Although both intermediates can undergo 
cyclization and ester hydrolysis to form cyclopentenone 36, 4π-electrocyclization is today widely 
accepted. The fact that the catalyst is so close to the site where new a bond is formed stimulates the 
development of enantioselective variant of this reaction.31 
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Scheme 22. Pd(II)-catalyzed 1,2-acetoxy migration/cyclization (Rautenstrauch rearrangement). 
In 2005, Toste and co-workers reported a gold(I)-catalyzed transformation of propargylic pivolates 37 
to 2- cyclopentenones 41 (Scheme 23). To rationalize the high degree of observed chirality transfer for 
the reactions of chiral substrates, it was proposed that the cyclization occurs through helical, 
pentadienyl cationic intermediate 38.32  
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Scheme 23. Gold(I)-catalyzed Rautenstrauch rearrangement.  
Interested in the generation of pentadienyl cation which will undergo ring closure to afford 
cyclopentenone, we decided to investigate if the same approach could furnish pentannulated N-
heterocycles with the C=O group at the central position of the 5-membered ring.  
The substrates 45 and 48 were synthesized as shown in Scheme 24. N-Tosyl protected δ-valerolactam 
11a was transformed into corresponding phosphate 12a which was subjected to Pd-catalyzed 
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methoxycarbonylation. Obtained enecarbamate ester 42 was reduced to alcohol and then oxidized to 
aldehyde 43 because the selective reduction of 42 to 43 at low temperature (T < - 50 °C) did not work 
well. Reaction of aldehyde with lithiated hexine gave desired propargylic alcohol 44 in 92 % yield, 
whereas the reaction with lithiated triethylsilylacetylene led to the formation of desired terminal alkyne 
47 in poor yield. Compound 47 was obtained as minor product in a mixture with secondary alcohol 46 
which is formed via nucleophilic addition of n-BuLi to the carbonyl group of 43.  
However, both propargylic alcohol 44 and 47 were acetylated under standard conditions to give 
propargyl acetates 45 and 48 in excellent yields.  
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Scheme 24. Synthesis of propargyl acetates 45 and 48. Reagents and conditions: (a) 20 % 
Pd(OAc)2, 40 % Ph3P, CO, Et3N, MeOH, DMF, 60 °C, 2.5 h (70 %); (b) 1. DIBAL-H, DCM,    
0 °C, 2. DMP, 0 °C (62 %); (c), n-BuLi, alkyne, THF, -78 °C (93 % for 44); (d), TBAF, THF,     
0 °C, 1 h (11 % for 47 over 2 steps); (e) Ac2O, Et3N, DMAP, DCM, r.t., on.   
The treatment of 45 with 5 mol % of Ph3PAu/AgSbF6 in DCM at room temperature (Scheme 25) 
afforded complex crude for which 1H NMR analysis indicated the formation of cyclised product. The 
purification afforded only few milligrams of relatively pure compound whose structure was assigned as 
49 based on 1H NMR, gCOSY and HSQC spectra. If the structure is correctly assigned, then 49 was 
formed via expected 1,2-acetoxy migration followed by 4π-cyclization in less than 10 % yield.  
The formation of complex crude could be rationalized through electrophilic activation of the alkyne 
followed by non-selective 1,2- and 1,3-acetoxy migration.  
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Scheme 25. Au(I)-catalyzed Rautenstrauch rearrangement of 45.  
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On the contrary, terminal propargyl acetate 48 when treated with 5 mol % of Ph3PAuCl/AgSbF6 in DCM 
at room temperature in 30 min was transformed into pure acetate 52 which was hydrolyzed to ketone 
53 (Scheme 26).33  
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Scheme 26. Au(I)-catalyzed Rautenstrauch rearrangement of 48.  
Formation of the planar acetate 52 led to the conclusion that the proton necessary for the 
protodeautration step is abstracted from the ring junction of the oxyallyl cation 50, thus removing the 
chiral information that could be, in case of enantioenriched propargyl acetate transferred through 
cyclization step. In addition, the observed difference in the protodeauration step in comparison with the 
gold(I)-catalyzed tandem process described by Toste32 could be attributed to the influence of the 
nitrogen atom.  
 Although the preliminary results showed that gold(I)-catalyzed Rautenstrauch rearrangement 
of 48 followed by the hydrolysis led to the formation of cyclopenta-fused piperidine 53, we decided not 
to explore this process in detail due to the formation of planar acetate 52 which indicate the possible 
loss of chiral information in reactions of chiral or enantioenriched propargyl acetates. In addition, we 
predicted narrow scope of the reaction due to the observed incompatibility of alkyl substituted 
propargyl acetate 45.  
 
 
5.5. Experimental Part 
General information 
Solvents and reagents were used either as received from commercial suppliers or, when necessary, 
purified using standard laboratory techniques according to methods published in “Purification of 
Laboratory Chemicals” by Perrin, Armarego, and Perrin (Pergamon Press, 1966). All reactions were 
conducted in oven- or flame-dried glassware under an inert atmosphere of dry nitrogen. 
Chromatographic separations were performed under pressure on silica gel by flash-column 
techniques; Rf values refer to TLC carried out on 0.25-mm silica gel plates (Merck F254), with the same 
eluent as indicated for the column chromatography. Melting points were recorded on a Buchi-540 
melting point apparatus and are uncorrected. Optical rotation values were recorded on a Jasco DIP-
370 polarimeter at indicated temperature in the specified solvents and concentrations. 1H NMR and 
13C NMR spectra were recorded at 400 and 100.4 MHz, respectively, in the specified deuterated 
solvent at room temperature. Solvent reference lines were set at 7.26 and 77.00 (CDCl3) in 1H and 13C 
NMR spectra, respectively. Mass spectra were carried out by direct inlet of a 20 ppm solution either in 
CH3OH or CH3OH + 0.1% HCO2H on a LCQ FleetTM Ion Trap LC/MS system (Thermo Fisher 
Scientific) with an electrospray ionization (ESI) interface in the positive mode. Microanalyses were 
carried out with a CHN Thermo FlashEA 1112 Series elemental analyzer. 
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Compounds 10g,41 10i,33 10j,42 11l,3711m,16 11n,16 11o,17 11p,18 12b,34 12c,35 12d,36 12m,38 12n,15 and 
12o17  were prepared as reported, whereas starting δ-valerolactames as well as compounds 11e,15 
11f,15 17e,15 17f,15 17d,39 17ae,40 25a43 and 25c44 are known.  
N
OO
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8-(Toluene-4-sulfonyl)-1,4-dioxa-8-aza-spiro[4.5]decan-7-one (11k). 
NaIO4 (18.2 g, 84.3 mmol) was dissolved in water (50 mL) and RuO2 x nH2O (600 mg, 4.44 mmol) was 
added. The solution rapidly turned yellow while being stirred. Then a solution of 8-(toluene-4-sulfonyl)-
1,4-dioxa-8-aza-spiro[4.5]decane (5 g, 16.8 mmol) in EtOAc (100 mL) was added, the reaction mixture 
was stirred at room temperature, and the course of reaction was monitored by TLC. After 24 h the 
catalyst was quenched by the addition of i-PrOH (5 mL). Reaction mixture was filtered and the two 
phases were separated. The aqueous layer was extracted with EtOAc (2 x 60 mL), and the combined 
organic layer was dried over Na2SO4. After filtration and evaporation of the solvent, the crude was 
purified by flash chromatography (hepatane/EtOAc, 1 : 1, Rf = 0.16) to give 11k (1.3 g, 20 %) as a 
yellow oil. 1H NMR (400 MHz, CDCl3) δ = 7.89 (d, J = 8.4 Hz, 2H, Ts), 7.30 (d, J = 8.4 Hz, 2H, Ts), 3.98 
(t, J = 6.2 Hz, 2H, 6-H), 3.94 (s, 4H, OCH2), 2.63 (s, 2H, 3-H), 2.43 (s, 3H, CH3-Ts), 2.06 (t, J = 6.9 Hz, 
2H, 5-H) ppm. 
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General procedure for N-tosylation (11). 
A 1.6 M solution of n-BuLi in hexane (0.7 mL, 1.1 mmol) was added dropwise to the solution of δ-
valerolactam (1 mmol) in THF (8 mL) at -78 °C. After 30 min, a solution of 4-toluenesulfonyl chloride 
(195 mg, 1.1 mmol) in THF (2.5 mL) was added dropwise and the resulting mixture was stirred for an 
additional 30 min below -70 °C. The temperature was risen slowly to 0 °C and the reaction was 
quenched with saturated NaHCO3 solution (5 mL) and water (5 mL). The product was extracted with 
Et2O (3 x 5 mL), dried over anhydrous Na2SO4, filtered and concentrated. Flash chromatography 
afforded pure product 11. 
N
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Ts  
(5S)-5-(tert-Butyl-dimethyl-silanyloxy)-1-(toluene-4-sulfonyl)-piperidin-2-one (11g).  
Compound 11g was prepared according to the general procedure starting from 10g (467 mg, 2.04 
mmol). After chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.29) product 11g was obtained (547 mg, 
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70 %) as a white solid. M.p. = 188.9 – 189.5 °C. [𝛼]$%) = - 8.57 (c = 0.88, CHCl3). 1H NMR (400 MHz, 
CDCl3) δ = 7.89 (d, J = 8.3 Hz, 2H, Ts), 7.28 (d, J = 8.3 Hz, 2H, Ts), 4.26 (m, 1H, 5-H), 3.97 (dd, J = 
12.6, 4.0 Hz, 1H, 6-H), 3.82 (dd, J = 12.6, 3.1 Hz, 1H, 6-H'), 2.60 (ddd, J = 17.6, 10.3, 7.0 Hz, 1H, 3-
H), 2.46 – 2.32 (m, 4H, 3-H' and CH3-Ts), 1.95 – 1.78 (m, 2H, 4-H), 0.85 (s, 9H, SiC(CH3)3), 0.11 (s, 
3H, SiCH3), 0.08 (s, 3H, SiCH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.7 (s, C2), 144.6 (s, Ts), 
136.1 (s, Ts), 129.2 (d, 2C, Ts), 128.5 (d, 2C, Ts), 64.0 (d, C5), 53.3 (t, C6), 29.5 (t, C3), 28.2 (t, C4), 
25.6 (q, 3C, SiC(CH3)3), 21.6 (q, CH3-Ts), 17.9 (s, SiC(CH3)3), -4.9 (q, 2C, Si(CH3)2) ppm. MS (ESI) 
m/z (%): 789 ([2M+Na]+, 100), 406 ([M+Na]+, 18), 384 ([M+1]+, 29). Elemental analysis calcd (%) for 
C18H29NO4SiS: C 56.36, H 7.62, N 3.65; found: C 56.46, H 7.85, N 3.56. 
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4-tert-Butoxy-1-(toluene-4-sulfonyl)-piperidin-2-one (11i). 
Compound 11i was prepared according to the general procedure starting from 10i (707 mg, 4.13 
mmol). After chromatography (n-hexane/EtOAc, 3 : 1; Rf = 0.28) product 11i was obtained (670 mg, 50 
%) as a yellow solid. [𝛼]$%% = - 0.3 (c = 1.25, CHCl3). M.p. = 99.3 - 100.7 °C. 1H NMR (400 MHz, CDCl3) 
δ = 7.87 (d, J = 8.0 Hz, 2H, Ts), 7.28 (d, J = 8.0 Hz, 2H, Ts), 4.07 - 4.00 (m, 1H, 4-H), 3.95 - 3.87 (m, 
2H, 6-H), 2.56 - 2.51 (m, 1H, 3-H), 2.40 (s, 3H, CH3-Ts), 2.40 - 2.34 (m, 1H, 3-H), 1.98 - 1.86 (m, 2H, 
5-H) 1.13 (s, 9H, t-Bu) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.3 (s, C2), 144.6 (s, Ts), 136.2 (s, 
Ts), 129.2 (d, 2C, Ts), 128.4 (d, 2C, Ts), 74.3 (d, C4), 63.2 (s, C-t-Bu), 42.9 (t, C3), 42.8 (t, C6), 31.1 (t, 
C5), 28.1 (q, 3C, C-t-Bu), 21.6 (q, CH3-Ts) ppm. MS (ESI) m/z (%): 672 ([2M+Na]+, 100), 348 
([M+Na]+, 14), 325.60 ([M]+, 35). 
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2,2-Dimethyl-5-(toluene-4-sulfonyl)-tetrahydro-[1,3]dioxolo[4,5-c]pyridin-6-one (11j). 
Compound 11j was prepared according to the general procedure starting from 10j (147 mg, 0.86 
mmol). After chromatography (n-hexane/EtOAc, 1 : 1; Rf = 0.31) product 11j was obtained (162 mg,  
58 %) as a white solid. [𝛼]$%& = - 10.6 (c = 0.8, CHCl3). M.p. = 191.6 – 193.0 °C. 1H NMR (400 MHz, 
CDCl3) δ = 7.96 (d, J = 8.4 Hz, 2H, Ts), 7.29 (d, J = 8.4 Hz, 2H, Ts), 4.67 (dd, J = 15.0, 2.1 Hz, 1H, 3-
H), 4.60 (ddd, J = 7.6, 3.8, 2.1 Hz, 1H, 2-H), 4.53 (dt, J = 7.6, 2.1 Hz, 1H, 2-H), 3.48 (dd, J = 15.0, 1.8 
Hz, 1H, 4-H), 2.68 (dd, J = 15.0, 2.2 Hz, 1H, 5-H), 2.46 – 2.36 (m, 4H, 5-H and CH3-Ts), 1.27 (s, 3H, 
CH3), 1.01 (s, 3H, CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 167.6 (s, CO), 144.6 (s, Ts), 135.5 (s, 
Ts), 129.2 (d, 2C, Ts), 129.1 (d, 2C, Ts), 109.0 (s, C(CH3)2), 72.0 (d, C3), 71.6 (d, C4), 47.0 (t, C2), 
39.0 (t, C5), 25.2 (q, CH3), 23.8 (q, CH3), 21.6 (q, CH3-Ts) ppm. MS (ESI) m/z (%): 672 ([2M+Na]+, 
100), 347([M+Na]+, 22), 325 ([M+1]+, 21). Elemental analysis calcd (%) for C15H19NO5S: C 55.37, H 
5.87, N 4.30; found: C 55.41, H 5.60, N 4.69. 
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General procedure for phosphate preparation (12). 
A 0.5 M solution of KHMDS (2.5 mL, 1.25 mmol) in toluene was diluted in anhydrous THF (8 mL) and 
cooled to -78 °C. A solution of protected δ-valerolactam 11 (1 mmol) in anhydrous THF (4 mL) was 
added dropwise. The resulting mixture was stirred for 1.5 h at -78 °C and then diphenylchloro-
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phosphate (260 mL, 1.25 mmol) was slowly added and the stirring continued below -70 °C for 1 h. The 
mixture was first allowed to warm to 0 °C and then quenched with aqueous 10% NaOH (25 mL). The 
product was extracted with Et2O (4 x 12 mL); the combined organic extracts were washed with 10 % 
NaOH (12 mL) and dried over anhydrous K2CO3 for 30 min. After filtration and evaporation of the 
solvent, the crude was purified by flash chromatography (eluent containing 1 % Et3N) and obtained 
phosphate was stored at 4 °C as 0.1 M solution in the eluent containing 1 % Et3N until use. 
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Phosphoric Acid Diphenyl Ester 1-(Toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl ester 
(12a).  
Compound 12a was prepared according to the general procedure starting from 1-(toluene-4-sulfonyl)-
piperidin-2-one (900 mg, 3.55 mmol). After chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 
0.29) product 12a was obtained (1.38 g, 80 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ = 7.75 
(d, J = 8.2 Hz, 2H, Ts), 7.35 – 7.17 (m, 12H, Ts and Ph), 5.25 (dd, J = 6.6, 3.8 Hz, 1H, 3-H), 3.66 – 
3.64 (m, 2H, 6-H), 2.37 (s, 3H, CH3-Ts), 2.08 – 2.03 (m, 2H, 4-H), 1.56 – 1.51 (m, 2H, 5-H) ppm. 13C 
NMR (100.4 MHz, CDCl3) δ = 150.4 (s, C2), 143.8 (s, Ts), 139.6 (s, 2C, Ph), 137.0 (s, Ts), 129.7 (d, 
4C, Ph), 129.6 (d, 2C, Ts), 127.6 (d, 2C, Ts), 125.5 (d, 2C, Ph), 120.4 (d, 4C, Ph), 100.5 (d, C3), 47.5 
(t, C6), 21.5 (q, CH3-Ts), 21.3 (t, C4), 20.9 (t, C5) ppm. MS (ESI) m/z (%): 993 ([2M+Na]+, 100), 508 
([M+Na]+, 13.1), 486 ([M+1]+, 8). 
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Phosphoric Acid (±)-6-Methyl-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl Ester 
Diphenyl Ester (12e).  
Compound 12e was prepared according to the general procedure starting from 11e (566 mg, 2.12 
mmol). After chromatography (n-hexane/EtOAc, 3 : 1 +1 % Et3N; Rf = 0.19) phosphate 12e was 
obtained (807 mg, 76 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ = 7.72 (d, J = 8.3 Hz, 2H, 
Ts), 7.34 – 7.16 (m, 12H, Ts and Ph), 5.27 (dd, J = 6.6, 3.8 Hz, 1H, 3-H), 4.58 – 4.41 (m, 1H, 6-H), 
2.37 (s, 3H, CH3-Ts), 2.11 – 1.96 (m, 2H, 4-H and 5-H), 1.46 – 1.34 (m, 2H, 4-H' and 5-H'), 1.12 (d, J = 
6.8 Hz, 3H, 6-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 150.4 (s, C2), 143.7 (s, Ts), 137.7 (s, 2C, 
Ph), 136.7 (s, Ts), 129.7 (d, 4C, Ph), 129.6 (d, 2C, Ts), 127.6 (d, 2C, Ts), 125.5 (d, 2C, Ph), 120.4 (d, 
4C, Ph), 100.2 (d, C3), 51.9 (d, C6), 25.1 (t, C4), 21.5 (q, CH3 Ts), 18.0 (t, C5), 16.7 (q, C6-CH3) ppm. 
MS (ESI) m/z (%): 1021 ([2M+Na]+, 100), 522 ([M+Na]+, 10), 500 ([M+1]+, 6). 
N O P OPh
O
OPhTs  
Phosphoric Acid (±)-4-Methyl-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl Ester 
Diphenyl Ester (12f).  
Compound 12f was prepared according to the general procedure starting from 11f (550 mg, 2.05 
mmol). After chromatography (n-hexane/EtOAc, 3 : 1 +1 % Et3N; Rf = 0.20) phosphate 12f was 
obtained (855 mg, 84 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ = 7.75 (d, J = 8.4 Hz, 2H, 
Ts), 7.36 – 7.31 (m, 4H, Ph), 7.24 – 7.17 (m, 8H, Ph and Ts), 5.14 (m, 1H, 3-H), 3.73 (ddd, J = 13.8, 
6.9, 3.1 Hz, 1H, 6-H), 3.54 (ddd, J = 13.8, 9.0, 2.8 Hz, 1H, 6-H'), 2.37 (s, 3H, CH3-Ts), 2.34 – 2.27 (m, 
1H, 4-H), 1.66 – 1.61 (m, 1H, 5-H), 1.16 – 1.08 (m, 1H, 5-H'), 0.86 (t, J = 7.0 Hz, 3H, 4-CH3) ppm. 13C 
NMR (100.4 MHz, CDCl3) δ = 150.4 (s, C2), 143.8 (s, Ts), 139.1 (s, 2C, Ph), 136.7 (s, Ts), 129.7 (d, 
4C, Ph), 129.5 (d, 2C, Ts), 127.7 (d, 2C, Ts), 125.5 (d, 2C, Ph), 120.1 (d, 4C, Ph), 106.0 (d, C3), 46.3 
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(t, C6), 29.1 (d, C4), 27.3 (t, C5), 21.5 (q, CH3 Ts), 21.0 (q, C4-CH3) ppm. MS (ESI) m/z (%): 1021 
([2M+Na]+, 100), 522 ([M+Na]+, 5), 500 ([M+1]+, 2). 
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Phosphoric Acid (5S)-5-(tert-Butyl-dimethyl-silanyloxy)-1-(toluene-4-sulfonyl)-1,4,5,6-
tetrahydro-pyridin-2-yl Ester Diphenyl Ester (12g).  
Compound 12g was prepared according to the general procedure starting from 11g (530 mg, 1.4 
mmol). After chromatography (n-hexane/EtOAc, 3 : 1 +1% Et3N; Rf = 0.24) phosphate 12g was 
obtained (640 mg, 74 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ = 7.75 (d, J = 8.4 Hz, 2H, 
Ts), 7.35 – 7.13 (m, 12H, Ts and Ph), 5.15 (dd, J = 6.4, 3.8 Hz, 1H, 3-H), 3.91 (dd, J = 13.0, 3.9 Hz, 
1H, 6-H), 3.81 – 3.73 (m, 1H, 5-H), 3.16 (dd, J = 13.0, 9.7 Hz, 1H, 6-H'), 2.36 – 2.27 (m, 4H, CH3-Ts 
and 4-H), 1.98 (ddt, J = 17.6, 7.5, 3.8 Hz, 1H, 4-H'), 0.87 (s, 9H, SiC(CH3)3), 0.07 (s, 3H, SiCH3), 0.04 
(s, 3H, SiCH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 150.3 (s, C2), 143.8 (s, Ts), 139.0 (s, 2C, Ph), 
137.3 (s, Ts), 129.7 (d, 4C, Ph), 129.6 (d, 2C, Ts), 127.5 (d, 2C, Ts), 125.6 (d, 2C, Ph), 120.1 (d, 4C, 
Ph), 97.6 (d, C3), 63.7 (d, C5), 52.3 (t, C6), 31.6 (t, C4), 25.7 (q, 3C, SiC(CH3)3), 21.5 (q, CH3 Ts), 18.0 
(s, SiC(CH3)3), -4.8 (q, SiCH3), -4.9 (q, SiCH3) ppm. MS (ESI) m/z (%): 1253 ([2M+Na]+, 100), 638 
([M+Na]+, 93), 616 ([M+1]+, 5).  
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Phosphoric acid 6-(tert-butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-sulfonyl)-1,4,5,6-
tetrahydro-pyridin-2-yl ester diphenyl ester (12h). 
Compound 12h was prepared according to the general procedure starting from 11h (1.050 g, 2.65 
mmol). After chromatography (heptane/EtOAc, 4 : 1 +1 % Et3N; Rf = 0.24) phosphate 12h was 
obtained   (1.63 g, 98 %) as a yellowish oil. 1H NMR (400 MHz, CDCl3) δ = 7.80 (d, J = 8.3 Hz, 2H, Ts), 
7.37 – 7.16 (m, 12H, Ts and Ph), 5.28 – 5.25 (m, 1H, 3-H), 4.47 – 4.38 (m, 1H, 6-H), 3.62 (dd, J = 
10.0, 6.4 Hz, 1H, 6-CH2OTBS), 3.46 (dd, J = 10.0, 8.5 Hz, 1H, 6-CH2OTBS), 2.37 (s, 3H, CH3-Ts), 
2.05 – 1.96 (m, 2H, 4-H), 1.90 – 1.78 (m, 1H, 5-H), 1.41 – 1.30 (m, 1H, 5-H), 0.85 (s, 9H, CH3-TBS), 
0.10 (s, 3H, CH3-TBS), 0.00 (s, 3H, CH3-TBS) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 155.9 (s, C2), 
149.4 (s, 2C, Ph), 144.1 (s, Ts), 142.2 (s, Ts), 135.3 (d, Ar), 133.3 (d, Ar), 131.0 (d, Ar), 125.8 (d, Ar), 
105.5 (d, C3), 66.9 (t, CH2OTBS), 62.6 (d, C6), 35.3 (t, C5), 31.4 (q, 3C, CH3), 27.1 (t, C4), 26.0 (s, 
TBS), 23.8 (q, CH3-Ts), 0.3 (q, CH3-TBS), -0.3 (q, CH3-TBS). MS (ESI) m/z (%): 630 ([M+1]+, 35). 
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Phosphoric acid 4-tert-butoxy-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl ester 
diphenyl ester (12i). 
Compound 12i was prepared according to the general procedure starting from 11i (690 mg, 2.12 
mmol). After chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.28) phosphate 12i was 
obtained  (860 mg, 73 %) as a colourless oil. The compound was highly unstable and decomposed in 
NMR tube during the characterization. The product was immediately used in next step.  
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Phosphoric acid 2,2-dimethyl-5-(toluene-4-sulfonyl)-3a,4,5,7a-tetrahydro-[1,3]dioxolo[4,5-
c]pyridin-6-yl ester diphenyl ester (12j). 
Compound 12j was prepared according to the general procedure starting from 11j (158 mg, 0.49 
mmol). After chromatography (n-hexane/EtOAc, 3 : 1 + 1% Et3N; Rf = 0.3) phosphate 12j was obtained     
(253 mg, 93 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ = 7.75 (d, J = 8.0 Hz, 2H, Ts), 7.52 – 
6.88 (m, 12H, Ph and Ts), 5.48 – 5.42 (m, 1H, 3-H), 4.55 – 4.47 (m, 1H, 4-H), 4.17 – 4.08 (m, 1H, 6-H), 
3.99 (dd, J = 13.3, 4.4 Hz, 1H, 6-H), 3.26 (dd, J = 13.3, 9.1 Hz, 1H, 5-H), 2.37 (s, 3H, CH3-Ts), 1.41 (s, 
3H, CH3), 1.33 (s, 3H, CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 150.1 (s, C2), 144.3 (s, 2C, Ph), 
142.2 (s, Ts), 136.9 (s, Ts), 129.8 (d, Ar) 129.7 (d, Ar), 127.5 (d, Ar), 125.7 (d, Ar), 120.1 (d, Ar), 109.7 
(d, C3), 96.5 (s, C(CH3)2), 71.3 (d, C4), 69.9 (d, C5), 48.3 (t, C6), 27.8 (q, CH3), 25.6 (q, CH3), 21.3 (q, 
CH3-Ts) ppm. MS (ESI) m/z (%): 1136 ([2M+Na]+, 100), 579 ([M+Na]+, 31), 557 ([M+1]+, 9).  
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Phosphoric acid diphenyl ester 8-(toluene-4-sulfonyl)-1,4-dioxa-8-aza-spiro[4.5]dec-6-en-7-yl 
ester (12k). 
Compound 12k was prepared according to the general procedure starting from 11k (1.3 g, 4.18 mmol). 
After chromatography (heptane/EtOAc, 3 : 2 +1 % Et3N; Rf = 0.22) phosphate 12k was obtained    
(860 mg, 73 %) as a colourless oil and used immediately in next step. 1H NMR (400 MHz, CDCl3) δ = 
7.72 (d, J = 8.3 Hz, 2H, Ts), 7.34 – 7.14 (m, 12H, Ts and Ph), 5.13 (s, 1H, 3-H), 3.94 – 3.82 (m, 6H, 6-
H and OCH2-TBS), 2.34 (s, 3H, CH3-Ts), 1.87 – 1.79 (m, 2H, 5-H) ppm. 
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Phosphoric Acid Diphenyl Ester 1-(Toluene-4-sulfonyl)-4,5,6,7-tetrahydro-1H-azepin-2-yl ester 
(12l).  
Compound 12l was prepared according to the general procedure starting from 1-(toluene-4-sulfonyl)-
azepan-2-one (600 mg, 2.24 mmol). After chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 
0.23) phosphate 12l was obtained (958 mg, 86 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ = 
7.79 (d, J = 8.3 Hz, 2H, Ts), 7.31 – 7.11 (m, 12H, Ts and Ph), 5.69 (td, J = 6.9, 3.2 Hz, 1H, 3-H), 3.50 – 
3.39 (m, 2H, 7-H), 2.35 (s, 3H, CH3-Ts), 2.09 – 2.02 (m, 2H, 4-H), 1.87 – 1.75 (m, 2H, 6-H), 1.56 – 1.45 
(m, 2H, 5-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 150.3 (s, C2), 143.8 (s, Ts), 143.5 (s, 2C, Ph), 
137.5 (s, Ts), 129.7 (d, 4C, Ph), 129.5 (d, 2C, Ts), 127.5 (d, 2C, Ts), 125.5 (d, 2C, Ph), 120.0 (d, 4C, 
Ph), 113.9 (d, C3), 46.3 (t, C7), 29.8 (t, C6), 23.8 (t, C4), 23.6 (t, C5), 21.5 (q, CH3-Ts) ppm. MS (ESI) 
m/z (%): 1021 ([2M+Na]+, 100), 522 ([M+Na]+, 24), 499 ([M]+, 7).  
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Trifluoro-methanesulfonic acid 3-methyl-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl 
ester (12p). 
A 0.5 M solution of KHMDS (6.5 mL, 3.25 mmol) in toluene was diluted in anhydrous THF (16 mL) and 
cooled to -78 °C. A solution of 11p (700 mg, 2.6 mmol) in anhydrous THF (4 mL) was added dropwise. 
The resulting mixture was stirred for 1.5 h at -78 °C and then N-phenyl-bis(trifluoromethane-
sulfonimide) (1.2 g, 3.25 mmol) was slowly added and the stirring continued below -70 °C for 1 h. The 
mixture was first allowed to warm to 0 °C and then quenched with aqueous 10 % NaOH (50 mL). The 
product was extracted with Et2O (4 x 25 mL); the combined organic extracts were washed with 10 % 
NaOH (25 mL) and dried over anhydrous K2CO3 for 30 min. After filtration and evaporation of the 
solvent, the crude was purified by flash chromatography (n-hexane/EtOAc, 3 : 1 +1 % Et3N; Rf = 0.44) 
and phosphate 12p (890, 86 %) was obtained as a colourless oil. 1H NMR (400 MHz, CDCl3) δ = 7.75 
(d, J = 8.0 Hz, 2H, Ts), 7.33 (d, J = 8.0 Hz, 2H, Ts), 3.57 - 3.54 (m, 2H, 6-H), 2.45 (s, 3H, CH3-Ts), 2.00 
– 1.96 (m, 2H, 4-H), 1.83 (s, 3H, CH3), 1.55 – 1.39 (m, 2H, 5-H) ppm. 13C NMR (101 MHz, CDCl3) δ = 
144.7 (s, C2), 135.3 (s, Ts), 134.2 (s, Ts), 129.9 (d, 2C, Ts), 128.0 (d, 2C, Ts), 122.4 (d, C3), 119.9 (s, 
CF3), 48.1 (t, C-6), 27.7 (t, C-5), 21.7 (t, C-4), 20.1 (q, CH3-Ts), 17.2 (q, CH3). MS (ESI) m/z (%): 821 
([2M+Na]+, 98.8), 422 ([M+Na]+, 72), 399 ([M]+, 63.98). 
 
General procedure for the synthesis of enynyl acetates (7). 
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Step A: Sonogashira coupling (13)2a 
Phosphate/triflate 12 (1 mmol) was dissolved in an anhydrous 2 : 1 Et3N/CHCl3 mixture (6 mL), and 
alkyne (1 mmol), CuI (19 mg, 0.1 mmol) and (Ph3P)2PdCl2 (35 mg, 0.05 mmol) were added under 
nitrogen atmosphere. The reaction mixture was heated at 55 °C (external) for 3 h and then a second 
portion of alkyne (0.5 mmol), CuI (9.5 mg, 0.05 mmol) and (Ph3P)2PdCl2 (7 mg, 0.01 mmol) was 
added. Heating was continued at 55 °C for 3 h. The mixture was cooled to room temperature and 
water (15 mL) was added. The product was extracted with Et2O (3 x 15 mL) and the combined organic 
extracts were dried over anhydrous K2CO3 for 30 min. After filtration and evaporation of the solvent, 
the crude was purified by flash chromatography and used immediately in the next step. 
Step B: Acetylation (7) 
A solution of enynyl alcohol 13 (1 mmol), DMAP (24 mg, 0.2 mmol) and Et3N (0.38 mL, 3 mmol) in 
DCM (4 mL) was cooled (ice bath) and Ac2O (0.19 mL, 2 mmol) was added. The reaction mixture was 
stirred at room temperature and followed by TLC. When the conversion was complete, satd solution of 
NaHCO3 (10 mL) was added and the product extracted with DCM (3 x 10 mL). The combined organic 
extracts were dried over anhydrous K2CO3 for 30 min. After filtration and evaporation of the solvent, 
the crude was purified by flash chromatography and stored at 4 °C as 0.1 M solution in the eluent 
containing 1 % Et3N until use. 
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Acetic Acid 1-[1-(Toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-ylethynyl]-pentyl Ester (7aa). 
Sonogashira coupling of phosphate 12a (1.16 g, 2.4 mmol) and (±)-heptyn-3-ol after chromatography 
(n-hexane/Et2O, 2 : 1 + 1 % Et3N; Rf = 0.30) afforded enynyl alcohol 13aa as a pale yellow oil (515 mg, 
62 %). 1H NMR (400 MHz, CDCl3) δ = 7.72 (d, J = 8.2 Hz, 2H, Ts), 7.30 (d, J = 8.2 Hz, 2H, Ts), 5.63 (t, 
J = 4.3 Hz, 1H, 3-H), 4.43 (t, J = 6.6 Hz, 1H, 1'-H), 3.68 – 3.65 (m, 2H, 6-H), 2.42 (s, 3H, CH3-Ts), 2.06 
(td, J = 6.6, 4.3 Hz, 3H, 4-H and OH), 1.76 – 1.59 (m, 4H, 5-H and 2'-H), 1.47 – 1.23 (m, 4H, 3'-H and 
4'-H), 0.91 (t, J = 7.2 Hz, 3H, 5'-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 143.5 (s, Ts), 137.3 (s, Ts), 
129.5 (d, 2C, Ts), 127.4 (d, 2C, Ts), 123.6 (d, C3), 120.4 (s, C2), 90.9 (s, C2a), 80.9 (s, C2b), 62.8 (d, 
C1'), 46.0 (t, C6), 37.2 (t, C2'), 27.2 (t, C5), 23.2 (t, C4), 22.4 (t, C3'), 22.3 (q, CH3 Ts), 21.5 (t, C4'), 
13.9 (q, C5') ppm. MS (ESI) m/z (%): 717 ([2M+Na]+, 100), 348 ([M+1]+, 14). 
According to the above described procedure, compound 13aa (515 mg, 1.48 mmol) was subjected to 
acetylation. After chromatography (n-hexane/EtOAc, 8 : 1 + 1% Et3N; Rf = 0.21) pure 7aa was 
obtained as a pale yellow oil (455 mg, 79 %). 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.2 Hz, 2H, 
Ts), 7.29 (d, J = 8.2 Hz, 2H, Ts), 5.65 (t, J = 4.2 Hz, 1H, 3-H), 5.45 (t, J = 6.6 Hz, 1H, 1'-H), 3.64 – 3.62 
(m, 2H, 6-H), 2.42 (s, 3H, CH3-Ts), 2.08 (s, 3H, CH3-Ac), 2.06 – 2.03 (m, 2H, 4-H), 1.72 – 1.74 (m, 2H, 
5-H), 1.65 – 1.59 (m, 2H, 2'-H), 1.44 – 1.31 (m, 4H, 3'-H and 4'-H), 0.90 (t, J = 7.2 Hz, 3H, 5'-H) ppm. 
13C NMR (100.4 MHz, CDCl3) δ = 170.0 (s, CO), 143.4 (s, Ts), 137.2 (s, Ts), 129.5 (d, 2C, Ts), 127.5 
(d, 2C, Ts), 124.4 (d, C3), 120.2 (s, C2), 97.2 (s, C2b), 81.1 (s, C2a), 64.4 (d, C1'), 46.0 (t, C6), 34.2 (t, 
C2'), 27.0 (t, C3'), 23.2 (t, C4), 22.2 (t, C4'), 21.5 (q, CH3-Ts), 21.0 (q, CH3-Ac), 21.0 (t, C5), 13.9 (q, 
C5') ppm. MS (ESI) m/z (%): 801 ([2M+Na]+, 100), 412 ([M+Na]+, 13). 
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Acetic Acid 3-[1-(Toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-ynyl Ester (7ab). 
Sonogashira coupling of phosphate 12a (220 mg, 0.45 mmol) and propargyl alcohol after 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.22) afforded enynyl alcohol 13ab as a 
colourless oil (80 mg, 60 %). 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.4 Hz, 2H, Ts), 7.30 (d, J = 
8.4 Hz, 2H, Ts), 5.65 (t, J = 4.1 Hz, 1H, 3-H), 4.33 (s, 2H, 1'-H), 3.67 – 3.64 (m, 2H, 6-H), 2.42 (s, 3H, 
CH3 Ts), 2.06 (td, J = 6.6, 4.1 Hz, 2H, 4-H), 1.63 – 1.57 (m, 2H, 5-H) ppm. 13C NMR (100.4 MHz, 
CDCl3) δ = 143.6 (s, Ts), 137.2 (s, Ts), 129.5 (d, 2C, Ts), 127.5 (d, 2C, Ts), 124.1 (d, C3), 120.4 (s, 
C2), 87.9 (s, C2'), 81.8 (s, C3'), 51.5 (t, C1'), 45.9 (t, C6), 23.2 (t, C4), 21.5 (q, CH3 Ts), 20.9 (t, C5) 
ppm. MS (ESI) m/z (%): 314 ([M+Na]+, 100), 291 ([M]+, 24). 
According to the above described procedure, compound 13ab was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.17) pure 7ab was obtained as a colourless 
oil (73 mg, 88 %). 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.2 Hz, 2H, Ts), 7.29 (d, J = 8.2 Hz, 2H, 
Ts), 5.69 (t, J = 4.2 Hz, 1H, 3-H), 4.79 (s, 2H, 1'-H), 3.65 – 3.62 (m, 2H, 6-H), 2.42 (s, 3H, CH3-Ts), 
2.09 (s, 3H, CH3-Ac), 2.06 (td, J = 6.6, 4.2 Hz, 2H, 4-H), 1.65 – 1.59 (m, 2H, 5-H) ppm. 13C NMR 
(100.4 MHz, CDCl3) δ = 170.2 (s, CO), 143.5 (s, Ts), 137.2 (s, Ts), 129.5 (d, 2C, Ts), 127.5 (d, 2C, Ts), 
124.9 (d, C3), 120.1 (s, C2), 83.6 (s, C2'), 82.4 (s, C3'), 52.6 (d, C1'), 45.9 (t, C6), 23.2 (t, C4), 21.5 (q, 
CH3-Ts), 20.9 (q, CH3-Ac), 20.7 (t, C5) ppm. MS (ESI) m/z (%): 689 ([2M+Na]+, 100), 356 ([M+Na]+, 
53), 334 ([M+1]+, 8). 
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Acetic Acid 1-Methyl-3-[1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-ynyl Ester 
(7ac).  
Sonogashira coupling of phosphate 12a (775 mg, 1.6 mmol) and (±)-butyn-3-ol after chromatography 
(n-hexane/EtOAc, 4 : 1 + 1 % Et3N; Rf = 0.23) afforded 13ac which was used immediately in the next 
step. 1H NMR (400 MHz, CDCl3) δ = 7.78 (d, J = 8.2 Hz, 2H, Ts), 7.30 (d, J = 8.2 Hz, 2H, Ts), 5.63 (t, J 
= 4.2 Hz, 1H, 3-H), 4.60 (q, J = 6.8 Hz, 1H, 1'-H), 3.68 – 3.65 (m, 2H, 6-H), 2.43 (s, 3H, CH3 Ts), 2.06 
(td, J = 6.7, 4.2 Hz, 2H, 4-H), 1.64 – 1.58 (m, 2H, 5-H), 1.44 (d, J = 6.8 Hz, 3H, 1'-CH3) ppm.  
According to the above described procedure, compound 13ac was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 8 : 1 + 1 % Et3N; Rf = 0.16) pure 7ac was obtained as a colourless 
oil (372 mg, 67 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.2 Hz, 2H, Ts), 7.28 (d, 
J = 8.2 Hz, 2H, Ts), 5.64 (t, J = 4.0 Hz, 1H, 3-H), 5.53 (q, J = 6.6 Hz, 1H, 1'-H), 3.63 – 3.61 (m, 2H, 6-
H), 2.41 (s, 3H, CH3-Ts), 2.06 (s, 3H, CH3-Ac), 2.05 – 2.01 (m, 2H, 4-H), 1.63 – 1.57 (m, 2H, 5-H), 1.47 
(d, J = 6.6 Hz, 3H, 1'-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.8 (s, CO), 143.4 (s, Ts), 137.1 
(s, Ts), 129.4 (d, 2C, Ts), 127.4 (d, 2C, Ts), 124.4 (d, C3), 120.0 (s, C2), 87.8 (s, C3'), 80.6 (s, C2'), 
60.5 (d, C1'), 45.9 (t, C6), 23.2 (t, C4), 21.5 (q, CH3-Ts), 21.0 (q, CH3-Ac), 20.9 (t, C5), 20.8 (q, C1'-
CH3) ppm. MS (ESI) m/z (%): 717 ([2M+Na]+, 100). 
N
Ts
OAc
 
Acetic Acid 1,1-Dimethyl-3-[1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-ynyl 
Ester (7ad).  
Sonogashira coupling of phosphate 12a (193 mg, 0.4 mmol) and 2-methyl-3-butyn-2-ol after 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.23) afforded 13ad which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.4 Hz, 2H, Ts), 7.29 (d, J = 
8.4 Hz, 2H, Ts), 5.59 (t, J = 4.1 Hz, 1H, 3-H), 3.66 – 3.63 (m, 2H, 6-H), 2.42 (s, 3H, CH3-Ts), 2.06 (td, J 
= 6.6, 4.1, Hz, 2H, 4-H), 1.63 – 1.57 (m, 2H, 5-H), 1.49 (s, 6H, 1'-CH3) ppm.  
According to the above described procedure, compound 13ad was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 15 : 1 + 1 % Et3N; Rf = 0.14) pure 7ad was obtained as a pale 
yellow oil (90 mg, 62 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.81 (d, J = 8.6 Hz, 2H, Ts), 
7.30 (d, J = 8.6 Hz, 2H, Ts), 5.64 (t, J = 4.1 Hz, 1H, 3-H), 3.63 – 3.60 (m, 2H, 6-H), 2.41 (s, 3H, CH3 
Ts), 2.04 – 2.00 (m, 5H, CH3-Ac and 4-H), 1.68 (s, 6H, 1'-CH3), 1.59 – 1.56 (m, 2H, 5-H) ppm. 13C 
NMR (100.4 MHz, CDCl3) δ = 169.3 (s, CO), 143.3 (s, Ts), 137.0 (s, Ts), 129.5 (d, 2C, Ts), 127.4 (d, 
2C, Ts), 123.9 (d, C3), 120.2 (s, C2), 90.4 (s, C3'), 80.3 (s, C2'), 72.3 (s, C1'), 46.0 (t, C6), 28.5 (q, 2C, 
C1'-CH3), 23.1 (t, C4), 21.9 (q, CH3 Ac), 21.5 (q, CH3 Ts), 20.7 (t, C5) ppm. MS (ESI) m/z (%): 745 
([2M+Na]+, 100), 384 ([M+Na]+, 3). 
N
Ts
OAc
Ph  
Acetic Acid 1-Phenyl-3-[1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-ynyl Ester 
(7ae).  
Sonogashira coupling of phosphate 12a (210 mg, 0.43 mmol) and (±)-1-phenyl-2-propyn-1-ol after 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.20) afforded 13ae which was used 
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immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.4 Hz, 2H, Ts), 7.55 – 7.53 
(m, 2H, Ph), 7.38 – 7.30 (m, 3H, Ph), 7.19 (d, J = 8.4 Hz, 2H, Ts), 5.66 (t, J = 4.1 Hz, 1H, 3-H), 5.54 (s, 
1H, 1'-H), 3.66 – 3.63 (m, 2H, 6-H), 2.37 (s, 3H, CH3-Ts), 2.04 (td, J = 6.4, 4.1 Hz, 2H, 4-H), 1.63 – 
1.57 (m, 2H, 5-H) ppm. 
According to above describe procedure, compound 13ae was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 5 : 1 + 1 % Et3N; Rf = 0.17) pure 7ae was obtained as a pale 
yellow oil (109 mg, 62 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.70 (d, J = 8.4 Hz, 2H, Ts), 
7.56 – 7-53 (m, 2H, Ph), 7.41 - 7.34 (m, 3H, Ph), 7.20 (d, J = 8.4 Hz, 2H, Ts), 6.57 (s, 1H, 1'-H), 5.70 (t, 
J = 4.0 Hz, 1H, 3-H), 3.69 – 3.59 (m, 2H, 6-H), 2.38 (s, 3H, CH3-Ts), 2.11 (s, 3H, CH3-Ac), 2.09 – 2.04 
(m, 2H, 4-H), 1.67 – 1.61 (m, 2H, 5-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.7 (s, CO), 143.3 (s, 
Ts), 137.0 (s, Ts), 136.6 (s, Ph), 129.4 (d, 2C, Ts), 128.8 (d, 2C, Ph), 128.6 (d, 2C, Ph), 127.9 (d, Ph), 
127.4 (d, 2C, Ts), 124.7 (d, C3), 120.0 (s, C2), 85.9 (s, C3'), 82.8 (s, C2'), 65.9 (d, C1'), 45.9 (t, C6), 
23.1 (t, C4), 21.5 (q, CH3 Ts), 21.0 (q, CH3 Ac), 20.9 (t, C5) ppm. MS (ESI) m/z (%): 841 ([2M+Na]+, 
100), 432 ([M+Na]+, 7). 
N
Boc
OAc
1'
2
3
6
2'
3'
7' 
6-(3-Acetoxyhept-1-ynyl)-3,4-dihydro-2H-pyridine-1-carboxylic Acid tert-Butyl Ester (7b).  
Sonogashira coupling of phosphate 12b (536 mg, 1.24 mmol) and (±)-heptyn-3-ol after 
chromatography (n-hexane/Et2O, 7 : 1 + 1 % Et3N; Rf = 0.28) afforded enynyl alcohol 13b which was 
used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 5.54 (t, J = 4.0 Hz, 1H, 5-H), 4.47 (t, 
J = 6.6, 1H, 3'-H), 3.57 – 3.48 (m, 2H, 2-H), 2.48 – 2.27 (bs, 1H, OH), 2.17 – 2.12 (m, 2H, 4-H), 1.82 – 
1.66 (m, 4H, 3-H and 4'-H), 1.49 (s, 9H, C(CH3)3), 1.48 – 2.29 (m, 4H, 5'-H and 6'-H), 0.90 (t, J = 6.6 
Hz, 3H, 7'-H) ppm.  
According to the above described procedure, compound 13b was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 18 : 1 + 1 % Et3N; Rf = 0.14) pure 7b was obtained as a pale 
yellow oil (250 mg, 60 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 5.56 (t, J = 3.8 Hz, 1H, 5-H), 
5.52 (t, J = 6.6 Hz, 1H, 3'-H), 3.61 – 3.46 (m, 2H, 2-H), 2.17 – 2.13 (m, 2H, 4-H), 2.05 (s, 3H, CH3-Ac), 
1.80 – 1.73 (m, 4H, 3-H and 4'-H), 1.49 (s, 9H, C(CH3)3), 1.45 – 1.30 (m, 4H, 5'-H and 6'-H), 0.90 (t, J 
= 7.2 Hz, 3H, 7'-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s, CO-Ac), 153.0 (s, CO-Boc), 123.5 
(d, C5), 121.7 (s, C6), 84.6 (s, C1'), 82.4 (s, C2'), 81.2 (s, C(CH3)3), 64.5 (d, C3'), 43.3 (t, C2), 34.6 (t, 
C4'), 28.2 (q, 3C, C(CH3)3), 27.1 (t, C5'), 23.7 (t, C4), 22.6 (t, C6'), 22.2 (q, CH3-Ac), 21.0 (t, C3), 13.9 
(q, C7') ppm. MS (ESI) m/z (%): 358 ([M+Na]+, 100). 
N
Cbz
OAc  
6-(3-Acetoxyhept-1-ynyl)-3,4-dihydro-2H-pyridine-1-carboxylic Acid Benzyl Ester (7c).  
Sonogashira coupling of phosphate 12c (242 mg, 0.52 mmol) and (±)-heptyn-3-ol after 
chromatography (n-hexane/Et2O, 2 : 1 + 1 % Et3N; Rf = 0.31) afforded enynyl alcohol 13c which was 
used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.42 – 7.29 (m, 5H, Cbz), 5.59 (t, J 
= 4.1 Hz, 1H, 5-H), 5.18 (s, 2H, CH2Ph), 4.29 (t, J = 6.6 Hz, 1H, 3'-H), 3.66 – 3.61 (m, 2H, 2-H), 2.18 – 
2.14 (m, 2H, 4-H), 1.84 – 1.76 (m, 3H, 3-H and OH), 1.63 – 1.54 (m, 2H, 4'-H), 1.45 – 1.24 (m, 4H, 5'-
H and 6'-H), 0.88 (t, J = 6.6 Hz, 3H, 7'-H) ppm.  
According to the above described procedure, compound 13c was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 20 : 1 + 1 % Et3N; Rf = 0.14) pure 7c was obtained as an orange 
oil (118 mg, 61 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.38 – 7.29 (m, 5H, Cbz), 5.61 (t, J 
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= 3.8 Hz, 1H, 5-H), 5.37 (t, J = 6.6 Hz, 1H, 3'-H), 5.19 (part A of an AB system, J = 12.6 Hz, 1H, 
CH2Ph), 5.14 (part B of an AB system, J = 12.6 Hz, 1H, CH2Ph), 3.61 – 3.55 (m, 2H, 2-H), 2.16 – 2.03 
(m, 2H, 4-H), 1.99 (s, 3H, CH3-Ac), 1.78 – 1.72 (m, 2H, 3-H), 1.68 – 1.59 (m, 2H, 4'-H) 1.33 – 1.22 (m, 
4H, 5'-H and 6'-H), 0.84 (t, J = 7.2 Hz, 3H, 7'-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s, CO-
Ac), 153.6 (s, CO-Cbz), 136.3 (s, Cbz), 128.4 (d, 2C, Cbz), 128.0 (d, Cbz), 127.9 (d, 2C, Cbz), 124.2 
(d, C5), 121.2 (s, C6), 85.5 (s, C1'), 81.7 (s, C2'), 67.5 (t, Cbz), 64.5 (d, C3'), 43.9 (t, C2), 34.4 (t, C4'), 
27.0 (t, C5'), 23.6 (t, C4), 22.4 (q, CH3-Ac), 22.2 (t, C6'), 21.0 (t, C3), 13.9 (q, C7') ppm. MS (ESI) m/z 
(%): 761 ([2M+Na]+, 100), 392 ([M+Na]+, 9). 
N
CO2Me
OAc  
6-(3-Acetoxy-hept-1-ynyl)-3,4-dihydro-2H-pyridine-1-carboxylic Acid Methyl Ester (7d).  
Sonogashira coupling of phosphate 12d (385 mg, 0.99 mmol) and (±)-heptyn-3-ol after 
chromatography (n-hexane/EtOAc, 4 : 1 + 1 % Et3N; Rf = 0.28) afforded enynyl alcohol 13d which was 
used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 5.59 (t, J = 4.1 Hz, 1H, 5-H), 4.56 – 
4.38 (m, 1H, 3'-H), 3.74 (s, 3H, OCH3), 3.63 – 3.58 (m, 2H, 2-H), 2.53 – 2.38 (bs, 1H, OH), 2.21 – 2.12 
(m, 2H, 4-H), 1.85 – 1.63 (m, 4H, 3-H and 4'-H), 1.52 – 1.22 (m, 4H, 5'-H and 6'-H), 0.91 (t, J = 7.0 Hz, 
3H, 7'-H) ppm.  
According to the above described procedure, compound 13d was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 15 : 1 + 1 % Et3N; Rf = 0.16) pure 7d was obtained as an orange 
oil (200 mg, 69 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 5.61 (t, J = 4 Hz, 1H, 5-H), 5.45 (t, J 
= 6.6 Hz, 1H, 3'-H), 3.73 (s, 3H, OCH3), 3.65 – 3.54 (m, 2H, 2-H), 2.16 (dt, J = 6.7, 4.0 Hz, 2H, 4-H), 
2.06 (s, 3H, CH3-Ac), 1.80 – 1.72 (m, 4H, 3-H and 4'-H), 1.46 – 1.29 (m, 4H, 5'-H and 6'-H), 0.9 (t, J = 
7.2 Hz, 3H, 7'-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.0 (s, CO-Ac), 154.4 (s, CO2CH3), 123.8 
(d, C5), 121.1 (s, C6), 85.3 (s, C1'), 81.6 (s, C2'), 64.5 (d, C3'), 52.6 (q, CO2CH3), 43.7 (t, C2), 34.4 (t, 
C4'), 27.0 (t, C5'), 23.5 (t, C4), 22.4 (q, CH3-Ac), 22.2 (t, C6'), 21.0 (t, C3), 13.9 (q, C7') ppm. MS (ESI) 
m/z (%): 316 ([M+Na]+, 100), 294 ([M+1]+, 5). 
N
Ts
OAc
 
Acetic Acid 1-Methyl-3-[6-methyl-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-
ynyl Ester (7e).  
Sonogashira coupling of phosphate 12e (807 mg, 1.62 mmol) and (±)-3-butyn-2-ol after 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.29) afforded enynyl alcohol 13e which was 
used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.3 Hz, 2H, Ts), 7.29 (d, 
J = 8.3 Hz, 2H, Ts), 5.67 – 5.62 (m, 1H, 3-H), 4.61 – 4.57 (m, 1H, 6-H), 4.57 – 4.49 (m, 1H, 1'-H), 2.41 
(s, 3H, CH3-Ts), 2.32 – 2.18 (m, 1H, OH), 2.14 – 2.02 (m, 1H, 5-H), 2.00 – 1.91 (m, 1H, 4-H), 1.53 – 
1.31 (m, 5H, 1'-CH3, 4-H' and 5-H'), 1.14 (d, J = 6.8 Hz, 3H, 6-CH3) ppm.  
According to the above described procedure, compound 13e was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 8 : 1 + 1 % Et3N; Rf = 0.17) pure 7e was obtained as a pale yellow 
oil (350 mg, 60 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.74 (d, J = 8.3 Hz, 2H, Ts), 7.27 (d, 
J = 8.3 Hz, 2H, Ts), 5.66 (d, J = 4.0 Hz, 1H, 3-H), 5.56 – 5.49 (m, 1H, 1'-H), 4.53 – 4.47 (m, 1H, 6-H), 
2.40 (s, 3H, CH3-Ts), 2.07 – 1.93 (m, 5H, CH3-Ac and 4-H), 1.46 (m, 4H, 1'-CH3 and 5-H), 1.38 – 1.29 
(m, 1H, 5-H'), 1.09 (d, J = 6.8 Hz, 6-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s, CO), 143.3 
(s, Ts), 137.1 (s, Ts), 129.5 (d, 2C, Ts), 127.4 (d, 2C, Ts), 124.0 (d, C3), 117.6 (s, C2), 87.8 (s, C3'), 
81.4 (s, C2'), 60.6 (d, C1',), 49.7 (d, C6), 25.0 (t, C4,), 21.5 (q, CH3-Ts), 21.1 (q, CH3-Ac), 20.9 (q, C1'-
CH3), 19.2 (t, C5), 17.3 (q, C6-CH3) ppm. MS (ESI) m/z (%): 745 ([2M+Na]+, 100), 384 ([M+Na]+, 9), 
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362 ([M+1]+, 13). 
N
Ts
OAc
 
Acetic Acid 1-Methyl-3-[4-methyl-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-
ynyl Ester (7f).  
Sonogashira coupling of phosphate 12f (855 mg, 2.05 mmol) and (±)-3-butyn-2-ol after 
chromatography (n-hexane/EtOAc, 2:1 + 1 % Et3N; Rf = 0.24) afforded enynyl alcohol 13f which was 
used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.2 Hz, 2H, Ts), 7.29 (d, 
J = 8.2 Hz, 2H, Ts), 5.50 (d, J = 3.4 Hz, 1H, 3-H), 4.60 (q, J = 6.5 Hz, 1H, 1'-H), 3.79 – 3.73 (m, 1H, 6-
H), 3.54 – 3.47 (m, 1H, 6-H), 2.55 – 2.33 (m, 4H, CH3-Ts and OH), 2.27 – 2.21 (m, 1H, 4-H), 1.72 – 
1.65 (m, 1H, 5-H), 1.43 (d, J = 6.5 Hz, 3H, 1'-CH3), 1.22 – 1.14 (m, 1H, 5-H'), 0.87 (d, J = 7.0 Hz, 3H, 
4-CH3) ppm.  
According to the above described procedure, compound 13f was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 8 : 1 + 1 % Et3N; Rf = 0.17) pure 7f was obtained as a pale yellow 
oil (350 mg, 57% after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.75 (d, J = 8.1 Hz, 2H, Ts), 7.28 (d, 
J = 8.1 Hz, 2H, Ts), 5.56 – 5.51 (m, 2H, 3-H and 1'-H), 3.77 – 3.70 (m, 1H, 6-H), 3.51 – 3.45 (m, 1H, 6-
H'),  2.40 (s, 3H, CH3-Ts), 2.26 – 2.20 (m, 1H, 4-H), 2.06 (s, 3H, CH3-Ac), 1.72 – 1.65 (m, 1H, 5-H), 
1.48 (d, J = 6.7 Hz, 3H, 1'-CH3), 1.23 – 1.15 (m, 1H, 5-H'), 0.86 (d, J = 7.1 Hz, 4-CH3) ppm. 13C NMR 
(100.4 MHz, CDCl3) δ = 169.9 (s, CO), 143.5 (s, Ts), 136.9 (s, Ts), 130.1 (d, C3), 129.5 (d, 2C, Ts), 
127.5 (d, 2C, Ts), 119.1 (s, C2), 87.5 (s, C3'), 80.5 (s, C2'), 60.6 (d, C1'), 44.7 (t, C6), 29.0 (t, C5), 28.6 
(d, C4), 21.6 (q, CH3-Ts), 21.1 (q, CH3-Ac), 20.9 (q, C1'-CH3), 20.6 (q, C6-CH3) ppm. MS (ESI) m/z 
(%): 745 ([2M+Na]+, 100), 384 ([M+Na]+, 38). 
N
Ts
OAc
TBSO
 
Acetic Acid 3-[5-(tert-Butyl-dimethyl-silanyloxy)-1-(toluene-4-sulfonyl)-1,4,5,6-tetra-hydro-
pyridin-2-yl]-prop-2-ynyl Ester (13ga).  
Sonogashira coupling of phosphate 12g (640 mg, 1.04 mmol) and propargyl alcohol after 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.16) afforded enynyl alcohol 13ga which 
was used immediately in the next step. 1H NMR (200 MHz, CDCl3) δ = 7.79 (d, J = 8.2 Hz, 2H, Ts), 
7.31 (d, J = 8.2 Hz, 2H, Ts), 5.56 (t, J = 4.0 Hz, 1H, 3-H), 4.31 (s, 2H, 1'-H), 4.01 (dd, J = 12.7, 3.1 Hz, 
1H, 6-H), 3.82 – 3.63 (m, 1H, 5-H), 3.03 (dd, J = 12.7, 9.8 Hz, 1H, 6-H'), 2.43 – 2.27 (m, 4H, CH3-Ts 
and 4-H), 2.00 (ddd, J = 19.1, 7.8, 4.0 Hz, 1H, 4-H'), 1.77 (bs, 1H, OH), 0.86 (s, 9H, SiC(CH3)3), 0.06 
(s, 6H, Si(CH3)2) ppm. 
According to the above described procedure, compound 13ga was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.22) pure 7ga was obtained as a pale 
yellow oil (202 mg, 42 % after two steps). [𝛼]$%+ = + 61.6 (c = 0.98, CHCl3). 1H NMR (400 MHz, CDCl3) 
δ = 7.76 (d, J = 8.0 Hz, 2H, Ts), 7.29 (d, J = 8.0 Hz, 2H, Ts), 5.58 (t, J = 4.0 Hz, 1H, 3-H), 4.72 (s, 2H, 
1'-H), 3.98 (ddd, J = 12.8, 3.9, 1.1 Hz, 1H, 6-H), 3.75 (dddd, J = 9.9, 8.0, 5.7, 3.9 Hz, 1H, 5-H), 2.99 
(dd, J = 12.8, 9.9 Hz, 1H, 6-H'), 2.41 (s, 3H, CH3-Ts), 2.34 (dt, J = 19.2, 5.7 Hz, 1H, 4-H), 2.08 (s, 3H, 
CH3-Ac), 1.99 (ddd, J = 19.2, 8.0, 4.0 Hz, 1H, 4-H'), 0.87 (s, 9H, SiC(CH3)3), 0.07 (s, 3H, SiCH3), 0.04 
(s, 3H, SiCH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.1 (s, CO), 143.6 (s, Ts), 137.3 (s, Ts), 129.5 
(d, 2C, Ts), 127.4 (d, 2C, Ts), 122.6 (d, C3), 119.6 (s, C2), 84.2 (s, C3'), 81.6 (s, C2'), 63.6 (t, C1'), 52.4 
(t, C6), 51.2 (d, C5), 33.4 (t, C4), 25.7 (q, 3C, SiC(CH3)3), 21.5 (q, CH3-Ts), 20.7 (q, CH3-Ac), 18.0 (s, 
SiC(CH3)3), -4.8 (q, SiCH3), -4.9 (q, SiCH3) ppm. MS (ESI) m/z (%): 949 ([2M+Na]+, 100), 486 
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Acetic acid 3-[6-(tert-butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-
pyridin-2-yl]-prop-2-ynyl ester (7h). 
Sonogashira coupling of phosphate 12h (1.63 g, 2.6 mmol) and propargyl alcohol after 
chromatography (heptane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.34) afforded enynyl alcohol 13h which was 
used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.78 (d, J = 8.2 Hz, 2H, Ts), 7.29 (d, 
J = 8.2 Hz, 2H, Ts), 5.66 (t, J = 3.8 Hz, 1H, 3-H), 4.46 – 4.37 (m, 1H, 6-H), 4.31 (s, 2H, 3’-H), 3.64 (dd, 
J = 10.0, 6.3 Hz, 1H, 6-CH2OTBS), 3.76 (dd, J = 10.0, 8.9 Hz, 1H, 6-CH2OTBS), 2.42 (s, 3H, CH3-Ts), 
2.06 – 1.86 (m, 4H, 4 and 5-H), 0.86 (s, 9H, CH3-TBS), 0.04 (s, 3H, CH3-TBS), 0.03 (s, 3H, CH3-TBS) 
ppm.  
According to the above described procedure, compound 13h was subjected to acetylation. After 
chromatography (heptane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.31) pure 7h was obtained as a pale yellow 
oil (550 mg, 44 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.78 (d, J = 8.2 Hz, 2H, Ts), 7.28 (d, 
J = 8.2 Hz, 2H, Ts), 5.70 (t, J = 3.8 Hz, 1H, 3-H), 4.75 (s, 2H, 3’-H), 4.46 – 4.39 (m, 1H, 6-H), 3.63 (dd, 
J = 9.6, 6.3 Hz, 1H, 6-CH2OTBS), 3.45 (t, J = 6.3 Hz, 1H, 6-CH2OTBS), 2.42 (s, 3H, CH3-Ts), 2.10 (s, 
3H, CH3-Ac), 2.04 – 1.87 (m, 3H, 4 and 5-H), 1.32 – 1.21 (m, 1H, 5-H), 0.86 (s, 9H, CH3-TBS), 0.04 (s, 
3H, CH3-TBS), 0.03 (s, 3H, CH3-TBS) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 175.6 (s, CO), 149.1 (s, 
Ts), 142.3 (s, Ts), 134.9 (d, 2C, Ts), 132.8 (d, 2C, Ts), 130.5 (d, C3), 123.8 (s, C2), 88.7 (s, C1’), 88.5 
(s, C2’), 66.8 (t, C3’), 60.3 (t, 6-CH2), 58.2 ( (d, C6), 31.4 (q, 3C, CH3-TBS), 27.2 (t, C4), 26.4 (t, C5), 
25.0 (q, CH3-Ts), 23.8 (q, CH3-Ac), 0.2 (q, CH3-TBS), 0.0 (q, CH3-TBS) ppm. MS (ESI) m/z (%): 478 
([M+1]+, 65).  
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Acetic acid 3-[4-tert-butoxy-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-ynyl 
ester (7i) 
Sonogashira coupling of phosphate 12i (530 mg, 0.7 mmol) and propargyl alcohol after 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.30) afforded enynyl alcohol 13i which was 
used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.3 Hz, 2H, Ts), 7.29 (d, 
J = 8.0 Hz, 2H, Ts), 5.48 (d, J = 4.3 Hz, 1H, 3-H), 4.32 (s, 2H, 1'-H), 4.04 (dt, J = 12.8, 3.7, 1H, 4-H), 
3.87 (q, J = 4.4 Hz, 1H, 6-H), 3.39 - 3.34 (m, 1H, 6-H), 2.42 (s, 3H, CH3-Ts), 1.75 - 1.76 (m, 3H, 5-H, 
OH), 1.16 (s, 9H, CH3-t-Bu)  ppm. 
According to the above described procedure, compound 13i was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.43) pure 7i was obtained as a colourless 
oil (82 mg, 30 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.75 (d, J = 8.3 Hz, 2H, Ts), 7.28 (d, J 
= 8.3 Hz, 2H, Ts), 5.50 (d, J = 4.3 Hz, 1H, 3-H), 4.75 (s, 2H, 1'-H), 3.02 (dt, J = 9.0, 3.9, 1H, 4-H), 3.91 
(q, J = 4.3, 1H, 6-H), 3.38 - 3.31 (m, 1H, 6-H), 2.41 (s, 3H, CH3-Ts), 2.09 (s, 3H, CH3-Ac), 1.72 (q, J = 
4.15 Hz, 2H, 5-H), 1.15 (s, 9H, t-Bu) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.1 (s, CO), 143.6 (s, 
Ts), 137.1 (s, Ts), 129.5 (s, 2C, Ts), 127.4 (s, 2C, Ts), 124.0 (d, C3), 120.9 (s, C2), 85.1 (s, C1’), 81.5 
(s, C2’), 74.3 (d, C4), 60.5 (t, C3’), 52.4 (s, t-Bu), 42.6 (s, C6), 31.3 (s, C5) 28.2 (s, 3C, CH3-t-Bu), 21.5 
(q, CH3-Ts), 20.7 (s, CH3-Ac) ppm. MS (ESI) m/z (%): 832 ([2M+Na]+, 100), 428 ([M+Na]+, 25). 
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Acetic acid 3-[2,2-dimethyl-5-(toluene-4-sulfonyl)-3a,4,5,7a-tetrahydro-[1,3]dioxolo[4,5-
c]pyridin-6-yl]-1-methyl-prop-2-ynyl ester (7j) 
Sonogashira coupling of phosphate 12j (250 mg, 0.45 mmol) and (±)-3-butyn-2-ol after 
chromatography (heptane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.28) afforded enynyl alcohol 13j which was 
used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.80 (d, J = 8.2 Hz, 2H, Ts), 7.31 (d, 
J = 8.1 Hz, 2H, Ts), 5.73 (d, J = 4.7 Hz, 1H, 3-H), 4.58 (q, J = 6.6 Hz, 1H, 3’-H), 4.38 (dd, J = 5.9, 3.8 
Hz, 1H, 4-H), 4.25 – 4.00 (m, 2H, 6-H), 3.09 (dt, J = 12.1, 3.8 Hz, 1H, 5-H), 2.43 (s, 3H, CH3-Ts), 1.42 
(d, J = 6.6 Hz, 3H, 3’-CH3), 1.37 (s, 3H, CH3), 1.33 (s, 3H, CH3) ppm. 
According to the above described procedure, compound 13j was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 8 : 1 + 1 % Et3N; Rf = 0.19) pure 7j was obtained as a yellowish oil 
(75 mg, 41 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.80 (d, J = 8.2 Hz, 2H, Ts), 7.30 (d, J = 
8.2 Hz, 2H, Ts), 5.86 – 5.62 (m, 1H, 3-H), 5.52 (q, J = 6.7 Hz, 1H, 3’-H), 4.37 (dd, J = 6.0, 4.4 Hz, 1H, 
4-H), 4.20 – 4.10 (m, 1H, 6-H), 4.04 (dd, J = 12.9, 4.4 Hz, 1H, 5-H), 3.01 (ddd, J = 12.9, 9.5, 8.0 Hz, 
1H, 6-H), 2.42 (s, 3H, CH3-Ts), 2.08 (s, 3H, CH3-Ac), 1.46 (d, J = 6.7 Hz, 3H, 3’-CH3), 1.35 (s, 3H, 
CH3), 1.32 (s, 3H, CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.6 (s, CO), 143.5 (s, Ts), 136.7 (s, 
Ts), 129.4 (d, 2C, Ts), 127.5 (d, 2C, Ts), 122.9 (s, C2), 119.5 (d, C3), 108.9 (s, C(CH3)2), 90.4 (s, C1’), 
78.9 (s, C2’), 70.6 (d, C5), 68.9 (d, C4), 60.3 (d, C3’), 47.1 (t, C6), 27.8 (q, CH3), 24.9 (q, CH3), 21.5 (q, 
CH3), 20.9 (q, CH3) 20.7 (q, CH3) ppm. MS (ESI) m/z (%): 860 ([2M+Na]+, 100), 441 ([M+Na]+, 74), 
419 ([M+1]+, 25). 
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Acetic acid 1-methyl-3-[8-(toluene-4-sulfonyl)-1,4-dioxa-8-aza-spiro[4.5]dec-6-en-7-yl]-prop-2-
ynyl ester (7k) 
Sonogashira coupling of phosphate 12k (2.1 g, 2.86 mmol) and (±)-3-butyn-2-ol after chromatography 
(heptane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.30) afforded enynyl alcohol 13k which was used immediately 
in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.3 Hz, 2H, Ts), 7.27 (d, J = 8.3 Hz, 2H, 
Ts), 5.30 (s, 1H, 3-H), 4.57 (q, J = 6.6 Hz, 1H, 3’-H), 3.91 – 3.87 (m, 4H, OCH2), 3.84 – 3.81 (m, 2H, 6-
H), 2.42 (s, 3H, CH3-Ts), 1.86 – 1.81 (m, 2H, 5-H), 1.40 (d, J = 6.6 Hz, 3H, 3’-CH3) ppm. 
According to the above described procedure, compound 13k was subjected to acetylation. After 
chromatography (heptane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.19) pure 7k was obtained as a yellowish oil 
(120 mg, 11 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.3 Hz, 2H, Ts), 7.30 (d, J 
= 8.3 Hz, 2H, Ts), 5.54 (q, J = 6.7 Hz, 1H, 3’-H), 5.35 (s, 1H, 3-H), 3.96 – 3.88 (m, 4H, OCH2), 3.85 – 
3.82 (m, 2H, 6-H), 2.42 (s, 3H, CH3-Ts), 2.08 (s, 3H, CH3-Ac), 1.87 – 1.85 (m, 2H, 5-H), 1.50 (d, J = 
6.4 Hz, 3H, 3’-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.0 (s, CO), 143.8 (s, Ts), 136.6 (s, Ts), 
129.5 (d, 2C, Ts), 127.4 (d, 2C, Ts), 123.1 (s, C2), 119.5 (d, C3), 102.8 (s, C4), 90.9 (s, C1’), 78.9 (s, 
C2’), 64.7 (t, 2C, OCH2), 60.4 (d, C3’), 45.8 (t, C6), 32.6 (t, C5), 21.6 (q, CH3), 21.0 (q, CH3-Ts), 20.6 
(q, CH3-Ac) ppm. MS (ESI) m/z (%): 406 ([M+1]+, 100). 
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Acetic Acid 1-Methyl-3-[1-(toluene-4-sulfonyl)-4,5,6,7-tetrahydro-1H-azepin-2-yl]-prop-2-ynyl 
ester (7la).  
Sonogashira coupling of phosphate 12l (838 mg, 1.68 mmol) and (±)-3-butyn-2-ol after 
chromatography (n-hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.20) afforded enynyl alcohol 13la which was 
used immediately in the next step. 1H NMR (200 MHz, CDCl3) δ = 7.86 (d, J = 8.0 Hz, 2H, Ts), 7.33 (d, 
J = 8.0 Hz, 2H, Ts), 6.15 (t, J = 6.9 Hz, 1H, 3-H), 4.50 (q, J = 6.6 Hz, 1H, 1'-H), 3.50 – 3.34 (m, 2H, 7-
H), 2.43 (s, 3H, CH3-Ts), 2.32 – 2.16 (m, 2H, 4-H), 1.94 – 1.81 (m, 2H, 5-H), 1.77 – 1.61 (bs, 1H, OH), 
1.58 – 1.43 (m, 2H, 6-H), 1.37 (d, J = 6.6 Hz, 3H, CH3) ppm. 
According to the above described procedure, compound 13la was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 4 : 1 + 1 % Et3N; Rf = 0.26) pure 7la was obtained as a colourless 
oil (362 mg, 60 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.88 (d, J = 8.4 Hz, 2H, Ts), 7.28 (d, 
J = 8.4 Hz, 2H, Ts), 6.18 (t, J = 6.9 Hz, 1H, 3-H), 5.46 (q, J = 6.7 Hz, 1H, 1'-H), 3.40 – 3.31 (m, 2H, 7-
H), 2.41 (s, 3H, CH3-Ts), 2.24 – 2.22 (m, 2H, 4-H), 2.05 (s, 3H, CH3-Ac), 1.90 – 1.82 (m, 2H, 5-H), 1.54 
– 1.45 (m, 2H, 6-H), 1.39 (d, J = 6.4 Hz, 3H, 1'-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.7 (s, 
CO), 143.2 (s, Ts), 138.4 (s, C2), 137.8 (s, Ts), 129.3 (d, 2C, Ts), 127.5 (d, 2C, Ts), 124.6 (d, C3), 87.0 
(s, C3'), 81.3 (s, C2'), 60.4 (d, C1'), 49.8 (t, C7), 30.7 (t, C6), 27.4 (t, C5), 23.3 (t, C4), 21.5 (q, CH3-Ts), 
21.0 (q, CH3-Ac), 20.9 (q, C1'-CH3) ppm. MS (ESI) m/z (%): 745 ([2M+Na]+, 100), 362 ([M+1]+, 11). 
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Acetic Acid 3-[1-(Toluene-4-sulfonyl)-4,5,6,7-tetrahydro-1H-azepin-2-yl]-prop-2-ynyl Ester (7lb). 
Sonogashira coupling of phosphate 12l (382 mg, 0.764 mmol) and propargyl alcohol after 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.24) afforded enynyl alcohol 13lb which 
was used immediately in the next step. 1H NMR (200 MHz, CDCl3) δ = 7.84 (d, J = 8.2 Hz, 2H, Ts), 
7.29 (d, J = 8.2 Hz, 2H, Ts), 6.16 (t, J = 6.9 Hz, 1H, 3-H), 4.24 (s, 2H, 1'-H), 3.41 – 3.36 (m, 2H, 7-H), 
2.42 (s, 3H, CH3-Ts), 2.28 – 2.15 (m, 2H, 6-H), 2.02 – 1.77 (m, 3H, 4-H and OH), 1.57 – 1.42 (m, 2H, 
5-H) ppm. 
According to the above described procedure, compound 13lb was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.22) pure 7lb was obtained as a colourless 
oil (156 mg, 59 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.83 (d, J = 8.2 Hz, 2H, Ts), 7.28 (d, 
J = 8.2 Hz, 2H, Ts), 6.19 (t, J = 6.9 Hz, 1H, 3-H), 4.65 (s, 2H, 1'-H), 3.41 – 3.33 (m, 2H, 7-H), 2.41 (s, 
3H, CH3-Ts), 2.25 – 2.21 (m, 2H, 4-H), 2.07 (s, 3H, CH3-Ac), 1.88 – 1.82 (m, 2H, 5-H), 1.51 – 1.47 (m, 
2H, 6-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.1 (s, CO), 143.3 (s, Ts), 138.5 (s, C2), 137.8 (s, 
Ts), 129.3 (d, 2C, Ts), 127.6 (d, 2C, Ts), 124.6 (d, C3), 83.1 (s, C3'), 82.8 (s, C2'), 52.4 (t, C1'), 49.9 (t, 
C7), 30.7 (t, C6), 27.4 (t, C5), 23.4 (t, C4), 21.5 (q, CH3-Ts), 20.7 (q, CH3-Ac) ppm. MS (ESI) m/z (%): 
717 ([2M+Na]+, 100). 
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Acetic Acid 3-[5-Methyl-1-(toluene-4-sulfonyl)-4,5-dihydro-1H-pyrrol-2-yl]-prop-2-ynyl Ester 
(7m).  
Sonogashira coupling of triflate 12m (454 mg, 1.18 mmol) and propargyl alcohol after chromatography 
(n-hexane/EtOAc, 1 : 1 + 1 % Et3N; Rf = 0.17) afforded enynyl alcohol 13m which was used 
immediately in the next step. 1H NMR (200 MHz, CDCl3) δ = 7.76 (d, J = 8.2 Hz, 2H, Ts), 7.30 (d, J = 
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8.2 Hz, 2H, Ts), 5.49 (t, J = 3.3 Hz, 1H, 3-H), 4.45 (s, 2H, 1'-H), 4.29 – 4.04 (m, 1H, 5-H), 2.70 – 2.24 
(m, 5H, OH, 4-H and CH3-Ts), 1.92 (dt, J = 17.9, 3.3 Hz, 1H, 4-H), 1.35 (d, J = 6.5 Hz, 3H, 5-CH3) 
ppm. 
According to the above described procedure, compound 13m was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 4 : 1 + 1 % Et3N; Rf = 0.24) pure 7m was obtained as a colourless 
oil (168 mg, 43 % after three steps). 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.5 Hz, 2H, Ts), 7.29 
(d, J = 8.5 Hz, 2H, Ts), 5.52 (t, J = 3.3 Hz, 1H, 3-H), 4.85 (s, 2H, 1'-H), 4.24 – 4.12 (m, 1H, 5-H), 2.43 – 
2.36 (m, 4H, CH3-Ts and 4-H), 2.11 (s, 3H, CH3-Ac), 1.94 (dt, J = 18.0, 3.3 Hz, 1H, 4-H'), 1.35 (d, J = 
6.5 Hz, 3H, 5-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.2 (s, CO), 143.7 (s, Ts), 134.6 (s, Ts), 
129.5 (d, 2C, Ts), 127.7 (d, 2C, Ts), 123.24 (d, C3), 123.21 (s, C2), 87.3 (s, C3'), 80.0 (s, C2'), 57.6 (t, 
C1'), 52.5 (d, C5), 36.5 (t, C4), 23.4 (q, C5-CH3), 21.5 (q, CH3-Ts), 20.7 (q, CH3-Ac) ppm. MS (ESI) 
m/z (%): 689 ([2M+Na]+, 100), 334 ([M+1]+, 9). 
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Acetic Acid 1-Methyl-3-[1-(toluene-4-sulfonyl)-4,5-dihydro-1H-pyrrol-2-yl]-prop-2-ynyl Ester (7n).  
Sonogashira coupling of triflate 12n (450 mg, 1.2 mmol) and (±)-3-butyn-2-ol after chromatography (n-
hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.15) afforded enynyl alcohol 13n which was used immediately 
in the next step. 1H NMR (200 MHz, CDCl3) δ = 7.81 (d, J = 8.2 Hz, 2H, Ts), 7.33 (d, J = 8.2 Hz, 2H, 
Ts), 5.51 (t, J = 3.0 Hz, 1H, 3-H), 4.73 (q, J = 6.6 Hz, 1H, 1'-H), 3.75 (t, J = 9.9 Hz, 2H, 5-H), 2.48 – 
2.33 (m, 5H, 4-H and CH3-Ts), 1.54 (d, J = 6.6 Hz, 1'-CH3) ppm. 
According to the above described procedure, compound 13n was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.27) pure 7n was obtained as a colourless 
oil (143 mg, 36 % after three steps). 1H NMR (400 MHz, CDCl3) δ = 7.80 (d, J = 8.2 Hz, 2H, Ts), 7.32 
(d, J = 8.2 Hz, 2H, Ts), 5.62 (q, J = 6.7 Hz, 1H, 1'-H), 5.52 (t, J = 3.0 Hz, 1H, 3-H), 3.74 (t, J = 9.0 Hz, 
2H, 5-H), 2.43 (s, 3H, CH3-Ts), 2.38 (td, J = 9.0, 3.0 Hz, 2H, 4-H), 2.10 (s, 3H, CH3-Ac), 1.58 (d, J = 
6.7 Hz, 3H, 1'-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s, CO), 143.8 (s, Ts), 133.8 (s, Ts), 
129.5 (d, 2C, Ts), 128.1 (d, 2C, Ts), 124.5 (s, C2), 122.5 (d, C3), 92.5 (s, C3'), 75.6 (s, C2'), 60.5 (d, 
C1'), 49.3 (t, C5), 28.2 (t, C4), 21.5 (q, CH3-Ts), 21.0 (q, C1'-CH3), 20.7 (q, CH3-Ac) ppm. MS (ESI) m/z 
(%): 689 ([2M+Na]+, 100). 
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2-(3-Acetoxybut-1-ynyl)-indole-1-carboxylic Acid Methyl Ester (7o).  
Sonogashira coupling of triflate 12o (359 mg, 1.11 mmol) and (±)-3-butyn-2-ol after chromatography 
(n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.15) afforded enynyl alcohol 13o which was used 
immediately in the next step. 1H NMR (200 MHz, CDCl3) δ = 8.11 (d, J = 8.1 Hz, 1H, 4-H), 7.52 (d, J = 
7.0 Hz, 1H, 7-H), 7.50 – 7.21 (m, 2H, 5-H and 6-H), 6.90 (s, 1H, 3-H), 4.82 – 4.75 (m, 1H, 3'-H), 4.06 
(s, 3H, OCH3), 2.18 – 2.05 (bs, 1H, OH), 1.59 (d, J = 6.6 Hz, 3H, 4'-H) ppm. 
According to the above described procedure, compound 13o was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.28) pure 7o was obtained as a yellowish oil 
(158 mg, 50 % after three steps). 1H NMR (400 MHz, CDCl3) δ = 8.16 (d, J = 8.2 Hz, 1H, 4-H), 7.52 (d, 
J = 7.8 Hz, 1H, 7-H), 7.39 – 7. 35 (m, 1H, 6-H), 7.27 – 7.24 (m, 1H, 5-H), 6.94 (s, 1H, 3-H), 5.73 (q, J = 
6.6 Hz, 1H, 3'-H), 4.06 (s, 3H, OCH3), 2.13 (s, 3H, CH3-Ac), 1.63 (d, J = 6.6 Hz, 3H, 4'-H) ppm. 13C 
NMR (100.4 MHz, CDCl3) δ = 169.8 (s, CO-Ac), 151.4 (s, CO2CH3), 136.0 (s, C7a), 128.4 (s, C3a), 
125.9 (d, C5), 123.5 (d, C4), 120.8 (d, C6), 119.3 (s, C2), 117.3 (d, C3), 115.5 (d, C7), 93.1 (s, C1'), 
76.7 (s, C2'), 60.8 (d, C3'), 53.5 (q, CO2CH3), 21.1 (q, C4'), 21.0 (q, CH3-Ac) ppm. MS (ESI) m/z (%): 
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593 ([2M+Na]+, 100), 308 ([M+Na]+, 25). 
N
Ts
OAc 
Acetic acid 1-methyl-3-[3-methyl-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-
ynyl ester (7p). 
Sonogashira coupling of triflate 12p (345 mg, 0.86 mmol) and (±)-3-butyn-2-ol after chromatography 
(n-hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.40) afforded enynyl alcohol 13p which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.78 (d, J = 8.0 Hz, 2H, Ts), 7.30 (d, J = 
8.0 Hz, 2H, Ts), 4.61 (q, J = 8.0 Hz, 1H, 1’-H), 3.63 - 3.60 (m, 2H, 6-H), 2.43 (s, 3H, CH3-Ts), 2.27 – 
2.03 (m, 2H, 4-H), 1.88 (s, 3H, 3-CH3), 1.69 – 1.63 (m, 2H, 5-H), 1.43 (d, J = 4.0 Hz, 3H, 1'-CH3) ppm. 
According to the above described procedure, compound 13p was subjected to acetylation. After 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.23) pure 7p was obtained as a yellowish oil 
(177 mg, 57 % after two steps). 1H NMR (400 MHz, CDCl3) δ = 7.25 (d, J = 8.0 Hz, 2H, Ts), 7.26 (d, J 
= 8.0 Hz, 2H, Ts), 5.53 (q, J = 8.0 Hz, 1H, 1’-H), 3.56 - 3.54 (m, 2H, 6-H), 2.40 (s, 3H, CH3-Ts), 2.06 – 
2.01 (m, 2H, 4-H), 2.05 (s, 3H, CH3-Ac), 1.85 (s, 3H, 3-CH3), 1.68 – 1.62 (m, 2H, 5-H), 1.45 (d, J = 8.0 
Hz, 3H, 1'-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.8 (s, CO), 143.1 (s, Ts), 137.8 (s, Ts), 
134.3 (s, C2), 129.4 (d, 2C, Ts), 127.4 (d, 2C, Ts), 115.2 (s, C3), 91.9 (s, C1’), 79.5 (s, C2’), 60.7 (d, 
C3’), 45.7 (t, C6), 28.9 (q, CH3-3), 21.8 (q, CH3-Ts), 21.5 (t, C4), 21.0 (q, CH3-Ac), 20.9 (t, C5), 20.8 (q, 
CH3-3’) ppm. MS (ESI) m/z (%): 745.01 ([2M+Na]+, 65), 384 ([M+23]+, 100), 378 ([M+18]+, 14). 
N
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Acetic Acid (5S)-3-[5-Hydroxy-1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-ynyl 
Ester (7gb).  
To the solution of enynyl acetate 7ga (133 mg, 0.29 mmol) in THF (14 mL), a freshly prepared solution 
of TBAF·3H2O (0.33 mmol, 104 mg) in THF (0.33 mL) was added at room temperature. After 1 h THF 
was removed under reduced pressure. After chromatography (n-hexane/EtOAc, 1 : 1 + 1 % Et3N; Rf = 
0.40) pure 7gb was obtained as a pale yellow oil (82 mg, 82 %). [𝛼]$%+ =	 + 8.7 (c = 0.86, CHCl3). 1H 
NMR (400 MHz, CDCl3) δ = 7.81 (d, J = 8.2 Hz, 2H, Ts), 7.30 (d, J = 8.2 Hz, 2H, Ts), 5.59 (t, J = 4.1 
Hz, 1H, 3-H), 4.72 (s, 2H, 1'-H), 4.07 – 4.01 (m, 1H, 5-H), 3.74 – 3.67 (m, 1H, 6-H), 3.59 (dd, J = 13.1, 
7.2 Hz, 1H, 6-H'), 2.51 – 2.38 (m, 5H, OH, 4-H and CH3-Ts), 2.20 – 2.05 (m, 4H, 4-H' and CH3-Ac) 
ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.1 (s, CO), 143.7 (s, Ts), 137.3 (s, Ts), 129.5 (d, 2C, Ts), 
127.6 (d, 2C, Ts), 121.4 (d, C3), 119.7 (s, C2), 84.6 (s, C3'), 81.2 (s, C2'), 62.8 (t, C1'), 52.4 (t, C6), 
50.8 (d, C5), 32.5 (t, C4), 21.5 (q, CH3-Ts), 20.7 (q, CH3-Ac) ppm. MS (ESI) m/z (%): 721 ([2M+Na]+, 
100). 
General procedure for gold(I)-catalyzed Nazarov reaction. 
Precatalyst LAuCl (3 mol %, 0.006 mmol) was dissolved in DCM (1.5 mL) and silver salt (3 mol %, 
0.006 mmol) was added. The formed suspension was left to stir at room temperature under nitrogen 
atmosphere. After 20 min a solution of enynyl acetate 7 (0.2 mmol) in DCM (2.5 mL) was added and 
reaction mixture was stirred at room temperature. The progress of the reaction was followed by TLC. 
After complete consumption of enynyl acetate (1 – 5 h) the reaction mixture was left to stir at room 
temperature overnight. Water (5 mL) was added and the product extracted with DCM (3 x 5 mL). The 
combined organic extracts were dried over anhydrous Na2SO4, filtered and concentrated. The oily 
residue was purified by flash chromatography to give the corresponding cyclopentane-fused piperidine 
derivatives.  
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5-Butyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (17aa).  
Compound 17aa was prepared according to the above described procedure starting from 7aa (59 mg, 
0.15 mmol). Reaction was carried out with 3 mol % of Ph3PAuCl/AgSbF6. Chromatography (n-
hexane/EtOAc, 6 : 1) afforded pure ketone 17aa (Rf = 0.17; 37 mg, 70 %) as a yellow oil and acetate 
14aa (Rf = 0.24; 8 mg, 14 %) as an orange oil. 
17aa: 1H NMR (400 MHz, CDCl3) δ = 7.99 (d, J = 8.2 Hz, 2H, Ts), 7.29 (d, J = 8.2 Hz, 2H, Ts), 3.50 – 
3.36 (m, 2H, 2-H), 2.72 – 2.68 (m, 1H, 5-H), 2.60 (dd, J = 18.2, 6.4 Hz, 1H, 6-H), 2.47 (dt, J = 19.9, 6.8 
Hz, 1H, 4-H), 2.41 (s, 3H, CH3-Ts), 2.28 (dt, J = 19.9, 6.4 Hz, 1H, 4-H'), 2.13 (dd, J = 18.2, 2.2 Hz, 1H, 
6-H'), 2.01 – 1.99 (m, 2H, 3-H), 1.76 – 1.71 (m, 1H, 1'-H), 1.43 – 1.21 (m, 5H, 1'-H', 2'-H and 3'-H), 
0.90 (t, J = 7.0 Hz, 3H, 4'-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 200.1 (s, C7), 162.6 (s, C7a), 
143.6 (s, Ts),  138.2 (s, C4a), 137.5 (s, Ts), 129.5 (d, 2C, Ts), 127.9 (d, 2C, Ts), 46.2 (t, C2), 40.1 (t, 
C6), 39.3 (d, C5), 32.9 (t, C1'), 29.0 (t, C2'), 24.1 (t, C4), 22.9 (t, C3'), 21.9 (t, C3), 21.7 (q, CH3-Ts), 
14.1 (q, C4') ppm. MS (ESI) m/z (%): 717 ([2M+Na]+, 100), 370 ([M+Na]+, 12). Elemental analysis 
calcd (%) for C19H25NO3S: C 65.68, H 7.25, N 4.03; found: C 65.36, H 7.43, N 4.07. 
14aa: 1H NMR (400 MHz, CDCl3) δ = 7.67 (d, J = 8.0 Hz, 2H, Ts), 7.25 (d, J = 8.0 Hz, 
2H, Ts), 6.03 (bs, 1H, 6-H), 4.16 – 4.09 (m, 1H, 2-H), 3.05 (td, J = 13.6, 2.8 Hz, 1H, 2-
H'), 2.41 (s, 3H, CH3-Ts), 2.21 – 2.03 (m, 7H, CH3-Ac, 4-H, 4a-H and 1'-H), 1.64 – 
1.56 (m, 1H, 3-H), 1.48 – 1.23 (m, 5H, 3-H', 2'-H and 3'-H), 1.04 (qd, J = 12.8, 3.6 Hz, 
1H, 4-H'), 0.88 (t, J = 7.2 Hz, 4'-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 168.5 (s, 
CO), 150.3 (s, C7), 143.6 (s, Ts), 137.4 (s, Ts), 129.5 (d, 2C, Ts), 127.4 (d, 2C, Ts), 123.7 (s, C7a), 
122.9 (d, C6), 49.5 (t, C2), 45.5 (d, C4a), 30.7 (t, C2'), 29.7 (s, C5), 28.4 (t, C4), 28.1 (t, C1'), 25.0 (t, 
C3), 22.4 (t, C3'), 21.5 (q, CH3-Ts), 20.7 (q, CH3-Ac), 13.9 (q, C4') ppm. MS (ESI) m/z (%): 801 
([2M+Na]+, 100), 390 ([M+Na]+, 12). Elemental analysis calcd (%) for C21H27NO4S: C 64.75, H 6.99, N 
3.06; found: C, 64.82, H 7.08, N 3.04.  
N
Cbz O  
5-Butyl-7-oxo-2,3,4,5,6,7-hexahydro-[1]pyrindine-1-carboxylic Acid Benzyl Ester (17c).  
Compound 17c was prepared according to the above described procedure starting from 7c (28 mg, 
0.075 mmol). Reaction was carried out with 8 mol % of Ph3PAuCl/AgSbF6 in refluxing DCM. 
Chromatography (n-hexane/EtOAc, 6 : 1; Rf = 0.17) afforded pure ketone 17c (15 mg, 62 %) as a 
yellow oil. 1H NMR (400 MHz, CDCl3) δ = 7.40 – 7.27 (m, 5H, Cbz), 5.17 (s, 2H, CH2Ph), 3.61 – 3.58 
(m, 2H, 2-H), 2.72 – 2.64 (m, 1H, 5-H), 2.58 (dd, J = 18.0, 6.4 Hz, 1H, 6-H), 2.49 (dt, J = 19.6, 6.8 Hz, 
1H, 4-H), 2.25 (dt, J = 19.6, 6.6 Hz, 1H, 4-H'), 2.12 (dd, J = 18.0, 1.8 Hz, 1H, 6-H'), 1.92 – 1.86 (m, 2H, 
3-H), 1.77 – 1.66 (m, 1H, 1'-H), 1.37 – 1.20 (m, 5H, 1'-H', 2'-H and 3'-H), 0.90 (t, J = 6.8 Hz, 3H, 4'-H) 
ppm. 13C NMR (100.4 MHz, CDCl3) δ = 199.0 (s, C7), 160.7 (s, CO-Cbz), 153.9 (s, C7a), 138.3 (s, 
C4a), 136.2 (s, Cbz), 128.4 (d, 2C, Cbz), 128.1 (d, 2C, Cbz), 128.0 (d, Cbz), 68.0 (t, CH2Ph), 44.3 (t, 
C2), 40.5 (t, C6), 38.8 (d, C5), 32.8 (t, C1'), 29.0 (t, C2'), 24.3 (t, C4), 22.7 (t, C3'), 22.3 (t, C3), 13.2 (q, 
C4') ppm. MS (ESI) m/z (%): 677 ([2M+Na]+, 100), 328 ([M+Na]+, 4). Elemental analysis calcd (%) for 
C20H25NO3: C 73.37, H 7.70, N 4.28; found: C 73.67, H 7.77, N 4.52. 
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5-Butyl-7-oxo-2,3,4,5,6,7-hexahydro-[1]pyrindine-1-carboxylic Acid Methyl Ester (17d).  
Compound 17d was prepared according to the above described procedure starting from 7d (37 mg, 
0.13 mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6 in refluxing DCM. 
Chromatography (n-hexane/EtOAc, 5 : 1) afforded pure ketone 17d (Rf = 0.16; 20 mg, 64 %) as a 
yellow oil and acetate 14d (Rf = 0.29; 5 mg, 14 %) as a yellow oil. 
17d: 1H NMR (400 MHz, CDCl3) δ = 3.73 (s, 3H, OCH3), 3.63 – 3.49 (m, 2H, 2-H), 2.72 – 2.62 (m, 1H, 
5-H), 2.58 (dd, J = 18.0, 6.5 Hz, 1H, 6-H), 2.47 (dt, J = 19.8, 6.6 Hz, 1H, 4-H), 2.25 (dt, J = 19.8, 6.5 
Hz, 1H, 4-H'), 2.13 (dd, J = 18.0, 2.0 Hz, 1H, 6-H'), 1.92 – 1.86 (m, 2H, 3-H), 1.77 – 1.71 (m, 1H, 1'-H), 
1.41 – 1.17 (m, 5H, 1'-H', 2'-H and 3'-H), 0.89 (t, J = 7.0 Hz, 3H, 4'-H) ppm. Spectroscopical data 
identical to those reported in the literature.39 
14d: 1H NMR (400 MHz, CDCl3) δ = 5.92 (s, 1H, 6-H), 4.33 – 4.09 (m, 1H, 2-H), 
3.69 (s, 3H, OCH3), 2.92 – 2.81 (m, 1H, 2-H'), 2.62 (dd, J = 12.6, 5.5 Hz, 1H, 4a-H), 
2.33 – 2.18 (m, 3H, 4-H and 1'-H), 2.15 (s, 3H, CH3-Ac), 1.93 – 1.84 (m, 1H, 3-H), 
1.84 – 1.71 (m, 1H, 3-H'), 1.54 – 1.40 (m, 2H, 2'-H), 1.40 – 1.27 (m, 2H, 3'-H), 1.14 
(qd, J = 12.6, 3.7 Hz, 1H, 4-H'), 0.89 (t, J  = 7.2 Hz, 3H, 4'-H) ppm. 
N
OAcTs  
Acetic Acid 5,5-Dimethyl-1-(toluene-4-sulfonyl)-2,3,4,5-tetrahydro-1H-[1]pyrindin-7-yl Ester 
(16ad).  
Compound 16ad was prepared according to the above described procedure starting from 7ad (90 mg, 
0.25 mmol). Reaction was carried out with 3 mol % of Ph3PAuCl/AgSbF6. Chromatography (n-
hexane/EtOAc, 10 : 1 + 1 % Et3N; Rf = 0.14) afforded pure acetate 16ad (72 mg, 86 %) as a yellow 
solid. M.p. = 108.0 – 109.4 °C. 1H NMR (400 MHz, CDCl3) δ = 7.65 (d, J = 8.2 Hz, 2H, Ts), 7.24 (d, J = 
8.2 Hz, 2H, Ts), 5.93 (s, 1H, 6-H), 3.54 – 3.51 (m, 2H, 2-H), 2.41 (s, 3H, CH3-Ts), 2.19 (s, 3H, CH3-Ac), 
1.91 (t, J = 6.6 Hz, 2H, 4-H), 1.36 – 1.33 (m, 2H, 3-H), 1.09 (s, 6H, 5-CH3) ppm. 13C NMR (100.4 MHz, 
CDCl3) δ = 168.8 (s, CO), 144.3 (s, C7), 143.4 (s, Ts), 142.1 (s, C7a), 136.1 (s, Ts), 129.7 (s, C4a), 
129.4 (d, 2C, Ts), 127.7 (d, 2C, Ts), 127.5 (d, C6), 47.4 (t, C2), 45.7 (s, C5), 22.6 (q, 2C, C5-CH3), 21.5 
(q, CH3-Ts), 21.1 (q, CH3-Ac), 18.9 (t, C4), 18.6 (t, C3) ppm. MS (ESI) m/z (%): 745 ([2M+Na]+, 100), 
384 ([M+Na]+, 20), 362 ([M+1]+, 14). Elemental analysis calcd (%) for C19H23NO4S: C 63.13, H 6.14, N 
3.88; found: C 62.93, H 6.22, N 3.79. 
N
OTs  
1-(Toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (17ab).  
Compound 17ab was prepared according to the above described procedure starting from 7ab (36 mg, 
0.11 mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6 in refluxing DCM. 
Chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.26) afforded pure ketone 17ab (26 mg, 83 %) as a 
white solid. M.p. = 138.1 – 141.1 °C. 1H NMR (400 MHz, CDCl3) δ = 8.00 (d, J = 8.1 Hz, 2H, Ts), 7.30 
(d, J = 8.1 Hz, 2H, Ts), 3.44 – 3.41 (m, 2H, 2-H), 2.53 – 2.50 (m, 2H, 6-H), 2.45- 2.48 (m, 2H, 5-H), 
2.41 – 2.38 (m, 5H, CH3-Ts and 4-H), 2.02 – 1.96 (m, 2H, 3-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 
200.6 (s, C7), 159.8 (s, C7a), 143.4 (s, Ts), 138.0 (s, C4a), 137.6 (s, Ts), 129.3 (d, 2C, Ts), 127.7 (d, 
2C, Ts), 46.2 (t, C2), 33.4 (t, C6), 27.5 (t, C5), 26.1 (t, C4), 21.8 (t, C3), 21.5 (q, CH3 Ts) ppm. MS (ESI) 
N
OAcMeO2C
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m/z (%): 605 ([2M+Na]+, 100), 292 ([M+1]+, 18). Elemental analysis calcd (%) for C15H17NO3S: C 
61.83, H 5.88, N 4.81; found: C 61.48, H 5.84, N 4.76. 
N
OTs  
5-Methyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (17ac).  
Compound 17ac was prepared according to the above described procedure starting from 7ac (68 mg, 
0.2 mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6. Chromatography (n-
hexane/EtOAc, 5 : 1) afforded pure ketone 17ac (Rf = 0.16; 44 mg, 72 %) as a yellow oil and acetate 
14ac (Rf = 0.24; 8 mg, 14 %) as a grey solid. 
17ac: 1H NMR (400 MHz, CDCl3) δ = 8.00 (d, J = 8.1 Hz, 2H, Ts), 7.30 (d, J = 8.1 Hz, 2H, Ts), 3.49 – 
3.36 (m, 2H, 2-H), 2.82 – 2.75 (m, 1H, 5-H), 2.69 (dd, J = 17.8, 6.5 Hz, 1H, 6-H), 2.49 (dt, J = 19.9, 6.8 
Hz, 1H, 4-H), 2.41 (s, 3H, CH3-Ts), 2.24 (dt, J = 19.9, 6.6 Hz, 1H, 4-H'), 2.04 (dd, J = 17.8, 2.0 Hz, 1H, 
6-H'), 2.01 – 1.97 (m, 2H, 3-H), 1.19 (d, J = 7.1, 3H, 5-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 
199.8 (s, C7), 163.3 (s, C7a), 143.4 (s, Ts),  138.1 (s, C4a), 136.9 (s, Ts), 129.3 (d, 2C, Ts), 127.8 (d, 
2C, Ts), 46.0 (t, C2), 42.4 (t, C6), 33.8 (d, C5), 23.6 (t, C4), 21.8 (t, C3), 21.5 (q, CH3-Ts), 19.1 (q, C5-
CH3) ppm. MS (ESI) m/z (%): 633 ([2M+Na]+, 100), 306 ([M+Na]+, 10). Elemental analysis calcd (%) 
for C16H19NO3S: C 62.93, H 6.27, N 4.59; found: C 62.79, H 6.05, N 4.41. 
14ac: M.p. = 100.8 – 102.2 °C. 1H NMR (400 MHz, CDCl3) δ = 7.67 (d, J = 8.0 Hz, 2H, 
Ts), 7.26 (d, J = 8.0 Hz, 2H, Ts), 6.04 – 6.01 (m, 1H, 6-H), 4.17 – 4.09 (m, 1H, 2-H), 3.06 
(td, J = 13.6, 2.8 Hz, 1H, 2-H'), 2.41 (s, 3H, CH3-Ts), 2.19 (s, 3H, CH3-Ac), 2.12 – 2.06 
(m, 2H, 4-H, 4a-H), 1.87 (d, J = 1.6 Hz, 3H, 5-CH3), 1.62 – 1.56 (m, 1H, 3-H), 1.33 (qt, J 
= 14, 3.2 Hz, 1H, 3-H'), 1.03 (qd, J = 13.2, 3.2 Hz, 1H, 4-H') ppm. 13C NMR (100.4 MHz, 
CDCl3) δ = 168.8 (s, CO), 145.4 (s, C7), 143.4 (s, Ts), 142.6 (s, C7a), 137.4 (s, Ts), 134.1 (d, C6), 
129.6 (d, 2C, Ts), 127.4 (d, 2C, Ts), 124.1 (s, C5), 49.4 (t, C2), 46.5 (d, C4a), 27.9 (t, C3), 24.9 (t, C4), 
21.5 (q, CH3 Ts), 20.8 (q, CH3 Ac), 14.4 (q, C5-CH3) ppm. MS (ESI) m/z (%): 717 ([2M+Na]+, 100), 370 
([M+Na]+, 3), 348 ([M+1]+, 19). Elemental analysis calcd (%) for C18H21NO4S: C 62.23, H 6.09, N 4.03; 
found: C 61.92, H 5.81, N 3.96.  
N
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5-Phenyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (17ae).  
Compound 17ae was prepared according to the above described procedure starting from 7ae (86 mg, 
0.2 mmol). Reaction was carried out with 3 mol % of Ph3PAuCl/AgSbF6 in toluene. Chromatography (n-
hexane/EtOAc, 8 : 1; Rf = 0.16) afforded pure ketone 17ae (37 mg, 55 %) as a pale yellow oil. 1H NMR 
(400 MHz, CDCl3) δ = 8.04 (d, J = 8.4 Hz, 2H, Ts), 7.35 – 7.25 (m, 5H, Ph), 7.11 (d, J = 8.4 Hz, 2H, 
Ts), 3.87 (br d, J = 7.0 Hz, 1H, 5-H), 3.40 – 3.40 (m, 2H, 2-H), 2.98 (dd, J = 18.3, 7.0 Hz, 1H, 6-H), 
2.44 (dd, J = 18.3, 2.2 Hz, 1H, 6-H'), 2.43 (s, 3H, CH3-Ts), 2.16 – 2.08 (m, 2H, 4-H), 1.96 – 1.90 (m, 
2H, 3-H) ppm. Spectroscopical data identical to those reported in the literature.40 
N
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Acetic Acid 5-Phenyl-1-(toluene-4-sulfonyl)-2,3,4,4a-tetrahydro-1H-[1]pyrindin-7-yl Ester (14ae). 
The reaction was carried out with 3 mol % of Ph3PAuCl/AgOTf in toluene according to the above 
described procedure. Starting from 7ae (58 mg, 0.14 mmol) acetate 14ae was obtained in a mixture 
N
OAcTs
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with ketone 17ae in 3.4 : 1 ratio. During the purification on silica gel (n-hexane/EtOAc, 6 : 1; Rf = 0.27) 
14ae was isolated in 34 % (19 mg) due to [1,5]H-shift. Attempts of the purification under basic (Et3N) 
and neutral (alumina) conditions led to hydrolysis and [1,5]H-shift. M.p. = 65.0 – 67.0 °C. 1H NMR (400 
MHz, CDCl3) δ = 7.72 (d, J = 8.0 Hz, 2H, Ts), 7.33 – 7.20 (m, 7H, Ph and Ts), 6.70 (s, 1H, 6-H), 4.20 – 
4.12 (m, 1H, 2-H), 3.17 (td, J = 13.6, 2.8 Hz, 1H, 2-H'), 2.78 (dd, J = 12.8, 5.2 Hz, 1H, 4a-H), 2.41 (s, 
3H, CH3 Ts), 2.27 - 2.19 (m, 4H, CH3-Ac and 4-H), 1.66 – 1.59 (m, 1H, 3-H), 1.50 (qt, J = 13.6, 3.6 Hz, 
1H, 3-H'), 1.17 (qd, J = 12.8, 3.6 Hz, 1H, 4-H') ppm. 13C NMR (100.4 MHz, CDCl3) δ = 168.4 (s, CO), 
146.9 (s, C5), 143.5 (s, Ts), 143.1 (s, C7), 137.3 (s, Ts), 134.0 (s, Ph), 129.7 (d, 2C, Ts), 128.6 (d, 2C, 
Ph), 127.5 (d, Ph), 127.4 (d, 2C, Ts), 126.4 (s, C7a), 125.7 (d, 2C, Ph), 124.1 (d, C6), 49.9 (t, C2), 43.9 
(d, C4a), 30.0 (t, C4), 25.8 (t, C3), 21.6 (q, CH3-Ts), 20.7 (q, CH3-Ac) ppm. MS (ESI) m/z (%): 841 
([2M+Na]+, 100), 432 ([M+Na]+, 18), 410 ([M+1]+, 16). Elemental analysis calcd (%) for C23H23NO4S: C 
67.46, H 5.66, N 3.42; found: C 67.92, H 5.81, N 3.76.  
N
Ts O  
2,5-Dimethyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (17e).  
Compound 17e was prepared according to the above described procedure starting from 7e (52 mg, 
0.15 mmol). Reaction was carried out with 5 mol % of (Cy)3PAuCl/AgSbF6. Chromatography (n-
hexane/EtOAc, 6 : 1; Rf = 0.16) afforded pure cis ketone 17e (37 mg, 83 %) as a white solid. 
1H NMR (400 MHz, CDCl3) δ = 8.00 (d, J = 8.4 Hz, 2H, Ts), 7.27 (d, J = 8.4 Hz, 2H, Ts), 4.37 – 4.30 
(m, 1H, 2-H) 2.89 – 2.82 (m, 1H, 5-H), 2.78 (dd, J = 18.0, 7.0 Hz, 1H, 6-H), 2.46 – 2.36 (m, 4H, CH3-Ts 
and 4-H), 2.26 (dd, J = 20.0, 6.5 Hz, 1H, 6-H'), 2.11 – 2.03 (m, 1H, 4-H'), 1.99 (d, J = 19.0 Hz, 1H, 3-
H), 1.79 – 1.73 (m, 1H, 3-H'), 1.17 (d, J = 7.0 Hz, 3H, 5-CH3), 0.85 (d, J = 8.9 Hz, 3H, 2-CH3) ppm. 
Spectroscopical data identical to those reported in the literature.15 
N
Ts O  
4,5-Dimethyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (17f).  
Compound 17f was prepared according to the above described procedure starting from 7f (76 mg, 0.2 
mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6. Chromatography (n-
hexane/EtOAc, 6 : 1) afforded cis ketone 17f (Rf = 0.16; 37 mg, 56 %) as a white solid and acetate 14f 
(Rf = 0.22; 14 mg, 18 %) as a colourless oil. 
17f: 1H NMR (400 MHz, CDCl3) δ = 7.97 (d, J = 8.4 Hz, 2H, Ts), 7.28 (d, J = 8.4 Hz, 2H, Ts), 3.54 (ddd, 
J = 13.6, 7.0, 2.9 Hz, 1H, 2-H), 3.31 (ddd, J = 13.6, 8.7, 2.7 Hz, 1H, 2-H'), 2.96 – 2.89 (m, 1H, 5-H), 
2.70 (dd, J = 18.3, 6.6 Hz, 1H, 6-H), 2.64 – 2.57 (m, 1H, 3-H), 2.41 (s, 3H, CH3-Ts), 2.10 – 2.03 (m, 
1H, 3-H'), 2.04 (dd, J = 18.3, 1.2 Hz, 1H, 6-H'), 1.72 – 1.64 (m, 1H, 4-H), 1.16 (d, J = 7.1 Hz, 3H, 5-
CH3), 1.13 (d, J = 7.2 Hz, 3H, 4-CH3) ppm. Spectroscopical data identical to those reported in the 
literature.15 
14f: 1H NMR (200 MHz, CDCl3) δ = 7.67 (d, J = 8.4 Hz, 2H, Ts), 7.27 (d, J = 8.4 Hz, 2H, 
Ts), 6.08 – 6.04 (m, 1H, 6-H), 4.07 (ddd, J = 14.0, 4.2, 2.4 Hz, 1H, 2-H), 3.05 (td, J = 
14.0, 2.4 Hz, 1H, 2-H'), 2.42 (s, 3H, CH3-Ts), 2.17 (s, 3H, CH3-Ac), 2.00 (d, J = 1.6 Hz, 
3H, 5-CH3), 1.81 (d, J = 11.1 Hz, 1H, 4a-H), 1.54 – 1.28 (m, 3H, 4-H and 3-H), 1.05 (d, J 
= 6.2 Hz, 3H, 4-CH3) ppm.  
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(3S)-3-(tert-Butyl-dimethyl-silanyloxy)-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-
7-one (17ga).  
Compound 17ga was prepared according to the above described procedure starting from 7ga (69 mg, 
0.15 mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6 in refluxing DCM. 
Chromatography (n-hexane/EtOAc, 4 : 1; Rf = 0.21) afforded ketone 17ga (47 mg, 75 %) as a yellow 
foam. [𝛼]$%% = - 74.4 (c = 0.91, CHCl3). M.p. = 61.7 – 63.4 °C. 1H NMR (400 MHz, CDCl3) δ = 8.00 (d, J 
= 8.3 Hz, 2H, Ts), 7.31 (d, J = 8.3 Hz, 2H, Ts), 4.32 – 4.23 (m, 1H, 3-H), 3.80 (dd, J = 13.0, 4.0 Hz, 1H, 
2-H), 2.83 (dd, J = 13.0, 10.0 Hz, 1H, 2-H'), 2.70 (dd, J = 20.0, 6.3 Hz, 1H, 4-H), 2.61 – 2.49 (m, 7H, 5-
H, 6-H and CH3-Ts), 2.27 (dd, J = 20.0, 8.2 Hz, 1H, 4-H'), 0.91 (s, 9H, SiC(CH3)3), 0.15 (s, 3H, SiCH3), 
0.14 (s, 3H, SiCH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 199.6 (s, C7), 158.7 (s, C7a), 143.6 (s, Ts), 
138.3 (s, C4a), 137.3 (s, Ts), 129.3 (d, 2C, Ts), 127.8 (d, 2C, Ts), 64.7 (d, C3), 51.7 (t, C2), 36.9 (t, 
C6), 34.1 (t, C5), 27.1 (t, C4), 25.8 (q, 3C, SiC(CH3)3), 21.5 (q, CH3 Ts) 18.0 (s, SiC(CH3)3), -4.68 (q, 
SiCH3), -4.95 (q, SiCH3) ppm. MS (ESI) m/z (%): 865 ([2M+Na]+, 100), 444 ([M+Na]+, 8). Elemental 
analysis calcd (%) for C21H31NO4SSi: C 59.82, H 7.41, N 3.32; found: C 60.04, H 7.13, N 3.49. 
N
Ts
TBSO
O  
2-(tert-Butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-
[1]pyrindin-7-one (17h). 
Compound 17h was prepared according to the above described procedure starting from 7h (550 mg, 
1.15 mmol). Reaction was carried out with 5 mol¸% of Ph3PAuCl/AgSbF6 in refluxing DCM. 
Chromatography (heptane/EtOAc, 3:1; Rf = 0.21) afforded ketone 17h (375 mg, 75%) as a yellow 
solid. [𝛼]$%% = - 68.2 (c = 1, DCM). M.p. = 105.7 – 106.5 °C. 1H NMR (400 MHz, CDCl3) δ = 8.02 (d, J = 
8.3 Hz, 2H, Ts), 7.29 (d, J = 8.3 Hz, 2H, Ts), 4.27 – 4.19 (m, 1H, 2-H), 3.29 (dd, J = 10.2, 6.3 Hz, 1H, 
2-CH2OTBS), 3.20 (dd, J = 10.2, 8.4 Hz, 1H, 2-CH2OTBS), 2.62 – 2.46 (m, 3H), 2.41 (s, 3H, CH3-Ts), 
2.40 – 2.21 (m, 3H), 2.17 – 2.07 (m, 1H), 2.04 – 1.93 (m, 1H), 0.76 (s, 9H, CH3-TBS), -0.12 (s, 6H, 
CH3-TBS) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 206.6 (s,C-7), 164.7 (s, C-7a), 149.2 (s, Ts), 143.5 
(s, Ts), 141.8 (s, C-4a), 134.9 (d, 2C, Ts), 133.7 (d, 2C, Ts), 67.3 (t, 2-CH2OTBS), 61.4 (d, C2), 39.2 (t, 
C6), 33.2 (t, C5), 31.4 (q, 3C, TBS), 28.6 (t, C4), 27.7 (t, C3), 25.1 (q, CH3-Ts), 23.9 (s, TBS), 0.2 (q, 
TBS), 0.1 (q, TBS) ppm. MS (ESI) m/z (%):436 ([M+1]+, 100). Elemental analysis calcd (%) for 
C22H33NO4SSi; C 60.65; H 7.63; N 3.22; found C 60.55, H 7.65, N 3.24. 
 
Acetic acid (3S)-7-Oxo-1-(toluene-4-sulfonyl)-2,3,4,5,6,7-hexahydro-1H-[1]pyrindin-3-yl ester 
(22) and (3S)-3-Hydroxy-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (17gb). 
Compound 22 was prepared according to the above described procedure starting from 7gb (50 mg, 
0.14 mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6 in refluxing DCM. 
Chromatography (n-hexane/EtOAc, 1 : 1) afforded pure ketone 22 (Rf = 0.29; 37 mg, 75 %) as a white 
foam and product 17gb as white solid (Rf = 0.14; 12 mg, 16 %). 
22: [𝛼]$%+ = + 69.7 (c = 0.24, CHCl3). M.p. = 65.2 – 67.8 °C. 1H NMR (400 MHz, CDCl3) 
δ = 7.94 (d, J = 8.3 Hz, 2H, Ts), 7.28 (d, J = 8.3 Hz, 2H, Ts), 5.27 – 5.21 (m, 1H, 3-H), 
4.10 (dd, J = 13.4, 5.1 Hz, 1H, 2-H), 3.29 (d, J = 13.4, 1H, 2-H), 2.76 (dd, J = 20.3, 5.6 
Hz, 1H, 4-H), 2.56 – 2.35 (m, 8H, 4-H, 5-H, 6-H and CH3-Ts), 2.13 (s, 3H, CH3-Ac) 
ppm. 13C NMR (100.4 MHz, CDCl3) δ = 199.6 (s, C7), 170.6 (s, CO-Ac), 155.2 (s, C7a), 143.4 (s, Ts), 
138.7 (s, C4a), 137.7 (s, Ts), 129.1 (d, 2C, Ts), 127.6 (d, 2C, Ts), 64.4 (d, C3), 47.9 (t, C2), 33.6 (t, 
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C6), 32.2 (t, C4), 27.1 (t, C5), 21.5 (q, CH3 Ts), 21.2 (q, CH3 Ac) ppm. MS (ESI) m/z (%): 720 
([2M+Na]+, 100), 372 ([M+Na]+, 3). Elemental analysis calcd (%) for C17H19NO5S: C 58.44, H 5.48, N 
4.01; found: C 58.72, H 5.17, N 3.89. 
17gb: [𝛼]$%+ = + 28.5 (c = 0.33, CHCl3). M.p. = 172.6 - 177.8 °C. 1H NMR (400 MHz, 
CDCl3) δ = 8.04 (d, J = 8.3 Hz, 2H, Ts), 7.31 (d, J = 8.3 Hz, 2H, Ts), 4.36 – 4.34 (m, 
1H, 3-H), 3.68 (dd, J = 13.8, 5.6 Hz, 1H, 2-H), 2.68 (dd, J = 13.8, 2.0 Hz, 1H, 2-H), 
2.68 – 2.44 (m, 7H, 4-H, 5-H, 6-H and OH), 2.43 (s, 3H, CH3-Ts) ppm. 13C NMR 
(100.4 MHz, CDCl3) δ = 199.7 (s, C7), 157.4 (s, C7a), 143.8 (s, Ts), 138.0 (s, C4a), 137.2 (s, Ts), 
129.4 (d, 2C, Ts), 127.8 (d, 2C, Ts), 62.8 (d, C3), 51.1 (t, C2), 35.1 (t, C4), 33.7 (t, C6), 27.4 (t, C5), 
21.6 (q, CH3-Ts) ppm. MS (ESI) m/z (%): 637 ([2M+Na]+, 100), 330 ([M+Na]+, 8), 308 ([M+1]+, 4). 
Elemental analysis calcd (%) for C15H17NO4S: C 58.61, H 5.57, N 4.56; found: C 58.93, H 5.22, N 4.23. 
N
OTs  
6-Methyl-1-(toluene-4-sulfonyl)-2,3,4,5,6,7-hexahydro-1H-cyclopenta[b]azepin-8-one (17la).  
Compound 17la was prepared according to the above described procedure starting from 7la (135 mg, 
0.37 mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6 in DCM at room temperature. 
Chromatography (n-hexane/EtOAc, 4 : 1; Rf = 0.22) afforded pure ketone 17la (98 mg, 82 %) as a pale 
orange solid. M.p. = 98.7 – 100.5 °C. 1H NMR (400 MHz, CDCl3) δ = 8.08 (d, J = 8.2 Hz, 2H, Ts), 7.30 
(d, J = 8.2 Hz, 2H, Ts), 3.37 – 3.02 (m, 2H, 2-H), 2.82 (m, 1H, 6-H), 2.71 (dd, J = 18.4, 6.5 Hz, 1H, 7-
H), 2.57 – 2.44 (m, 2H, 5-H), 2.41 (s, 3H, CH3-Ts), 2.08 (dd, J = 18.4, 1.5 Hz, 1H, 7-H'), 2.02 – 1.82 
(m, 2H, 3-H), 1.77 – 1.68 (m, 1H, 4-H), 1.59 – 1.49 (m, 1H, 4-H'), 1.21 (d, J = 7.1 Hz, 3H, 6-CH3) ppm. 
13C NMR (100.4 MHz, CDCl3) δ = 202.1 (s, C8), 177.1 (s, C8a), 143.4 (s, Ts), 140.0 (s, C5a), 137.3 (s, 
Ts), 129.2 (d, 2C, Ts), 128.4 (d, 2C, Ts), 48.9 (t, C2), 42.3 (t, C5), 35.2 (t, C7), 30.37 (d, C6), 29.45 (t, 
C4), 23.9 (t, C3), 21.5 (q, CH3-Ts), 19.0 (q, C6-CH3) ppm. MS (ESI) m/z (%): 661 ([2M+Na]+, 100), 319 
([M]+, 5). Elemental analysis calcd (%) for C17H21NO3S: C 63.92, H 6.63, N 4.39; found: C 63.67, H 
6.91, N 4.02. 
O
N
Ts  
1-(Toluene-4-sulfonyl)-2,3,4,5,6,7-hexahydro-1H-cyclopenta[b]azepin-8-one (17lb).  
Compound 17lb was prepared according to the above described procedure starting from 7lb (103 mg, 
0.30 mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6 in refluxing DCM. 
Chromatography (n-hexane/EtOAc, 3 : 2; Rf = 0.22) afforded pure ketone 17lb (75 mg, 83 %) as a 
white solid. M.p. = 115.0 – 118.5 °C. 1H NMR (400 MHz, CDCl3) δ = 8.06 (d, J = 8.2 Hz, 2H, Ts), 7.29 
(d, J = 8.2 Hz, 2H, Ts), 3.24 – 3.11 (m, 2H, 2-H), 2.62 – 2.54 (m, 2H, 6-H), 2.53 – 2.47 (m, 2H, 5-H), 
2.47 – 2.40 (m, 2H, 7-H), 2.40 (s, 3H, CH3-Ts), 1.91 – 1.85 (m, 2H, 3-H), 1.69 – 1.59 (m, 2H, 4-H) ppm. 
13C NMR (100.4 MHz, CDCl3) δ = 202.9 (s, C8), 173.5 (s, C8a), 143.5 (s, Ts), 140.6 (s, C5a), 137.3 (s, 
Ts), 129.3 (d, 2C, Ts), 128.4 (d, 2C, Ts), 49.0 (t, C2), 33.8 (t, C7), 31.7 (t, C5), 30.3 (t, C6), 29.5 (t, C3), 
23.6 (t, C4), 21.6 (q, CH3-Ts) ppm. MS (ESI) m/z (%): 633 ([2M+Na]+, 100), 328 ([M+Na]+, 5). 
Elemental analysis calcd (%) for C16H19NO3S: C 62.93, H 6.27, N 4.59; found: C 63.11, H 5.96, N 4.34. 
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1-Methyl-3-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic Acid Methyl Ester (17o).  
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Compound 17o was prepared according to above described procedure starting from 7o (66 mg, 0.23 
mmol). Reaction was carried out with 5 mol % of Ph3PAuCl/AgSbF6 in refluxing DCM. Chromatography 
(n-hexane/EtOAc, 6 : 1; Rf = 0.26) afforded pure ketone 17o (47 mg, 84 %) as a yellow solid. M.p. = 
113.4 – 115.2 °C. 1H NMR (400 MHz, CDCl3) δ = 8.33 (d, J = 8.6 Hz, 1H, 8-H), 7.70 (d, J = 8.2 Hz, 1H, 
5-H), 7.55 – 7.51 (m, 1H, 6-H), 7.37 – 7.33 (m, 1H, 7-H), 4.07 (s, 3H, OCH3), 3.51 – 3.44 (m, 1H, 1-H), 
3.25 (dd, J = 18.3, 6.6 Hz, 1H, 2-H), 2.60 (dd, J = 18.3, 2.3 Hz, 1H, 2-H'), 1.48 (d, J = 7.4 Hz, 3H, 1-
CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 189.9 (s, C3), 158.0 (s, CO2CH3), 151.3 (s, C4a), 143.1 
(s, C3a), 137.4 (s, C8a), 129.1 (d, C7), 124.4 (s, C8b), 123.7 (d, C6), 121.5 (d, C8), 116.9 (d, C5), 54.0 
(t, C2), 50.4 (q, OCH3), 27.4 (d, C1), 20.4 (q, C1-CH3) ppm. MS (ESI) m/z (%): 509 ([2M+Na]+, 100), 
266 ([M+Na]+, 9), 244 ([M+1]+, 8). Elemental analysis calcd (%) for C14H13NO3: C 69.12, H 5.39, N 
5.76; found: C 69.37, H 5.14, N 5.47. 
 
Acetic acid 4a,5-dimethyl-1-(toluene-4-sulfonyl)-2,3,4,4a-tetrahydro-1H-[1]pyrindin-7-yl ester 
(14p) and 4a,5-Dimethyl-1-(toluene-4-sulfonyl)-1,2,3,4,4a,7a-hexahydro-[1]pyrindin-7-one (15p).  
Compound 14p was prepared according to the above described procedure starting from 7p (115 mg, 
0.32 mmol). Reaction was carried out with 10 mol % of Ph3PAuCl/AgOTf in refluxing DCM. 
Chromatography (n-hexane/EtOAc, 5 : 1) afforded acetate 14p (Rf = 0.39; 20 mg, 17 %) as a yellow oil 
and ketone 15p as colourless oil (Rf = 0.17; 25 mg, 25 %). 
14p: 1H NMR (400 MHz, CDCl3) δ = 7.75 (d, J = 8.0 Hz, 2H, Ts), 7.24 (d, J = 8.0 Hz, 2H, 
Ts), 5.90 (s, 1H, 6-H), 3.99 (dd, J = 8.0, 4.0 Hz, 1H, 2-H), 2.99 (td, J =12.0, 4.0 Hz, 1H, 
2-H), 2.39 (s, 3H, CH3-Ts), 2.10 (s, 3H, CH3-Ac), 1.87 - 1.74 (m, 2H, 5-H), 1.79 (d, J = 
4.0 Hz, 3H, 5-CH3), 1.60 – 1.54 (m, 1H, 4-H), 1.15 (td, J = 16.0, 4.0 Hz, 1H, 4H), 0.77 (s, 
3H, 4a-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 168.3 (s, CO), 151.5 (s, C7a), 143.1 
(s, Ts), 140.0 (s, C7), 138.7 (s, Ts), 129.4 (d, 2C, Ts), 128.7 (s, C5), 127.2 (d, 2C, Ts), 121.3 (d, C-6), 
49.3 (t, C2), 47.6 (s, C4a), 33.6 (t, C4), 22.8 (q, CH3-Ac), 21.4 (CH3-Ts), 20.7 (t, C3), 17.9 (CH3-5), 
12.4 (CH3-4a) ppm. MS (ESI) m/z (%): 745 ([2M+Na]+, 100), 379 ([M+18]+, 17), 362 ([M+1]+,32). 
15p: 1H NMR (400 MHz, CDCl3) δ = 7.86 (d, J = 8.0 Hz, 2H, Ts), 7.30 (d, J = 8.0 Hz, 2H, 
Ts), 5.91 (s, 1H, 6-H), 4.32 (s, 1H, 7a-H), 3.61 (dt, J =12.0, 8.0 Hz, 1H, 2-H), 2.82 - 2.76 
(m, 1H, 2-H), 2.42 (s, 3H, CH3-Ts), 2.02 (s, 3H, 5-CH3), 1.74 - 1.58 (m, 2H, 3-H), 1.46 – 
1.40 (m, 1H, 4-H), 1.33 (s, 3H, 4a-CH3), 1.29 – 1.25 (m, 1H, 4-H) ppm. 13C NMR (100.4 
MHz, CDCl3) δ = 202.2 (s, CO), 180.6 (d, C-6), 143.1 (s, Ts), 137.4 (s, Ts), 129.3 (d, 2C, 
Ts), 127.7 (d, 2C, Ts), 127.7 (s, C5), 66.8 (s, C4a), 45.1 (d, C7a), 42.1 (t, C2), 32.7 (5-CH3), 21.7 (t, C-
5), 21.5 (q, CH3-Ts), 18.4 (t, C-4), 15.0 (q, CH3-4a) ppm. MS (ESI) m/z (%): 661.24 ([2M+Na]+, 100), 
337 ([M+18]+, 28), ([M+1]+,24). Elemental analysis calcd (%) for C17H21NO3S: C 63.92, H 6.63, N 4.39; 
found: C 64.02, H 6.50, N 4.21. 
 
General procedure for acetate hydrolysis 
Catalytic amount of pTsOH was added to the solution of the acetate (0.06 mmol) in 1 : 1 mixture of 
DCM and MeOH (3 mL) and the reaction mixture was left to stir at room temperature. After 20 h the 
solvent was concentrated and the oily residue was dissolved in DCM (3 mL); the organic solution was 
washed with water (3 mL) and dried over anhydrous Na2SO4. After filtration and evaporation of the 
solvent, the desired product was obtained and, when it was necessary, purified by flash 
chromatography. In some cases, the desired product was obtained in a mixture with ketone 23 due to 
[1,5]H-shift (up to 10%). 
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5-Butyl-1-(toluene-4-sulfonyl)-1,2,3,4,4a,7a-hexahydro-[1]pyrindin-7-one (15aa). 
According to the above described procedure, hydrolysis of acetate 14aa (23 mg, 0.06 mmol) afforded 
ketone 15aa (20 mg, 96 %) as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ = 7.87 (d, J = 8.3 Hz, 
2H, Ts), 7.30 (d, J = 8.3 Hz, 2H, Ts), 5.91 (s, 1H, 6-H), 4.72 (d, J = 6.8 Hz, 1H, 7a-H), 3.66 (dt, J = 
12.5, 6.1 Hz, 1H, 2-H), 2.98 (q, J = 6.8 Hz, 1H, 4a-H), 2.78 (ddd, J = 12.5, 7.3, 4.9 Hz, 1H, 2-H'), 2.44 
– 2.36 (m, 4H, CH3-Ts and 1'-H), 2.32 – 2.24 (m, 1H, 1'-H'), 2.09 – 2.01 (m, 1H, 4-H), 1.63 – 1.44 (m, 
3H, 3-H and 2'-H), 1.42 – 1.30 (m, 3H, 3-H' and 3'-H), 1.28 – 1.18 (m, 1H, 4-H'), 2.01 (t, J = 9.3 Hz, 4'-
H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 203.4 (s, C7), 182.3 (s, C5), 143.2 (s, Ts), 137.5 (s, Ts), 
129.4 (d, 2C, Ts), 127.7 (d, 2C, Ts), 126.3 (d, C6), 60.4 (d, C7a) 42.3 (t, C2), 41.0 (d, C4a), 31.5 (t, 
C1'), 28.5 (t, C2'), 26.6 (t, C3'), 22.4 (t, C4), 21.5 (q, CH3 Ts), 19.4 (t, C3) 13.8 (q, C4') ppm. MS (ESI) 
m/z (%): 717 ([2M+Na]+, 100), 370 ([M+Na]+, 5), 348 ([M+1]+, 6). Elemental analysis calcd (%) for 
C19H25NO3S: C 65.68, H 7.25, N 4.03; found: C 65.36, H 7.43, N 4.07. 
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5-Methyl-1-(toluene-4-sulfonyl)-1,2,3,4,4a,7a-hexahydro-[1]pyrindin-7-one (15ac). 
According to the above described procedure, hydrolysis of acetate 14aa (142 mg, 0.41 mmol) afforded 
ketone 15aa (98 mg, 80 %) in a mixture with ketone 17ac (8 %). M.p. = 114.5 – 115.8 °C. 1H NMR 
(400 MHz, CDCl3) δ = 7.86 (d, J = 8.2 Hz, 2H, Ts), 7.30 (d, J = 8.2 Hz, 2H, Ts), 5.94 (s, 1H, 6-H), 4.71 
(d, J = 6.8 Hz, 1H, 7a-H), 3.65 (dt, J = 12.6, 6.3 Hz, 1H, 2-H), 2.93 (q, J = 6.8 Hz, 1H, 4a-H), 2.80 (ddd, 
J = 12.6, 7.3, 5.1 Hz, 1H, 2-H), 2.07 (s, 3H, CH3-Ts), 2.05 (s, 3H, CH3-5), 1.56 – 1.42 (m, 1H, 4-H), 
1.39 – 1.26 (m, 1H, 5-H), 1.29 – 1.19 (m, 2H, 4-H and 5-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 
203.4 (s, C-7), 177.65, 143.3 (s, Ts), 137.3 (s, Ts), 129.3 (d, 2C, Ts), 127.4 (s, 2C, Ts), 60.6 (d, C-7a), 
42.4 (t, C-2), 41.7 (d, C-4a), 25.3 (q, CH3), 21.4 (q, CH3-Ts), 18.8 (t, C-3), 18.1 /t, C-4). MS (ESI) m/z 
(%): 632 ([2M+Na]+, 100), 327 ([M+Na]+, 48), 305 ([M+1]+, 37). Elemental analysis calcd (%) for 
C16H19NO3S: C 62.93, H 6.27, N 4.57; found: C 62.80, H 6.36, N 4.55. 
N
OTs  
5,5-Dimethyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (17ad).  
According to the above described procedure, hydrolysis of acetate 16ad (72 mg, 0.19 mmol) afforded 
ketone 17ad (55 mg, 86 %) after flash chromatography (n-hexane/EtOAc, 4 : 1; Rf = 0.21) as a yellow 
solid. M.p. = 102.3 – 104.0 °C. 1H NMR (400 MHz, CDCl3) δ = 7.99 (d, J = 8.4 Hz, 2H, Ts), 7.30 (d, J = 
8.4 Hz, 2H, Ts), 3.41 – 3.39 (m, 2H, 2-H), 2.41 (s, 3H, CH3-Ts), 2.34 (s, 2H, 6-H), 2.33 (t, J = 6.5 Hz, 
2H, 4-H), 2.01 – 1.95 (m, 2H, 3-H), 1.21 (s, 6H, 5-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 199.3 
(s, C7), 166.2 (s, C7a), 143.4 (s, Ts), 137.9 (s, Ts), 135.6 (s, C4a), 129.3 (d, 2C, Ts), 127.7 (d, 2C, Ts), 
50.0 (t, C6), 45.8 (t, C2), 38.5 (s, C5), 27.2 (q, 2C, C5-CH3), 21.6 (t, C4), 21.5 (q, CH3-Ts), 20.5 (t, C3) 
ppm. MS (ESI) m/z (%): 661 ([2M+Na]+, 100), 342 ([M+Na]+, 12), 320 ([M+1]+, 11). Elemental analysis 
calcd (%) for C17H21NO3S: C 63.92, H 6.63, N 4.39; found C 63.54, H 6.42, N 4.59. 
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5-Phenyl-1-(toluene-4-sulfonyl)-1,2,3,4,4a,7a-hexahydro-[1]pyrindin-7-one (15ae).  
According to the above described procedure, hydrolysis of acetate 14ae (13 mg, 0.032 mmol) afforded 
ketone 15ae (6 mg, 51 %) after flash chromatography (n-hexane/EtOAc, 4 : 1; Rf = 0.25) as a yellow 
oil. 1H NMR (400 MHz, CDCl3) δ = 7.91 (d, J = 8.2 Hz, 2H, Ts), 7.65 – 7.61 (m, 2H, Ph), 7.50 – 7.44 
(m, 3H, Ph), 7.29 (d, J = 8.2 Hz, 2H, Ts), 6.55 (s, 1H, 6-H), 4.92 (d, J = 6.9 Hz, 1H, 7a-H), 3.73 (dt, J = 
12.6, 6.1 Hz, 1H, 2-H), 3.67 (q, J = 6.9 Hz, 1H, 4a-H), 2.87 (ddd, J = 12.6, 7.8, 4.7 Hz, 1H, 2-H'), 2.21 
(dtd, J = 10.3, 6.9, 3.0 Hz, 1H, 4-H), 1.61 – 1.51 (m, 1H, 3-H), 1.46 – 1.38 (m, 1H, 3-H'), 1.37 – 1.28 
(m, 1H, 4-H') ppm. 13C NMR (100.4 MHz, CDCl3) δ = 202.9 (s, C7), 173.53 (s, C5), 143.3 (s, Ts), 137.5 
(s, Ts), 132.3 (s, Ph), 131.6 (d, Ph), 129.5 (d, 2C, Ts), 129.2 (d, 2C, Ph), 127.7 (d, 2C, Ts), 127.0 (d, 
2C, Ph), 124.0 (d, C6), 61.0 (d, C7a) 42.6 (t, C2), 38.3 (d, C4a), 27.9 (t, C4), 21.5 (q, CH3-Ts), 19.8 (t, 
C3) ppm. MS (ESI) m/z (%): 757 ([2M+Na]+, 100), 390 ([M+Na]+, 12), 368 ([M+1]+, 11). Elemental 
analysis calcd (%) for C21H21NO3S: C 68.64, H 5.76, N 3.81; found C 68.49, H 5.41, N 3.64. 
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1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydro-pyridine (25a). 
A solution of 11a (500 mg, 2 mmol) in DCM (10 mL) was cooled to -78 °C and 1 M solution of DIBAL-H 
(2.2 mL, 2.2 mmol) was slowly added keeping the temperature below -70 °C. Reaction mixture was 
stirred below -70 °C and after 1 h MeOH (1 mL) was added followed by satd solution of Rochelle salt. 
Formed two-phase system was stirred at room temperature for 1 h. Layers were separated, 1-
(toluene-4-sulfonyl)-piperidin-2-ol was extracted with DCM (2 x 15 mL) and the organic layer was dried 
over anhydrous Na2CO3 for 30 min. After filtration and evaporation of the solvent, obtained 1-(toluene-
4-sulfonyl)-piperidin-2-ol was dissolved in DCM (10 mL) and DMAP (9.6 mg, 0.78 mmol) and Et3N 
(0.83 mL, 6 mmol) were added. This solution was cooled to 0 °C and MsCl (0.3 mL, 3 mmol) was 
added. Reaction was stirred at room temperature. After 3 h satd solution of NH4Cl (10 mL) was added 
and the product extracted with DCM (3 x 10 mL). The organic extracts were dried over anhydrous 
Na2CO3 for 30 min. After filtration and evaporation of the solvent, flash chromatography (n-
hexane/EtOAc, 5 : 1; Rf = 0.40) afforded pure 1-(toluene-4-sulfonyl)-1,2,3,4-tetrahydro-pyridine (333 
mg, 70 %) as a white wax. 1H NMR (400 MHz, CDCl3): δ = 7.69 (d, J = 7.6 Hz, 2H, Ts), 7.33 (d, J = 7.6 
Hz, 2H, Ts), 6.66 (d, J = 8.4 Hz, 1H, 2-H), 4.98 (bs, 1H, 3-H), 3.39 (t, J = 3.6 Hz, 2H, 6-H), 2.44 (s, 3H, 
CH3-Ts), 1.92 (bs, 2H, 4-H), 1.68 – 1.65 (m, 2H, 5-H) ppm. Spectroscopical data correspond to the 
literature values.43 
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3,4-Dihydro-2H-pyridine-1-carboxylic acid benzyl ester (25c). 
A solution of 11c (1.16 g, 5 mmol) in THF (10 mL) was cooled to -78 °C and 1 M solution of Super-H (6 
mL, 6 mmol) was slowly added keeping the temperature below -70 °C. Reaction mixture was stirred 
below -70 °C and after 1 h NaHCO3 (25 mL) was added followed by 35 % solution of H2O2 (5 mL). 
Reaction mixture was stirred on ice bath for 1 h. The product, 2-hydroxy-piperidine-1-carboxylic acid 
benzyl ester, was extracted with DCM (3 x 30 mL) and the organic layer was dried over anhydrous 
Na2CO3 for 30 min. After filtration and evaporation of the solvent, obtained material was dissolved in 
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DCM (25 mL) and DMAP (245 mg, 0.2 mmol) and Et3N (1.52 mL, 15 mmol) were added. This solution 
was cooled to 0 °C and MsCl (0.6 mL, 7.5 mmol) was added. Reaction was stirred at room 
temperature overnight. A satd solution of NH4Cl (30 mL) was added and the product extracted with 
DCM (3 x 30 mL). The organic extracts were dried over anhydrous Na2CO3 for 30 min. After filtration 
and evaporation of the solvent, flash chromatography (n-hexane/EtOAc, 8 : 1; Rf = 0.36) afforded pure 
25c (660 mg, 62 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) mixture of rotamers: δ = 7.43 - 7.27 
(m, 5 H, PhH), 6.89 (d, J = 8.6 Hz, 0.4 H, 2-H), 6.80 (d, J = 8.6 Hz, 0.6 H, 2-H), 5.18 (s, 2 H, CH2O), 
4.97 (m, 0.4 H, 3-H), 4.86 (m, 0.6 H, 3-H), 3.63 (m, 2 H, 6-H), 2.04 (m, 2 H, 4-H), 1.83 (m, 2 H, 5-H) 
ppm. Spectroscopical data correspond to the literature values.44 
N
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1-(Toluene-4-sulfonyl)-2,3,4,5-tetrahydro-1H-azepine (25l). 
A solution of 12l (975 mg, 1.94 mmol) in DME (5 mL), Pd(OAc)2 (21.8 mg, 0.097 mmol) and PPh3 
(49.8 mg, 0.19 mmol) was prepared under nitrogen atmosphere. This solution was added dropwise, 
under nitrogen atmosphere, into a solution of formic acid (0.147 mL, 3.9 mmol) and Et3N (0.75 mL, 
5.82 mmol) in DME (5 mL). Reaction mixture was refluxed (85 °C) for 30 min and then cooled to room 
temperature. Water (10 mL) was added, and the product was extracted with EtOAc (3 x 10 mL). The 
organic phase was dried over Na2SO4 and concentrated. Flash chromatography (n-hexane/EtOAc, 10 : 
1; Rf = 0.22) afforded desired product (290 mg, 62 %) as a white solid. M.p. = 59.2 – 60.8 °C. 1H NMR 
(400 MHz, CDCl3) δ = 7.70 (d, J = 8.2 Hz, 2H, Ts), 7.29 (d, J = 8.2 Hz, 2H, Ts), 6.41 (d, J = 8.8 Hz, 1H, 
7-H), 5.09 (dt, J = 8.8, 5.7 Hz, 1H, 6-H), 3.50 (t, 2H, J = 6.1 Hz, 2-H), 2.42 (s, 3H, CH3-Ts), 2.11 – 2.06 
(m, 2H, 5-H), 1.71 – 1.68 (m, 2H, 3-H), 1.50 – 1.44 (m, 2H, 4-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ 
= 143.4 (s, Ts), 136.7 (s, Ts), 129.8 (d, 2C, Ts), 129.2 (d, C-7), 126.9 (d, 2C, Ts), 116.8 (d, C6), 49.7 (t, 
C2), 28.9 (t, C5), 26.1 (t, C3), 24.9 (t, C4), 21.5 (q, CH3-Ts). MS (ESI) m/z (%): 252 ([M+1]+, 100), 274 
([M+Na]+, 32), 524 ([2M+Na]+, 11). Elemental analysis calcd (%) for C13H17NO2S: C 62.12, H 6.82, N 
5.57; found C 61.63, H 6.58, N 5.63. 
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General procedure for synthesis of enesulfonamides derived enynyl acetates. 
STEP A: Iodination of enesulfonamides (27) 
Enesulfonamide (1 mmol) and NaOCH3 (105 mg, 2 mmol) were suspended in MeOH (4 mL) and 1 M 
solution of ICl in DCM (1.1 mL, 1.1 mmol) was added dropwise. Resulting brown suspension was 
stirred at room temperature for 30 min and then a 10 % aqueous solution of Na2S2O3 was added and 
stirring continued for 30 min. The layers were separated; organic layer was dried over Na2SO4, filtered 
and concentrated to give brown oil. Obtained oil was dissolved in toluene (8 mL) and a solution of TFA 
(11 μL, 0.15 mmol) in toluene (20 μL) was added. Obtained purple solution was submersed into an oil 
bath preheated to 140 °C. After 5 min, reaction flask was put on ice and immediately, a solution of Et3N 
(62 μL, 0.5 mmol) in toluene (200 μL) was added. Reaction mixture was concentrated and crude was 
purified by flash chromatography to give the corresponding β-iodo-enesulfonamides.  
STEP B: Sonogashira coupling (28) 
β-Iodo-enesulfonamide 27 (1 mmol), CuI (19 mg, 0.1 mmol) and (Ph3P)2PdCl2 (35 mg, 0.05 mmol) 
were dissolved in an anhydrous 4 : 1 Et2NH/DMF mixture (10 mL), and alkyne (1.2 mmol) was added 
under nitrogen atmosphere. The reaction mixture was heated at 40 °C for 10 min, and water (15 mL) 
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was added. The product was extracted with Et2O (3 x 10 mL) and the combined organic extracts were 
dried over anhydrous K2CO3 for 30 min. After filtration and evaporation of the solvent, the crude was 
purified by flash chromatography and obtained enynyl alcohol was used in the next step. 
STEP C: Acetylation (29) 
A solution of enynyl alcohol 28 (1 mmol), DMAP (24 mg, 0.2 mmol) and Et3N (0.38 mL, 3 mmol) in 
DCM (4 mL) was cooled by ice bath and Ac2O (0.19 mL, 2 mmol) was added. The reaction mixture 
was stirred at room temperature and followed by TLC. When the conversion was complete, satd 
solution of NaHCO3 (10 mL) was added and the product extracted with DCM (3 x 10 mL). The 
combined organic extracts were dried over anhydrous K2CO3 for 30 min. After filtration and evaporation 
of the solvent, the crude was purified by flash chromatography and stored at 4°C as 0.1 M solution in 
the eluent containing 1 % Et3N until use. 
N
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Acetic acid 1-methyl-3-[1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-3-yl]-prop-2-ynyl ester 
(29a). 
Compound 27a was prepared according to the above described procedure starting from 25a (230 mg, 
1 mmol). Flash chromatography (n-hexane/EtOAc, 3 : 2; Rf = 0.22) afforded 13 (327 mg, 77 %) 
contaminated by unknown impurity. 1H NMR (400 MHz, CDCl3) δ = 7.65 (d, J = 8.3 Hz, 2H, Ts), 7.32 
(d, J = 10.8 Hz, 2H, Ts), 7.12 (s, 1H, 2-H), 3.22 – 3.12 (m, 2H, 6-H), 2.43 (s, 3H, CH3-Ts), 2.32 (td, J = 
6.3, 2.7 Hz, 2H, 4-H), 1.76 – 1.66 (m, 2H, 5-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 143.9 (s, Ts), 
134.6 (s, Ts), 130.4 (d, C-2), 129.9 (d, 2C, Ts), 126.9 (d, 2C, Ts), 87.7 (s, C3), 42.2 (t, C6), 34.0 (t, C4), 
23.0 (t, C5), 21.4 (q, CH3-Ts) ppm. MS (ESI) m/z (%): 364 ([M+1]+, 100), 385 ([M+Na]+, 8).  
Sonogashira coupling of β-iodo-enesulfonamides 27a (193 mg, 0.9 mmol) and (±)-3-butyn-2-ol after 
flash chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.16) afforded enynyl alcohol 28a 
which was used immediately in the next step (220 mg, 80 %). 
1H NMR (400 MHz, CDCl3) δ = 7.66 (d, J = 8.3 Hz, 2H, Ts), 7.31 (d, J = 8.3 Hz, 2H, Ts), 7.06 (s, 1H, 2-
H), 4.63 (q, J = 6.6 Hz, 1H, 3’-H), 3.35 – 3.31 (m, 2H, 6-H), 2.43 (s, 3H, CH3-Ts), 2.05 – 2.02 (m, 4-H), 
1.77 (bs, 1H, OH), 1.71 – 1.65 (m, 2H, 5-H), 1.45 (d, J = 6.6 Hz, 3H, 3’-CH3)  ppm. 13C NMR (100.4 
MHz, CDCl3) δ = 144.0 (s, Ts), 134.8 (s, Ts), 130.7 (d, C2), 129.9 (d, 2C, Ts), 127.0 (d, 2C, Ts), 100.9 
(s, C3), 89.4 (s, C1’), 83.7 (C2’), 58.9 (C3’), 43.6 (t, C6), 25.5 (C4), 24.5 (q, CH3-3’), 21.6 (q, CH3-Ts), 
20.6 (t, C-5) ppm. MS (ESI) m/z (%): 306 ([M+1]+, 100), 328 ([M+Na]+, 31), 633 ([2M+Na]+, 35).  
According to the above described procedure, compound 28a was subjected to acetylation. After flash 
chromatography (n-hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.18) pure 15 was obtained as a colourless 
oil (210 mg, 84 %). 1H NMR (400 MHz, CDCl3) δ =  7.66 (d, J = 8.3 Hz, 2H, Ts), 7.32 (d, J = 8.0 Hz, 
2H, Ts), 7.09 (s, 1H, 2-H), 5.69 – 5.44 (m, 1H, 3’-H), 3.43 – 3.21 (m, 2H, 6-H), 2.43 (s, 3H, CH3-Ts), 
2.08 (s, 3H, CH3-Ac), 2.04 (td, J = 6.2, 1.3 Hz, 2H, 4-H), 1.73 – 1.63 (m, 2H, 5-H), 1.49 (d, J = 6.7 Hz, 
3H, 3’-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s, CO), 144.1 (s, Ts), 134.8 (s, Ts), 131.3 
(d, C2), 129.9 (d, 2C, Ts), 127.0 (d, 2C, Ts), 100.5 (C3), 85.8 (s, C1’), 84.4 (s, C2’), 60.9 (s, C3’), 43.4 
(t, C6), 25.3 (q, CH3-Ac), 21.6 (q, CH3-3’), 21.5 (q, CH3-Ts), 21.1 (t, C-4), 20.6 (t, C-5)  ppm. MS (ESI) 
m/z (%): 288 ([C16H18NO2S]+, 100), 369 ([M+Na]+, 17). 
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5-(3-Acetoxy-but-1-ynyl)-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester (29c). 
Compound 27c was prepared according to the above described procedure starting from 25c (340 mg, 
1.56 mmol). Flash chromatography (n-hexane/EtOAc, 10 : 1; Rf = 0.24) afforded 27c (353 mg, 66 %).  
1H NMR (400 MHz, CDCl3) δ = 7.44 – 7.28 (m, 5H, Ph), 7.27 – 7.25 (s, 1H, 2-H), 5.18 (s, 2H, CH2O), 
3.70 – 3.59 (m, 2H, 6-H), 2.46 (t, J = 7.0 Hz, 4-H), 1.95 – 1.84 (m, 2H, 5-H) ppm.  
Sonogashira coupling of β-iodo-enecarbamate 27c (177 mg, 0.52 mmol) and (±)-3-butyn-2-ol after 
flash chromatography (n-hexane/EtOAc, 5:2 + 1 % Et3N; Rf = 0.19) afforded enynyl alcohol 28c which 
was used immediately in the next step (120 mg, 75 %). 1H NMR (400 MHz, CDCl3) δ = 7.42 – 7.32 (m, 
5H, Ph), 7.18 (s, 1H, 2-H), 4.66 – 4.60 (m, 1H, 3’-H), 3.62 – 3.56 (m, 2H, 6-H), 2.16 (t, J = 5.7 Hz, 2H, 
4-H), 1.88 – 1.79 (bs, 2H, 5-H), 1.46 (d, J = 6.6 Hz, 4H) ppm. 
According to the above described procedure, compound 28c was subjected to acetylation. After flash 
chromatography (n-hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.21) pure 29c was obtained as a colourless 
oil (108 mg, 85 %). 1H NMR (400 MHz, CDCl3) δ = 7.40 – 7.29 (m, 5H, Ph), 7.20 (s, 1H, 2-H), 5.57 (q, 
J = 6.5 Hz, 1H, 3’-H), 5.19 (s, 2H, CH2O), 3.63 – 3.54 (m, 2H, 6-H), 2.16 (t, J = 5.9 Hz, 2H, 4-H), 2.06 
(s, 3H, CH3-Ac), 1.85 – 1.75 (m, 2H, 5-H), 1.49 (d, J = 6.6 Hz, 3H) ppm. 13C NMR (100.4 MHz, CDCl3) 
δ = 169.9 (s, CO-Ac), 152.5 (s, CO-Cbz), 135.8 (s, Cbz), 131.4 (d, Cbz), 128.7 (d, 2C, Cbz) 128.5 (d, 
2C, Cbz), 128.1 (d, C2), 99.1 (s, C3), 84.9 (s, C1’), 68.0 (C2’), 67.9 (t, CH2-Cbz), 61.0 (d, C3’), 41.9 (t, 
C6), 25.8 (d, C4), 21.7 (d, C5), 21.2 (q, CH3-3’), 21.0 (q, CH3-Ac) ppm. MS (ESI) m/z (%): 268 ([M-
OAc]+, 100), 349 ([M+Na]+, 34), 676 ([2M+Na]+, 7).  
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Acetic acid 1-methyl-3-[1-(toluene-4-sulfonyl)-4,5,6,7-tetrahydro-1H-azepin-3-yl]-prop-2-ynyl 
ester (29l). 
Compound 27l was prepared according to the above described procedure starting from 25l (156 mg, 
0.62 mmol). Flash chromatography (n-hexane/EtOAc, 3 : 2; Rf = 0.22) afforded 27l (201 mg, 85 %) 
contaminated by unknown impurity. 1H NMR (400 MHz, CDCl3) δ = 7.70 (d, J = 8.2 Hz, 2H, Ts), 7.32 
(d, J = 8.2 Hz, 2H, Ts), 6.92 (s, 1H, 7-H), 3.60 – 3.52 (m, 2H, 2-H), 2.72 – 2.59 (m, 2H, 5-H), 2.44 (s, 
3H, CH3-Ts), 1.78 – 1.66 (m, 2H, 3-H), 1.47 (dt, J = 12.2, 6.1 Hz, 2H, 4-H) ppm.  
Sonogashira coupling of 27l (193 mg, 0.51 mmol) and (±)-3-butyn-2-ol after flash chromatography (n-
hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.16) afforded enynyl alcohol 28l which was used immediately in 
the next step (115 mg, 71 %). 1H NMR (400 MHz, CDCl3) δ = 7.71 (d, J = 8.2 Hz, 2H, Ts), 7.32 (d, J = 
8.2 Hz, 2H, Ts), 6.84 (s, 1H, 2-H), 4.62 (q, J = 6.6 Hz, 1H, 1'-H), 3.55 (t, J = 6.3 Hz, 2H, 7-H), 2.43 (s, 
3H, CH3-Ts), 2.35 – 2.21 (t, J = 6.2 Hz, 2H, 4-H), 1.72 (dt, J = 12.2, 6.3 Hz, 3H, 6-H and OH), 1.55 (dt, 
J = 12.2, 6.2 Hz, 2H, 5-H), 1.46 (d, J = 6.6 Hz, 3H, 1'-CH3) ppm. 
According to the above described procedure, compound 28l was subjected to acetylation. After flash 
chromatography (n-hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.18) pure 29l was obtained as a colourless 
oil (100 mg, 84 %). 1H NMR (400 MHz, CDCl3) δ = 7.69 (d, J = 8.2 Hz, 2H, Ts), 7.31 (d, J = 8.2 Hz, 2H, 
Ts), 6.86 (s, 1H, 2-H), 5.54 (q, J = 6.7 Hz, 1H, 3'-H), 3.46 (t, J = 6.1 Hz, 2H, 7-H), 2.42 (s, 3H, CH3-Ts), 
2.27 (t, J = 6.0 Hz, 2H, 4-H), 2.06 (s, 3H, CH3-Ac), 1.70 (dt, J = 12.2, 6.1 Hz, 2H, 6-H), 1.54 (dt, J = 
12.2, 6.0 Hz, 2H, 5-H), 1.47 (d, J = 6.7 Hz, 3H, 3'-CH3). ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 
(s, CO), 143.8 (s, Ts), 136.1 (s, Ts), 135.7 (d, C2), 129.8 (d, 2C, Ts), 126.7 (d, 2C, Ts), 109.5 (s, C3), 
85.8 (s, C2'), 85.4 (d, C1'), 60.9 (d, C3'), 48.8 (t, C7), 31.2 (t, C6), 28.0 (t, C4), 24.03 (t, C5), 21.4 (q, 
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CH3-Ac), 21.5 (q, CH3-Ts), 21.1 (q, CH3-3') ppm. MS (ESI) m/z (%): 302 ([M-OAc]+, 100), 384 
([M+Na]+, 49), 744 ([2M+Na]+, 6).  
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7-Methyl-1-(toluene-4-sulfonyl)-1,2,3,4,6,7-hexahydro-[1]pyrindin-5-one (30a). 
Compound 30a was prepared according to the general procedure for the Au(I)-catalyzed Nazarov 
reaction starting from 29a (52 mg, 0.16 mmol). Reaction was carried out with 5 mol % of 
Ph3PAuCl/AgSbF6 in DCM at room temperature. Flash chromatography (n-hexane/EtOAc, 3 : 1; Rf = 
0.15) afforded pure product 30a (32 mg, 66 %) as a white solid. 1H NMR (400 MHz, CDCl3) δ = 7.63 
(d, J = 14.8 Hz, 2H, Ts), 7.33 (d, J = 8.4 Hz, 2H, Ts), 3.83 (ddd, J = 13.6, 5.0, 3.5 Hz, 1H, 2-H), 3.67 (p, 
J = 6.7 Hz, 1H, 7-H), 3.41 – 3.27 (m, 1H, 2-H), 2.71 (dd, J = 18.4, 6.8 Hz, 1H, 6-H), 2.48 – 2.37 (m, 
4H, CH3-Ts and 4-H), 2.13 – 1.95 (m, 2H, 6-H and 5-H), 1.72 – 1.54 (m, 1H, 5-H), 1.41 (d, J = 6.8 Hz, 
2H, 7-CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 204.1 (s, CO), 170.1 (s, C7a), 144.8 (s, Ts), 135.3 
(s, Ts), 130.2 (d, 2C, Ts), 127.1 (d, 2C, Ts), 123.8 (s, C4a), 47.9 (d, C6), 43.0 (t, C2), 35.4 (d, C7), 22.1 
(t, C5), 21.6 (q, CH3-Ts), 19.3 (t, C4), 18.3 (q, CH3-7) ppm. MS (ESI) m/z (%): 306 ([M+1]+, 100), 328 
([M+Na]+, 15), 633 ([2M+Na]+, 35). Elemental analysis calcd (%) for C16H19NO3S: C 62.93, H 6.27, N 
4.59; found: C 62.70, H 6.33, N 4.54. 
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8-Methyl-1-(toluene-4-sulfonyl)-2,3,4,5,7,8-hexahydro-1H-cyclopenta[b]azepin-6-one (30l). 
Compound 30l was prepared according to the general procedure for the Au(I)-catalyzed Nazarov 
reaction starting from 29l (50 mg, 0.14 mmol). Reaction was carried out with 5 mol % of 
Ph3PAuCl/AgSbF6 in DCM at room temperature. Flash chromatography (n-hexane/EtOAc, 3 : 1; Rf = 
0.15) afforded pure product 30a (24 mg, 54 %) as a white solid. M.p. = 118.4 – 119.0 °C. 1H NMR (400 
MHz, CDCl3) δ = 7.72 (d, J = 8.3 Hz, 2H, Ts), 7.32 (d, J = 8.3 Hz, 2H, Ts), 4.31 (dt, J = 15.0, 3.7 Hz, 
1H, 2-H), 3.62 – 3.49 (m, 1H, 8-H), 3.12 (ddd, J = 15.3, 12.3, 3.3 Hz, 1H, 2-H), 2.78 (dd, J = 19.5, 8.8 
Hz, 1H, 7-H), 2.47 – 2.33 (m, 4H, CH3-Ts and 5-H), 2.09 (dd, J = 19.5, 1.7 Hz, 1H, 7-H), 1.88 – 1.73 
(m, 1H, 3-H), 1.67 – 1.45 (m, 3H, 3-H and 4-H), 1.41 – 1.32 (m, 1H, 5-H), 1.21 (d, J = 7.0 Hz, 3H, 8-
CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 205.7 (s, C6), 174.3 (s, C8a), 144.3 (s, Ts), 137.2 (s, Ts), 
133.7 (s, C6a), 129.9 (d, 2C, Ts), 126.9 (d, 2C, Ts), 52.4 (t, C7), 43.0 (t, C2), 35.6 (t, C8), 28.1 (d, C5), 
22.9 (t, C3), 21.6 (t, C4), 21.6 (q, CH3-Ts), 20.3 (q, CH3-8) ppm. MS (ESI) m/z (%): 320 ([M+1]+, 100). 
Elemental analysis calcd (%) for C17H21NO3S: C 63.92, H 6.63, N 4.39; found: C 62.93, H 6.53, N 4.06. 
 
7-Methyl-5-oxo-2,3,4,5,6,7-hexahydro-[1]pyrindine-1-carboxylic acid benzyl ester (30c) and 5-
But-2-enoyl-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester (31c). 
Compound 30c was prepared according to the above described procedure for gold(I)-catalyzed 
reaction starting from 29c (50 mg, 0.15 mmol). Reaction was carried out with 5 mol % of 
Ph3PAuCl/AgOTf in DCM : t-BuOH = 1 : 1. Chromatography (n-hexane/EtOAc, 3 : 1) afforded α,β-
unsaturated ketone 31c (Rf = 0.57; 12 mg, 28%) as a yellow oil and Nazarov product 30c as an 
orange oil (Rf = 0.28; 12 mg, 26%). 
   30c. 1H NMR (400 MHz, CDCl3) δ = 7.43 – 7.29 (m, 5H, Ph), 5.23 (s, 2H, CH2O), 4.08     
   (dt, J = 9.6, 4.7 Hz, 1H, 6-H), 3.75 – 3.65 (m, 1H, 7-H), 3.45 (ddd, J = 12.6, 9.6, 3.0 Hz,    
   1H, 6-H), 2.65 (dd, J = 18.2, 6.8 Hz, 1H, 6-H), 2.20 (t, J = 6.6 Hz, 2H, 4-H), 1.99 (d, J =  
   18.2 Hz, 1H, 6-H), 1.91 – 1.71 (m, 2H, 3-H), 1.14 (d, J = 6.8 Hz, 3H, CH3) ppm. 
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31c. mixture of E/Z isomers: 1H NMR (400 MHz, CDCl3) δ = 7.79 – 7.68 (bs, 1H, 2-H), 
7.45 – 7.29 (m, 5H, Ph), 6.87 (q, J = 6.9 Hz, 0.35H, 7-H), 6.84 (q, J = 6.9 Hz, 0.65H, 7-
H), 6.75 – 6.62 (bs, 0.65H, 6-H), 6.62 – 6.49 (bs, 0.35H, 6-H), 5.26 (s, 2H, CH2O) 3.66 
– 3.63 (m, 2H, 2-H), 2.36 (t, J = 6.0 Hz, 2H, 4-H), 1.89 (d, J = 6.9 Hz, 3H, CH3), 1.87 – 
1.82 (m, 2H, 5-H) ppm. 
N
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1-(Toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridine-2-carboxylic acid methyl ester (42). 
Phosphate 12a (949 mg, 1.96 mmol) was dissolved in DMF (5 mL) and Pd(OAc)2 (44 mg, 0.2 mmol) 
and Ph3P (103 mg, 0.4 mmol) were added. Reaction mixture was flushed with CO and Et3N (0.5 mL, 
3.9 mmol) and MeOH (3.2 mL, 80 mmol) were added. The reaction mixture was stirred at 60 °C under 
CO atmosphere. After 2.5 h, water (50 mL) was added and the product extracted with Et2O (3 x 40 
mL). The combined organic extracts were dried over anhydrous K2CO3 for 30 min. After filtration and 
evaporation of the solvent, the crude was purified by flash chromatography. After chromatography (n-
hexane/EtOAc, 2 : 1 Rf = 0.31) pure 42 (405 mg, 70 %) was obtained as a colourless oil. 1H NMR (400 
MHz, CDCl3) δ = 7.85 (d, J = 8.2 Hz, 2H, Ts), 7.31 (d, J = 8.2 Hz, 2H, Ts), 6.31 (t, J = 3.9 Hz, 1H, 3-H), 
3.83 (s, 3H, OCH3), 3.51 – 3.05 (m, 2H, 6-H), 2.43 (s, 3H, CH3-Ts), 2.15 (td, J = 6.7, 3.9 Hz, 2H, 4-H), 
1.80 – 1.47 (m, 2H, 5-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 165.7 (s, CO), 144.0 (s, Ts), 135.9 (s, 
C2), 131.2 (s, Ts), 129.5 (d, 2C, Ts), 127.9 (d, 2C, Ts), 126.5 (d, C3), 52.0 (q, OCH3), 44.9 (t, C6), 22.3 
(t, C4), 21.6 (t, C5), 20.1 (q, CH3-Ts) ppm. Elemental analysis calcd (%) for C14H17NO4S: C 56.93, H 
5.80, N 4.74; found N 4.91, C 56.98, H 5.68. 
N
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1-(Toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridine-2-carbaldehyde (43). 
A solution of 42 (295 mg, 1 mmol) in DCM (16 mL) was cooled to 0 °C and 1 M solution of DIBAL-H 
(1.25 mL, 1.25 mmol) was slowly added. Reaction mixture was stirred on ice bath for 2 h. The reaction 
was quenched by the addition of MeOH (5 mL) and satd solution of Rochelle salt (20 mL). Formed 
two-phase system was stirred for 1 h and then the layers were separated. The organic layer was dried 
over anhydrous Na2CO3 for 30 min. After filtration and evaporation of the solvent, obtained material 
was dissolved in DCM (10 mL), cooled to 0 °C and Dess-Martin periodinane (509 mg, 1.2 mmol) was 
added. The reaction mixture was stirred at room temperature for 2 h, poured into satd solution of 
Na2S2O3 and stirred for 30 min. The layers were separated and the product extracted with DCM (3 x 6 
mL). The organic extracts were dried over anhydrous Na2CO3 for 30 min. After filtration and 
evaporation of the solvent, flash chromatography (n-hexane/EtOAc, 3 : 1; Rf = 0.27) afforded pure 43 
(223 mg, 84 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ = 9.56 (s, 1H), 7.71 (d, J = 8.5 Hz, 
2H, Ts), 7.31 (d, J = 8.5 Hz, 2H, Ts), 6.38 (t, J = 4.0 Hz, 1H, 3-H), 3.49 – 3.46 (m, 2H, H-6), 2.43 (s, 
3H, CH3-Ts), 2.13 (td, J = 6.6, 4.0, 2H, 4-H), 1.36 – 1.31 (m, 2H, 5-H) ppm. 13C NMR (100.4 MHz, 
CDCl3) δ = 187.7 (s, CO), 144.33 (s, Ts), 138.4 (s, Ts), 135.6 (s, C2), 129.8 (d, 2C, Ts), 128.9 (d, 2C, 
Ts), 127.8 (d, C3), 45.1 (t, C6), 22.6 (t, C4), 21.6 (t, C5), 19.6 (q, CH3-Ts) ppm. MS (ESI) m/z (%): 265 
([M]+, 12), 288 ([M+Na]+, 35), 553 ([2M+Na]+, 100). Elemental analysis for C13H15NO3S: calcd N 5.28, 
C 58.85, H 5.70, O 18.90, S 12.09; found N 5.33, C 58.73, H 5.71. 
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Acetic acid 1-[1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-prop-2-ynyl ester (48). 
A solution of triethysilylacetylene (0.135 mL, 0.75 mmol) ) in THF (2 mL) was cooled to -78 °C and  1.6 
M solution of n-BuLi (0.45 mL, 0.75 mmol) was slowly added keeping the temperature below -70 °C. 
Reaction mixture was stirred below -70 °C and after 30 min a solution of 43 (150 mg, 0.57 mmol) in 
THF (5 mL) was added. After 30 min the temperature was slowly risen to 0 °C and NaHCO3 (8 mL) 
was added. The product was extracted with Et2O (3 x 5 mL) and the organic layer was dried over 
anhydrous Na2CO3 for 30 min. After filtration and evaporation of the solvent, obtained material was 
dissolved in THF (10 mL) and TBAF (237 mg, 0.75 mmol) was added. Reaction was stirred at room 
temperature and after 1 h water was added. The product was extracted with Et2O (3 x 10 mL). The 
organic extracts were dried over anhydrous Na2CO3 for 30 min. After filtration and evaporation of the 
solvent, column chromatography (n-hexane/Et2O, 3 : 1 + 1 % Et3N; Rf = 0.36) afforded pure 47 (14 mg, 
6 %) as a colourless oil and 46 (111 mg, 46 %) as a yellow oil.  
47: 1H NMR (200 MHz, CDCl3) δ = 7.75 (d, J = 8.3 Hz, 2H, Ts), 7.32 (d, J = 8.3 Hz, 
2H, Ts), 6.02 (t, J = 3.8 Hz, 1H, 3-H), 5.49 (s, 1H, 1’-H), 3.69 (ddd, J = 14.1, 6.3, 3.6 
Hz, 1H, 6-H), 3.35 (ddd, J = 14.1, 9.2, 3.6 Hz, 1H, 6-H), 2.61 (d, J = 2.3 Hz, 1H, 3’-
H), 2.42 (s, 3H, CH3-Ts), 1.99 – 1.93 (m, 2H, 4-H), 1.23 – 1.16 (m, 2H, 5-H) ppm. 
46: 1H NMR (200 MHz, CDCl3) δ =7.73 (d, J = 8.3 Hz, 2H, Ts), 7.30 (d, J = 8.3 Hz, 
2H, Ts), 5.63 (t, J = 3.8 Hz, 1H, 3-H), 4.49 (t, J = 6.7 Hz, 1’-H), 3.56 – 3.44 (m, 2H, 
6-H), 2.43 (s, 3H, CH3-Ts), 1.94 – 1.83 (m, 2H, 4-H), 1.81 – 1.59 (m, 2H, 2’-H), 
1.18 – 1.39 (m, 6H, 5-H, 3’-H and 4’-H), 0.90 (t, J = 7.0 Hz, 3H, 5’-H) ppm. 
 
A solution of enynyl alcohol 47 (14 mg, 0.048 mmol), DMAP (1.2 mg, 0.1 mmol) and Et3N (0.02 mL, 
0.144 mmol) in DCM (0.5 mL) was cooled by ice bath and Ac2O (9 μL, 0.1 mmol) was added. The 
reaction mixture was stirred at room temperature and after 1 h reaction mixture was concentrated. 
Flash chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.4) afforded enynyl acetate 48 (13.1 
mg,  82 %). 1H NMR (400 MHz, CDCl3) δ = 7.73 (d, J = 8.2 Hz, 2H, Ts), 7.29 (d, J = 8.2 Hz, 2H, Ts), 
6.64 (bs, 1H, 1’-H), 6.04 (t, J = 3.8 Hz, 1H, 3-H), 3.72 – 3.54 (m, 1H, 6-H), 3.39 (ddd, J = 14.0, 7.3, 4.9 
Hz, 1H, 6-H), 2.57 (d, J = 2.2 Hz, 1H, 3’-H), 2.42 (s, 3H, CH3-Ts), 2.10 (s, 3H, CH3-Ac), 1.98 (ddd, J = 
8.1, 6.7, 2.6 Hz, 2H, 4-H), 1.41 – 1.23 (m, 2H, 5-H) ppm.   
N
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Acetic acid 1-(toluene-4-sulfonyl)-2,3,4,5-tetrahydro-1H-[1]pyrindin-6-yl ester (52). 
Compound 52 was prepared according to the above described procedure for gold(I)-catalyzed 
reactions starting from 48 (13.1 mg, 0.04 mmol). Reaction was carried out in DCM with 5 % of 
Ph3PAuCl/AgSbF6. Since the reaction was carried out on a very small scale, catalyst was added as 
0.05 M stock solution. The reaction was monitored by TLC and it was complete in 1 h. Solvent was 
evaporated and crude was dissolved in CDCl3. Based on the analysis of 1H NMR and gCOSY spectra 
compound 52 was obtained.45 1H NMR (400 MHz, CDCl3) δ = 7.55 (d, J = 8.6 Hz, 2H, Ts), 7.20 (d, J = 
8.6 Hz, 2H, Ts), 6.55 (s, 1H, 7-H), 3.54 – 3.51 (m, 2H, 2-H), 3.02 (s, 2H, 5-H), 2.34 (s, 3H, CH3-Ts), 
2.13 (s, 3H, CH3-Ac), 2.02 (t, J = 6.4 Hz, 2H, 4-H), 1.39 – 1.35 (m, 2H, 3-H) ppm.   
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1-(Toluene-4-sulfonyl)-1,2,3,4,4a,5-hexahydro-[1]pyrindin-6-one (53). 
To the solution of 52 in DCM/MeOH = 1 : 1 (1 mL) catalytic amount of pTsOH was added and reaction 
mixture was stirred at room temperature for 20 min. Solvent was evaporated and the crude was 
dissolved in CDCl3. Analysis of 1H NMR revealed the product in the mixture with pTsOH.45 1H NMR 
(400 MHz, CDCl3) δ = 7.71 (d, J = 8.4 Hz, 2H, Ts), 7.30 (d, J = 8.5 Hz, 2H, Ts), 6.18 (s, 1H, 7-H), 3.84 
– 3.78 (m, 1H, 2-H), 3.73 – 3.65 (m, 1H, 2-H), 2.91 – 2.79 (m, 1H, 4a-H), 2.69 (dd, J = 18.6, 6.4 Hz, 
1H, 5-H), 2.39 – 2.34 (m, 4H, CH3-Ts and 3-H), 2.12 – 2.05 (m, 1H, 4-H), 1.94 – 1.75 (m, 2H, 3-H), 
1.25 – 1.18 (m, 1H, 4-H) ppm. 
N
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1-[1-(Toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-hept-2-yn-1-ol (44). 
A solution of hexyne (28 μL, 0.24 mmol) in THF (2.5 mL) was cooled to -78 °C and 1.6 M solution of n-
BuLi (150 μL, 0.24 mmol) was slowly added keeping the temperature below -70 °C. Reaction mixture 
was stirred below -70 °C and after 30 min a solution of 43 (49 mg, 0.19 mmol) in THF (5 mL) was 
added. After 30 min the temperature was slowly risen to 0 °C and NaHCO3 (8 mL) was added. The 
product was extracted with Et2O (3 x 5 mL) and the organic layer was dried over anhydrous Na2CO3 
for 30 min. After filtration and evaporation of the solvent, obtained material was immediately used in 
next step. 1H NMR (200 MHz, CDCl3) δ = 7.74 (d, J = 8.4 Hz, 2H, Ts), 7.30 (d, J = 8.4 Hz, 2H, Ts), 6.00 
(t, J = 4.0 Hz, 1H, 3-H), 5.45 (bs, 1H, 1’-H), 3.80 (m, 2H, 6-H and OH), 3.38 (ddd, J = 14.0, 9.0, 3.4 Hz, 
6-H), 2.43 (s, 3H, CH3-Ts), 2.32 – 2.0 (m, 2H, 4-H), 2.02 – 1.94 (m, 2H, 4’-H), 1.62 – 1.14 (m, 6H, 5-H, 
5’-H and 6’-H), 0.90 (t, J = 6.9 Hz, 3H, 7’-H) ppm. 
Acetic acid 1-[1-(toluene-4-sulfonyl)-1,4,5,6-tetrahydro-pyridin-2-yl]-hept-2-ynyl ester (45) 
A solution of enynyl alcohol 44 (60 mg, 0.17 mmol), DMAP (4.2 mg, 0.04 mmol) and Et3N (67 μL, 0.52 
mmol) in DCM (1.5 mL) was cooled by ice bath and Ac2O (33 μL, 0.35 mmol) was added. The reaction 
mixture was stirred at room temperature and after 1 h reaction mixture was concentrated. Flash 
chromatography (n-hexane/EtOAc, 5 : 1 + 1 % Et3N; Rf = 0.27) afforded enynyl acetate 45 (48 mg,   72 
%). 1H NMR (200 MHz, CDCl3) δ = 7.75 (d, J = 8.4 Hz, 2H, Ts), 7.28 (d, J = 8.4 Hz, 2H, Ts), 6.60 (bs, 
1H, 1’-H), 6.05 (t, J = 4.0 Hz, 1H, 3-H), 3.78 – 3.61 (m, 1H, 6-H), 3.41 – 3.25 (m, 1H, 6-H), 2.43 (s, 3H, 
CH3-Ts), 2.27 – 2.20 (m, 2H, 4-H), 2.10 (s, 3H, CH3-Ac), 2.09 – 1.92 (m, 2H, 4’-H), 1.63 – 1.25 (m, 6H, 
5-H, 5’-H and 6’-H), 0.90 (t, J = 6.9 Hz, 3H, 7’-H) ppm. 
Acetic acid 6-butyl-1-(toluene-4-sulfonyl)-2,3,4,4a-tetrahydro-1H-[1]pyrindin-5-yl ester (49) 
Propargy acetate 45 (45 mg, 0.116 mmol) was treated with 5 mol % of Ph3PAuCl/AgSbF6 in DCM at 
room temperature according to the general procedure for gold(I)-catalyzed reactions. The reaction was 
monitored by TLC and it was complete in 1 h. The reaction mixture was concentrated and the crude 
was purified by column chromatography. Among 4 sets of fractions, only one was pure enough to carry 
on with the analysis. Based on the analysis of 1H NMR, gCOSY and HSQC spectra structure 49 (Rf = 
0.29, 4.5 mg) was assigned. 1H NMR (200 MHz, CDCl3) δ = 7.57 (d, J = 8.3 Hz, 2H, Ts), 7.25 (d, J = 
8.3 Hz, 2H, Ts), 5.81 (s, 1H, 7-H), 4.52 (dd, J = 7.0, 3.0 Hz, 1H, 4a), 3.73 – 3.65 (m, 1H, 2-H), 3.50 
(ddd, J = 11.9, 10.1, 4.8 Hz, 1H, 2-H), 2.60 (dtd, J = 9.4, 6.1, 3.0 Hz, 1H, 4-H), 2.54 – 2.34 (m, 5H, 1’-H 
and CH3-Ts), 2.34 – 2.18 (m, 1H, 3-H), 2.06 – 1.96 (m, 1H, 4-H), 1.97 (s, 3H, CH3-Ac), 1.76 (ddt, J = 
 99	
14.1, 9.4, 4.8 Hz, 1H, 3-H), 1.53 (m, 2H, 2’-H), 1.45 – 1.29 (m, 2H, 3’-H), 0.92 (t, J = 7.3 Hz, 3H, 4’-H) 
ppm. 
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Chapter 6: Transformations of Pentannulated Piperidines 
 In a view of possible applications of pentannulated piperidines as conformationally restricted 
iminosugar analogues, we decided to explore a few preliminary transformations such as hydrogenation 
of the double bond, reduction of the carbonyl group and α-hydroxylation of compounds prepared in 
previous chapter.  
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Scheme 1. Transformations of cyclopentenone 1.  
6.1. Hydrogenation   
 The hydrogenation of cyclopentenones 1, obtained via gold(I)-catalyzed tandem [3,3]-
rearrangement/Nazarov cyclization of piperidine-derived propargyl acetates (see section 5.2), gave 
corresponding ketones 3 in moderate to high diastereoselectivity (Scheme 2). It was assumed that the 
delivery of the hydrogen was preferred from the less hindered face of α,β-unsaturated ketone 1 thus 
providing isomer 3 as the major product. The cis ring fusion was assigned on the basis of coupling 
constant of 6 – 8 Hz between bridgehead protons on the ring junction (7a-H and 4-aH). Assigned cis-
configuration was further confirmed by crystal structure of alcohol 4a, obtained after the reduction of 
the ketone 3a.  
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Scheme 2. Hydrogenation of cyclopentenones 1a-d. Note: a Diastereomeric ratio determined by 
1H NMR of crude reaction mixture. b Reaction carried out under pressure of 4 bar. 
The hydrogenation of C-5 alkyl substituted compounds 1a and 1b led to the formation of 
corresponding diastereomers 3a and 3b in a mixture with epi-3a and epi-3b in diastereomeric ratio     
9 : 1 and 10 : 1 respectively. The hydrogenation of substrate bearing a C-5-phenyl ring (1c) or a C-2-
side chain (1d) was completely selective. In both cases we could not detect any trace of the 
corresponding diastereomer in the 1H NMR spectra of crude reaction mixture.  
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6.2. Carbonyl Reduction  
 The reduction of the ketones 3a, 3b and 3d using DIBAL-H in THF at -78 °C provided 
alcohols 4a, 4b and 4d,  respectively, with notably high selectivity (Scheme 3).   
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Scheme 3. Reduction of the carbonyl group in 3. 
The diastereoselectivity in the reduction of the mixtures 3a/epi-3a and 3b/epi-3b was very high since 
we could detect only trace (< 5%) of the isomer in 1H NMR sprectrum of crude reaction mixture. The 
reduction of 3d provided 4d in enantiopure form.  
A recrystallization of 4a from DCM/hexane = 1 : 1 solution provided material suitable for X-ray 
crystallography thereby confirming the tentatively assigned structures on Schemes 2 and 3.  
 
Figure 1. X-Ray structure of 4a. 
 
6.3. α-Hydroxylation  
 The initial strategy for installing α-hydroxyl into unsymmetrical ketones 3 was based on the 
generation of enolate 5 under the kinetic control, which would be oxidized in the next step (Scheme 4).   
Unfortunately, all attempts to selectively generate and trap enolate 5a at -78 °C in THF using LiHDMS 
or KHDMS as a base and TMSCl or TIPSCl as a trapping electrophile failed.1 In addition, the direct 
oxidation of metal enolate 5b using oxaziridine failed too,2 and therefore we sought for an alternative 
procedure.  
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Scheme 4. Initial startegy for the α-hydroxylation of 3. 
Hypervalent iodine oxidation, also known as Moriarity two-step approach for the preparation α-hydroxyl 
derivatives from enolisable carbonyl compounds3 led to the formation of desired product along with 
unknown side-products. In the first step, the treatment of 3a with iodobenzene diacetate (DIB) in 
methanolic potassium hydroxide led to the formation of hydroxyl dimethylketal 7a in a mixture with 
unknown side-products. However, the crude α-hydroxydimethylacetal 7a was treated with 10 % H2SO4 
in DCM and after chromatography gave α-hydroxyl ketone 6a in 30 % yield (Scheme 5). The 
assignment of the stereochemistry was based on the evaluation of the vicinal coupling constant of 8.7 
Hz between methine protons on the five membered ring.   
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Scheme 5. α-Hydroxylation of 3a. Reagents and conditions: (a) DIB, KOH, MeOH, 2 h; (b) 10 % 
H2SO4 in DCM, 1h.  
The experimentally observed difficulties to prepare α-hydroxylated products 6 were attributed to the 
acidity of the proton on the ring junction (7a-H, Scheme 1) that prevents the generation of desired, 
kinetic enolate in selective manner and therefore we resorted to explore α-hydroxylation of α,β-
unsaturated ketone 1b.  
Attempts of oxidation with Pb(OAc)4 in cyclohexane,4 PhI(OAc)2 in KOH/MeOH3 and enolization with 
KHMDS were all unsuccessful. Enolization of 1b with LiHMDS in THF at -78 °C followed by trapping of 
the formed enol with TMSCl led to the formation of triethylsilyl enol ether which was isolated, and the 
crude material was subsequently treated with mCPBA at -78 °C in DCM to accomplish α-
hydroxylation.5 The 1H NMR of crude reaction mixture revealed 70 % conversion and formation of 
diastereomers. The flash chromatography afforded the mixture of diastereomers in 2:1 ratio and the 
yield of 61 %. The HPLC purification allowed the isolation of major diastereomer and its complete 
characterization. The vicinal coupling constant of 3.2 Hz between methine protons on the five 
membered ring (C-5 and C-6) indicated the trans relationship between these protons and therefore the 
structure 9b could tentatively be assigned to the major product.  On the other hand, the coupling 
constant of 6.5 Hz in minor diastereomer epi-9b is consistent with cis relationship between methine 
protons as in 6b.  
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Scheme 6. α-Hydroxylation of 1b. Reagents and conditions: (a) LiHMDS, THF, -78 °C, 30 min 
followed by the addition of TMSCl, -78 – 0 °C, 1.5 h; (b) mCPBA, NaHCO3, DCM, -78 °C, 
1h (9b : epi-9b = 2 : 1, 61 %).  
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6.4. Experimental Part 
General information 
Solvents and reagents were used either as received from commercial suppliers or, when necessary, 
purified using standard laboratory techniques according to methods published in “Purification of 
Laboratory Chemicals” by Perrin, Armarego, and Perrin (Pergamon Press, 1966). All reactions were 
conducted in oven- or flame-dried glassware under an inert atmosphere of dry nitrogen. 
Chromatographic separations were performed under pressure on silica gel by flash-column 
techniques; Rf values refer to TLC carried out on 0.25-mm silica gel plates (Merck F254), with the same 
eluent as indicated for the column chromatography. Melting points were recorded on a Buchi-540 
melting point apparatus and are uncorrected. Optical rotation values were recorded on a Jasco DIP-
370 polarimeter at indicated temperature in the specified solvents and concentrations. 1H NMR and 
13C NMR spectra were recorded at 400 and 100.4 MHz, respectively, in the specified deuterated 
solvent at room temperature. Solvent reference lines were set at 7.26 and 77.00 (CDCl3) in 1H and 13C 
NMR spectra, respectively. Mass spectra were carried out by direct inlet of a 20 ppm solution either in 
CH3OH or CH3OH + 0.1% HCO2H on a LCQ FleetTM Ion Trap LC/MS system (Thermo Fisher 
Scientific) with an electrospray ionization (ESI) interface in the positive mode. Microanalyses were 
carried out with a CHN Thermo FlashEA 1112 Series elemental analyzer. 
General procedure for hydrogenation. 
Cyclopenta-fused piperidine 1 (1 mmol) was dissolved in anhydrous ethanol (10 mL) under a nitrogen 
atmosphere. Then, 10 % Pd/C catalyst (15 mol %) was added and the reaction flask flushed first with 
N2 and then with hydrogen and left under a hydrogen atmosphere (balloon) at room temperature for  
48 h. The suspension was filtered through a Celite pad and the filtrate concentrated under vacuum. 
The purification of the crude by flash chromatography afforded desired product.  
N
Ts O
H
H  
5-Butyl-1-(toluene-4-sulfonyl)-octahydro-[1]pyrindin-7-one (3a).  
Compound 3a was prepared according to the above described procedure for hydrogenation starting 
from 5-butyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (125 mg, 0.36 mmol). 
Flash chromatography (n-hexane/Et2O, 3 : 1; Rf = 0.25) afforded product 3a (111 mg, 89 %) in a 
mixture with diastereomer in  
9 : 1 ratio. 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 10.4 Hz, 2H, Ts), 7.28 (d, J = 10.4 Hz, 2H, Ts), 
4.64 (d, J = 6.2 Hz, 1H, 7a-H), 3.73 – 3.57 (m, 1H, 2-H), 2.58 (td, J = 13.1, 2.5 Hz, 1H, 2-H), 2.42 (s, 
3H, CH3-Ts), 2.41 – 2.38 (m, 2H, 6-H), 2.39 – 2.21 (m, 2H, 4a-H and 5-H), 1.78 – 1.65 (m, 1H, 4-H), 
1.60 – 1.52 (m, 1H, 3-H), 1.44 – 1.21 (m, 7H, 3-H, 1’-H, 2’-H and 3’H), 0.89 (t, J = 6.9 Hz, 3H), 0.93 – 
0.89 (m, 1H, 4-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 212.5 (s, C7), 142.9 (s, Ts), 137.7 (s, Ts), 
129.3 (d, 2C, Ts), 127.4 (d, 2C, Ts), 65.2 (d, C7a), 42.4 (t, C2), 38.5 (t, C6), 36.5 (d, C5), 34.9 (d, C4a), 
30.2 (t, C1’), 29.5 (t, C2’), 23.2 (t, C3), 22.7 (t, C3’), 21.6 (q, CH3-Ts), 20.6 (t, C4), 13.7 (q, C4’) ppm. 
MS (ESI) m/z (%): 349 ([M+1]+, 100), 372 ([M+1]+, 42). Elemental analysis calcd (%) for C19H27NO3S: 
C 65.3, H 7.79, N 4.01; found: C 65.13, H 7.53, N 3.86. 
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5-Methyl-1-(toluene-4-sulfonyl)-octahydro-[1]pyrindin-7-one (3b). 
Compound 3b prepared according to the procedure for hydrogenation starting from 5-methyl-1-
(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (372 mg, 1.22 mmol). The crude was 
purified by flash chromatography (n-hexane/EtOAc, 4 : 1; Rf = 0.28) affording product 3b (290 mg,    
77 %) in a mixture with diastereomer in 10 : 1 ratio. 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.4 Hz, 
2H, Ts), 7.27 (d, J = 8.4 Hz, 2H, Ts), 4.65 (d, J = 6.8 Hz, 1H, 7a-H), 3.66 (d, J = 12.6 Hz, 1H, 2-H), 2.57 
(td, J = 12.6, 2.3 Hz, 1H, 2-H), 2.40 (s, 3H, Ts), 2.47 – 2.32 (m, 2H, 6-H), 2.24 – 2.11 (m, 1H, 4a-H), 
1.82 – 1.63 (m, 2H, 4-H and 5-H), 1.63 – 1.48 (m, 1H, 3-H), 1.43 – 1.25 (m, 1H, 3-H), 1.03 (d, J = 6.3 
Hz, 3H, CH3-5), 0.83 (m, 1H, 4-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 212.5 (s, C7), 142.6 (s, Ts), 
137.7 (s, Ts), 129.3 (d, 2C, Ts), 127.3 (d, 2C, Ts), 65.2 (d, C7a), 42.4 (t, C2), 39.5 (t, C6), 37.7 (d, C5), 
29.1 (d, C4a), 22.9 (t, C3), 21.3 (q, CH3-Ts), 20.6 (t, C4), 15.2 (q, CH3) ppm. MS (ESI) m/z (%): 307 
([M+1]+, 32), 330 ([M+Na]+, 33), 636 ([2M+Na]+, 100). Elemental analysis calcd (%) for C16H21NO3S: C 
62.11, H 7.49, N 4.53; found: C 62.71, H 6.70, N 4.47. 
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5-Phenyl-1-(toluene-4-sulfonyl)-octahydro-[1]pyrindin-7-one (3c). 
Prepared according to the procedure for hydrogenation starting from 5-phenyl-1-(toluene-4-sulfonyl)-
1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (90 mg, 0.25 mmol). The crude was purified by flash 
chromatography (n-hexane/EtOAc, 4 : 1; Rf = 0.28) affording pure product 3c (68 mg, 75 %) as a white 
solid. M.p. = 74.2 – 75.1 °C. 1H NMR (400 MHz, CDCl3) δ = 7.81 (d, J = 8.2 Hz, 2H, Ts), 7.38 – 7.22 
(m, 5H, Ph), 7.18 (d, J = 8.2 Hz, 2H, Ph), 4.90 (d, J = 6.8 Hz, 1H, 7a-H), 3.80 – 3.62 (m, 2H, 2-H), 2.71 
– 2.47 (m, 3H, 3-H and 6-H), 2.43 (s, 3H, CH3-Ts), 1.52 - 1.49 (m, 1H, 4a-H), 1.37 - 1.23 (m, 2H, 3-H 
and 4-H), 0.79 (qd, J = 13.4, 3.0 Hz, 1H, 4-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 211.6 (s, C7), 
143.3 (s, Ts), 137.9 (s, Ts), 137.4 (s, Ph), 129.4 (d, 2C, Ar), 128.5 (d, 2C, Ar), 127.4 (d, 2C, Ar), 127.3 
(d, 2C, Ar), 126.9 (d, Ar), 65.3 (d, C7a), 42.4 (t, C2), 39.9 (t, C6), 39.2 (d, C5), 36.1 (d, C4a), 23.1 (t, 
C3), 21.6 (q, CH3-Ts), 21.4 (t, C4) ppm. MS (ESI) m/z (%): 370 ([M+1]+, 57), 392 ([M+Na]+, 52), 760 
([2M+Na]+, 100). Elemental analysis calcd (%) for C21H23NO3S: C 68,27, H 6,27, N 3,79; found: C 
68.15, H 6.33, N 3.77. 
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2-(tert-Butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-sulfonyl)-octahydro-[1]pyrindin-7-one (3d). 
Prepared according to the procedure for hydrogenation starting from 2-(tert-butyl-dimethyl-
silanyloxymethyl)-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one  (370 mg, 0.85 mmol). 
Reaction was carried out under pressure of 4 bar. After 72 h at conversion of 80 % reaction was 
stopped. The crude was purified by flash chromatography (n-heptane/EtOAc, 3 : 1; Rf = 0.25) affording 
pure product 3d (220 mg, 60 %) as a white solid. M.p. = 117.7 – 118.5 °C. [𝛼]$%% = + 84 (c = 0.86, 
DCM). 1H NMR (400 MHz, CDCl3) δ = 7.86 (d, J = 7.2 Hz, 2H,Ts), 7.36 (d, J = 7.2 Hz, 2H, Ts), 4.58 (d, 
J = 7.9 Hz, 1H, 7a-H), 3.80 (bs, 1H, 2-H), 3.57 – 3.43 (m, 1H, 2-CH2OTBS), 3.26 (t, J = 12.0 Hz, 1H, 2-
CH2OTBS), 2.49 (s, 3H, CH3-Ts), 2.46 – 2.06 (m, 5H, 3-H, 4a-H and 6-H), 1.96 – 1.90 (m, 1H, C-4), 
1.84 – 1.79 (m, 1H, 5-H), 1.25 – 1.16 (m, 2H, 4-H and 6-H), 0.87 (s, 9H, TBS), -0.00 (s, 6H, TBS) ppm. 
13C NMR (100.4 MHz, CDCl3) δ = 214.1 (s, C7), 43.4 (s, Ts), 137.8 (s, Ts), 129.7 (d, 2C, Ts), 127.2 (d, 
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2C, Ts), 62.1 (d, C7a), 60.5 (t, CH2OTBS), 52.7 (d, C2), 33.1 (t, C6), 31.2 (t, C5), 25.6 (q, 3C, TBS), 
23.8 (d, C4a), 21.7 (t, C3), 21.5 (q, CH3-Ts), 20.3 (t, C4), 18.1 (s, TBS), -5.22 (q, 2C, TBS) ppm. 
MS (ESI) m/z (%): 438 ([M+1]+, 100). Elemental analysis calcd (%) for C22H35NO4SSi; C 60.37; H 8.06; 
N 3.20; found: C 60.40, H 8.10, N 3.21.  
General procedure for carbonyl reduction. 
A solution of 3 (1 mmol) in DCM (10 mL) was cooled to -78 °C and a 1 M DIBAL-H solution in hexane 
(1 mL, 1 mmol) was slowly added at -78 °C under nitrogen atmosphere. After 1 h, the excess of the 
reagent was quenched by addition of MeOH (1 mL) and saturated aqueous solution of Rochelle salt 
(10 mL). The reaction mixture was warmed to room temperature and poured into DCM (10 mL). The 
formed 2-phase system was stirred for 30 min and then the layers were separated and the product 
was extracted with EtOAc (2 x 10 mL). The combined organic extracts were dried over anhydrous 
Na2SO4 for 30 min, filtered and concentrated. The crude was purified by flash chromatography to give 
the product. 
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5-Butyl-1-(toluene-4-sulfonyl)-octahydro-[1]pyrindin-7-ol (4a). 
Prepared according to the procedure for hydrogenation starting from 3a (65 mg, 0.19 mmol). The 
crude was purified by flash chromatography (n-hexane/EtOAc, 4 : 1; Rf = 0.35) affording pure product 
4a (52 mg, 78 %) as a white solid. The product was recrystallized from DCM : hexane, 1 : 1. M.p. = 
90.0 – 91.2 °C. 1H NMR (400 MHz, CDCl3) δ = 7.73 (d, J = 8.2 Hz, 2H, Ts), 7.30 (d, J = 8.2 Hz, 2H, 
Ts), 4.32 (dt, J = 6.8, 3.5 Hz, 1H, 7-H), 3.80 (t, J = 6.8 Hz, 1H, 7a-H), 3.75 – 3.67 (m, 1H, 2-H), 3.30 
(td, J = 12.4, 3.0 Hz, 1H, 2-H), 2.42 (s, 3H, CH3-Ts), 2.24 (dt, J = 14.2, 8.0 Hz, 1H, 6-H), 1.96 (s, 1H, 
OH), 1.82 – 1.58 (m, 3H, 4a-H, 5-H and 3-H), 1.58 – 1.41 (m, 1H, 4-H), 1.39 – 1.06 (m, 9H, 1’-H, 2’-H, 
3’-H, H-3, 6-H and 4-H), 0.86 (t, J = 7.0 Hz, 3H, 4’-H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 143.3 (s, 
Ts), 137.1 (s, Ts), 129.7 (d, 2c, Ts), 127.1 (s, 2C, Ts), 73.3 (d, C7), 59.1 (d, C7a), 44.4 (t, C2), 39.3 (d, 
C4a), 38.4 (d, C5), 38.1 (t, C6), 30.4 (t, C1’), 30.0 (t, C2’), 23.5 (t, C3), 23.0 (t, C3’), 21.5 (q, CH3-Ts), 
20.1 (t, C4), 13.9 (q, C4’) ppm. MS (ESI) m/z (%): 310 ([M+1]+, 42), 333 ([M+Na]+, 8), 641 ([2M+Na]+, 
100). Elemental analysis calcd (%) for C19H29NO3S: C 64.92, H 8.32, N 3.98; found: C 64.83, H 8.52, 
N 3.68. 
N
Ts OH
H
H  
5-Methyl-1-(toluene-4-sulfonyl)-octahydro-[1]pyrindin-7-ol (4b). 
Prepared according to the procedure for the ketone reduction starting from 5-methyl-1-(toluene-4-
sulfonyl)-octahydro-[1]pyrindin-7-one (75 mg, 0.24 mmol). The crude was purified by flash 
chromatography (n-hexane/EtOAc, 5 : 1; Rf = 0.23) affording product 4b (73 mg, 97 %). 1H NMR (400 
MHz, CDCl3) δ = 7.74 (d, J = 8.2 Hz, 2H, Ts), 7.31 (d, J = 8.2 Hz, 2H, Ts), 4.39 – 4.31 (m, 1H, 7-H), 
3.83 (t, J = 6.8 Hz, 1H, 7a-H), 3.73 (dt, J = 14.4, 3.2 Hz, 1H, 2-H), 3.30 (td, J = 12.5, 3.2 Hz, 1H, 2-H), 
2.43 (s, 3H, CH3-Ts), 2.30 – 2.18 (m, 1H, 6-H), 1.91 (d, J = 3.1 Hz, OH), 1.85 (m, 1H, 5-H), 1.75 – 1.62 
(m, 2H, 4a-H and 3-H), 1.55 – 1.47 (m, 1H, 4-H), 1.39 – 1.26 (m, 1H, 6-H), 1.26 – 1.11 (m, 2H, 3-H and 
4-H), 0.95 (d, J = 6.8 Hz, 3H, CH3-5) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 143.2 (s, Ts), 137.1 (s, 
Ts), 129.7 (d, 2C, Ts), 126.9 (d, 2C, Ts), 73.8 (d, C7), 59.4 (d, C7a), 44.6 (t, C2), 40.8 (d, C-4a), 39.7 (t, 
C6), 32.8 (d, C5), 23.5 (t, C3), 21.5 (q, CH3-Ts), 20.1 (t, C4), 14.7 (q, CH3-5) ppm. MS (ESI) m/z (%): 
310 ([M+1]+, 42), 331 ([M+Na]+, 7), 641 ([2M+Na]+, 100). Elemental analysis calcd (%) for 
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C16H23NO3S: C 62,11, H 7,49, N 4,53; found: 62.12, H 7.29, N 4.61. 
N
Ts
TBSO
OH
H
H  
2-(tert-Butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-sulfonyl)-octahydro-[1]pyrindin-7-ol (4d).  
A solution of 3d (150 mg, 0.34 mmol) in DCM (4.25 mL) was cooled to -78 °C and a 1.2 M DIBAL-H 
solution in toluene (0.6 mL, 0.68 mmol) was slowly added at -78 °C under nitrogen atmosphere. After 2 
h, the excess of the reagent was quenched by addition of MeOH (2 mL) and saturated aqueous 
solution of Rochelle salt (10 mL) at -78 °C. Reaction mixture was warmed to room temperature and 
poured into DCM (10 mL). The formed 2-phase system was stirred for 30 min and then the layers were 
separated and the product was extracted with DCM (2 x 5 mL). The combined organic extracts were 
dried over anhydrous Na2SO4 for 30 min, filtered and concentrated. The oily residue was purified by 
flash chromatography (heptanes/EtOAc, 4:1; Rf = 0.30) to give the product 4d (110 mg, 77 %) as a 
colourless oil. [𝛼]$%% = - 3.3 (c = 0.9, DCM). 1H NMR (400 MHz, CDCl3) δ = 7.71 (d, J = 8.0 Hz, 2H, Ts), 
7.29 (d, J = 8.0 Hz, 2H, Ts), 4.17 – 4.11 (m, 1H, 7a-H), 4.02 (dd, J = 9.9, 7.1 Hz, 1H, 2-CH2OTBS), 
3.84 – 3.78 (m, 2H, 7a-H and 2-H), 3.70 (dd, J = 9.9, 4.4 Hz, 1H, 2-CH2OTBS), 3.45 (bs, 1H, OH), 
2.42 (s, 3H, Ts), 2.01 – 1.89 (m, 1H, 3-H), 1.89 – 1.80 (m, 1H, 5-H), 1.75 – 1.64 (m, 3H, 5-H, 6-H and 
4a-H), 1.64 – 1.51 (m, 1H, 6-H), 1.42 – 1.30 (m, 1H, 4-H), 1.30 – 1.08 (m, 2H, 3-H and 4-H), 0.93 (s, 
9H, TBS), 0.12 (s, 6H, TBS) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 143.3 (s, Ts), 136.8 (s, Ts), 129.7 
(d, 2C, Ts), 127.1 (d, 2C, Ts), 73.5 (d, C7), 65.2 (t, CH2OTBS-2), 59.5 (d, C7a), 54.3 (d, C2), 33.8 (d, 
C4a), 30.9 (t, C6), 29.1 (s, C-TBS) , 25.8 (q, 3C, CH3-TBS), 23.2 (t, C4), 22.2 (t, C2), 21.4 (q, CH3-Ts), 
18.17 (t, C5), -5.40 (q, 2C, CH3-TBS) ppm. Elemental analysis calcd (%) for C22H37NO4SSi; C 60.10; H 
8.48; N 3.19; found: C 60.03, H 8.50, N 3.16. 
N
Ts O
OH
 
6-Hydroxy-5-methyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (9b). 
A solution of 5-methyl-1-(toluene-4-sulfonyl)-1,2,3,4,5,6-hexahydro-[1]pyrindin-7-one (130 mg, 0.42 
mmol) in dry THF (4.2 mL) was cooled to -78 °C and a 1 M solution of LiHMDS in THF (0.462 mL, 
0.462 mmol) was added dropwise. The resulting mixture was stirred for 30 min at -78 °C and then 
TMSCl (57 µL, 0.462 mmol) was slowly added and the stirring continued below -70 °C for another 30 
min. The mixture was allowed to warm to 0 °C and then quenched with water (5 mL). The product was 
extracted with EtOAc (4 x 5 mL); the combined organic extracts were dried over anhydrous Na2SO4 for 
30 min. After filtration and evaporation of the solvent, obtained yellow oil was dissolved in DCM (8 mL) 
and NaHCO3 (84 mg, 1.05 mmol) was added. The resulting suspension was cooled to -78 °C and then 
mCPBA (72.5 mg, 0.42 mmol) was added. After 1 h at -78 °C, saturated Na2S2O3 (4 mL) and NaHCO3      
(4 mL) were added, cooling bath was removed and the formed 2-phase system was vigorously stirred 
for 1 h. Layers were separated and the product was extracted with DCM (2 x 10 mL). The combined 
organic extracts were dried over anhydrous Na2SO4 for 30 min, filtered and concentrated. The oily 
residue was purified by flash chromatography (n-hexane/EtOAc, 3 : 2; Rf = 0.14) to give                               
α-hydroxylated product as a 2 : 1 mixture of diastereomers (82 mg, 61 %). Analyticaly pure major 
diastereomer 9b was obtained by HPLC purification (35 % ACN, 65 % H2O, Rt = 16.5 min). 1H NMR 
(400 MHz, CDCl3) δ = 7.97 (d, J = 8.2 Hz, 2H, Ts), 7.32 (d, J = 8.2 Hz, 2H, Ts), 3.97 (d, J = 3.2 Hz, 1H, 
6-H), 3.92 (dt, J = 13.5, 3.5 Hz, 1H, 2-H), 2.98 – 2.88 (m, 1H, 2-H), 2.83 (bs, 1H, OH), 2.65 – 2.56 (m, 
1H, 5-H), 2.54 – 2.45 (m, 1H, 4-H), 2.43 (s, 3H, CH3-Ts), 2.28 – 2.14 (m, 1H, 4-H), 1.97 (m, 2H, 3-H), 
1.34 (d, J = 7.2 Hz, 1H, CH3) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 200.1 (s, C7), 158.3 (s, C7a), 
143.9 (s, Ts), 137.2 (s, C4a), 134.0 (s, Ts), 129.4 (d, 2C, Ts), 127.8 (d, 2C, Ts), 78.8 (d, C6), 45.5 (t, 
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C2), 42.6 (d, C5), 23.1 (t, C4), 21.8 (q, CH3-Ts), 21.5 (t, C3), 16.26 (q, CH3-5). MS (ESI) m/z (%): 322 
([M+1]+, 34), 344 ([M+Na]+, 92), 665 ([2M+Na]+, 100). Elemental analysis calcd (%) for C16H19NO4S: C 
59.79, H 5.96, N 4.36; found: C 59.82, H 5.99, N 4.32. 
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Chapter 7: Synthesis of Cyclopenta[b]indoles 
 The work described in this chapter was published as “Construction of Cyclopenta[b]indol-1-
ones by a Tandem Gold(I)-Catalyzed Rearrangement/Nazarov Reaction and Application to the 
Synthesis of Bruceolline H” in Org. Lett. 2016, 18, 3922 – 3925.  
 
 Cyclopenta[b]indoles are commonly found in many natural and biologically active 
compounds1,2 and therefore there has been much interest in the development of new methods for the 
pentannulation of indoles.3,4 During the last decade, gold(I) catalysis has emerged as a powerful tool 
for the pentannulation of indoles. As shown in introduction, cyclization reactions triggered by 
electrophilic activation of an unsaturated side chain of the heterocycle, sequential gold(I)-catalyzed 
hydroamination/cyclization reactions, and cascade gold(I)-catalyzed rearrangement/cyclization 
processes, have all successfully been employed for the pentannulation of indoles (Chapter 3).  
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Scheme 1. Au(I)-catalyzed [3,3]-rearrangement/Nazarov cyclization of indole-derived enynyl 
acetates 1 and 4. 
The fact that indole bearing a propargylic ester moiety at position 2 (1, Chapter 5) in the presence of a 
gold(I) catalyst undergoes [3,3]-sigmatropic rearrangement thus generating pentadienyl cation 2 which 
after the cyclization gives cyclopentannulated indoles 3, prompted us to investigate if indole bearing 
the propargylic moiety at position 3 under the gold(I) catalysis could provide cyclopenta-fused indoles 
6 (Scheme 1) with a substitution pattern on the five-membered ring which would allow an easy entry to 
the bruceollines2 and other natural products possessing the cyclopenta[b]indol-1-one nucleus. 
 
 
7.1. Optimization of Reaction Conditions 
The synthesis of the model compound 4a (Scheme 2) was carried out by iodination of the indole at 
position C3 followed by N-protection. This time CO2Me was chosen as nitrogen protecting group 
because it did not cause trouble in gold(I)-catalyzed [3,3]-rearrangement/Nazarov cyclization of 1 and 
it is easier to remove then the tosyl group. Sonogashira coupling5 of N-CO2Me 3-iodoindole (13a) with 
(±)-3-butyn-2-ol gave alcohol 14a whose O-acetylation provided compound 4a in 86 % after 
chromatography.  
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Scheme 2. Synthesis of 4a. Reagents and conditions: (a) 1. I2, KOH, DMF, 0 – 25 °C, 1 h, 2. 
CH3COCl, Et3N, THF, 0 – 25 °C, 3 h (86 % two steps); (b) (±)-3-butyn-2-ol, 3 mol % CuI,      
5 mol % (Ph3P)2PdCl2, DMF-Et3N, 1 : 5, 40 °C, 3 h; (c) Ac2O, Et3N, DMAP, DCM, 0 – 25 °C, 
3 h (86 % two steps). 
Initially, model substrate 4a was treated with 3 mol % of Ph3PAuCl/AgSbF6 in DCM at room 
temperature, the optimized reaction conditions for the cyclization of N-heterocycles bearing propargyl 
side chain at position C2. The reaction mixture was left to stir and the progress of the reaction was 
monitored by TLC. After 6 h, the starting material was consumed and the analysis of 1H NMR spectra 
of the crude reaction mixture revealed cyclopenta-fused indole 6a in the mixture with α,β-unsaturated 
ketone 7a (3 : 1 E/Z mixture). The clean reaction profile and isolation of 6a in 79 % yield after 
chromatography indicated that 4a shows different reactivity in comparison with already described 
cyclization of C-3 substituted piperidine analogue (Chapter 5.2.).  
In an attempt to optimize the reaction conditions, the reaction was carried out by varying gold ligand, 
counterion and the solvent (Table 1). The experiments were carried out with 3 mol % of LAuCl/AgX at 
room temperature. Monitoring the reaction by 1H NMR revealed that the reaction was complete in two 
hours when ligand [(4-CF3C6H4)3P] was used, providing cyclopenta[b]indole 6a in 83 % yield (entry 2). 
Interestingly, while monitoring the reaction, we could not observe any NMR signal associated to 
acetate intermediate, which according to the mechanism, is formed after the cyclization process, due 
to its immediate transformation into final compound 6a.  
	
Table 1. Au(I)-catalyzed [3,3]-rearrangement/Nazarov cyclization of 4a.a  
N
CO2Me
OAc
4a
3% LAuCl
3% AgX
DCM, 25 °C N
CO2Me
6a
O
N
CO2Me
7a
+
O
 
Entry Ligand, L Anion, X Time (h) 
Yieldb 
6a 7a 
1 Ph3P SbF6 ̶ 6 94 (79)c 6 
2 (4-CF3C6H4)3P SbF6 ̶ 2 98 (83)c 2 
3 cHex3P SbF6 ̶ 22 77 23 
4 t-Bu3P Tf2N ̶ 24 37 3 
5 cHexJohnPhos SbF6 ̶ 24 31 traces 
6 (2,4-di-t-BuC6H3O)3P SbF6 ̶ 1.5 79 (73)c - 
7 (4-CF3C6H4)3P Tf2N ̶ 4 99 1 
8 (4-CF3C6H4)3P TfO ̶ 2 96 4 
9 (4-CF3C6H4)3P dBARF- 4 - - 
10 - SbF6 ̶ 2 6  
a Reactions carried out on 0.2 mmol. b Conversion measured by 1H NMR. c Yield after chromatography.  
d NaBARF was used. 
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When more electron-rich ligands were used (Cy3P, t-Bu3P, and CyJohnPhos), the reaction was very 
slow, with only partial conversions even after 24 h and the formation of higher (up to 23 %) relative 
amounts of α,β-unsaturated compound 7a (entries 3-5). Given the marked effect of electron-poor 
phospine, a phospite ligand was used (entry 6) but, although the reaction was slightly faster, a lower 
yield than with [(4-CF3C6H4)3P] was obtained because of the formation of unidentified side products. 
Less important was the role of the counterion: using ligand [(4-CF3C6H4)3P], the reaction rates were 
approximately the same with SbF6- (entry 2) and TfO- (entry 8) and slightly lower with Tf2N- (entry 7). 
With 3 mol % of AgSbF6 alone, the reaction did occur but the conversion was only 6 % after 2 h, thus 
showing that the Au(I) complex is the real catalyst for this process (entry 10).   
 
Figure 1. Effect of phosphine ligands on the reaction rate. 
 
7.2. Scope of the Reaction  
The scope of the reaction was investigated with a series of differently substituted enynyl 
acetates 4 and (4-CF3C6H4)3PAuCl precatalyst. To this end, N-protected 3-iodoindoles 13a-j, bearing 
various electron-withdrawing and electron-donating  groups, were coupled to alkyn-3-ols under 
Sonogashira conditions to provide, after O-acetylation of alcohols 14a-o, requisite substrates 4a-o 
(Scheme 3) in good to excellent overall yields (51 – 91 %, unstable when neat). 
 
Figure 2. X-Ray structure of 6h. 
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Scheme 3. Synthesis of substrates 4 from commercially available indoles. Reagents and 
conditions: (a) 1. I2, KOH, DMF, 0 – 25 °C, 1 h, 2. CH3COCl, Et3N, THF, 0 – 25 °C, 3 h; (b) 
(±)-3-butyn-2-ol, 3 mol % CuI, 5 mol % (Ph3P)2PdCl2, DMF-Et3N, 1 : 5, 40 °C, 3 h; (c) Ac2O, 
Et3N, DMAP, DCM, 0 – 25 °C, 3 h. Yield given over 2 steps, from 2 to 4. 
The prepared substrates (4b-4o) were subjected to the 3 mol % of (4-CF3C6H4)3PAu/AgSbF6 in DCM 
at 25 °C and monitored by TLC. Analysis of the results revealed that the outcome of the tandem 
reaction varied with the electronic properties of the substituent on the indole ring (Scheme 4), with 
EWGs (in 4l-o) lowering both the reaction rate and conversion into the Nazarov product. In the cases 
of 4m and 4o, bearing an EWG at position 5, a particularly high amount of the corresponding α,β-
unsaturated compound 7 was also obtained (37 % and 50 %, respectively). With ED groups, the 
isolated yields of cyclopenta[b]indolones 6 were good to excellent and reaction rates very high, 
especially with methoxy-substituted substrates 4f-k where conversion was complete in less than 1 h.  
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To further confirm the effect of the indole substituent on the outcome of the reaction and to exclude 
influence of factors we are not able to control,6 a competition experiment was carried out on a 1 : 1 
mixture of 6-MeO- and 6-CO2Me-substituted substrates 4i and 4n, respectively, in the presence of      
3 mol % of the catalyst. Monitoring the reaction by 1H NMR revealed the almost immediate conversion 
(less than 15 min) of the substrate with the ED group on the ring into 6i, whereas substrate 4n was 
completely converted into 6n in 4 h.  
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Scheme 4. Scope of the Au(I)-catalyzed [3,3]-rearrangement/Nazarov cyclization of 4. 
 
 
7.3. Reaction Mechanism and DFT Calculations 
 The formation of α,β-unsaturated ketone 7a and its relative increase when the reaction 
becomes very slow on changing the phosphine ligand or by effect of an EWG on the indole ring, 
suggest that the Nazarov cyclization is the rate determining step of the whole process. When the 
cyclization of intermediate 5a to form oxyallyl cation 8a is very slow (Scheme 5), dissociation of LAu+ 
from 5a could become a competing pathway providing 7a via hydrolysis and protodeauration or 
through putative acetyloxy allene intermediate 9a.  
However, the formation of 6a through classical Lewis-acid assisted Nazarov cyclization of 7a could be 
ruled out because 7a when treated with 3 mol % of the gold(I) in DCM did not undergo cyclization.  
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Scheme 5. Postulated reaction pathways.  
In order to identify the structures and the energies of the critical steps of the mechanism, especially the 
formation of 7a, and to understand the very strong ligand influence on the reaction rate, the potential 
reaction coordinates of the whole tandem [3,3]-rearrangement/Nazarov cyclization were studied 
computationally.7 
The structures were located using the B3LYP8 density functional theory method as implemented in the 
Gaussian suite of programs.9 The alkynyl-gold(I) cationic complexe Ia was considered as the starting 
point of the mechanism (G = 0 kcal/mol), and all reported energies in the following discussion are 
relative to it. The energy values correspond to Gibbs free energies (ΔG), computed at B3LYP/6-31G** 
level (LANL2DZ10 for gold atom) and include single-point refinements at M06/6-311+G(d,p) (SDD for 
Au) level of theory.11 
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Scheme 6. Computed reaction profile for the reaction of 4a. Energies are in kcal/mol. 
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From the computed reaction profile (Scheme 6) it could be seen that the acetate rearrangement 
proceeds with a low activation barrier (ΔGact = 8.6 kcal/mol) and in a slightly exergonic fashion (ΔGreact 
= - 2.6 kcal/mol) to form intermediate III (i.e. 5a). The next cyclization step, from III to IV (i.e. 8a) has 
the highest activation barrier (ΔGact = 14.8 kcal/mol) and therefore it is a rate-determining step what is 
in accordance with experimental observations. Final step, deprotonation and protodeauration of IV is 
highly exergonic (-19.6 kcal/mol) ensuring the irreversibility of the overall process.  
On these grounds, the effect of the indole substituents and gold ligands on the reaction rate can be 
easily explained. The electrophilic attack by the cationic side chain is favoured by electron-donating 
substituents which makes the indole ring in intermediate III more electron-rich, and disfavoured by 
EWGs. On the other hand, the accelerating effect by electron-poor gold ligands could be justified by a 
more electrophilic, and thus more reactive, allylic side chain.12   
According to the calculations, α,β-unsaturated ketone 7a should directly derive from 5a (ΔGreact = +8.1 
kcal/mol) because alternative pathway which includes the formation of allene 9a from 5a is 
energetically very demanding (ΔGreact = + 31.7 kcal/mol) and thus never operative (Scheme 7).  
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Scheme 7. Computed possible pathways for the formation of α,β-unsaturated ketone 7a. 
 
 
7.4. Synthesis of Bruceolline H 
 To demonstrate the synthetic usefulness of the methodology, we exploited the high reactivity 
of methoxy-substituted indole derivatives to synthesize bruceolline H. While the synthesis of 
unsubstituted bruceollines has been described,4a bruceolline H has been isolated quite recently and its 
synthesis never reported.2a  
N
H
O
Bruceolline D
N
H
O
R = H Bruceolline E
R = OH Bruceolline H
O
R NH
OH
R = H Bruceolline J
R = OH Bruceolline I
O
R
 
Scheme 8. The structures of bruceolline family of natural products. 
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Scheme 9. Synthesis of Bruceolline H (12). Reagents and conditions: (a) SeO2, dioxane, reflux 
(82 %); (b) 1. t-BuNH2, MeOH reflux, 2. BBr3, DCM (93 %). 
To this end, cyclopenta[b]indolone 6j was first oxidized into the corresponding diketo derivative 11    
(82 %) by using SeO2 in refluxing dioxane.4b Sequential N-deprotection13 and O-demethylation14 
completed the synthesis of this natural product, which was obtained in 69 % overall yield from the 
corresponding 3-iodoindole (Scheme 9). 1H and 13C NMR spectra of 12 were identical to those 
reported for the natural product.2a 
 
Figure 3. X-Ray structure of Bruceolline H (12). 
 
 
7.5. Experimental Part 
General Information 
Solvents and reagents were used either as received from commercial suppliers or, when necessary, 
purified using standard laboratory techniques according to methods published in “Purification of 
Laboratory Chemicals” by Perrin, Armarego, and Perrin (Pergamon Press, 1966). All reactions were 
conducted in oven- or flame-dried glassware under an inert atmosphere of dry nitrogen. 
Chromatographic separations were performed under pressure on silica gel by flash-column 
techniques; Rf values refer to TLC carried out on 0.25-mm silica gel plates (Merck F254), with the same 
eluent as indicated for the column chromatography. Melting points were recorded on a Buchi-540 
melting point apparatus and are uncorrected. 1H NMR and 13C NMR spectra were recorded at 400 and 
100.4 MHz, respectively, in the specified deuterated solvent at room temperature. Solvent reference 
lines were set at 7.26 and 77.00 (CDCl3), 2.05 and 29.84 (acetone-d6), 3.31 and 49.00 (CD3OD), 2.50 
and 39.52 ppm (DMSO-d6) in 1H and 13C NMR spectra, respectively. Mass spectra were carried out by 
direct inlet of a 20 ppm solution either in CH3OH or CH3OH + 0.1% HCO2H on a LCQ FleetTM Ion Trap 
LC/MS system (Thermo Fisher Scientific) with an electrospray ionization (ESI) interface in the positive 
mode. Microanalyses were carried out with a CHN Thermo FlashEA 1112 Series elemental analyzer. 
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General procedure for the preparation of methyl 3-iodoindole-1-carboxylates (13).5  
Crushed KOH (1.4 g, 25 mmol) was added to a solution of the indole (10 mmol) in anhydrous DMF  
(18 mL) and the resulting suspension was stirred at room temperature for 20 min. A solution of I2 (2.54 
g, 10 mmol) in anhydrous DMF (3 mL) was then dropwise added and, after 1 h, the reaction mixture 
was poured into ice water (230 mL) containing NH4OH (0.5 %) and K2S2O5 (0.1 %). A precipitate 
immediately formed was collected by filtration, washed with chilled water (30 mL) and dried under 
reduced pressure. The obtained 3-iodo-1H-indole was immediately used in next step. 
In few cases, as no filterable precipitate formed, the product was extracted with a 1 : 1 mixture of n-
hexane and EtOAc (3 x 100 mL) and the combined organic extracts were washed once with chilled 
water (150 mL) and dried over anhydrous Na2SO4. After filtration and evaporation of the solvent, the 
obtained 3-iodoindole was used in the next step without any further purification. 
3-Iodo-1H-indole (10 mmol) was dissolved in anhydrous DCM or THF (60 mL) and, after cooling at 0°C 
(ice bath), Et3N (4.2 mL, 30 mmol) and methyl chloroformate (1.5 mL, 20 mmol) were added. After 10 
minutes, the ice bath was removed and the reaction mixture was stirred at room temperature until 
complete consumption of the starting material (TLC; usually 2-3 h). Water was then added (60 mL) and 
the product extracted with DCM (3 x 60 mL). The combined organic extracts were washed with water 
(50 mL), brine (50 mL) and dried over anhydrous Na2SO4. After filtration and evaporation of the 
solvent, the product was isolated either by flash chromatography or by crystallization from acetone. 
N
I
CO2Me 
Methyl 3-Iodo-5-methylindole-1-carboxylate (13d). 
3-Iodo-5-methyl-1H-indole was prepared starting from 5-methyl-1H-indole (262 mg, 2 mmol) and 
isolated by filtration.2 1H NMR (400 MHz, CDCl3) δ = 8.24 (bs, 1 H), 7.27-7.24 (m, 3 H), 7.07 (d, J =  
8.0 Hz, 1 H), 2.49 (s, 3 H) ppm. 
The protection step was carried out in THF. Crystallization from acetone afforded pure 13d (428 mg,  
68 %) as a white solid. M.p. = 117.4 – 118.9 °C. 1H NMR (400 MHz, DMSO-d6) δ = 7.98 (d, J = 8.5 Hz, 
1 H), 7.89 (s, 1 H), 7.26 (d, J = 8.5 Hz, 1 H), 7.18 (s, 1 H), 3.99 (s, 3 H), 2.45 (s, 3 H) ppm. 13C NMR 
(100.4 MHz, DMSO-d6) δ = 150.5 (s), 133.4 (s), 133.0 (s), 132.2 (s), 130.3 (d), 127.3 (d), 121.5 (d), 
114.8 (d), 67.3 (s), 54.6 (q), 21.6 (q) ppm. MS (ESI) m/z (%): 338 ([M+Na]+, 100). Elemental analysis 
calcd (%) for C11H10INO2: C 41.93, H 3.20, N 4.45; found: C 42.04, H 3.14, N 4.45. 
N
I
CO2Me 
Methyl 3-Iodo-6-methylindole-1-carboxylate (13e). 
3-Iodo-6-methyl-1H-indole was prepared starting from 6-methyl-1H-indole (250 mg, 1.9 mmol) and 
isolated by filtration. 1H-NMR (400 MHz, CDCl3) δ = 8.18 (bs, 1 H), 7.33 (d, J = 8.0 Hz, 1 H), 7.20 (d, J 
= 2.0 Hz, 1 H), 7.16 (s, 1 H), 7.04 (d, J = 8.4 Hz, 1 H), 2.48 (s, 3 H) ppm. 
The protection step was carried out in THF. Purification by flash chromatography (n-hexane/EtOAc, 10 
: 1; Rf = 0.38) afforded pure 13e (421 mg, 70 %) as a pink solid. M.p. = 92.5 – 94.1°C. 1H NMR (400 
MHz, CDCl3) δ = 7.97 (s, 1 H), 7.67 (s, 1 H), 7.27 (d, J = 7.7 Hz, 1 H), 7.15 (d, J = 7.7 Hz, 1 H), 4.03 
(s, 3 H), 2.51 (s, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 150.3 (s), 136.2 (s), 135.0 (s), 130.0 (s), 
128.4 (d), 125.3 (d), 121.5 (d), 114.7 (d), 66.5 (s), 54.0 (q), 21.9 (q) ppm. MS (ESI) m/z (%): 338 
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([M+Na]+, 33), 189 ([M+1-I]+, 100). Elemental analysis calcd (%) for C11H10INO2: C 41.93, H 3.20, N 
4.45; found: C 42.08, H 3.17, N 4.25. 
N
I
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Methyl 3-Iodo-4-methoxyindole-1-carboxylate (13f). 
3-Iodo-4-methoxy-1H-indole was prepared starting from 4-methoxy-1H-indole (174 mg, 1.2 mmol) and 
isolated by extraction.3 1H-NMR (400 MHz, CDCl3) δ = 8.34 (bs, 1 H, N-H), 7.18 (s, 1 H, 2-H), 7.13 (t, J 
= 8.0 Hz, 1 H), 7.01 (d, J = 8.4 Hz, 1 H), 6.53 (d, J = 7.6 Hz, 1 H), 3.95 (s, 3 H) ppm. 
The protection step was carried out in DCM. Purification by flash chromatography (n-hexane/EtOAc, 8 
: 1; Rf = 0.39) afforded pure 13f (288 mg, 74 %) as a pale pink solid. M.p. = 103.9 ‒ 104.8 °C. 1H NMR 
(400 MHz, CDCl3) δ = 7.83 (d, J = 8.4 Hz, 1 H), 7.65 (s, 1H, 2-H), 7.29 (d, J = 8.0 Hz, 1 H), 6.71 (d, J = 
8.0 Hz, 1 H), 4.03 (s, 3 H), 3.94 (s, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 153.3 (s), 150.4 (s), 
136.4 (s), 129.6 (d), 126.3 (d), 119.5 (s), 107.9 (d), 104.4 (d), 58.7 (s), 55.4 (q), 54.0 (q) ppm. MS (ESI) 
m/z (%): 332 ([M+1]+, 40), 205 ([M+1-I]+, 100). Elemental analysis calcd (%) for C11H10INO3: C 39.90, 
H 3.04, N 4.23; found: C 40.09, H 3.21, N 4.22. 
N
O
I
CO2Me 
Methyl 3-Iodo-5-methoxyindole-1-carboxylate (13h). 
3-Iodo-5-methoxy-1H-indole was prepared starting from 5-methoxy-1H-indole (200 mg, 1.36 mmol) 
and isolated by filtration.17 1H NMR (200 MHz, CDCl3) δ = 8.26 (bs, 1 H), 7.29-7.24 (m, 3 H), 6.88 (s, 1 
H), 3.90 (s, 3 H) ppm. 
The protection step was carried out in DCM. Purification by flash chromatography (n-hexane/EtOAc, 
15 : 1; Rf = 0.35) afforded pure 13h (278 mg, 62 %) as a purple solid. M.p. = 98.8 – 101.0 °C. 1H NMR 
(400 MHz, CDCl3) δ = 8.02 (d, J = 8.6 Hz, 1 H), 7.72 (s, 1 H), 6.98 (dd, J = 8.6, 2.5 Hz, 1 H), 6.84 (d, J 
= 2.5 Hz, 1 H), 4.03 (s, 3 H), 3.89 (s, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 156.8 (s), 150.4 (s), 
132.9 (s), 130.1 (d), 129.2 (s), 115.9 (d), 114.7 (d), 103.8 (d), 66.2 (s), 55.7 (q), 54.0 (q) ppm. MS (ESI) 
m/z (%): 569 ([2M+Na]+, 100), 274 ([M+1]+, 74). Elemental analysis calcd (%) for C11H10INO3: C 39.90, 
H 3.04, N 4.23; found: C 40.06, H 2.82, N 4.04. 
N
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Methyl 3-Iodo-6-methoxyindole-1-carboxylate (13i). 
3-Iodo-6-methoxy-1H-indole was prepared starting from 6-methoxy-1H-indole (263 mg, 1.79 mmol) 
and isolated by filtration.18 1H NMR (400 MHz, CDCl3) δ = 8.19 (bs, 1 H), 7.32 (d, J = 9.2 Hz, 1 H), 7.17 
(d, J = 2.4 Hz, 1 H), 6.87 (d, J = 7.2 Hz, 1 H), 3.85 (s, 3 H) ppm. 
The protection step was carried out in DCM. Purification by flash chromatography (n-hexane/EtOAc, 6 
: 1; Rf = 0.45) afforded pure 13i (399 mg, 67 %) as a pale pink solid. M.p. = 66.2 ‒ 67.5 °C. 1H NMR 
(400 MHz, CDCl3) δ = 7.71 (bs, 1 H), 7.59 (s, 1 H), 7.25 (d, J = 8.8 Hz, 1 H), 6.94 (dd, J = 8.8, 2.4 Hz, 
1 H), 4.01 (s, 3 H), 3.88 (s, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 158.7 (s), 150.4 (s), 135.6 (s), 
128.1 (d), 125.7 (s), 122.0 (d), 112.8 (d), 98.8 (d), 66.2 (s), 55.7 (q), 53.9 (q) ppm. MS (ESI) m/z (%): 
332 ([M+1]+, 15), 205 ([M+1-I]+, 100). Elemental analysis calcd (%) for C11H10INO3: C 39.90, H 3.04, N 
4.23; found: C 40.25, H 3.24, N 3.93. 
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3-Iodoindole-1,4-dicarboxylic acid dimethyl ester (13l). 
3-Iodo-4-carbomethoxy-1H-indole was prepared starting from 4-carbomethoxy-1H-indole (230 mg, 
1.31 mmol) and isolated by extraction.19 1H-NMR (400 MHz, CDCl3) δ =  8.65 (bs, 1 H, N-H), 7.54-7.51 
(m, 2 H), 7.43 (d, J = 2.8 Hz, 1 H), 7.25 (m, 1 H), 4.03 (s, 3 H) ppm. 
The protection step was carried out in THF. Purification by flash chromatography (n-hexane/EtOAc, 6 : 
1; Rf = 0.25) afforded pure 13l (317 mg, 61 %) as a pale yellow solid. M.p. = 108.9 ‒ 110.2 °C. 1H NMR 
(400 MHz, CDCl3) δ = 8.40 (d, J = 8.4 Hz, 1 H), 7.89 (s, 1 H), 7.57 (d, J = 7.6 Hz, 1 H), 7.40 (t, J = 8.4 
Hz, 1 H), 4.05 (s, 3 H), 4.01 (s, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 167.6 (s), 150.1 (s), 135.6 
(s), 133.3 (d), 127.6 (s), 126.3 (s), 124.8 (d), 124.6 (d), 117.7 (d), 61.6 (s), 54.3 (q), 52.1 (q) ppm. MS 
(ESI) m/z (%): 382 ([M+Na]+, 26), 360 ([M+1]+, 41), 232 ([M+1-I]+, 100). Elemental analysis calcd (%) 
for C12H10INO4: C 40.13, H 2.81, N 3.90; found: C 40.39, H 2.75, N 3.84. 
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3-Iodoindole-1,5-dicarboxylic acid dimethyl ester (13m). 
3-Iodo-5-carbomethoxy-1H-indole was prepared starting from 5-carbomethoxy-1H-indole (350 mg, 2.0 
mmol) and isolated by filtration.20 1H NMR (400 MHz, acetone-d6) δ = 11.0 (bs, 1 H, N-H), 8.12 (s, 1 
H), 7.88 (dd, J = 8.4, 1.2 Hz, 1 H), 7.65 (s, 1 H), 7.55 (d, J = 8.4 Hz, 1 H), 3.91 (s, 3 H) ppm. 
The protection step was carried out in THF. Crystallization from acetone afforded pure 13m (543 mg, 
76 %) as a white solid. M.p. = 157.2 ‒ 158.3 °C. 1H NMR (400 MHz, DMSO-d6) δ = 8.18 (d, J = 8.8 
Hz, 1 H), 8.04 (s, 1 H), 8.01 (dd, J = 8.8, 1.6 Hz, 1 H), 7.94 (d, J = 1.2 Hz, 1 H), 4.01 (s, 3 H), 3.90 (s, 3 
H) ppm. 13C NMR (100.4 MHz, DMSO-d6) δ = 166.0 (s), 149.8 (s), 137.0 (s), 131.8 (s), 131.6 (d), 
126.2 (d), 125.0 (s), 122.7 (d), 115.0 (d), 67.5 (s), 54.6 (q), 52.2 (q) ppm. MS (ESI) m/z (%): 360 
([M+1]+, 22), 232 ([M+1-I]+, 100). Elemental analysis calcd (%) for C12H10INO4: C 40.13, H 2.81, N 
3.90; found: C 40.11, H 2.74, N 3.79. 
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3-Iodoindole-1,6-dicarboxylic acid dimethyl ester (13n). 
3-Iodo-6-carbomethoxy-1H-indole was prepared starting from 6-carbomethoxy-1H-indole (350 mg, 2.0 
mmol) and isolated by filtration.21 1H NMR (200 MHz, CDCl3) δ = 8.59 (bs, 1 H), 8.14 (s, 1 H), 7.89 (d, 
J = 8.4 Hz, 1 H), 7.51-7.45 (m, 2 H), 3.95 (s, 3 H) ppm. 
The protection step was carried out in THF. Purification by flash chromatography (n-hexane/EtOAc, 10 
: 1; Rf = 0.43) afforded pure 13n (500 mg, 70 %) as a white solid. M.p. = 126.2 – 127.1 °C. 1H NMR 
(400 MHz, DMSO-d6) δ = 8.62 (d, J = 1.2 Hz, 1 H), 8.06 (s, 1 H), 7.90 (dd, J = 8.3, 1.2 Hz, 1 H), 7.43 
(d, J = 8.3 Hz, 1 H), 4.01 (s, 3 H), 3.89 (s, 3 H) ppm. 13C NMR (100.4 MHz, DMSO-d6) δ = 166.3 (s), 
149.6 (s), 135.4 (s), 133.9 (s), 132.9 (d), 126.2 (s), 123.9 (d), 121.3 (d), 115.9 (d), 66.7 (s), 54.6 (q), 
52.3 (q) ppm. MS (ESI) m/z (%): 360 ([M+1]+, 57), 232 ([M+1-I]+, 100). Elemental analysis calcd (%) 
for C12H10NIO4: C 40.13, H 2.81, N 3.90; found: C 40.36, H 2.94, N 3.85. 
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Methyl 3-Iodo-5-nitroindole-1-carboxylate (13o). 
3-Iodo-5-nitro-1H-indole was prepared starting from 5-nitro-1H-indole (330 mg, 2.0 mmol) and isolated 
by filtration.21 1H NMR (200 MHz, CDCl3) δ = 8.72 (bs, 1 H), 8.46 (d, J = 2.4 Hz, 1 H), 8.17 (dd, J = 9.2, 
2.2 Hz, 1 H), 7.48 (s, 1 H), 7.45 (d, J = 7.4 Hz, 1 H)  ppm. 
The protection step was carried out in THF. Purification by flash chromatography (n-hexane/EtOAc, 5 : 
1; Rf = 0.50) afforded pure 11j (540 mg, 78 %) as a yellow solid. M.p. = 150.4 – 151.0 °C. 1H NMR 
(400 MHz, DMSO) δ = 8.29 (m, 2 H), 8.24 (s, 1 H), 8.15 (bs, 1 H), 4.03 (s, 3 H) ppm. 13C NMR (100.4 
MHz, DMSO) δ = 149.6 (s), 143.7 (s), 137.6 (s), 133.4 (d), 132.0 (s), 120.5 (d), 117.0 (d), 115.6 (d), 
67.4 (s), 54.9 (q) ppm. MS (ESI) m/z (%): 369 ([M+Na]+, 100). Elemental analysis calcd (%) for 
C10H7N2IO4: C 34.71, H 2.04, N 8.09; found: C 34.79, H 2.42, N 7.98. 
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General procedure for the synthesis of indole derived enynyl acetates (4). 
STEP A Sonogashira coupling (14)5 
 A 5 : 1 (v/v) solution of Et3N/DMF (4.5 mL) was added in a round bottom flask containing 3-iodoindole-
1-carboxylic acid methyl ester 13 (1 mmol), (Ph3P)2PdCl2 (35.1 mg, 0.05 mmol) and CuI (5.7 mg, 0.03 
mmol), followed by 0.5 mL increments of DMF as necessary to complete dissolve 11.1 The alkynol (1.2 
mmol) was then added and the reaction mixture heated at 40 or 55 °C (external) under vigorous 
stirring until complete consumption of the starting material (TLC; usually 1-3 h). The mixture was the 
cooled at rt and quenched by water (12.5 mL). The product was extracted by EtOAc (3 x 10 mL) and 
the combined organic extracts dried over anhydrous K2CO3. After filtration and evaporation of the 
solvent, the crude was purified by flash chromatography affording the intermediate 14 that was used in 
the next step. 
STEP B Acetylation (4) 
A solution of enynyl alcohol 13 (1 mmol) in anhydrous DCM (10 mL) was cooled at 0 °C (ice bath) and 
DMAP (6 mg, 0.05 mmol), Et3N (0.42 mL, 3 mmol) and Ac2O (0.25 mL, 2 mmol) were added. After 10 
min, the ice bath was removed and the reaction mixture was stirred at room temperature for 3 h, then 
quenched by addition of a satd solution of NaHCO3 (10 mL). After separation of the phases, the 
aqueous layer was extracted with DCM (2 x 10 mL) and the combined organic extracts were dried over 
anhydrous K2CO3. After filtration and evaporation of the solvent, crude 4 was obtain. This was purified 
by flash chromatography and pure acetate 4 was stored at 4 °C as 0.1 M solution in the eluent + 1% 
Et3N until use. 
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3-(3-Acetoxybut-1-ynyl)-indole-1-carboxylic acid methyl ester (4a). 
Compound 14a was obtained by Sonogashira coupling of 13a (301 mg, 1 mmol) and (±)-3-butyn-2-ol 
(94 µL, 1.2 mmol), heating at 40 °C for 3 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.22) afforded pure enynyl alcohol 14a which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.16 (d, J = 8.4 Hz, 1 H), 7.76 (s, 1 H), 
7.66 (d, J = 8.0 Hz, 1 H), 7.38 (t, J = 7.2 Hz, 1 H), 7.32 (t, J = 7.2 Hz, 1 H), 4.83 (q, J = 6.8 Hz, 1 H), 
4.06 (s, 3 H), 1.61 (d, J = 6.8 Hz, 3 H) ppm. 
Acetylation of compound 14a afforded 4a, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf =0.28). Pure 4a was obtained as a colourless oil (240 mg, 86 % 
over 2 steps). 1H NMR (400 MHz, CDCl3) δ = 8.15 (d, J = 8.0 Hz, 1 H), 7.79 (s, 1 H), 7.66 (d, J = 7.6 
Hz, 1 H), 7.38 (td, J = 7.6, 1.2 Hz, 1 H), 7.32 (td, J = 7.6, 1.2 Hz, 1 H), 5.74 (q, J = 6.8 Hz, 1 H), 4.05 
(s, 3 H), 2.12 (s, 3 H), 1.63 (d, J = 6.8 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.0 (s), 150.9 
(s), 134.5 (s), 130.3 (s), 128.9 (d), 125.5 (d), 123.6 (d), 120.1 (d), 115.1 (d), 103.4 (s), 91.3 (s), 76.3 
(s), 60.9 (d), 54.1 (q), 21.6 (q), 21.1 (q) ppm. MS (ESI) m/z (%): 226 ([M-CO2Me]+, 100).  
N
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3-(3-Acetoxyhept-1-ynyl)-indole-1-carboxylic acid methyl ester (4b). 
Compound 14b was obtained by Sonogashira coupling of 13a (301 mg, 1 mmol) and (±)-2-heptyn-3-ol 
(155 µL, 1.2 mmol), heating at 40 °C for 4 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.33) afforded pure enynyl alcohol 14b which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.16 (d, J = 8.4 Hz, 1 H), 7.76 (s, 1 H), 
7.65 (d, J = 8.0 Hz, 1 H), 7.38 (t, J = 7.2 Hz, 1 H), 7.32 (t, J = 7.2 Hz, 1 H), 4.66 (t, J = 6.8 Hz, 1 H), 
4.05 (s, 3 H), 1.88-1.82 (m, 2 H), 1.59-1.51 (m, 2 H), 1.47-1.37 (m, 2 H), 0.96 (t, J = 7.2 Hz, 3 H) ppm. 
Acetylation of compound 14b afforded 4b, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.39). Pure 4b was obtained as a colourless oil (274 mg, 84 % 
over 2 steps). 1H NMR (400 MHz, CDCl3) δ = 8.15 (d, J = 8.0 Hz, 1 H), 7.78 (s, 1 H), 7.65 (d, J = 7.2 
Hz, 1 H), 7.37 (td, J = 7.6, 1.2 Hz, 1 H), 7.31 (td, J = 7.6, 1.2 Hz, 1 H), 5.65 (t, J = 6.8 Hz, 1 H), 4.04 (s, 
3 H), 2.13 (s, 3 H), 1.93-1.87 (m, 2 H), 1.57-1.49 (m, 2 H), 1.46-1.37 (m, 2 H), 0.96 (t, J = 7.2 Hz, 3 H) 
ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.0 (s), 150.8 (s), 134.5 (s), 130.3 (s), 128.8 (d), 125.4 (d), 
123.5 (d), 120.0 (d), 115.1 (d), 103.4 (s), 90.5 (s), 76.9 (s), 64.7 (d), 54.0 (q), 34.6 (t), 27.2 (t), 22.2 (t), 
21.1 (q), 13.9 (q) ppm. MS (ESI) m/z (%): 677 ([2M+Na]+, 67), 350 ([M+Na]+, 100), 268 ([M-CO2Me]+, 
67).  
 122	
N
CO2Me
OAc
 
3-(3-Acetoxyprop-1-ynyl)-indole-1-carboxylic acid methyl ester (4c). 
Compound 14c was obtained by Sonogashira coupling of 13a (139 mg, 0.46 mmol) and propargylic 
alcohol (32 µL, 0.55 mmol), heating at 40 °C for 3.5 h. Purification of the crude by flash 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf  = 0.10) afforded pure enynyl alcohol 14c 
which was used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.16 (d, J = 7.8 Hz, 1 H), 
7.78 (s, 1 H), 7.68 (d, J = 8.0 Hz, 1 H), 7.39 (td, J = 8.4, 1.2 Hz, 1 H), 7.32 (td, J = 7.6, 1.2 Hz), 4.57 (s, 
2 H), 4.06 (s, 3 H) ppm. 
Acetylation of compound 14c afforded 4c, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.27). Pure 4c was obtained as a colourless oil (64 mg, 51 % 
over 2 steps). 1H NMR (400 MHz, CDCl3) δ = 8.16 (d, J = 8.0 Hz, 1 H), 7.81 (s, 1 H), 7.68 (d, J = 7.6 
Hz, 1 H), 7.39 (td, J = 8.4, 1.2 Hz, 1 H), 7.32 (td, J = 7.6, 1.2 Hz), 4.97 (s, 2 H), 4.06 (s, 3 H), 2.15 (s, 3 
H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.3 (s), 150.8 (s), 134.5 (s), 130.3 (s), 129.2 (d), 125.5 
(d), 123.6 (d), 120.1 (d), 115.2 (d), 130.3 (s), 86.7 (s), 78.3 (s), 54.1 (q), 52.9 (t), 20.8 (q) ppm.  MS 
(ESI) m/z (%): 294 ([M+Na]+, 41), 212 ([M-CO2Me]+, 100).  
N
CO2Me
OAc
 
3-(3-Acetoxybut-1-ynyl)-5-methylindole-1-carboxylic acid methyl ester (4d).  
Compound 14d was obtained by Sonogashira coupling of 13d (315 mg, 1 mmol) and (±)-3-butyn-2-ol 
(94 µL, 1.2 mmol), heating at 40 °C for 1 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.20) afforded pure enynyl alcohol 14d which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.01 (d, J = 8.5 Hz, 1 H), 7.71 (s, 1 H), 
7.43 (s, 1 H), 7.19 (d, J = 8.5 Hz, 1 H), 4.83 (q, J = 6.6 Hz, 1 H), 4.04 (s, 3 H), 2.47 (s, 3 H), 2.19 - 2.23 
(br s, 1 H), 1.61 (d, J = 6.6 Hz, 3 H) ppm. 
Acetylation of compound 14d afforded 4d, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf =0.19). Pure 4d was obtained as a yellow oil (210 mg, 70 % over 2 
steps). 1H NMR (400 MHz, CDCl3) δ = 8.01 (d, J = 9.0 Hz, 1 H), 7.75 (s, 1 H), 7.43 (s, 1 H), 7.19 (d, J 
= 9.0 Hz, 1 H), 5.75 (q, J = 6.7 Hz, 1 H), 4.04 (s, 3 H), 2.47 (s, 3 H), 2.13 (s, 3 H), 1.63 (d, J = 6.7 Hz, 3 
H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s), 150.8 (s), 133.2 (s), 132.8 (s), 130.6 (s), 129.2 
(d), 126.6 (d), 120.1 (d), 114.7 (d), 102.8 (s), 90.8 (s), 76.5 (s), 60.9 (d), 54.2 (q), 21.6 (q), 21.3 (q), 
21.1 (q) ppm. MS (ESI) m/z (%): 620 ([2M+Na]+, 12), 321 ([M+Na]+, 43), 240 ([M-CO2Me]+, 100).  
N
CO2Me
OAc
 
3-(3-Acetoxybut-1-ynyl)-6-methylindole-1-carboxylic acid methyl ester (4e). 
Compound 14e was obtained by Sonogashira coupling of 13c (315 mg, 1 mmol) and (±)-3-butyn-2-ol 
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(94 µL, 1.2 mmol), heating at 40 °C for 1 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.20) afforded pure enynyl alcohol 14e which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.97 (s, 1 H), 7.68 (s, 1 H), 7.52 (d, J = 
8.0 Hz, 1 H), 7.13 (d, J = 8.0 Hz, 1 H), 4.81 (q, J = 6.6 Hz, 1 H), 4.04 (s, 3 H), 2.49 (s, 3 H), 1.59 (d, J = 
6.6 Hz, 3 H) ppm. 
Acetylation of compound 14e afforded 4e, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf  = 0.19). Pure 4e was obtained as a colourless oil (188 mg, 63 % 
over 2 steps). 1H NMR (400 MHz, CDCl3) δ = 7.97 (s, 1 H), 7.71 (s, 1 H), 7.52 (d, J = 8.4 Hz, 1 H), 
7.14 (d, J = 8.4 Hz, 1 H), 5.73 (q, J = 6.7 Hz, 1 H), 4.04 (s, 3 H), 2.49 (s, 3 H), 2.12 (s, 3 H), 1.62 (d, J 
= 6.7 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s), 150.9 (s), 135.5 (s), 134.7 (s), 128.3 
(d), 128.0 (s), 125.0 (d), 119.5 (d), 115.3 (d), 103.2 (s), 90.9 (s), 76.5 (s), 60.9 (d), 54.0 (q), 21.9 (q), 
21.6 (q), 21.1 (q) ppm. MS (ESI) m/z (%): 620 ([2M+Na]+, 10), 321 ([M+Na]+, 38), 240 ([M-CO2Me]+, 
100).  
N
CO2Me
OAc
OMe
 
3-(3-Acetoxybut-1-ynyl)-4-methoxyindole-1-carboxylic acid methyl ester (4f). 
Compound 14f was obtained by Sonogashira coupling of 13f (266 mg, 0.80 mmol) and (±)-3-butyn-2-
ol (76 µL, 0.96 mmol), heating at 55 °C for 3 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.15) afforded pure enynyl alcohol 14f which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.4 Hz, 1 H), 7.62 (s, 1 H), 
7.25 (t, J = 8.4 Hz, 1 H), 6.69 (d, J = 8.0 Hz, 1 H), 4.79 (q, J = 6.4 Hz, 1 H), 4.02 (s, 3 H), 3.92 (s, 3 H), 
1.58 (d, J = 6.4 Hz, 3 H) ppm. 
Acetylation of compound 14f afforded 4f, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf =0.18). Pure 4f was obtained as a white solid (154 mg, 61 % over 
2 steps). 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.4 Hz, 1 H), 7.69 (s, 1 H), 7.27 (t, J = 8.4 Hz, 1 
H), 6.70 (d, J = 7.6 Hz, 1 H), 5.73 (q, J = 6.8 Hz, 1 H), 4.03 (s, 3 H), 3.93 (s, 3 H), 2.11 (s, 3 H), 1.62 
(d, J = 6.8 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s), 153.9 (s), 150.7 (s), 136.0 (s), 
128.4 (d), 126.4 (d), 119.2 (s), 108.0 (d), 104.4 (d), 101.5 (s), 89.3 (s), 78.1 (s), 61.1 (d), 55.5 (q), 54.0 
(q), 21.4 (q), 21.1 (q) ppm. MS (ESI) m/z (%): 653 ([2M+Na]+, 47), 338 ([M+Na]+, 82), 256 ([M-
CO2Me]+, 100).  
N
CO2Me
OAc
OMe
 
3-(3-Acetoxy-3-methylbut-1-ynyl)-4-methoxyindole-1-carboxylic acid methyl ester (4g). 
Compound 14g was obtained by Sonogashira coupling of 13f (127 mg, 0.38 mmol) and 3-methyl-3-
butyn-2-ol (45 µL, 0.46 mmol), heating at 55 °C for 2 h. Purification of the crude by flash 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf  = 0.36) afforded pure enynyl alcohol 14g 
which was used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.4 Hz, 1 H), 
7.64 (s, 1 H), 7.27 (t, J = 8.4 Hz, 1 H), 6.70 (d, J = 8.0 Hz, 1 H), 4.03 (s, 3 H), 3.93 (s, 3 H), 1.65 (s, 6 
H) ppm. 
Acetylation of compound 14g was carried out by increasing the amounts of both Ac2O (3 eq) and Et3N 
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(5 eq) and by prolonging the reaction time up to 16 h. The purification of the crude by flash 
chromatography (n-hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf =0.16) afforded pure 4g as a colourless oil (82 
mg, 66 % over 2 steps). 1H NMR (400 MHz, CDCl3) δ = 7.76 (d, J = 8.4 Hz, 1 H), 7.69 (s, 1 H), 7.26 (t, 
J = 8.4 Hz, 1 H), 6.69 (d, J = 8.0 Hz, 1 H), 4.02 (s, 3 H), 3.94 (s, 3 H), 2.06 (s, 3 H), 1.80 (s, 6 H) ppm. 
13C NMR (100.4 MHz, CDCl3) δ = 169.3 (s), 154.0 (s), 150.8 (s), 136.1 (s), 128.2 (d), 126.3 (d), 119.5 
(s), 108.0 (d), 104.4 (d), 102.0 (s), 92.1 (s), 77.5 (s), 72.8 (s), 55.5 (q), 54.0 (q), 29.0 (q, 2 C), 22.0 (q) 
ppm. MS (ESI) m/z (%): 681 ([2M+Na]+, 84), 352 ([M+Na]+, 55), 270 ([M-CO2Me]+, 100). 
N
CO2Me
OAc
MeO
 
3-(3-Acetoxybut-1-ynyl)-5-methoxyindole-1-carboxylic acid methyl ester (4h). 
Compound 14h was obtained by Sonogashira coupling of 13h (270 mg, 0.82 mmol) and (±)-3-butyn-2-
ol (77 µL, 0.98 mmol), heating at 40 °C for 1 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.30) afforded pure enynyl alcohol 14h which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.02 (d, J = 8.9 Hz, 1 H), 7.73 (s, 1 H), 
7.08 (d, J = 2.5 Hz, 1 H), 6.98 (dd, J = 8.9, 2.5 Hz, 1 H), 4.90 – 4.74 (m, 1 H), 4.03 (s, 3 H), 3.89 (s, 3 
H), 1.93 – 1.88 (br s, 1 H), 1.61 (d, J = 6.6 Hz, 3 H) ppm. 
Acetylation of compound 14h afforded 4h, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.24). Pure 4h was obtained as a yellow oil (190 mg, 77 % over 
2 steps). 1H NMR (400 MHz, CDCl3) δ = 8.00 (d, J = 8.7 Hz, 1 H), 7.74 (s, 1 H), 7.07 (t, J = 2.2 Hz, 1 
H), 6.96 (dt, J = 8.7, 2.2 Hz, 1 H), 5.74 (q, J = 6.7 Hz, 1 H), 4.02 (s, 3 H), 3.88 (s, 3 H), 1.63 (d, J = 6.7 
Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.8 (s), 156.7 (s), 150.8 (s), 131.2 (s), 129.4 (d), 
129.0 (s), 115.9 (d), 114.4 (d), 103.2 (s), 102.2 (d), 91.3 (s), 76.1 (s), 60.8 (d), 55.5 (q), 54.0 (q), 21.2 
(q), 20.9 (q) ppm. MS (ESI) m/z (%): 652 ([2M+Na]+, 3), 337 ([M+Na]+, 10), 256 ([M-CO2Me]+, 100).  
N
CO2Me
OAc
MeO
 
3-(3-Acetoxybut-1-ynyl)-6-methoxyindole-1-carboxylic acid methyl ester (4i).  
Compound 14i was obtained by Sonogashira coupling of 13i (295 mg, 0.9 mmol) and (±)-3-butyn-2-ol 
(85 µL, 1.1 mmol), heating at 40 °C for 1 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.23) afforded pure enynyl alcohol 14i which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.72 (bs, 1 H), 7.61 (s, 1 H), 7.49 (d, J = 
8.6 Hz, 1 H), 6.93 (dd, J = 8.6, 2.3 Hz, 1 H), 4.80 (q, J = 6.6 Hz, 1 H), 4.03 (s, 3 H), 3.88 (s, 3 H), 1.59 
(d, J = 6.6 Hz, 3 H) ppm. 
Acetylation of compound 14i afforded 4i, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.28). Pure 4i was obtained as a yellow oil (170 mg, 73 % over 2 
steps). 1H NMR (400 MHz, CDCl3) δ = 7.74 (br s, 1 H), 7.67 (s, 1 H), 7.51 (d, J = 8.6 Hz, 1 H), 6.94 
(dd, J = 8.6, 2.3 Hz, 1 H), 5.72 (q, J = 6.6 Hz, 1 H), 4.03 (s, 3 H), 3.88 (s, 3 H), 2.11 (s, 3 H), 1.62 (d, J 
= 6.6 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.0 (s), 158.5 (s), 150.9 (s), 135.5 (s), 127.6 
(s), 124.0 (d), 120.6 (d), 112.8 (d), 102.9 (s), 99.3 (d), 90.9 (s), 76.5 (s), 61.0 (d), 55.7 (q), 54.1 (q), 
21.5 (q), 21.0 (q) ppm. MS (ESI) m/z (%): 652 ([2M+Na]+, 15), 337 ([M+Na]+, 41), 256 ([M-CO2Me]+, 
100).  
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3-(3-Acetoxy-3-mehylbut-1-ynyl)-6-methoxyindole-1-carboxylic acid methyl ester (4j). 
Compound 14j was obtained by Sonogashira coupling of 13i (87 mg, 0.26 mmol) and 3-methyl-3-
butyn-2-ol (31 µL, 0.32 mmol), heating at 40 °C for 1 h. Purification of the crude by flash 
chromatography (n-hexane/EtOAc, 2 : 1 + 1 % Et3N; Rf = 0.26) afforded pure enynyl alcohol 14j which 
was used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.73 (br s, 1 H), 7.62 (s, 1 H), 
7.49 (d, J = 8.4 Hz, 1 H), 6.93 (dd, J = 8.4, 2.0 Hz, 1 H), 4.03 (s, 3 H), 3.88 (s, 3 H), 1.66 (s, 6 H) ppm. 
Acetylation of compound 14j was carried out by increasing the amounts of both Ac2O (3 eq) and Et3N 
(5 eq) and by prolonging the reaction time up to 16 h. The purification of the crude by flash 
chromatography (n-hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.19) afforded pure 4j as a colourless oil (78 
mg, 91 % over 2 steps). 1H NMR (400 MHz, CDCl3) δ = 7.72 (bs, 1 H), 7.65 (s, 1 H), 7.54 (d, J = 8.8 
Hz, 1 H), 6.94 (dd, J = 8.4, 2.4 Hz, 1 H), 4.02 (s, 3 H), 3.88 (s, 3 H), 2.06 (s, 3 H), 1.78 (s, 6 H) ppm. 
13C NMR (100.4 MHz, CDCl3) δ = 169.4 (s), 158.5 (s), 151.0 (s), 135.6 (s), 127.1 (d), 124.2 (s), 120.7 
(d), 112.8 (d), 103.6 (s), 99.1 (d), 93.9 (s), 75.8 (s), 72.5 (s), 55.7 (q), 54.0 (q), 29.2 (q, 2 C), 22.0 (q) 
ppm.  MS (ESI) m/z (%): 368 ([M+K]+, 100), 352 ([M+Na]+, 16), 270 ([M-CO2Me]+, 48). 
N
CO2Me
OAc
Ph
MeO
 
3-(3-Acetoxy-3-phenylprop-1-ynyl)-6-methoxyindole-1-carboxylic acid methyl ester (4k). 
Compound 14k was obtained by Sonogashira coupling of 13i (210 mg, 0.63 mmol) and (±)-1-phenyl-2-
propyn-1-ol (93 µL, 0.76 mmol), heating at 40 °C for 1 h. Purification of the crude by flash 
chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N; Rf = 0.16) afforded pure enynyl alcohol 14k which 
was used immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 7.74 (br s, 1 H), 7.67 (s, 1 H), 
7.66-7.63 (m, 2 H), 7.52 (d, J = 8.8 Hz, 1 H), 7.46-7.40 (m, 3 H), 6.94 (dd, J = 8.4, 2.4 Hz, 1 H), 5.75 
(s, 1 H), 4.03 (s, 3 H), 3.88 (s, 3 H) ppm. 
Acetylation of compound 14k afforded 4k, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.13). Pure 4k was obtained as a yellow oil (204 mg, 86 % over 
2 steps). 1H NMR (400 MHz, CDCl3) δ = 7.74 (br s, 1 H), 7.71 (s, 1 H), 7.64-7.61 (m, 2 H), 7.52 (d, J = 
8.8 Hz, 1 H), 7.46 – 7.38 (m, 3 H), 6.94 (dd, J = 8.4, 2.4 Hz, 1 H), 6.74 (s, 1 H), 4.04 (s, 3 H), 3.88 (s, 3 
H), 2.15 (s, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3): δ = 169.8 (s), 158.6 (s), 150.8 (s), 137.1 (s), 
135.6 (s), 128.9 (d), 128.7 (d, 2 C), 127.8 (d), 127.7 (d, 2 C), 123.9 (s), 120.5 (d), 112.8 (d), 103.0 (s), 
99.3 (d), 89.1 (s), 79.1 (s), 66.2 (d), 55.6 (q), 54.0 (q), 21.1 (q), 21.0 (q) ppm. MS (ESI) m/z (%): 777 
([2M+Na]+, 100), 695 ([2M-CO2Me]+, 75), 400 ([M+Na]+, 36), 318 ([M-CO2Me]+, 82). 
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3-(3-Acetoxybut-1-ynyl)-indole-1,4-dicarboxylic acid dimethyl ester (4l). 
Compound 14l was obtained by Sonogashira coupling of 13l (260 mg, 0.72 mmol) and (±)-3-butyn-2-ol 
(68 µL, 0.86 mmol), heating at 40 °C for 1 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.23) afforded pure enynyl alcohol 14l which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.41 (d, J = 8.5 Hz, 1 H), 7.88 (s, 1 H), 
7.70 (d, J = 8.5 Hz, 1 H), 7.40 (t, J = 8.5 Hz, 1 H), 4.77 (q, J = 6.6 Hz, 3 H), 4.06 (s, 3 H), 3.98 (s, 3 H), 
2.30 – 2.21 (br s, 1 H), 1.56 (d, J = 6.6 Hz, 3 H) ppm. 
Acetylation of compound 14l afforded 4l, which was purified by flash chromatography (n-
hexane/EtOAc, 4 : 1 + 1 % Et3N; Rf = 0.21). Pure 4l was obtained as a yellow oil (84 mg, 51 % over 2 
steps). 1H NMR (400 MHz, CDCl3) δ = 8.39 (d, J = 8.0 Hz, 1 H), 7.94 (s, 1 H), 7.71 (d, J = 8.0 Hz, 1 H), 
7.40 (t, J = 8.0 Hz, 1 H), 5.74 (q, J = 6.7 Hz, 1 H), 4.05 (s, 3 H), 3.98 (s, 3 H), 2.10 (s, 3 H), 1.61 (d, J = 
6.6 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 169.9 (s), 167.4 (s), 150.6 (s), 135.3 (s), 132.5 
(d), 126.6 (s), 125.4 (d), 125.3 (s), 124.8 (d), 118.7 (d), 103.2 (s), 90.1 (s), 77.5 (s), 60.8 (d), 54.6 (q), 
51.2 (q), 21.9 (q), 21.0 (q) ppm. MS (ESI) m/z (%): 708 ([2M+Na]+, 35), 365 ([M+Na]+, 43), 283 ([M-
CO2Me]+, 100).  
N
CO2Me
OAc
O
O
 
3-(3-Acetoxybut-1-ynyl)-indole-1,5-dicarboxylic acid dimethyl ester (4m). 
Compound 14m was obtained by Sonogashira coupling of 13m (360 mg, 1 mmol) and (±)-3-butyn-2-ol 
(94 µL, 1.2 mmol), heating at 40 °C for 1 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.25) afforded pure enynyl alcohol 14m which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.26 (s, 1 H), 8.10 (d, J = 8.7 Hz, 1 H), 
8.00 (d, J = 8.7 Hz, 1 H), 7.69 (s, 1 H), 4.83 (q, J = 6.6 Hz, 1 H), 4.04 (s, 3 H), 3.94 (s, 3 H), 1.60 (d, J 
= 6.6 Hz, 3 H) ppm. 
Acetylation of compound 14m afforded 4m, which was purified by flash chromatography (n-
hexane/EtOAc, 4 : 1 + 1 % Et3N; Rf =0.18). Pure 4m was obtained as a colourless oil (220 mg, 66 % 
over 2 steps). 1H NMR (400 MHz, CDCl3) δ = 8.31 (s, 1 H), 8.14 (d, J = 8.7 Hz, 1 H), 8.02 (d, J = 8.7 
Hz, 1 H), 7.79 (s, 1 H), 5.74 (q, J = 6.7 Hz, 1 H), 4.04 (s, 3 H), 3.94 (s, 3 H), 2.11 (s, 3 H), 1.63 (d, J = 
6.7 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.2 (s), 167.4 (s, 5-CO), 150.9 (s), 136.9 (s), 
130.1 (d), 126.6 (d), 125.6 (s), 122.3 (d), 115.0 (d), 103.8 (s), 91.6 (s), 77.2 (s), 60.8 (d), 54.3 (q), 52.1 
(q), 21.5 (q), 21.1 (q) ppm. MS (ESI) m/z (%): 708 ([2M+Na]+, 18), 365 ([M+Na]+, 40), 284 ([M-
CO2Me]+, 100).  
 127	
N
CO2Me
OAc
O
O
 
3-(3-Acetoxybut-1-ynyl)-indole-1,6-dicarboxylic acid dimethyl ester (4n). 
Compound 14n was obtained by Sonogashira coupling of 13n (360 mg, 1 mmol) and (±)-3-butyn-2-ol 
(94 µL, 1.2 mmol), heating at 40 °C for 1 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.33) afforded pure enynyl alcohol 14n which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.83 (s, 1 H), 8.01 (d, J = 8.2 Hz, 1 H), 
7.89 (s, 1 H), 7.69 (d, J = 8.2 Hz, 1 H), 4.85 – 4.78 (m, 1 H), 4.10 (s, 3 H), 3.96 (s, 3 H), 1.99 – 1.93 
(bs, 1 H), 1.61 (d, J = 6.6 Hz, 3 H) ppm. 
Acetylation of compound 14n afforded 4n, which was purified by flash chromatography (n-
hexane/EtOAc, 6 : 1 + 1 % Et3N; Rf = 0.27). Pure 4n was obtained as a white solid (240 mg, 70 % over 
2 steps). 1H NMR (400 MHz, CDCl3) δ = 8.80 (s, 1 H), 8.00 (dd, J = 8.2, 1.1 Hz, 1 H), 7.90 (s, 1 H), 
7.67 (d, J = 8.2 Hz, 1 H), 5.72 (q, J = 6.7 Hz, 1 H), 4.08 (s, 3 H), 3.94 (s, 3 H), 2.12 (s, 3 H), 1.62 (d, J 
= 6.7 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 170.1 (s), 166.7 (s), 150.5 (s), 133.7 (s), 131.3 
(d), 127.1 (s), 125.0 (d), 120.0 (d), 116.9 (d), 103.3 (s), 92.0 (s), 75.5 (s), 60.8 (d), 54.6 (q), 52.1 (q), 
21.5 (q), 21.0 (q) ppm. MS (ESI) m/z (%): 708 ([2M+Na]+, 6), 365 ([M+Na]+, 7), 284 ([M-CO2Me]+, 100). 
N
CO2Me
OAc
O2N
 
3-(3-Acetoxybut-1-ynyl)-5-nitroindole-1-carboxylic acid methyl ester (4o). 
Compound 14o was obtained by Sonogashira coupling of 13o (345 mg, 1 mmol) and (±)-3-butyn-2-ol 
(94 µL, 1.2 mmol), heating at 40 °C for 1 h. Purification of the crude by flash chromatography (n-
hexane/EtOAc, 3 : 2 + 1 % Et3N; Rf = 0.20) afforded pure enynyl alcohol 14o which was used 
immediately in the next step. 1H NMR (400 MHz, CDCl3) δ = 8.57 (s, 1 H), 8.36 – 8.21 (m, 2 H), 7.89 
(s, 1 H), 4.85 (q, J = 6.6 Hz, 1 H), 1.63 (d, J = 6.6 Hz, 3 H) ppm. 
Acetylation of compound 14o afforded 4o, which was purified by flash chromatography (n-
hexane/EtOAc, 4 : 1 + 1 % Et3N; Rf = 0.19). Pure 4o was obtained as a colourless oil (168 mg, 51 % 
over 2 steps). 1H NMR (400 MHz, CDCl3) δ = 8.52 (s, 1 H), 8.28 – 8.20 (m, 2 H), 7.89 (s, 1 H), 5.73 (q, 
J = 6.7 Hz, 1 H), 4.09 (s, 3 H), 2.13 (s, 3 H), 1.64 (d, J = 6.7 Hz, 3 H) ppm. 13C NMR (100.4 MHz, 
CDCl3) δ = 169.8 (s), 150.1 (s), 144.2 (s), 137.4 (s), 131.3 (d), 130.3 (s), 120.7 (d), 116.5 (d), 115.5 (d), 
104.3 (s), 92.8 (s), 74.5 (s), 60.7 (d), 54.7 (q), 21.2 (q), 21.1 (q) ppm. MS (ESI) m/z (%): 682 
([2M+Na]+, 17), 352 ([M+Na]+, 44), 270 ([M-CO2Me]+, 100).  
N
CO2Me
OAc
R2
4
R1
R3
N
CO2Me
6
R1
O
R2
R3
 
  
 128	
General procedure for gold(I)-catalyzed Nazarov reaction (6). 
The solution of 4 in the eluent was concentrated and dried under vacuum (no heating) for 30 minutes. 
Gold(I) complex (4-CF3C6H4)3PAuCl (3 mol %, 0.006 mmol) was dissolved in DCM (1.2 mL, 0.005 M) 
and AgSbF6 (3 mol %, 0.006 mmol) was added. The formed suspension was left to stir at room 
temperature under nitrogen atmosphere. After 20 min a solution of enynyl acetate 4 (0.2 mmol) in 
DCM (2.8 mL; final concentration 0.05 M) was added and reaction mixture was stirred at room 
temperature.  After complete consumption of 4 (TLC monitoring), water (5 mL) was added; the phases 
were separated and the aqueous layer was extracted with DCM (2 x 5 mL). The organic layer was 
dried over anhydrous Na2SO4, filtered and concentrated. The oily residue was purified by flash 
chromatography followed by trituration with Et2O to give the corresponding cyclopentane-fused indole 
derivative.  
N
CO2Me
O
 
3-Methyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester (6a). 
Compound 6a was prepared starting from 4a (67 mg, 0.24 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 3 : 1; Rf = 0.16) followed by trituration with Et2O afforded pure 6a 
(48 mg, 83 %) as a yellow solid. M.p. = 126.8 ‒ 127.8 °C. 1H NMR (400 MHz, CDCl3) δ = 8.13 (d, J = 
8.0 Hz, 1 H), 7.88 (d, J = 8.0 Hz, 1 H), 7.39 - 7.31 (m, 2 H), 4.12 (s, 3 H), 3.73 (m, 1 H), 3.24 (dd, J = 
18.0, 6.8 Hz, 1 H), 2.55 (dd, J = 18.0, 1.2 Hz, 1 H), 1.45 (d, J = 6.8 Hz, 3 H) ppm. 13C NMR (100.4 
MHz, CDCl3) δ = 196.4 (s), 171.0 (s), 150.8 (s), 140.8 (s), 125.6 (d), 124.9 (s), 124.6 (d), 122.1 (s), 
120.8 (d), 115.9 (d), 54.3 (q), 49.8 (t), 32.2 (d), 20.7 (q) ppm. MS (ESI) m/z (%): 244 ([M+1]+, 100).  
Elemental analysis calcd (%) for C14H13NO3: C 69.12, H 5.39, N 5.76; found: C 69.08, H 5.44, N 5.82. 
N
CO2Me
O
nBu
 
3-Butyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester (6b). 
Compound 6b was prepared starting from 4b (177 mg, 0.54 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 4 : 1; Rf = 0.26) followed by trituration with Et2O afforded pure 6b 
(105 mg, 68 %) as a yellow solid. M.p. = 106.6 ‒ 108.1 °C. 1H NMR (400 MHz, CDCl3) δ = 8.13 (d, J = 
7.6 Hz, 1 H), 7.88 (d, J = 7.6 Hz, 1 H), 7.39 – 7.31 (m, 2 H), 4.11 (s, 3 H), 3.64 (t, J = 6.8 Hz, 1 H), 3.13 
(dd, J = 18.0, 6.4 Hz, 1 H), 2.65 (d, J = 18.0, 1 H), 2.07 - 2.01 (m, 1 H), 1.53 – 1.44 (m, 1 H), 1.41 – 
1.25 (m, 4 H), 0.90 (t, J = 6.4 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 196.5 (s), 170.0 (s), 
150.8 (s), 140.8 (s), 125.5 (d), 125.3 (s), 124.6 (d), 122.1 (s), 120.8 (d), 115.8 (d), 54.2 (q), 47.4 (t), 
37.2 (d), 34.1 (t), 29.4 (t), 22.5 (t), 13.9 (q) ppm. MS (ESI) m/z (%): 593 ([2M+Na]+, 64), 308 ([M+Na]+, 
27), 286 ([M+1]+, 100). Elemental analysis calcd (%) for C17H19NO3: C 71.56, H 6.71, N 4.91; found: C 
71.23, H 6.51, N 5.19. 
N
CO2Me
O
 
1-Oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester (6c). 
Compound 6c was prepared starting from 4c (57 mg, 0.21 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.16) followed by trituration with Et2O afforded pure 6c 
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(37 mg, 76 %) as a white solid. M.p. = 153.8 ‒ 155.2 °C. 1H NMR (400 MHz, CDCl3) δ = 8.14 (d, J = 
7.2 Hz, 1 H), 7.87 (dd, J = 6.4, 1.6 Hz, 1 H), 7.39 – 7.31 (m, 2 H), 4.09 (s, 3 H), 3.30 – 3.28 (m, 2 H), 
2.96 – 2-93 (m, 2 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 196.8 (s), 167.1 (s), 151.0 (s), 140.7 (s), 
125.5 (s and d, 2 C), 124.6 (d), 122.3 (s), 120.7 (d), 115.7 (d), 54.3 (q), 40.4 (t), 24.9 (t) ppm. MS (ESI) 
m/z (%): 230 ([M+1]+, 100). Elemental analysis calcd (%) for C13H11NO3: C 68.11, H 4.84, N 6.11; 
found: C 67.96, H 4.52, N 6.25. 
N
CO2Me
O
 
3,7-Dimethyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester (6d). 
Compound 6d was prepared starting from 4d (59 mg, 0.20 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.22) followed by trituration with Et2O afforded pure 6d 
(41 mg, 80 %) as a white solid. M.p. = 125.5 – 126.8 °C. 1H NMR (400 MHz, CDCl3) δ = 7.98 (d, J = 
8.6 Hz, 1 H), 7.69 (s, 1 H), 7.18 (d, J = 8.6 Hz, 1 H), 4.12 (s, 3 H), 3.71 (m, 1 H), 3.24 (dd, J = 18.0, 6.5 
Hz, 1 H), 2.55 (dd, J = 18.0, 1.2 Hz, 1 H), 2.44 (s, 3 H), 1.45 (d, J = 6.9 Hz, 3 H) ppm. 13C NMR (100.4 
MHz, CDCl3) δ = 196.6 (s), 171.0 (s), 150.6 (s), 138.7 (s), 134.6 (s), 126.7 (d), 124.3 (s), 121.9 (s), 
120.7 (d), 115.5 (d), 54.1 (q), 49.6 (t), 31.8 (d), 21.5 (q), 20.8 (q) ppm. MS (ESI) m/z (%):536 
([2M+Na]+, 100), 280 ([M+Na]+, 9), 258 ([M+1], 53). Elemental analysis calcd (%) for C15H15NO3: C 
70.02, H 5.88, N 5.44; found: C 69.93, H 5.79, N 5.31. 
N
CO2Me
O
 
3,6-Dimethyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester (6e). 
Compound 6e was prepared starting from 4e (139 mg, 0.47 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.21) followed by trituration with Et2O afforded pure 6e 
(99 mg, 82 %) as a white solid. M.p. = 140.1 – 140.8 °C. 1H NMR (400 MHz, CDCl3) δ = 7.95 (s, 1 H), 
7.74 (d, J = 8.2 Hz, 1 H), 7.16 (d, J = 8.2 Hz, 1 H), 4.11 (s, 3 H), 3.76 – 3.63 (m, 1 H), 3.22 (dd, J = 
18.0, 6.5 Hz, 1 H), 2.53 (dd, J = 18.0, 1.3 Hz, 1 H), 2.48 (s, 3 H), 1.43 (d, J = 6.9 Hz, 3 H) ppm. 13C 
NMR (100.4 MHz, CDCl3) δ = 196.3 (s), 170.5 (s), 151.0 (s), 141.4 (s), 136.0 (s), 125.7 (d), 124.7 (s), 
120.4 (d), 119.7 (s), 116.0 (d), 54.1 (q), 49.8 (t), 32.2 (d), 22.0 (q), 20.8 (q) ppm. MS (ESI) m/z (%): 536 
([2M+Na]+, 14), 258 ([M+1]+, 100). Elemental analysis calcd (%) for C15H15NO3: C 70.02, H 5.88, N 
5.44; found: C 69.91, H 5.82, N 5.13. 
N
CO2Me
OMe
O
 
8-Methoxy-3-methyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester 
(6f). 
Compound 6f was prepared starting from 4f (60 mg, 0.19 mmol). Purification by flash chromatography 
(n-hexane/EtOAc, 3 : 2; Rf  = 0.16) followed by trituration with Et2O afforded pure 6f (39 mg, 75 %) as 
a pale yellow solid. M.p. = 191.5 ‒ 193.2 °C. 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.4 Hz, 1 H), 
7.31 (t, J = 8.4 Hz, 1 H), 6.80 (d, J = 8.0 Hz, 1 H), 4.11 (s, 3 H), 4.00 (s, 3 H), 3.75-3.68 (m, 1 H), 3.25 
(dd, J = 18.0, 6.8 Hz, 1 H), 2.57 (dd, J = 18.0, 1.2 Hz, 1 H), 1.43 (d, J = 6.8 Hz, 3 H) ppm. 13C NMR 
(100.4 MHz, CDCl3) δ = 195.1 (s), 170.0 (s), 154.0 (s), 150.8 (s), 142.1 (s), 126.9 (d), 124.2 (s), 112.6 
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(s), 108.6 (d), 105.8 (d), 56.1 (q), 54.3 (q), 49.7 (t), 31.9 (d), 20.9 (q) ppm. MS (ESI) m/z (%): 569 
([M+Na]+, 100), 274 ([M+1]+, 69). Elemental analysis calcd (%) for C15H15NO4·¼H2O: C 64.86, H 5.62, 
N 5.04; found: C 64.94, H 5.50, N 4.87. 
N
CO2Me
OMe
O
 
8-Methoxy-3,3-dimethyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl 
ester (6g). 
Compound 6g was prepared starting from 4g (76 mg, 0.23 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.19) followed by trituration with Et2O afforded pure 6g 
(41 mg, 62 %) as a pale yellow solid. The product decomposed at 175 °C. 1H NMR (400 MHz, CDCl3) 
δ = 7.72 (d, J = 8.4 Hz, 1 H), 7.31 (t, J = 8.4 Hz, 1 H), 6.80 (d, J = 8.0 Hz, 1 H), 4.13 (s, 3 H), 4.01 (s, 3 
H), 2.93 (s, 2 H), 1.60 (s, 6 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 194.5 (s), 171.2 (s), 154.0 (s), 
150.8 (s), 142.2 (s), 126.9 (d), 124.3 (s), 112.3 (s), 109.0 (d), 105.7 (d), 59.4 (t), 56.0 (q), 54.2 (q), 39.2 
(s), 26.8 (q, 2 C) ppm. MS (ESI) m/z (%): 597 ([M+Na]+, 100), 288 ([M+1-I]+, 36). Elemental analysis 
calcd (%) for C16H17NO4: C 66.89, H 5.96, N 4.88; found: C 66.67, H 5.71, N 4.66. 
N
CO2Me
MeO
O
 
7-Methoxy-3-methyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester 
(6h). 
Compound 6h was prepared starting from 4h (155 mg, 0.50 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.27) followed by trituration with Et2O afforded pure 6h 
(112 mg, 84 %) as a yellow solid. M.p. = 158.3 – 159.9 °C. 1H NMR (400 MHz, CDCl3) δ = 7.99 (d, J = 
9.2 Hz, 1 H), 7.34 (d, J = 2.6 Hz, 1 H), 6.94 (dd, J = 9.2, 2.6 Hz, 1 H), 4.10 (s, 3 H), 3.85 (s, 3 H), 3.77 
– 3.64 (m, 1 H), 3.23 (dd, J = 18.0, 6.5 Hz, 1 H), 2.54 (dd, J = 18.0, 1.2 Hz, 1 H), 1.45 (d, J = 6.9 Hz, 3 
H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 196.7 (s), 171.1 (s), 157.1 (s), 150.5 (s), 135.3 (s), 124.6 
(s), 122.8 (s), 116.6 (d), 114.7 (d), 103.2 (d), 55.7 (q), 54.2 (q), 49.6 (t), 32.2 (d) , 20.6 (q) ppm. MS 
(ESI) m/z (%): 296 ([M+Na]+, 6), 274 ([M+1], 100). Elemental analysis calcd (%) for C15H15NO4: C 
65.92, H 5.53, N 5.13; found: C 65.64, H 5.68, N 4.99. 
N
CO2Me
MeO
O
 
6-Methoxy-3-methyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester 
(6i). 
Compound 6i was prepared starting from 4i (75 mg, 0.24 mmol). Purification by flash chromatography 
(n-hexane/EtOAc, 2 : 1; Rf  = 0.24) followed by trituration with Et2O afforded pure 6i (55 mg, 84 %) as 
a white solid. M.p. = 98.1 – 99.0 °C. 1H NMR (400 MHz, CDCl3) δ = 7.74 (d, J = 8.6 Hz, 1 H), 7.72 (d, J 
= 2.2 Hz, 1 H), 6.94 (dd, J = 8.6, 2.2 Hz, 1 H), 4.10 (s, 3 H), 3.87 (s, 3 H), 3.71 – 3.65 (m, 1 H), 3.21 
(dd, J = 18.0, 6.4 Hz, 1 H), 2.52 (dd, J = 18.0, 1.2 Hz, 1 H), 1.43 (d, J = 6.9 Hz, 3 H) ppm. 13C NMR 
(100.4 MHz, CDCl3) δ = 196.4 (s), 170.0 (s), 158.4 (s), 150.9 (s), 142.2 (s), 124.8 (s), 121.2 (d), 115.7 
(s), 112.5 (d), 100.9 (d), 55.8 (q), 54.3 (q), 49.8 (t), 32.3 (d), 20.8 (q) ppm. MS (ESI) m/z (%): 568 
([2M+Na]+, 18), 295 ([M+Na]+, 5), 274 ([M+1], 100). Elemental analysis calcd (%) for C15H15NO4: C 
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65.92, H 5.53, N 5.13; found: C 66.02, H 5.68, N 4.80. 
N
CO2Me
MeO
O
 
6-Methoxy-3,3-dimethyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl 
ester (6j). 
Compound 6j was prepared starting from 4j (66 mg, 0.20 mmol). Purification by flash chromatography 
(n-hexane/EtOAc, 2 : 1; Rf  = 0.24) followed by trituration with Et2O afforded pure 6j (47 mg, 82 %) as 
a white solid. M.p. = 152.2 ‒ 154.1 °C. 1H NMR (400 MHz, CDCl3) δ = 7.78 (d, J = 8.8 Hz, 1 H), 7.70 
(d, J = 2.0 Hz, 1 H), 6.96 (dd, J = 8.8, 2.0 Hz, 1 H), 4.13 (s, 3 H), 3.88 (s, 3 H), 2.90 (s, 2 H), 1.60 (s, 6 
H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 196.1 (s), 171.4 (s), 158.5 (s), 150.8 (s), 142.0 (s), 124.9 
(s), 121.2 (d), 115.5 (s), 112.3 (d), 101.8 (d), 59.3 (t), 55.8 (q), 54.2 (q), 39.9 (s), 26.9 (q, 2 C) ppm. MS 
(ESI) m/z (%): 597 ([2M+Na]+, 100), 288 ([M+1]+, 38). Elemental analysis calcd (%) for C16H17NO4: C 
66.89, H 5.96, N 4.88; found: C 67.00, H 5.82, N 5.03. 
N
CO2Me
MeO
O
Ph
 
6-Methoxy-3-phenyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester 
(6k). 
Compound 6k was prepared starting from 4k (95 mg, 0.25 mmol). Purification by trituration with Et2O 
and n-hexane afforded pure 6k (51 mg, 61 %) as a yellow solid. M.p. = 141.7 – 143.1 °C. Rf = 0.18 (n-
hexane-EtOAc, 3 : 1). 1H NMR (400 MHz, CDCl3) δ = 7.84 (d, J = 8.8 Hz, 1 H), 7.77 (d, J = 2.0 Hz, 1 
H), 7.31 – 7.19 (m, 3 H), 7.07 – 7.05 (m, 2 H), 7.00 (dd, J = 8.4, 2.0 Hz, 1 H), 4.78 (dd, J = 7.2, 1.6 Hz, 
1 H), 3.88 (s, 3 H), 3.70 (s, 3 H), 3.48 (dd, J = 18.0, 7.2 Hz, 1 H), 2.78 (dd, J = 18.0, 1.6 Hz, 1 H) ppm. 
13C NMR (100.4 MHz, CDCl3) δ = 196.0 (s), 165.9 (s), 158.8 (s), 150.3 (s), 142.4 (s), 142.0 (s), 128.9 
(d, 2 C), 127.0 (d), 126.6 (s), 126.5 (d, 2 C), 121.4 (d), 115.4 (s), 113.1 (d), 100.7 (d), 55.7 (q), 53.7 (q), 
51.6 (t), 43.3 (d) ppm. MS (ESI) m/z (%): 693 ([2M+Na]+, 100), 336 ([M+1]+, 79). Elemental analysis 
calcd (%) for C20H17NO4: C 71.63, H 5.11, N 4.18; found: C 71.42, H 4.91, N 4.53. 
N
CO2Me
OO O
 
3-Methyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4,8-dicarboxylic acid dimethyl ester (6l). 
Compound 6l was prepared starting from 4l (55 mg, 0.16 mmol). Purification by flash chromatography 
(n-hexane/EtOAc, 2 : 1; Rf = 0.22) afforded pure 6l (40 mg, 83 %) as a white solid. M.p. = 104.2 – 
105.8 °C. 1H NMR (400 MHz, CDCl3) δ = 8.31 (d, J = 9.3 Hz, 1 H), 7.68 (d, J = 8.5 Hz, 1 H), 7.44 – 
7.34 (m, 1 H), 4.12 (s, 3 H), 4.00 (s, 3 H), 3.78 - 3.66 (m, 1 H), 3.21 (dd, J = 17.8, 6.8 Hz, 1 H), 2.54 
(dd, J = 17.8, 1.3 Hz, 1 H), 1.44 (d, J = 6.9 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 194.1 (s), 
171.7 (s), 168.6 (s), 150.8 (s), 140.7 (s), 126.2 (s), 125.2 (d, 2 C), 123.8 (s), 120.6 (s), 118.7 (d), 54.2 
(q), 52.3 (q), 49.9 (t), 31.2 (d), 20.9 (q) ppm. MS (ESI) m/z (%): 625 ([2M+Na]+, 100), 302 ([M+1]+, 54). 
Elemental analysis calcd (%) for C16H15NO5: C 63.78, H 5.05, N 4.65; found: C 63.52, H 4.96, N 4.43. 
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3-Methyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4,7-dicarboxylic acid dimethyl ester (6m). 
Compound 6m was prepared starting from 4m (135 mg, 0.40 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 2 : 1; Rf  = 0.24) followed by trituration with Et2O afforded pure 6m 
(52 mg, 43 %) as a yellow solid. M.p. = 153.0 – 154.9 °C. 1H NMR (400 MHz, CDCl3) δ = 8.45 (s, 1 H), 
8.05 (d, J = 8.8 Hz, 1 H), 7.97 (d, J = 8.8 Hz, 1 H), 4.10 (s, 3 H), 3.90 (s, 3 H), 3.79 – 3.56 (m, 1 H), 
3.20 (dd, J = 18.0, 6.5 Hz, 1 H), 2.52 (d, J = 18.0 Hz, 1 H), 1.43 (d, J = 6.6 Hz, 3 H) ppm. 13C NMR 
(100.4 MHz, CDCl3) δ = 195.7 (s), 172.0 (s), 166.5 (s), 150.5 (s), 143.3 (s), 126.9 (d), 126.5 (s), 124.8 
(s), 122.4 (d), 121.7 (s), 115.6 (d), 54.6 (q), 52.0 (q), 49.9 (t), 32.3 (d), 20.7 (q) ppm. MS (ESI) m/z (%): 
625 ([2M+Na]+, 100), 302 ([M+1]+, 54). Elemental analysis calcd (%) for C16H15NO5: C 63.78, H 5.05, 
N 4.65; found: C 64.00, H 4.93, N 4.44. 
N
CO2MeO
O
O
 
3-Methyl-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4,6-dicarboxylic acid dimethyl ester (6n). 
Compound 6n was prepared starting from 4n (175 mg, 0.51 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 2 : 1; Rf  = 0.24) followed by trituration with Et2O afforded pure 6n 
(98 mg, 64 %) as a pale yellow solid. M.p. = 128.6 – 130.0 °C. 1H NMR (400 MHz, CDCl3) δ = 8.78 (s, 
1 H), 8.03 (d, J = 8.2 Hz, 1 H), 7.90 (d, J = 8.2 Hz, 1 H), 4.16 (s, 3 H), 3.95 (s, 3 H), 3.77 (m, 1 H), 3.26 
(dd, J = 18.1, 6.6 Hz, 1 H), 2.57 (dd, J = 18.1, 1.0 Hz, 1 H), 1.48 (d, J = 6.9 Hz, 3 H) ppm. 13C NMR 
(100.4 MHz, CDCl3) δ = 195.7 (s), 172.9 (s), 166.8 (s), 150.6 (s), 140.6 (s), 127.3 (s), 126.0 (d), 125.7 
(s), 124.4 (s), 120.4 (d), 117.8 (d), 54.6 (q), 52.4 (q), 49.6 (t), 32.2 (d), 20.6 (q) ppm. MS (ESI) m/z (%): 
625 ([2M+Na]+, 26), 302 ([M+1], 100). Elemental analysis calcd (%) for C16H15NO5: C 63.78, H 5.02, N 
4.65; found: C 63.51, H 5.02, N 4.31. 
N
CO2Me
O2N
O
 
3-Methyl-7-nitro-1-oxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl ester (6o). 
Compound 6o was prepared starting from 4o (66 mg, 0.20 mmol). Purification by flash 
chromatography (n-hexane/EtOAc, 2 : 1; Rf  = 0.24) followed by trituration with Et2O afforded pure 6o 
(17 mg, 30 %) as a yellow solid. M.p. = 128 °C. 1H NMR (400 MHz, CDCl3) δ = 8.76 (d, J = 1.9 Hz, 1 
H), 8.33 – 8.23 (m, 2 H), 4.18 (s, 3 H), 3.80 (m, 1 H), 3.30 (dd, J = 18.5, 6.6 Hz, 1 H), 2.62 (d, J = 18.5 
Hz, 1 H), 1.50 (d, J = 6.9 Hz, 3 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 195.5 (s), 172.9 (s), 149.9 
(s), 144.7 (s), 143.4 (s), 124.7 (s), 122.2 (s), 120.9 (d), 116.8 (d), 116.3 (d), 54.9 (q), 49.6 (t), 32.5 (d), 
20.6 (q) ppm. MS (ESI) m/z (%): 598 ([2M+Na]+, 40), 289 ([M+1], 100). Elemental analysis calcd (%) 
for C14H12N2O5: C 58.33, H 4.20, N 9.72; found: C 58.13, H 4.43, N 9.62. 
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6-Methoxy-3,3-dimethyl-1,2-dioxo-2,3-dihydro-1H-cyclopenta[b]indole-4-carboxylic acid methyl 
ester (11). 
Compound 6j (42 mg, 0.15 mmol) was dissolved in 1,4-dioxane (1.6 mL) and SeO2 (65 mg, 0.58 
mmol) was then added in one portion.4 The mixture was heated at 100 °C (external) for 23 h; after 
cooling to room temperature, water (27 mL) was added and the product extracted with EtOAc (3 x 7 
mL). The combined organic extracts were dried over anhydrous Na2SO4, filtered and concentrated. 
Purification of the crude by flash chromatography (n-hexane/EtOAc, 2 : 1; Rf = 0.37) afforded pure 11 
(37 mg, 82 %) as a yellow solid. M.p. = 193.4 ‒ 195.1 °C. 1H NMR (400 MHz, CDCl3) δ = 7.89 (d, J = 
8.4 Hz, 1 H), 7.72 (d, J = 2.0 Hz, 1 H), 7.02 (dd, J = 8.4, 2.0 Hz, 1 H), 4.19 (s, 3 H), 3.90 (s, 3 H), 1.58 
(s, 6 H) ppm. 13C NMR (100.4 MHz, CDCl3) δ = 204.7 (s), 177.7 (s), 169.6 (s), 159.9 (s), 150.2 (s), 
139.9 (s), 127.4 (s), 122.4 (d), 115.4 (s), 113.2 (d), 101.8 (d), 55.8 (q), 54.9 (q), 45.9 (s), 22.5 (q, 2 C) 
ppm. MS (ESI) m/z (%): 625 ([2M+Na]+, 100), 324 ([M+Na]+, 18), 302 ([M+1]+, 4). Elemental analysis 
calcd (%) for C16H15NO5: C 63.78, H 5.02, N 4.65; found: C 63.95, H 4.82, N 4.49. 
N
HHO
O
O
 
Bruceolline H (12).2a 
Compound 11 (25 mg, 0.08 mmol) was suspended in MeOH (1.6 mL) and tert-butylamine (514 µL, 4.9 
mmol) was added. The clear solution was heated at 90 °C (external) for 30 min and, after cooling, 
volatiles were removed under vacuum. The obtained crude intermediate was used in the next step.13 
1H NMR (400 MHz, CD3OD) δ = 7.82 (d, J = 8.8 Hz, 1 H), 7.05 (d, J = 2.4 Hz, 1 H), 6.95 (dd, J = 8.8, 
2.4 Hz, 1 H), 3.88 (s, 3 H), 1.48 (s, 6 H) ppm. 
A suspension of the crude intermediate (20 mg, 0.08 mmol) in anhydrous DCM (0.82 mL) was cooled 
at 0 °C (ice bath) and BBr3 (31 µL, 0.32 mmol) was dropwise added.14 The temperature was allowed to 
warm to room temperature over 15 h. The mixture was cooled again at 0 °C, quenched by anhydrous 
MeOH (100 µL) and left under stirring for 10 minutes. The ice bath was removed and after 20 min the 
solvent was removed under vacuum. Purification of the residue by flash chromatography (n-
hexane/EtOAc, 1 : 4; Rf  = 0.26) afforded 12 that was further triturated with n-hexane. Pure Bruceolline 
H (12) was so obtain as a yellow solid (18 mg, 93 %). M.p. = 291-292 °C. 1H NMR (400 MHz, acetone-
d6) δ = 7.70 (d, J = 8.4 Hz, 1 H), 7.05 (d, J = 2.0 Hz, 1 H), 6.90 (dd, J = 8.4, 2.0 Hz, 1 H), 1.48 (s, 6 H) 
ppm.10 13C NMR (100.4 MHz, acetone-d6) δ = 207.0 (s), 175.9 (s), 171.3 (s), 157.2 (s), 142.7 (s), 
123.6 (s), 122.8 (d), 115.5 (s), 113.4 (d), 100.1 (d), 42.7 (s), 23.4 (q, 2 C) ppm.10 
1H NMR (400 MHz, CD3OD) δ = 7.73 (J = 8.4 Hz, 1 H), 6.91 (d, J = 2.4 Hz, 1 H), 6.82 (dd, J = 8.4, 2.0 
Hz, 1 H), 1.46 (s, 3 H) ppm. 13C NMR (100.4 MHz, CD3OD) δ = 207.4 (s), 176.7 (s), 174.1 (s), 158.2 
(s), 143.8 (s), 124.0 (s), 123.6 (d), 115.5 (s), 114.0 (d), 100.3 (d), 43.1 (s), 23.4 (q, 2 C) ppm. MS (ESI) 
m/z (%): 481 ([2M+Na]+, 100), 252 ([M+Na]+, 61), 230 ([M+1]+, 10). Elemental analysis calcd (%) for 
C13H11NO3: C 68.11, H 4.84, N 6.11; found: C 67.87, H 5.24, N 5.74.  
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Chapter 8: Diazenyl-Protected Lactams  
The work described in this chapter was accepted for publication as “Oxidation of Diazenyl-protected N-
Heterocycles – a New Entry to Functionalized Lactams” in RSC Advances.  
8.1. General Approach1 
 The immobilization of δ-valerolactam on the solid-support and the transfer of chemistry 
developed in the solution (Scheme 1) would allow combinatorial chemistry and thus a rapid synthesis 
of many piperidine derivatives without tedious and time consuming purifications.  
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Scheme 1. Solution-phase2 and alternative solid-phase synthesis of piperidine derivatives via 
Pd-catalyzed cross-coupling reactions of lactam derived enol triflates and phosphates.  
The transformations of chemical functionalities on the solid-support are similar to those in conventional 
solution-phase chemistry. Usually the choice of the linker plays a pivotal role in the success of the 
solid-phase organic chemistry and possibility of its application to combinatorial chemistry.3 Traditionally 
linkers are designed to release one particular functional group, acting more or less like bulky protecting 
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groups. These types of linkers could be defined as monofunctional linkers. On the other hand, so-
called multifunctional linkers are susceptible to cleavage upon treatment with different building blocks 
thus offering the opportunity to incorporate additional diversities.  
One of the well known multifunctional linkers is the triazene 4.4 It has already been used in the 
transformation of primary amines into different amides, ureas,5 thioureas and guanidines (Scheme 2).6 
In general, triazenes 4 and 5 are stable toward daylight, oxygen, moisture, transition metal complexes, 
reducing and oxidizing agents and under neutral and basic conditions. However, in the presence of 
Brønsted or Lewis acid they will cleave to give the diazonium salt and the corresponding product 6.  
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Scheme 2. Transformations of primary amines into amides, ureas, thioureas and guanidines on 
diazonium T2 resin.   
 With the aim to develop the synthesis of piperidine analogues on the diazonium resin in 
future, within this thesis in the context of my four-month secondment at KIT, the chemistry of diazenyl 
protected lactams 2 was explored in solution.7,8 Thus, a series of lactams 2 were prepared via RuO4 
oxidation of diazenyl protected N-heterocycles.  
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Scheme 3. Synthesis of diazenyl-protected lactams via RuO4 catalyzed oxidation of triazenes. 
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8.2. Oxidation of Diazenyl-Protected N-Heterocycles 
 In the past, it has been shown that lactams can be synthesized by the oxidation of 
corresponding heterocyclic amines protected as amides, carbamates or sulfonamines. In most of the 
oxidation procedures, ruthenium(VIII)9 and electrochemical oxidation10 have been used.  
In addition, a few N-diazenyl-protected piperidines have been oxidized by KMnO4 producing the 
corresponding lactams in very low yield (up to 25%).8a The lack of the tools for the latter conversion 
and the fact that the diazenyl protected lactams are unexplored class of compounds, prompted us to 
search for novel oxidation protocols.  
NH2 N2BF4
N
N
Na b
O
O
O
O
O
O
1a4a3a  
Scheme 4. Synthesis of N-diazenyl protected piperidine 1a. Reagents and conditions: (a) 
BF3·Et2O, isopentyl nitrite, THF, 0 °C, 2 h; (b) piperidine, Et3N, THF, 0 °C, 2 h (85 %). 
Aiming for	 the identification of an efficient	oxidation strategy, N-diazenyl protected piperidine 1a was 
chosen as a model system. The synthesis of this model compound was carried out by converting the 
4-amino-benzoic acid ethyl ester (3a) into the corresponding diazonium salt 4a which reacted with 
piperidine to give triazene 1a in 85 % after chromatography (Scheme 4). 
 
Table 1. Oxidation of N-diazenyl protected piperidine 1a.[a] 
O
O
N
N
N
O
O
N
N
N
O
conditions
1a 2a  
Entry Pre-catalyst Oxidant Solvent Time Temp Yield (%)[b] 
1 RuCl3 H2O 15 % NaIO4 2.5 eq 
CCl4/ACN/H2O 
2/2/3 2.5 h RT 39 % 
2 DIB 4 eq TBHP 3 eq ACN 14 h RT 19 % 
3  DIB 4 eq H2O2 3 eq ACN 14 h RT - 
4 Rh2(cap)4 5 % T-HYDRO 20 eq ACN 14 h RT 22 % 
5 Rh2(OAc)4 5 % T-HYDRO 20 eq ACN 14 h RT - 
6 NHPI (3eq) Co(OAc)2 
5 % - - ACN 3 h RT - 80°C - 
7 - - CrO3-DMP 20 DCM 14 h RT n.d. 
8 RuCl3·H2O 30 % NaIO4 5 eq CCl4/ACN/H2O 2/2/3 2 h RT 44 % 
9 RuCl3·H2O 30 % NaIO4 5 eq DCM/H2O 1/1 14 h RT 10 % 
10 RuCl3·H2O 30 % NaIO4 3 eq DCM/ACN/H2O 2/1/2 14 h RT 16 % 
11 RuCl3·H2O 30 % NaIO4 3 eq CHCl3/ACN/H2O 2/1/2 14 h RT 10 % 
12 RuCl3·H2O 45 % NaIO4 5 eq EtOAc/ACN/H2O 2/0.4/2 2.5 h RT 16 % 
13 RuO2·H2O 30 % NaIO4 5 eq CCl4/ACN/H2O 2/2/3 14 h RT 47 % 
14 RuCl3·H2O 30 % NaIO4 5 eq 
CCl4/ACN/buffer  
(pH = 8) 
2/2/3 
2 h RT 52 %  (61 %)[c] 
[a] Reaction carried out on 0.2 mmol scale. [b] Yield after chromatography. [c] Reaction carried out on 2 mmol scale. 
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Triazene 1a was subjected to the oxidation based on formerly published oxidation strategies (Table 
1).11-14 In metal-free DIB/TBHP oxidation protocol,11 active species bis(tert-butylperoxy)iodobenzene 
generated in situ by the reaction between diacetoxyiodobenzene and tert-butyl hydroperoxide was also 
able to activate the C–H methylene bond next to the nitrogen atom giving the desired product (2a) in 
19% yield (entry 2). Oxidation catalyzed by Rh2(cap)4/T-HYDRO12 system led to the formation of 
desired N-diazenyl protected lactam in 22 % yield while Rh2(OAc)2 under the same reaction conditions 
was not able to catalyze the reaction. N-Hydroxyphthalimide combined with cobalt salt13 was 
ineffective catalyst, too (entry 6). On the other hand, with the CrO3 · 3,5-dimethylpyrazole complex14 
we were able to carry out the oxidation of triazene 1a but it was not possible to get rid of 3,5-
dimethylpyrazole after two consecutive chromatographies (entry 7). Among tested methods, RuO4 
generated in situ from RuCl3·nH2O and NaIO4 in CCl4/ACN/H2O was the most efficient catalys for 
the oxidation of triazene 1a (entry 1) and therefore it was chosen for further optimization. The increase 
of the catalyst loading to 30 % and oxidant to 5 eq resulted in yield of 44 % (entry 8). When the 
reaction was carried out in less toxic solvent such as DCM, CHCl3 and EtOAc product 2a was obtained 
in low yields (entries 9-12). The use of RuO2 did not affect the outcome of the reaction (entry 13). The 
yield of 2a was further improved to 52 % by the use of phosphate buffer (entry 14).  
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Scheme 5. Synthesis of N-diazenyl protected heterocycles. Reagents and conditions: (a) 
BF3·Et2O, isopentyl nitrite, THF, 0 °C, 2 h; (b) piperidine, Et3N, THF, 0 °C – 25 °C,                  
2 h (85 %). 
 To explore the scope of the reaction a set of N-diazenyl protected heterocycles was prepared 
by varying the ring size, substituent pattern on the ring and electronic properties of the aryl moiety 
(Scheme 5). All N-diazenyl heterocycles 1b-1i were prepared in good yields from corresponding 
diazonium salts and cyclic amines. It is important to notice that among the prepared compounds are 
quite rare azetinyldiazenes.15 In addition, all compounds are stable at room temperature and in the 
contact with air. 
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Figure 4. X-Ray structure of triazene 1h. 
Triazenes 1a-i were oxidized under optimized reaction conditions to lactams 2a-i in yields ranging from 
28 to 65%, i.e. much higher than those reported with KMnO4.8a All reactions were carried out on 1 
mmol scale, except the oxidation of 1a which was repeated on a 2 mmol scale (Scheme 6).  
The electronic properties of the aryl ring influenced the outcome of the reaction. The yields were 
diminished when the aryl ring was bearing electron-donating substituents making the triazene linker 
more electron-rich and therefore more susceptible to the oxidation.  
In addition, N-diazenyl protected tetrahydroisoquinoline (1f), pyrrolidine (1h) and azepane (1i) were all 
successfully oxidized into corresponding lactams in good yields. Only oxidation of azetidine derivative 
1g proceeded in low yield.  
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Scheme 6. Oxidation of 1a-i to N-diazenyl-protected lactams 2a-i. Notes: [a] Reaction carried 
out on 2 mmol scale; [b] Reaction carried out on 1 mmol scale. 
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Under the herein described conditions, the obtained arenes are not degraded, and also the triazene 
linker was not oxidized. The structures of products 2a-2i were confirmed by standard techniques while 
the X-ray structure of compound 2a revealed that those lactams crystallize in s-trans conformation. In 
addition all products were stable at room temperature. At the time of writing this thesis, they have been 
kept at 4 °C for more than 14 months without decomposition.   
 
Figure 5. X-Ray structure of 2a. 
Althought the N-diazenyl protected lactams are obtained in moderate yields it is worth to mention that 
the herein described RuO4 mediated oxidation of triazenes is the first strategy for the synthesis of 
lactams with diazenyl unit from commercially available and very cheap starting materials.  
The fact that the functionalized lactams are highly important class of heterocycles in both material 
science and medicinal chemistry16 makes N-diazenyl protected lactams promising building blocks in 
the synthesis of novel materials as well as biologically active compounds.  In addition, hydrolysis of 
ester group under basic conditions allows the anchoring on the solid support.  
 
 
8.3. Transformations of N-Diazenyl Protected Lactams 
 As a preliminary investigation the alkylation of lactam 2d was carried out under strong basic 
conditions, using LiHMDS as the base and MeI as the electrophile (Scheme 7). Gratifyingly, the 
reaction provided the 3-methyl substituted lactam 7 in good yield (59 %) without decomposition or 
degradation of the protecting group. 
N
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a, b N
N
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2d 7  
Scheme 7. Alkylation of N-diazenyl-protected lactam 2d. Reagents and conditions: (a) LiHMDS, 
THF, -78 °C; (b) MeI, -78 – 25 °C (59 %).  
With the aim to extend the utility of these compounds for the preparation of N-heterocyclic libraries on 
the solid support in combinatorial mode, we explored the possibility of forming new C-C bonds by 
Pd(0)-catalyzed cross coupling reactions. Therefore N-diazenyl protected valerolactam 2a was 
transformed into enol phosphate 8 in quantitative yield and subjected to Pd-catalyzed 
methoxycarbonylation and Suzuki coupling under the conditions previously optimized for N-Ts and N-
CO2R (R = Me, CH2Ph, C(CH3)3)2a but to no avail. In all cases, phosphate was consumed in less than 
2 h but the 1H NMR analysis revealed complex crude without signals related to the desired products. 
All attempts to isolate and identify formed side-products failed. At this stage, due to the completion of 
my KIT secondement, no further experiments were performed.  
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Scheme 8. Attempts of Pd-catalyzed methoxycarbonylation and Suzuki coupling. Reagents and 
conditions: (a) KHMDS, THF, -78 °C, 1.5 h, then (PhO)2POCl, - 78 - 0 °C; (b) phenylboronic 
acid, 5% Pd(Ph3P)4, Na2CO3, DMF/H20, 40 °C, 2 h; (c) phenylboronic acid, 5% 
(Ph3P)PdCl2, 2 M Na2CO3/THF, 40 ° C, 2 h; (d) 10 % Pd(OAc)2, 20 % Ph3P, Et3N, 
MeOH/DMF,  40 °C, 1.5 h.  
 
 
8.4. Experimental Part  
General information 
1H and 13C NMR spectra were recorded on Bruker-AC-250 instrument using CDCl3 as solvent. The 
coupling constant J was assigned in Hertz (Hz). MS (EI) (electron impact mass spectrometry) and EI-
HRMS: Finnigan MAT 90 (70 eV). The molecular fragments are quoted as the relation between mass 
and charge (m/z), the intensities as a percentage value relative to the intensity of the base signal 
(100%). IR spectra of solids were recorded in KBr, and of oils as thin films on KBr. The deposit of the 
absorption band is given in wave numbers in cm-1. Melting points were recorded on a Buchi-540 
melting point apparatus and are uncorrected. Chromatographic separations were performed under 
pressure on silica gel by flash-column techniques; Rf values refer to TLC carried out on 0.25-mm silica 
gel plates (Merck F254), with the same eluent as indicated for the column chromatography. Solvents 
and chemicals used for reactions were purchased from commercial suppliers. Solvents and chemicals 
were used without further purification.  
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General procedure for the synthesis of triazenes (1). 
Triazenes were prepared under basic conditions in reaction between diazonium salt and cyclic amine 
according to the known procedure.17 
A solution of aniline (1 mmol) in DCM (4 mL) was rapidly added to the solution of BF3·Et2O (2 mmol) in 
THF (8 mL) at 0 °C. Few minutes later, isopentyl nitrite (2 mmol) was slowly added to the reaction 
mixture and the ice bath was removed. The reaction mixture was stirred at room temperature for 2 h. 
Formed precipitate was collected by filtration, washed with Et2O and the obtained diazonium salt was 
used in the next step.   
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A solution of cyclic amine (2 mmol) and Et3N (4 mmol) in THF (4 mL) was cooled by ice bath and the 
diazonium salt (1 mmol) was added portion-wise. The ice bath was removed and the reaction was 
stirred at room temperature for 30 min. Water (5 mL) was added and the product was extracted with 
Et2O (3 x 5 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated. The 
crude was purified by column chromatography. 
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4-(Piperidin-1-ylazo)-benzoic acid ethyl ester (1a). 
Compound 1a was synthesized according above described procedure from 4-aminobenzoic acid ethyl 
ester (3 mmol) and piperidine (6 mmol). After chromatography (cyclohexane/EtOAc = 10 : 1 + 1 % 
Et3N) pure 1a (675 mg, 85 %) was obtained as a yellow solid. - Rf  (cyclohexane/EtOAc = 10 : 1) = 
0.21. - m.p. = 128.4 - 129.5 °C. - 1H NMR (250 MHz, CDCl3) δ = 8.01 (d, J = 8.7 Hz, 2 H), 7.45 (d, J = 
8.7 Hz, 2 H), 4.36 (q, J = 7.7 Hz, 2 H), 3.90 – 3.78 (m, 4 H), 1.81 – 1.67 (m, 6 H), 1.39 (t, J = 7.7 Hz, 3 
H) ppm. - 13C NMR (63 MHz, CDCl3) δ = 167.7, 155.4, 131.6, 128.3, 121.2, 61.7, 27.9, 26.4, 25.3, 
15.4 ppm. MS (ESI) m/z (%): 543 (100) [2M+Na]+, 284 (11) [M+Na]+, 262 (30) [M+1]+. - EA 
(C14H19N3O2): calc. C 64.35, H 7.33, N 16.08; found C 64.27, H 7.12, N 15.96. 
N
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(4-Bromo-phenyl)-piperidin-1-yl-diazene (1b). 
Compound 1b was synthesized according above described procedure from 4-bromoaniline (1.5 mmol) 
and piperidine (3 mmol). After chromatography (cyclohexane/EtOAc = 10 : 1 + 1 % Et3N), pure product 
1b (291 mg, 72 %) was obtained as a brown solid. - Rf (cyclohexane/EtOAc = 10 : 1) = 0.27. - m.p. = 
55.9 – 56.6 °C. - 1H NMR (250 MHz, CDCl3) δ = 7.46 - 7.41 (m, 2 H), 7.33 - 7.28 (m, 2 H), 3.82 - 3.74 
(m, 4 H), 1.76 - 1.65 (m, 6 H) ppm. - 13C NMR (63 MHz, CDCl3) δ = 150.1, 132.1, 122.3, 118.7, 27.3, 
25.5, 24.6 ppm. - MS (EI), m/z (%): 267 (18) [C11H1479BrN3]+, 183 (46) [C6H479BrN2]+, 155 (100) 
[C6H479Br]+. - HRMS (C11H14N379Br): calc. 267.0366, found 267.0364. - IR (ATR, 𝜈): 2931, 2849, 1477, 
1426, 1394, 1349, 1295, 1258, 1216, 1184, 1106, 1000, 926, 888, 828, 704, 628, 578, 544, 517, 478 
cm-1. - EA (C11H14BrN3): calc. C 49.27, H 5.26, N 15.67; found C 49.05, H 5.26, N 15.46. 
N
N
N
O2N  
(4-Nitro-phenyl)-piperidin-1-yl-diazene (1c).18 
Compound 1c was synthesized according above described procedure from 4-nitroaniline (1.5 mmol) 
and piperidine (3 mmol). After chromatography (cyclohexane/EtOAc = 10 : 1 + 1 % Et3N), pure product 
1c (234 mg, 67 %) was obtained as an orange solid. - Rf (cyclohexane/EtOAc = 10 : 1) = 0.27. - m.p. = 
89.3 – 91.6 °C. - 1H NMR (300 MHz, CDCl3) δ = 8.20 (d, J = 9.1 Hz, 2 H), 7.51 (d, J = 9.1 Hz, 2 H), 
4.00 - 3.80 (m, 4 H), 1.87 - 1.65 (m, 6 H) ppm. - 13C NMR (75 MHz, CDCl3) δ = 156.1, 144.6, 124.8, 
120.4, 53.5, 43.8, 26.4, 24.5, 24.1 ppm. - HRMS (C11H14N4O2): calc. 234.1111, found. 234.1112. - IR 
(ATR, 𝜈): 2947, 2858, 1585, 1508, 1401, 1317, 1287, 1220, 1186, 1101, 1015, 992, 850, 753, 692, 
564, 515, 492 cm-1. - EA (C11H14N4O2): calc. C 56.40, H 6.02, N 23.92; found C 56.33, H 6.03, N 
23.85. 
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(4-Methoxy-phenyl)-piperidin-1-yl-diazene (1d).18 
Compound 1d was synthesized according above described procedure from 4-methoxyaniline (1.5 
mmol) and piperidine (3 mmol). After chromatography (cyclohexane/EtOAc = 10 : 1 + 1 % Et3N), pure 
1d (271 mg, 83 %) was obtained as an orange solid. - Rf (cyclohexane/EtOAc = 10 : 1) = 0.31. - m.p. = 
50.7 – 51.3 °C. - 1H NMR (250 MHz, CDCl3) δ = 7.39 (d, J = 9.0 Hz, 2 H), 6.88 (d, J = 9.0 Hz, 2 H), 
3.79 (s, 3 H), 3.73 - 68 (m, 4 H), 1.74 – 1.68 (m, 6 H) ppm. - 13C NMR (63 MHz, CDCl3) δ = 157.9, 
144.5, 121.5, 114.4, 55.6, 48.2, 25.2, 24.5 ppm.  
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4-(1,4-Dioxa-8-aza-spiro[4.5]dec-8-ylazo)-benzoic acid ethyl ester (1e). 
Compound 1e was synthesized according above described procedure from 4-aminobenzoic acid ethyl 
ester (2 mmol) and 1,4-dioxa-8-aza-spiro[4.5]decane (4 mmol). After chromatography 
(cyclohexane/EtOAc = 10 : 1 + 1 % Et3N), pure product 1e (350 mg, 55 %) was obtained as an orange 
solid. - Rf (cyclohexane/EtOAc = 10 : 1) = 0.34. - m.p. = 64.8 – 65.4 °C. 1H NMR (250 MHz, CDCl3) δ = 
8.02 (d, J = 8.6 Hz, 2 H), 7.46 (d, J = 8.6 Hz, 2 H), 4.36 (q, J = 7.1 Hz, 2 H), 4.02 (s, 4 H), 3.98 (m, 4 
H), 1.91 – 1.79 (m, 4 H), 1.39 (t, J = 7.1 Hz, 3 H) ppm. - 13C NMR (63 MHz, CDCl3) δ = 166.6, 154.0, 
130.2, 127.6, 120.2, 107.2, 64.8, 60.8, 14.5 ppm. - MS (EI), m/z (%): 319 (62) [M]+, 274 (13) 
[C14H16N3O3]+, 177 (58) [C9H9N2O]+, 149 (100) [C9H9O2]+. - HRMS (C16H21N3O4): calc. 319.1527, found 
319.1527. - IR (ATR, 𝜈): 2960, 1700, 1601, 1433, 1407, 1365, 1336, 1268, 1176, 1154, 1081, 1028, 
942, 911, 856, 772, 700, 659, 604, 559, 528, 493, 460 cm-1. - EA (C16H21N3O4): calc. C 60.17, H 6.63, 
N 13.16,; found C 60.14, H 6.49, N 13.20. 
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4-(3,4-Dihydro-1H-isoquinolin-2-ylazo)-benzoic acid ethyl ester (1f). 
Compound 1f was synthesized according above described procedure from 4-aminobenzoic acid ethyl 
ester (2 mmol) and 1,2,3,4-tetrahydroisoquinoline (4 mmol). After chromatography (cyclo-
hexane/EtOAc = 20 : 1 + 1 % Et3N), pure product 1f (490 mg, 80 %) was obtained as an orange solid. 
- Rf (cyclohexane/EtOAc = 20 : 1) = 0.26. - m.p. = 76.6 – 77.2 °C. - 1H NMR (300 MHz, CDCl3) δ = 
7.96 (d, J = 8.4 Hz, 2 H), 7.43 (d, J = 8.4 Hz, 2 H), 7.26 - 7.09 (m, 4 H), 4.92 (s, 2 H), 4.29 (q, J = 7.1 
Hz, 2 H), 4.25 - 3.98 (m, 2 H), 3.01 (t, J = 5.8 Hz, 2 H), 1.32 (t, J = 7.1 Hz, 3 H) ppm. 13C NMR (75 
MHz, CDCl3) δ = 166.6, 154.4, 130.6, 128.4, 127.2, 127.0, 126.8, 120.3, 60.7, 14.4 ppm. - MS (EI), 
m/z (%): 309 (26) [M]+, 149 (100) [C9H9O2]+, 132 (76) [C9H9N]+. - HRMS (C18H19N3O2): calc. 309.1472, 
found 309.1473. - IR (ATR, 𝜈): 2983, 1703, 1598, 1498, 1454, 1422, 1400, 1364, 1345, 1306, 1267, 
1205.3, 1157, 1099, 1042, 1012, 942, 914, 852, 773, 750, 702, 587, 560, 524, 484, 436 cm-1. - EA 
(C18H19N3O2) calc. C 69.88, H 6.19, N 13.58; found C 69.80, H 6.20, N 13.37. 
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4-(Azetidin-1-ylazo)-benzoic acid ethyl ester (1g). 
Diazonium salt, synthesized according above described procedure from 4-aminobenzoic acid ethyl 
ester (1 mmol), was slowly added to the cold solution of azetidin hydrochloride (2 mmol) in NaOH (1M, 
5 mL). The product was extracted with Et2O (3 x 5 mL) and combined organic layers were dried over 
Na2SO4, filtered and concentrated. After chromatography (cyclohexane/EtOAc = 10 : 1 + 1 % Et3N) 
pure 3a (145 mg, 62 %) was obtained as a yellow solid. - Rf (cyclohexane/EtOAc = 10 : 1) = 0.36. - 
m.p. = 54.1 – 54.8 °C.  - 1H NMR (250 MHz, CDCl3) δ = 7.95 (d, J = 8.6 Hz, 2 H), 7.38 (d, J = 8.6 Hz, 2 
H), 4.50 – 4.11 (m, 6 H), 2.47 – 2.16 (m, 2 H), 1.32 (t, J = 7.1 Hz, 3 H) ppm. - 13C NMR (63 MHz, 
CDCl3) δ = 166.6, 154.2, 130.7, 128.0, 120.3, 60.5, 55.7, 15.7, 14.5 ppm. MS (EI), m/z (%): 233 (30) 
[M]+, 188 (9) [C9H10N3O]+, 177 (40) [C9H9N2O]+, 149 (100) [C9H9O2]+. - HRMS (C12H15N3O2): calc. 
233.1159, found 233.1160. - IR (ATR, 𝜈): 2976, 1705, 1596, 1455, 1370, 1242, 1212, 1137, 1096, 
1023, 860, 773, 699, 548, 522, 503, 424 cm-1. - EA (C12H15N3O2): calc. C 61.79, H 6.48, N 18.01; 
found. C 61.76, H 6.38, N 17.76. 
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4-(Pyrrolidin-1-ylazo)-benzoic acid ethyl ester (1h).19 
Compound 1h was synthesized according above described procedure from 4-aminobenzoic acid ethyl 
ester (2 mmol) and pyrrolidine (4 mmol). After chromatography (cyclohexane/EtOAc = 20 : 1 + 1 % 
Et3N), pure 1h (384 mg, 78 %) was obtained in form of yellow crystals. - Rf (cyclohexane/EtOAc = 20 : 
1) = 0.34. - m.p. = 65.2 – 65.4°C. - 1H NMR (300 MHz, CDCl3) δ = 8.00 (d, J = 8.6 Hz, 2 H), 7.44 (d, J 
= 8.6 Hz, 2 H), 4.35 (q, J = 7.1 Hz, 2 H), 4.09 – 3.84 (m, 2 H), 3.84 – 3.58 (m, 2 H), 2.16 – 1.93 (m, 4 
H), 1.39 (t, J = 7.1 Hz, 3 H) ppm. - 13C NMR (75 MHz, CDCl3) δ = 166.7, 154.8, 130.7, 130.5, 126.8, 
120.3, 60.5, 23.7, 14.4 ppm. - HRMS (C13H17N3O2): calc. 247.1315, found 247.1317. - IR (ATR, 𝜈): 
2973, 2875, 1707, 1597, 1504, 1476, 1451, 1421, 1388, 1341, 1312, 1260, 1222, 1148, 1099, 1021, 
857, 772, 698, 611, 550, 524, 500, 416 cm-1. - EA (C13H17N3O2): calc. C 63.14, H 6.93, N 16.99; found 
C 63.21, H 6.92, N 16.91. 
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4-(Azepan-1-ylazo)-benzoic acid ethyl ester (1i). 
Compound 1i was synthesized according above described procedure from 4-aminobenzoic acid ethyl 
ester (2 mmol) and hexamethyleneimine (4 mmol). After chromatography (cyclohexane/EtOAc = 20 : 1 
+ 1 % Et3N), pure product 1i (402 mg, 73 %) was obtained as a red solid. - Rf (cyclohexane/EtOAc = 
20 : 1) = 0.24. - m.p. = 60.2 – 62.1 °C. - 1H NMR (300 MHz, CDCl3) δ = 8.00 (d, J = 8.6 Hz, 2 H), 7.44 
(d, J = 8.6 Hz, 2 H), 4.35 (q, J = 7.1 Hz, 2 H), 4.01 – 3.98 (m, 2 H), 3.83 – 3.79 (m, 2 H), 1.94 – 1.80 
(m, 4 H), 1.62 – 1.53 (m, 4 H), 1.38 (t, J = 7.1 Hz, 3 H) ppm. - 13C NMR (75 MHz, CDCl3) δ = 167.2, 
155.0, 130.3, 126.2, 119.6, 60.5, 54.6, 48.9, 29.9, 28.7, 28.4, 25.1, 14.2 ppm. - MS (m/z, %): 275 (18) 
[M]+, 149 (100) [C9H9O2]+. - HRMS (C15H21N3O2): calc. 275.1628, found 275.1628. – IR (ATR, 𝜈): 2989, 
2930, 2854, 1709, 1599, 1444, 1389, 1341, 1305, 1268, 1211, 1189, 1147, 1097, 1020, 990, 894, 861, 
847, 798, 772, 734, 701, 557, 526, 501, 437, 394 cm-1. - EA (C15H21N3O2): calc. C 65.43, H 7.69, N 
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15.26; found C 65.37, H 7.59, N 14.62. 
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General procedure for the oxidation of triazenes into N-diazenyl protected lactams (2). 
To a stirred mixture of phosphate buffer (pH = 8, c = 0.3 M)/CCl4/ACN = 3 : 2 : 2 (10 mL) were added 
NaIO4 (5 mmol) and RuCl3 · H2O (0.3 mmol). After 5 minutes the substrate (1 mmol) was slowly added 
and reaction mixture was left to stir at room temperature and the progress of the reaction was 
monitored by TLC. Isopropanol was added and formed precipitate was removed by filtration through 
the Celite pad (washed with 10 mL of DCM). Mother liquid was washed with water (10 mL). The 
organic layer was dried over Na2SO4, filtered and concentrated. The crude was purified by flash 
chromatography.  
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4-(2-Oxo-piperidin-1-ylazo)-benzoic acid ethyl ester (2a). 
Compound 2a was synthesized following above described procedure from corresponding triazene 1a 
(1.91 mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 2a (320 mg, 
61 %) was obtained as a yellow solid. - Rf (cyclohexane/EtOAc = 4 : 1) = 0.19. - m.p. = 128.4 – 129.5 
°C. - 1H NMR (300 MHz, CDCl3) δ = 8.09 (d, J = 8.6 Hz, 2 H), 7.70 (d, J = 8.6 Hz, 2 H), 4.38 (q, J = 7.1 
Hz, 2 H), 3.92 (t, J = 6.2 Hz, 2 H), 2.77 (t, J = 6.5 Hz, 2 H), 2.11 – 1.97 (m, 2 H), 1.92 – 1.82 (m, 2 H), 
1.40 (t, J = 7.1 Hz, 3 H) ppm. - 13C NMR (75 MHz, CDCl3) δ = 169.2, 166.3, 151.7, 130.6, 122.5, 
122.3, 61.1, 45.9, 34.1, 22.5, 20.4, 14.2 ppm. MS m/z, (%): 275 (26) [M]+, 177 (79) [(C9H9N2O3]+, 164 
(100) [(C9H8NO2]+. - HRMS (C14H19N3O2): calc. 275.1266; found 275.1264. – IR (ATR, 𝜈): 2944, 1688, 
1602, 1463, 1378, 1345, 1273, 1190, 1151, 1125, 1107, 1083, 1066, 1022, 987, 907, 864, 821, 770, 
743, 698, 647, 548, 477, 383 cm-1. EA (C14H17N3O3): calc. C 61.08, H 6.22, N 15.26; found C 60.05, H 
6.17, N 15.13. 
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1-(4-Bromo-phenyl-diazenyl)-piperidin-2-one (2b). 
Compound 2b was synthesized following above described procedure from corresponding triazene 1b 
(1 mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 2b (70 mg,    
25 %) was obtained. Recrystallization from DCM/cyclohexane gave brownish crystals. - Rf 
(cyclohexane/EtOAc = 4 : 1) = 0.19. - m.p. = 59.7 – 60.2 °C.  - 1H NMR (300 MHz, CDCl3) δ = 7.66 – 
7.45 (m, 4 H), 3.89 (t, J = 6.3 Hz, 2 H), 2.75 (t, J = 6.6 Hz, 2 H), 2.05 – 1.93 (m, 2 H), 1.95 – 1.79 (m, 2 
H) ppm. - 13C NMR (75 MHz, CDCl3) δ = 168.6, 147.5, 132.3, 124.3, 123.17, 45.3, 34.2, 22.4, 20.3 
ppm. MS m/z, (%): 281 (14) [C11H1279BrN3O]+, 183 (47) [C6H479BrN2]+, 155 (100) [C6H479Br]+. - HRMS 
(C11H12N3O79Br): calc. 281.0158, found 281.0160. - IR (ATR, 𝜈): 2952, 2881, 1683, 1571, 1480, 1457, 
1398, 1377, 1327, 1295, 1191, 1172, 1146, 1064, 1006, 988, 910, 827, 705, 659, 639, 546, 522, 473, 
385 cm-1. EA (C11H12BrN3O): calc. C 46.83, H 4.29, Br 28.32, N 14.89; found C 46.50, H 4.28, N 14.17. 
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1-(4-Nitro-phenyl-diazenyl)-piperidin-2-one (2c). 
Compound 2c was synthesized following above described procedure from corresponding triazene 1c 
(1 mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 2c (114 mg,    
49 %) was obtained as a yellow solid. - Rf (cyclohexane/EtOAc = 4 : 1) = 0.19. - m.p. = 153.3 – 154.1 
°C. - 1H NMR (300 MHz, CDCl3) δ = 8.29 (d, J = 8.8 Hz, 2 H), 7.79 (d, J = 8.8 Hz, 2 H), 3.95 (t, J = 6.3 
Hz, 2 H), 2.80 (t, J = 6.5 Hz, 2 H), 2.14 – 2.00 (m, 2 H), 2.00 – 1.85 (m, 2 H) ppm. - 13C NMR (75 MHz, 
CDCl3) δ = 169.2, 152.9, 147.5, 124.6, 123.1, 45.9, 33.9, 21.7, 19.6 ppm. - MS (ESI) m/z, (%): 271 
(44) [M+Na]+, 519 (100) [2M+Na]+. - HRMS (C11H12N4O3): calc. 248.0904 found 248.0902. - IR (ATR, 𝜈): 3103, 2952, 2879, 1684, 1611, 1526, 1454, 1376, 1340, 1190, 1170, 1149, 1110, 1082, 1008, 986, 
912, 865, 847, 755, 685, 662, 555, 520, 494, 385 cm-1. - EA (C11H12N4O3): calc. C 53.22, H 4.87, N 
22.57; found C 52.87, H 4.91, N 22.33. 
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1-(4-Methoxy-phenyl-diazenyl)-piperidin-2-one (2d). 
Compound 2d was synthesized following above described procedure from corresponding triazene 1d 
(1 mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 2d (88 mg,    
38 %) was obtained as a brown solid. - Rf (cyclohexane/EtOAc = 4 : 1) = 0.20. - m.p. = 103.8 – 104.5 
°C. - 1H NMR (300 MHz, CDCl3) δ = 7.68 (m, 2 H), 6.92 (m, 2 H), 3.94 – 3.84 (m, 2 H), 3.83 (s, 3 H), 
2.79 – 2.71 (m, 2 H), 2.04 – 1.95 (m, 2 H), 1.92 – 1.83 (m, 2 H) ppm.  - 13C NMR (75 MHz, CDCl3) δ = 
168.5, 160.5, 141.8, 123.0, 113.8, 54.4, 44.3, 33.3, 21.8, 19.9 ppm. MS m/z, (%): 233 (18) [M]+, 135 
(52) [C7H7N2O]+, 107 (100) [C7H7O]+. - HRMS (C12H15N3O2): calc. 233.1033, found. 233.1032. - IR 
(ATR, 𝜈): 2953, 1690, 1597, 1503, 1476, 1452, 1382, 1296, 1259, 1188, 1143, 1068, 1024, 986, 906, 
834, 792, 713, 635, 600, 571, 518, 472, 411 cm-1. - EA (C12H15N3O2): calc. C 61.79, H 6.48, N 18.01; 
found C 61.21, H 6.48, N 18.24. 
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4-(7-Oxo-1,4-dioxa-8-aza-spiro[4.5]dec-8-ylazo)-benzoic acid ethyl ester (2e). 
Compound 2e was synthesized following above described procedure from corresponding triazene 1e 
(1 mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 2e (196 mg,   
59 %) was obtained as a yellow solid. - Rf (cyclohexane/EtOAc) = 0.19. - m.p. = 121.2 – 122.3 °C. - 1H 
NMR (250 MHz, CDCl3) δ = 8.04 (d, J = 8.6 Hz, 2 H), 7.65 (d, J = 8.6 Hz, 2 H), 4.33 (q, J = 7.1 Hz, 2 
H), 4.11 – 3.71 (m, 6 H), 2.92 (s, 2 H), 2.12 (t, J = 6.5 Hz, 2 H), 1.34 (t, J = 7.1 Hz, 3 H) ppm. - 13C 
NMR (63 MHz, CDCl3) δ = 167.0, 166.0, 152.1, 131.2, 130.5, 122.5, 105.3, 65.06, 61.2, 44.0, 41.7, 
31.4, 14.4 ppm. - MS (EI), m/z (%): 333 (11) [M]+, 177 (58) [C9H9N2O]+, 149 (100) [C9H9O2]+. - HRMS 
(C16H19N3O5): calc. 333.1319, found 333.1320. – IR (ATR, 𝜈): 2900, 1694, 1604, 1465, 1368, 1269, 
1173, 1131, 1094, 1057, 1000, 963, 927, 866, 774, 718, 696, 670, 568, 523, 503, 423 cm-1. - EA 
(C16H19N3O5) calc. C 57.65, H 5.75, N 12.61; found C 57.76, H 5.77, N 12.37. 
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4-(1-Oxo-3,4-dihydro-1H-isoquinolin-2-ylazo)-benzoic acid ethyl ester (2f). 
Compound 2f was synthesized following above described procedure from corresponding triazene 1f (1 
mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 1f (149 mg, 47 %) 
was obtained as a yellow solid. - Rf (cyclohexane/EtOAc = 4 : 1) = 0.20. - m.p. = 137.2 – 138.0 °C.  - 
1H NMR (300 MHz, CDCl3) δ = 8.22 (d, J = 7.5 Hz, 1 H), 8.07 (d, J = 8.5 Hz, 2 H), 7.73 (d, J = 8.5 Hz, 
2 H), 7.49 (t, J = 7.5 Hz, 1 H), 7.38 (t, J = 7.5 Hz, 1 H), 7.25 (d, J = 7.5 Hz, 1 H), 4.38 – 4.26 (m, 4 H), 
3.14 (t, J = 6.5 Hz, 2 H), 1.35 (t, J = 7.1 Hz, 3 H) ppm. 13C NMR (75 MHz, CDCl3) δ = 165.8, 162.7, 
151.8, 138.7, 133.4, 130.8, 130.6, 130.6, 129.5, 128.7, 127.5, 127.3, 123.4, 122.4, 61.1, 41.5, 27.5, 
14.1 ppm. - MS (EI), m/z (%): 323 (17) [M]+, 177 (73) [C9H9N2O]+, 149 (100) [C9H9O2]+. - HRMS 
(C18H17N3O3): calc. 323.1264, found 323.1263. – IR (ATR, 𝜈): 2978, 1713, 1682, 1603, 1460, 1410, 
1367, 1310, 1270, 1227, 1185, 1125, 1091, 1009, 959, 890, 859, 789, 770, 739, 696, 643, 597, 528, 
483, 414 cm-1. - EA (C18H17N3O3) calc. C 66.86, H 5.30, N 13.00, O 14.84; found. C 66.30, H 5.27, N 
13.56. 
O
O
N
N
N
O
 
4-(2-Oxo-azetidin-1-ylazo)-benzoic acid ethyl ester (2g). 
Compound 2g was synthesized according above described procedure from corresponding triazene 1g 
(1 mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 2g (12.8 mg, 
10 %) was obtained as a brown solid. - Rf (cyclohexane/EtOAc = 4 : 1) = 0.22. - m.p. = 97.6 – 98.2 °C. 
- 1H NMR (250 MHz, CDCl3) δ = 8.07 (d, J = 9.8 Hz, 2 H), 7.66 (d, J = 9.8 Hz, 2 H), 4.35 (q, J = 7.1 Hz, 
2 H), 3.86 (t, J = 5.2 Hz, 2 H), 3.17 – 2.91 (t, J = 5.2 Hz, 2 H), 1.36 (t, J = 7.1 Hz, 3 H) ppm.  - MS (EI), 
m/z (%): 247 (27) [M]+, 177 (33) [C9H9N2O]+, 149 (100) [C9H9O2]+. - HRMS (C12H13N3O3): calc. 
247.0951, found 247.0950. - IR (ATR, 𝜈): 2977, 1773, 1702, 1602, 1453, 1408, 1368, 1322, 1273, 
1242, 1184, 1098, 1044, 870, 774, 698, 541, 525, 463, 393 cm-1. - EA (C12H13N3O3) calc. C 58.29, H 
5.30, N 16.99; found. C 58.39, H 5.54, N 17.12. 
 
O
O
N
N
N
O
 
4-(2-Oxo-pyrrolidin-1-ylazo)-benzoic acid ethyl ester (2h). 
Compound 2h was synthesized according above described procedure from corresponding triazene 1h 
(1 mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 1h (169 mg,  
65 %) was obtained as a pale orange solid. - Rf (cyclohexane/EtOAc = 4 : 1) = 0.32. - m.p. = 127.9 – 
128.8 °C. - 1H NMR (300 MHz, CDCl3) δ = 8.03 (d, J = 8.5 Hz, 2 H), 7.65 (d, J = 8.5 Hz, 2 H), 4.32 (q, 
J = 7.1 Hz, 2 H), 3.98 – 3.81 (m, 2 H), 2.67 (t, J = 8.1 Hz, 2 H), 2.25 – 2.06 (m, 2 H), 1.34 (t, J = 7.1 
Hz, 3 H) ppm. - 13C NMR (75 MHz, CDCl3) δ = 172.9, 166.0, 152.0, 131.3, 130.3, 122.1, 61.1, 44.4, 
31.1, 16.2, 13.9 ppm. - MS (EI), m/z (%): 261 (28) [M]+, 177 (50) [C9H9N2O]+, 149 (100) [C9H9O2]+. - 
HRMS (C13H15N3O3): calc. 261.1108, found 261.1109. - IR (ATR, 𝜈): 2986, 1734, 1706, 1601, 1456, 
1404, 1352, 1317, 1273, 1229, 1151, 1125, 1097, 1019, 867, 775, 695, 645, 559, 503, 476, 396 cm-1. - 
EA (C13H15N3O3) calc. C 59.76, H 5.79, N 16.08; found C 59.76, H 5.78, N 15.84.  
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4-(2-Oxo-azepan-1-ylazo)-benzoic acid ethyl ester (2i). 
Compound 2i was synthesized following above described procedure from corresponding triazene 1i (1 
mmol). After chromatography (cyclohexane/EtOAc = 4 : 1 + 1 % Et3N), pure product 2i (134 mg, 47 %) 
was obtained as an orange oil. - Rf (cyclohexane/EtOAc = 4:1) = 0.32. - 1H NMR (300 MHz, CDCl3) δ  
= 8.03 (d, J = 8.5 Hz, 2 H), 7.65 (d, J = 8.5 Hz, 2 H), 4.35 - 4.25 (m, 4 H), 2.80 - 2.77 (m, 2 H), 1.88 - 
1.65 (m, 4 H), 1.87 - 1.57 (s, 2 H), 1.34 (t, J = 7.1 Hz, 3 H) ppm. - 13C NMR (75 MHz, CDCl3) δ = 
174.2, 165.9, 151.3, 130.8, 130.4, 122.2, 60.9, 41.5, 37.8, 29.5, 27.3, 23.7, 14.4 ppm. - MS (EI), m/z 
(%): 289 (23) [M]+, 177 (57) [C9H9N2O]+, 149 (100) [C9H9O2]+. - HRMS (C15H19N3O3): calc. 289.1421, 
found 289.1421. - IR (ATR, 𝜈): 2930, 1706, 1603, 1477, 1377, 1269, 1137, 1096, 1077, 1014, 951, 
922, 862, 845, 773, 699, 584 cm-1. - EA (C15H19N3O3): calc. C 62.27; H 6.62; N 14.52; found C 62.01, 
H 6.74, N 14.34.  
N
N
N
O
O  
1-(4-Methoxy-phenyl-diazenyl)-3-methyl-piperidin-2-one (7). 
Compound 2d (61 mg, 0.26 mmol) was dissolved in anhydrous THF (3.2 mL) and, after cooling to        
-78 °C, a 1.0 M solution of LiHMDS in THF (290 mL, 0.29 mmol) was added dropwise, keeping the 
temperature below -70 °C. The resulting mixture was stirred under nitrogen at -78 °C; after 1 h, MeI 
(18 mL, 0.29 mmol) was slowly added and, after 10 min, the cooling bath was removed and the 
mixture stirred at room temperature for 2 h. After the dilution with Et2O (5 mL), water was added (10 
mL) and, after separation of the phases, the aqueous layer was extracted with Et2O (2 x 10 mL). The 
combined organic extracts were dried over anhydrous K2CO3. After filtration and evaporation of the 
solvent, the crude was purified by flash chromatography (n-hexane/EtOAc, 3 : 1 + 1 % Et3N), affording 
pure 7 as an orange solid (38 mg, 59 %). - Rf (n-hexane/EtOAc, 3 : 1) = 0.24. – m.p. = 87.7 - 89.2 °C. - 
1H NMR (400 MHz, CDCl3) δ = 7.67 (d, J = 9.1 Hz, 2H), 6.92 (d, J = 9.1 Hz, 2H), 4.05 (dddd, J = 13.5, 
5.8, 4.6, 1.4 Hz, 1H), 3.83 (s, 3H), 3.71 (ddd, J = 13.5, 9.2, 5.3 Hz, 1H), 2.78 – 2.67 (m, 1H), 2.17 – 
1.99 (m, 2H), 1.97 – 1.84 (m, 1H), 1.65 – 1.54 (m, 1H), 1.39 (d, J = 9.2 Hz, 3H) ppm. - 13C NMR (100.3 
MHz, CDCl3) δ = 172.5, 160.6, 142.5, 124.0, 114.1, 55.6, 45.4, 38.6, 28.5, 21.08, 17.6 ppm. - MS (ESI) 
m/z (%): 517 (100) [2M+Na]+, 270 (23) [M+Na]+. – EA (C13H17N3O2) calc C 63.14, H 6.93, N 16.99; 
found: C 62.99, H 7.38, N 17.21. 
O
O
N
N
N
O
P
O
OPhPhO  
4-[6-(Diphenoxy-phosphoryloxy)-3,4-dihydro-2H-pyridin-1-ylazo]-benzoic acid ethyl ester (8) 
A 0.5 M solution of KHMDS (0.45 mL, 0.22 mmol) in toluene was diluted in anhydrous THF (1 mL) and 
cooled to -78 °C. A solution of 2a (50 mg, 0.2 mmol) in anhydrous THF (1.5 mL) was added dropwise. 
The resulting mixture was stirred for 1.5 h at -78 °C and then diphenylchlorophosphate (45 μL, 0.22 
mmol) was slowly added and the stirring continued below -70 °C for 1 h. The mixture was first allowed 
to warm to 0 °C and then quenched with aqueous 10 % NaOH (25 mL). The product was extracted 
with Et2O (4 x 3 mL); the combined organic extracts were washed with 10 % NaOH (3 mL) and dried 
over anhydrous K2CO3 for 30 min. After filtration and evaporation of the solvent, the crude was purified 
by flash chromatography (n-hexane/EtOAc, 10 : 1 + 1 % Et3N; Rf = 0.24) to give product 8 (112 mg, 
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100 %) as a colourless oil. Rf (n-hexane/EtOAc, 2 : 1) = 0.48. - 1H NMR (400 MHz, CDCl3) δ = 7.88 (d, 
J = 8.5 Hz, 2H), 7.35 (d, J = 8.5 Hz, 2H), 7.30 – 7.05 (m, 10H), 4.93 (dd, J = 7.2, 4.4 Hz, 1H), 4.30 (q, 
J = 7.1 Hz, 2H), 4.06 – 3.93 (m, 2H), 2.26 – 2.15 (m, 2H), 1.92 – 1.82 (m, 2H), 1.33 (t, J = 7.1 Hz, 3H) 
ppm. - 13C NMR (100.3 MHz, CDCl3) δ = 166.3, 153.0, 150.3, 141.4, 130.4, 129.8, 129.0, 128.3, 128.2, 
125.6, 125.3, 121.2, 120.1, 120.1, 110.5, 92.9, 60.7, 43.3, 21.1, 21.0, 14.3. 
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Conclusions  
 The synthesized series of polyhydroxylated cyclopropane-fused piperidine derivatives 
demonstrated that OH-directed cyclopropanation is feasible approach toward conformationally 
restricted iminosugars. The syntheses of protected 6-hydroxymethyl-piperidin-2-one and 5-hydroxy-6-
hydroxymethyl-piperidin-2-one together with previously developed methodology for the synthesis of 
4,5-dihydroxy-piperidin-2-one offer versatility in the view of the number, position and the orientation of 
hydroxyls for the future syntheses of cyclopropane-fused piperidines as conformationally restricted 
iminosugar analogues (Chapter 4). 
 The developed tandem gold(I)-catalyzed [3,3]-rearrangement/Nazarov cyclization of N-
heterocycles bearing propargylic ester either at C2 or C3 position are general, reliable and scalable 
methods for the synthesis of cyclopenta-fused piperidine, azepane and indole derivatives. The two 
classes of compounds have been studied in detail: piperidine-derived enynyl acetates bearing 
propargylic moiety at position C2 (Chapter 5) and indole-derived enynyl acetates bearing propargylic 
moiety at position C3 (Chapter 7). 
 Preliminary transformations, hydrogenation of the double bond, reduction of the carbonyl 
group and α-hydroxylation of cyclopenta-fused piperidines prepared via tandem gold(I)-catalyzed [3,3]-
rearrangement/Nazarov cyclization demonstrated that herein developed pentannulations of piperidines 
is feasible approach toward conformationally restricted iminosugars (Chapter 6). Also, the developed 
methodologies present easy entry to cyclopenta-fused N-heterocycles, motif found in many natural 
products.  
 Indole derivatives bearing propargylic moiety on C3 underwent tandem gold(I)-catalyzed 
[3,3]-rearrangement/Nazarov cyclization providing cyclopenta[b]indol-1-ones as useful precursors for 
the synthesis of natural and bioactive compounds. It has been shown that both, gold(I) ligand and the 
substitution pattern on the indole core influence the reaction rate.  
Finally, this new strategy for cyclopenta-fused indole formation was applied to the first total synthesis 
of bruceolline H which was accomplished in yield of 46 % over 7 steps from commercially available 6-
methoxy-1H-indole (Chapter 7).  
 With the aim to develop solid-phase synthesis of piperidine derivatives using multifunctional 
triazene linker, the diazenyl protected lactams were prepared in solution via RuO4 oxidation of 
corresponding triazenes (Chapter 8). This oxidation presents the first strategy for the synthesis of 
functionalized lactams with diazenyl unit. Obtained δ-valerolactam was successfully transformed into 
corresponding phosphate but the Pd-catalyzed methoxycarbonylation and Suzuki cross coupling 
reaction failed. Therefore, to use triazene linker in the solid-phase synthesis of piperidine derivatives, 
the further work to explore the reactivity of diazenyl protected lactams is necessary. 
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Abbreviations 
 
Ac  acetyl 
Ac2O  acetic anhydride 
ACN  acetonitrile  
aq  aqueous 
Ar   aryl 
BARF  tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 
Bn  benzyl 
Boc  tert-butoxycarbonyl 
br   broad 
BrettPhos 2-(dicyclohexylphosphino)3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl 
n-Bu  butyl 
°C   degrees Celsius 
calcd   calculated 
cap  caprolactam 
cat  catalytic 
Cbz  Carboxybenzyl 
Cy  cyclohexyl 
δ  chemical shift 
DBU  1,8-diazabicyclo(5.4.0)undec-7-ene 
DCE   1,2-dichloroethane 
DCM   dichloromethane 
DNJ   deoxynojirimycin 
DFT   density functional theory 
DIB  (diacetoxyiodo)benzene 
DIBAL-H diisobutylaluminium hydride 
DIPEA   N,N-diisopropylethylamine 
DMAP,   4-dimethylaminopyridine 
DME  1,2-dimethoxyethane 
DMF   dimethylformamide 
DMP   Dess-Martin periodinane 
DMPU   1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMSO  dimethylsulfoxide 
DOWEX 50WX8 type of ion exchange resin 
E+   electrophile 
ED/EDG  electron-donating group 
E.I.   electron ionisation 
eq  equivalent 
Et   ethyl 
EWG  electron-withdrawing group 
gCOSY  the gradient selected coorrelation spectroscopy 
h   hour 
HMPA  hexamethylphosphoramide 
HPLC  High Performance Liquid Chromatography 
HRMS   High Resolution Mass Spectroscopy 
HSQC  Heteronuclear Single Quantum Coherence Spectroscopy 
Hz   Hertz 
IPr   [1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene] 
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J   coupling constant 
JohnPhos  (2-biphenyl)di-tert-butylphosphine 
KHMDS  potassium bis(trimethylsilyl)amide 
LHMDS   lithium bis(trimethylsilyl)amide 
mCPBA   meta-chloroperoxybenzoic acid 
Me   methyl 
Ms   mesyl 
min   minutes 
mol   mole 
M.p.   melting point 
MS   mass spectroscopy 
NHC  N-heterocyclic carbene 
NHPI   N-hydroxyphthalimide 
NIS  N-Iodosuccinimide 
NJ  Nojirimycin 
NMO  N-methylmorpholine N-oxide 
NMR   Nuclear Magnetic Resonance 
NOE  Nuclear Overhauser Effect 
on   overnight 
Ph   phenyl 
Pht  phthalimide 
PTSA   para-toluenesulfonic acid 
ppm   parts per million 
i-Pr   iso-propyl 
RCM   ring closing metathesis  
Rf  retention factor 
rt/r.t.  room temperature 
sat.  saturated 
Super-H  lithium triethylborohydride 
t-Bu  tert-butyl 
T-HYDRO  70% tert-butyl hydroperoxide in water 
TBAF   tetra-n-butylammonium fluoride 
TBAI  tetra-n-butylammonium iodide 
TBHP  tert-butyl hydroperoxide 
TBS   tert-butyldimethylsilyl 
TCP   2,4,6-trichlorophenol 
Tf  trifluoromethanesulfonate 
TFA  trifluoroacetic acid 
THF   tetrahydrofuran  
TIPS  triisopropylsilyl 
TLC  thin layer chromatography 
TMS   trimethylsilyl 
Ts  para-toluenesulfonyl (tosyl)  
UV   Ultraviolet  
[(S)-DTMB-Segphos]  (S)-(+)-5,5’-Bis[di(3,5-di-tert-butyl-4-methoxyphenyl)phosphino]-4,4'-bi-1,3-
   benzodioxole 
[(S)-DTMB-MeO-biphep] (−)-(5,5'-Dichloro-6,6'-dimethoxy-1,1'-biphenyl)-2,2'-diyl-  
   bis(diphenylphosphine) 
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